rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAATTTGGCGGGAGCAGGCAGATACGCAGTATTTTGGCCCA	CASSLIWREQADTQYF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	48	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	7	2	4	5	4	18	33	45	38	49														CASSLIWREQADTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCCTCGTAGCGGATCCGGGGAGCTGTTTTTTGGAGAA	CASSPRSGSGELFF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	5	5	6	5	2	18	30	41	35	43						01,02								CASSPRSGSGELFF+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGGTGTTAGCGGGGGGGCGGGCACAGATACGCAGTATTTTGGCCCA	CASSLGVSGGAGTDTQYF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	54	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	5	0	1	4	3	18	34	49	38	52														CASSLGVSGGAGTDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTCTCAGACCCCGGGGCCTTGTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	30	6.752072886376118E-5		50	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-07	01	3	7	0	3	10	5	18	32	47	42	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTCTTACAGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFLQGNTGELFF	In	VDJ	1	32	7.202211078801193E-5	8.468834688346883E-5	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	3	3	1	3	0	18	32	-1	35	41														CASSFLQGNTGELFF+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGGGCGGGGACTCCTACGAGCAGTACTTCGGGCCG	CASSLGGDSYEQYF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	7	3	0	2	1	18	32	40	34	41														CASSLGGDSYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCAAGACCGGGACGGGACAGCTTACACCTTCGGTTCG	CASSQDRDGTAYTF	In	VDJ	1	37	8.327556559863878E-5	9.792090108401084E-5	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	11	12	2	18	30	49	42	51														CASSQDRDGTAYTF+TCRBV07-06+TCRBJ01-02	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTCTCGGACAGTGGAAACACCATATATTTTGGAGAG	CASSFSDSGNTIYF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	1	5	3	3	0	18	32	-1	35	41														CASSFSDSGNTIYF+TCRBV07-06+TCRBJ01-03	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCATGTATCGCTGTGCCAGCACCGGGACTAGCGGGGGCTACGAGCAGTACTTCGGGCCG	CASTGTSGGYEQYF	In	VDJ	1	41	9.227832944714028E-5	1.0850694444444444E-4	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	0	2	3	2	0	18	28	-1	30	44														CASTGTSGGYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCCCCCCCCACAGGGGGCCCACTCGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	47	1.057824752198925E-4		55	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	0	1	8	6	18	30	47	38	53														X+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCACCATGACAGGGTTGGGCACTGAAGCTTTCTTTGGACAA	CASSTMTGLGTEAFF	In	VDJ	1	53	1.1928662099264474E-4	1.4026507452574526E-4	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	3	4	5	5	18	30	42	35	47														CASSTMTGLGTEAFF+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGGCGGGACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGGTNTGELFF	In	VDJ	1	55	1.2378800291689549E-4	1.4555809620596207E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	7	3	0	0	0	18	-1	-1	34	40														CASSLGGTNTGELFF+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCCCCGGGCGGGGGAGTCGACAATGAGCAGTTCTTCGGGCCA	CASSSPGGGVDNEQFF	In	VDJ	1	62	1.395428396517731E-4	1.6408367208672087E-4	48	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	7	2	5	6	5	18	31	44	37	49														CASSSPGGGVDNEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAAAGGCCGGGGACTATACGCAGTATTTTGGCCCA	CASSLKAGDYTQYF	In	VDJ	1	64	1.4404422157602385E-4	1.6937669376693767E-4	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	0	10	7	7	0	18	33	-1	40	46						01,02								CASSLKAGDYTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCACCAGGGGACTAGCGGGAGTAAAATTACTTCGGGCCG		Out	VDJ	1	32	7.202211078801193E-5		40	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	8	0	2	13	6	6	19	27	47	33	53														X+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGAGGGTAGTTACAATGAGCAGTTCTTCGGGCCA	CASSLEGSYNEQFF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	42	TCRBV07	TCRBV07-05	01				TCRBJ02	TCRBJ02-01	01	0	5	3	4	0	4	19	-1	39	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEGSYNEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTCGCGGGGGGGTCGTTGGCGGACTTCACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	38	8.552625656076415E-5		56	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	7	0	3	1	15	19	33	43	34	58														X+TCRBV07-05+TCRBJ01-01	TCRBV07-05*01	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAAACCAAAGAGGTGGGCCCCAGCATTTTGGTGAT	CASSLNQRGGPQHF	In	VDJ	1	39	8.777694752288953E-5	1.0321392276422765E-4	42	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	11	1	9	7	3	19	34	45	41	48														CASSLNQRGGPQHF+TCRBV07-05+TCRBJ01-05	TCRBV07-05*01	TCRBD02-01*02	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAAGGCCACGGGTATGGCTACATCTTCGGTTCG		Out	VDJ	1	51	1.14785239068394E-4		40	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	8	4	16	6	11	19	34	44	40	55						01,02								X+TCRBV07-05+TCRBJ01-02	TCRBV07-05*01	TCRBD02-01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTCGGACTCGTTTAGGTCCAAAGCTTTCTTTGGACAA	CASSSDSFRSKAFF	In	VDJ	2	128	2.880884431520477E-4	3.3875338753387534E-4	42	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	1	10	9	1	12	19	32	38	33	50						01,02								CASSSDSFRSKAFF+TCRBV07-05+TCRBJ01-01	TCRBV07-05*01	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCACCACCCTAGGGGGAGAGGGCAATGAGCAGTTCTTCGGGCCA	CASTTLGGEGNEQFF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	5	1	6	7	6	23	33	46	40	52			01,02										Vb 1	CASTTLGGEGNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGATTGTGGAGTACGAGCAGTACTTCGGGCCG	CASSVGIVEYEQYF	In	VDJ	1	32	7.202211078801193E-5	8.468834688346883E-5	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	10	2	4	7	0	23	39	-1	46	50			01,02										Vb 1	CASSVGIVEYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCGGCAGGGACAGCTACTCCTACGAGCAGTACTTCGGGCCG	CASGRDSYSYEQYF	In	VDJ	1	32	7.202211078801193E-5	8.468834688346883E-5	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	5	0	4	3	23	32	43	36	46			01,02										Vb 1	CASGRDSYSYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCGGACGCTTTGAACACTGAAGCTTTCTTTGGACAA	CASSADALNTEAFF	In	VDJ	1	33	7.427280175013729E-5	8.733485772357724E-5	42	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	3	1	7	0	1	4	23	36	41	37	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSADALNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGTGAGAGTCCCTATGGCTACACCTTCGGTTCG	CASSVGESPYGYTF	In	VDJ	1	33	7.427280175013729E-5	8.733485772357724E-5	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	11	2	4	2	5	23	39	44	41	49			01,02										Vb 1	CASSVGESPYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD02-01*02	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTCCGACACCGGGGAGCTGTTTTTTGGAGAA	CASSSDTGELFF	In	VDJ	1	33	7.427280175013729E-5	8.733485772357724E-5	36	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	8	6	3	2	0	23	35	-1	37	39			01,02			01,02							Vb 1	CASSSDTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGTCACACAAACAGGGAGACCCAGTACTTCGGGCCA	CASSVGHTNRETQYF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	3	4	5	9	0	23	39	-1	48	53			01,02										Vb 1	CASSVGHTNRETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGCCGGGACGGAAGACGAAACACCATATATTTTGGAGAG	CASSGRDGRRNTIYF	In	VDJ	1	35	7.877418367438804E-5	9.262787940379404E-5	45	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-03	01	3	0	7	5	3	7	23	36	44	39	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSGRDGRRNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01		TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGTGAGGGGCGCACGGAACAATGAGCAGTTCTTCGGGCCA	CASSVRGARNNEQFF	In	VDJ	1	39	8.777694752288953E-5	1.0321392276422765E-4	45	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-01	01	5	5	2	5	4	8	23	34	43	38	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVRGARNNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAAATGCGGAGGTTAACTATGGCTACACCTTCGGTTCG	CASSVNAEVNYGYTF	In	VDJ	1	40	9.00276384850149E-5	1.0586043360433605E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	1	10	1	1	5	1	23	38	48	43	49			01,02										Vb 1	CASSVNAEVNYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD02-01*02	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGCGGGACAGGGGTGGAACATTCAGTACTTCGGCGCC	CASSAGQGWNIQYF	In	VDJ	1	41	9.227832944714028E-5	1.0850694444444444E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	0	2	7	3	3	23	34	47	37	50			01,02										Vb 1	CASSAGQGWNIQYF+TCRBV09-01+TCRBJ02-04	TCRBV09-01	TCRBD01-01*01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTCGCTCCGGGGGAAGATACGCAGTATTTTGGCCCA	CASSVAPGEDTQYF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	8	2	5	5	1	23	37	48	42	49			01,02										Vb 1	CASSVAPGEDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCGAGGGACTAGTGGGGGCCGATGAGCAGTTCTTCGGGCCA	CASSPEGLVGADEQFF	In	VDJ	1	45	1.0128109329564176E-4	1.1909298780487805E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	8	8	5	9	23	35	48	40	57			01,02			01,02							Vb 1	CASSPEGLVGADEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGTGCCGGGAAGGGAGATGAACACTGAAGCTTTCTTTGGACAA	CASSVVPGREMNTEAFF	In	VDJ	1	47	1.057824752198925E-4	1.2438600948509485E-4	51	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	8	3	0	3	7	23	39	47	42	54			01,02										Vb 1	CASSVVPGREMNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD02-01*02	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSASYNEQFF	In	VJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	36	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-01	01	3	0	0	0	0	1	23	-1	36	-1	37			01,02										Vb 1	CASSASYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCACTGGACTCCGGGCTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSTGLRANTGELFF	In	VDJ	1	56	1.2603869387902087E-4	1.4820460704607045E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	1	10	2	3	7	23	35	43	38	50			01,02			01,02							Vb 1	CASSTGLRANTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGAGAGCGGGGGAGACAACAATGAGCAGTTCTTCGGGCCA	CASSESGGDNNEQFF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	6	2	5	2	5	23	36	46	38	51			01,02										Vb 1	CASSESGGDNNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTCGACAGGGAAGGAGAGGACAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	61	1.372921486896477E-4		50	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	3	3	2	10	23	35	44	37	54			01,02										Vb 1	X+TCRBV09-01+TCRBJ01-05	TCRBV09-01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCATCCCGACTAGCGGTCAGGAGACCCAGTACTTCGGGCCA	CASSIPTSGQETQYF	In	VDJ	1	70	1.5754836734877608E-4	1.8525575880758808E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	2	5	5	5	4	23	35	49	40	53			01,02			01,02							Vb 1	CASSIPTSGQETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCCGGGTTAGCGGGGGCAATGAGCAGTTCTTCGGGCCA	CASSPRVSGGNEQFF	In	VDJ	1	70	1.5754836734877608E-4	1.8525575880758808E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	5	2	6	8	0	23	35	-1	43	52			01,02										Vb 1	CASSPRVSGGNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGAAGGGCGGCTTACAATGAGCAGTTCTTCGGGCCA	CASSVGRAAYNEQFF	In	VDJ	1	71	1.5979905831090146E-4	1.8790226964769647E-4	45	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-01	01	0	5	3	4	2	5	23	39	45	41	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVGRAAYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTCAGGGGGCCGACTGACGAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSSGGRLTSSYNSPLHF	In	VDJ	1	78	1.7555389504577906E-4	2.064278455284553E-4	57	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	4	0	0	1	11	23	35	44	36	55			01,02										Vb 1	CASSSGGRLTSSYNSPLHF+TCRBV09-01+TCRBJ01-06	TCRBV09-01	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAGGGCGGGAGGCGGGATACGCAGTATTTTGGCCCA	CASSVEGGRRDTQYF	In	VDJ	1	79	1.778045860079044E-4	2.0907435636856368E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	7	1	6	3	3	23	39	50	42	53			01,02										Vb 1	CASSVEGGRRDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGCTCGGAGCACTAGCACAGATACGCAGTATTTTGGCCCA	CASSVARSTSTDTQYF	In	VDJ	1	81	1.8230596793215517E-4	2.143673780487805E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	10	2	0	3	4	23	39	46	42	50			01,02										Vb 1	CASSVARSTSTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCAGGGGGGGAGCATCCACAATGAGCAGTTCTTCGGGCCA	CASSQGGSIHNEQFF	In	VDJ	1	87	1.958101137049074E-4	2.302464430894309E-4	45	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-01	01	4	4	1	5	0	9	23	-1	42	35	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSQGGSIHNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTCGGACAGGGCGGTACCTACGAGCAGTACTTCGGGCCG	CASSVGQGGTYEQYF	In	VDJ	1	96	2.1606633236403576E-4	2.5406504065040653E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	3	2	1	5	23	37	46	38	51			01,02										Vb 1	CASSVGQGGTYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTGGGGGACCGCTCAACTGAAGCTTTCTTTGGACAA	CASSVGDRSTEAFF	In	VDJ	1	96	2.1606633236403576E-4	2.5406504065040653E-4	42	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	2	0	7	5	2	6	23	37	44	39	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVGDRSTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGCACGGGTGGCCACACTGAAGCTTTCTTTGGACAA	CASSGTGGHTEAFF	In	VDJ	1	101	2.273197871746626E-4	2.672975948509485E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	8	4	3	3	5	23	36	43	39	48			01,02			01,02							Vb 1	CASSGTGGHTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTTGGGGCATTCCAAGAGACCCAGTACTTCGGGCCA	CASSVGAFQETQYF	In	VDJ	2	122	2.745842973792954E-4	3.2287432249322495E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	7	0	1	1	3	23	37	43	38	46			01,02										Vb 1	CASSVGAFQETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGCAGGGGACTGAAAAACTGTTTTTTGGCAGT	CASSVGQGTEKLFF	In	VDJ	2	157	3.533584810536835E-4	4.1550220189701895E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	2	7	2	2	23	39	47	41	49			01,02										Vb 1	CASSVGQGTEKLFF+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCCCCGGGTTCGGGAGATGGAAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	196	4.41135428576573E-4		49	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	2	7	11	5	23	35	52	46	57			01,02										Vb 1	X+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGTCCACAGGGTCTCTGTATCAGAAAAACTGTTTTTTGGCAGT		Out	VDJ	4	278	6.256920874708535E-4		43	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	3	3	8	3	11	23	31	40	34	51			01,02										Vb 1	X+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGCCTCCAGTACTAGCACAGATACGCAGTATTTTGGCCCA	CASSVASSTSTDTQYF	In	VDJ	19	1450	0.00326350189508179	0.0038374407181571814	48	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-03	01	0	4	5	0	4	4	23	39	46	43	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVASSTSTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTTGACCGGGAGCGTGTACGAGCAGTACTTCGGGCCG	CASSLTGSVYEQYF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	42	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	8	2	4	3	4	19	33	42	36	46														CASSLTGSVYEQYF+TCRBV11-01+TCRBJ02-07	TCRBV11-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCATGTATCTCTGTGCCAGCACCATTCGGGTACAGCTTTGGAGGAGCGCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	30	6.752072886376118E-5		56	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	10	1	3	18	4	19	29	52	47	56														X+TCRBV11-01+TCRBJ02-01	TCRBV11-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTCAACTGCTAGCGGGGATACGCAGTATTTTGGCCCA	CASSSTASGDTQYF	In	VDJ	1	36	8.10248746365134E-5	9.527439024390244E-5	42	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	4	4	6	6	0	19	32	-1	38	46						01,02								CASSSTASGDTQYF+TCRBV11-01+TCRBJ02-03	TCRBV11-01*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTCTGGAGTTTATTTCTGTGCCAGCAGCCCCAAGTAGGGCTAGCGGGAGGGGGATCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	22	4.9515201166758194E-5		58	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	4	0	3	10	4	16	29	51	39	55													Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCCTCGGGGGTAGAGACCCAGTACTTCGGGCCA	CASSPSGVETQYF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	8	2	4	3	1	29	42	51	45	52													Vb 16	CASSPSGVETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATGGCGCCAAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	25	5.6267274053134314E-5		43	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-04	01	0	9	0	5	1	4	29	46	50	47	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01		TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCCACGTTTGGTGGCAGAACTGGAGGATCTGGAGTTTATTTCTGTGCCAGCAGCCAAAGTCCAGGGGGTACGCAGTATTTTGGCCCA	CASSQSPGGTQYF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	1	8	4	0	42	57	-1	61	68													Vb 16	CASSQSPGGTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTGGAGTTTATTTCTGTGCCAGCAGCAAAGGGGGCAGGGGGCTTATAAGGCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	30	6.752072886376118E-5		59	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	1	4	0	2	4	8	14	30	42	34	50													Vb 16	X+TCRBV14-01+TCRBJ02-06	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGACCCCACCACAGATACGCAGTATTTTGGCCCA	CASSQDPTTDTQYF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	42	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-03	01	0	3	7	2	4	0	29	46	-1	50	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQDPTTDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGACGTTGGCAGGGGAAAAACTGTTTTTTGGCAGT	CASSQGTLAGEKLFF	In	VDJ	1	32	7.202211078801193E-5	8.468834688346883E-5	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	4	3	8	9	0	29	45	-1	54	59													Vb 16	CASSQGTLAGEKLFF+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTCATCCTGGGACCTAGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	35	7.877418367438804E-5		46	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	4	0	7	3	7	5	29	42	54	49	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCTAGGAGCCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	39	8.777694752288953E-5		46	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	4	8	3	1	4	29	46	51	47	55						01,02							Vb 16	X+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01	TCRBD02-01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGCGAGAGGGGGTTCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	43	9.677971137139102E-5		47	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	5	1	3	4	2	29	45	55	49	57													Vb 16	X+TCRBV14-01+TCRBJ01-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGATATTAAGGGAAGGGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	48	1.0803316618201788E-4		44	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-02	01	6	0	8	5	7	4	29	40	51	47	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01		TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GATTCTGGAGTTTATTTCTGTGCCAGCAGCCACGGTTTTTTGGAGGGGAGCGGACTCTACAATGAGCAGTTCTTCGGGCCA	CASSHGFLEGSGLYNEQFF	In	VDJ	1	48	1.0803316618201788E-4	1.2703252032520327E-4	57	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	10	0	3	9	9	18	32	47	41	56													Vb 16	CASSHGFLEGSGLYNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCTATGGGACGGGACCATACAATGAGCAGTTCTTCGGGCCA	CASSYGTGPYNEQFF	In	VDJ	1	53	1.1928662099264474E-4	1.4026507452574526E-4	45	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-01	01	5	0	7	4	3	7	29	41	49	44	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSYGTGPYNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAAGCCCCGGGGGGACCCAGTACTTCGGGCCA	CASSQSPGGTQYF	In	VDJ	1	57	1.2828938484114622E-4	1.5085111788617887E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	8	2	7	5	0	29	44	-1	49	55													Vb 16	CASSQSPGGTQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAGCTTGGTCAATACAGCACAGATACGCAGTATTTTGGCCCA	CASSQELGQYSTDTQYF	In	VDJ	1	63	1.4179353061389847E-4	1.6673018292682928E-4	51	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-03	01	0	0	10	0	4	7	29	46	52	50	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQELGQYSTDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGGGACTGGGAGAGCAGTACTTCGGGCCG	CASSQGGLGEQYF	In	VDJ	1	64	1.4404422157602385E-4	1.6937669376693767E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	0	10	7	1	4	29	45	52	46	56						01,02							Vb 16	CASSQGGLGEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCTCTGGAGGATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	86	1.9355942274278205E-4		43	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	10	1	0	4	1	29	42	51	46	52													Vb 16	X+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01*02	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGACAGCTTTTAACAATGAGCAGTTCTTCGGGCCA	CASSQGTAFNNEQFF	In	VDJ	1	92	2.0706356851553427E-4	2.434789972899729E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	1	5	5	0	6	29	-1	51	45	57													Vb 16	CASSQGTAFNNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGTAGGGACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASRDSGANVLTF	In	VDJ	1	94	2.11564950439785E-4	2.487720189701897E-4	39	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-06	01	9	0	8	0	2	0	29	37	-1	39	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASRDSGANVLTF+TCRBV14-01+TCRBJ02-06	TCRBV14-01*01		TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGGCTCCCGGGACTAGCTGCTCTGGCGAGCAGTTCTTCGGGCCA		Out	VDJ	1	96	2.1606633236403576E-4		47	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	7	10	6	9	29	40	55	46	64						01,02							Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTACAGGCAGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLQAGNTGELFF	In	VDJ	2	122	2.745842973792954E-4	3.2287432249322495E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	3	4	1	1	4	29	42	48	43	52													Vb 16	CASSLQAGNTGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGGGTTACACCGGGGAGCTGTTTTTTGGAGAA	CASSQGGYTGELFF	In	VDJ	2	132	2.9709120700054917E-4	3.4933943089430895E-4	42	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-02	01	1	6	2	3	0	2	29	-1	49	45	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQGGYTGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01		TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCCACGTTTGGTGGCAGAACTGGAGGATTCTGGAGTTWWTTCTGTGCCAGCAGCCAAAGTCCAGGGGGTACGCAGTATTTTGGCCCA		Out	VDJ	2	137	3.08344661811176E-4		38	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	23	4	1	8	24	0	43	37	-1	61	68													Vb 16	X+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCACACCTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	140	3.1509673469755215E-4		44	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	6	0	2	2	29	46	51	48	53													Vb 16	X+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATGCCATAGACGTCTATGGCTACACCTTCGGTTCG	CASSQDAIDVYGYTF	In	VDJ	2	142	3.195981166218029E-4	3.7580453929539294E-4	45	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-02	01	0	2	7	4	7	2	29	46	56	53	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQDAIDVYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCCCAGCAGGGTTACAATGAGCAGTTCTTCGGGCCA	CASSPQQGYNEQFF	In	VDJ	2	146	3.286008804703044E-4	3.8639058265582655E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	3	4	5	1	29	42	52	47	53													Vb 16	CASSPQQGYNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCACCGGGATAAGCGGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	151	3.398543352809312E-4		43	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	6	5	5	9	0	29	41	-1	50	55						01,02							Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCTTGGACCACTAAGGATACGCAGTATTTTGGCCCA	CASSPWTTKDTQYF	In	VDJ	2	153	3.44355717205182E-4	4.0491615853658535E-4	42	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-03	01	4	1	7	6	3	7	29	42	49	45	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSPWTTKDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAATATGACTTCGAGCAGTACTTCGGGCCG	CASSQYDFEQYF	In	VDJ	2	172	3.871188454855641E-4	4.5519986449864497E-4	36	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	2	10	6	3	1	29	44	51	47	52						01,02							Vb 16	CASSQYDFEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCTTAGCGGGATAACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	172	3.871188454855641E-4		43	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	5	3	2	1	3	29	41	50	42	53													Vb 16	X+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGAACAGGGCCCAGAGGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	185	4.163778279931939E-4		44	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	3	8	2	8	29	42	50	44	58													Vb 16	X+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCCAGAGGGGGCCCACAGATACGCAGTATTTTGGCCCA	CASQRGPTDTQYF	In	VDJ	3	199	4.4788750146294913E-4	5.266556571815719E-4	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	5	0	2	3	1	29	38	48	41	49													Vb 16	CASQRGPTDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCGAAAACACAGATACGCAGTATTTTGGCCCA	CASSENTDTQYF	In	VDJ	3	200	4.501381924250745E-4	5.293021680216802E-4	36	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-03	01	5	2	8	2	0	3	29	-1	43	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSENTDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAACGATCACGGGACAGCGAACACTGAAGCTTTCTTTGGACAA	CASNDHGTANTEAFF	In	VDJ	3	202	4.546395743493252E-4	5.34595189701897E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	5	1	8	1	29	39	54	47	55													Vb 16	CASNDHGTANTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCTTACAGACAGGGGAAGGTGAAAAACTGTTTTTTGGCAGT	CASSLQTGEGEKLFF	In	VDJ	5	378	8.507611836833908E-4	0.0010003810975609756	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	2	7	5	4	29	41	54	46	58													Vb 16	CASSLQTGEGEKLFF+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCGGGTCACTGAAGCTTTCTTTGGACAA	CASSQDRVTEAFF	In	VDJ	7	582	0.0013099021399569667	0.0015402693089430894	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	8	4	4	1	1	29	46	51	47	52						01,02							Vb 16	CASSQDRVTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTACTCAGTCGGCGGACTCTTACTGGGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	9	676	0.0015214670903967518		58	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	1	10	5	12	10	16	32	49	44	59						01,02							Vb 16	X+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAATCCCCAGGGGGAAGGCAGTACTTCGGGCCG	CASSQSPGGRQYF	In	VDJ	21	1632	0.003673127650188608	0.004319105691056911	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	1	9	4	3	29	44	55	48	58													Vb 16	CASSQSPGGRQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAAGTCCAGGGGGTACGCAGTATTTTGGCCCA	CASSQSPGGTQYF	In	VDJ	136	10592	0.023839318670831944	0.028031842818428184	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	1	8	4	0	29	44	-1	48	55													Vb 16	CASSQSPGGTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGAGTCTGGAAACACCATATATTTTGGAGAG	CASSESGNTIYF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	36	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	11	2	1	0	0	24	-1	-1	36	39														CASSESGNTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGTGGCGGGAGCGCCAGATACGCAGTATTTTGGCCCA	CASSVVAGAPDTQYF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	7	2	4	6	3	24	36	49	42	52														CASSVVAGAPDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCCCGACAGGACCGCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	26	5.851796501525969E-5		44	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	4	2	4	5	24	36	46	40	51														X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGATATGGGGAGGCAGCCCCAGCATTTTGGTGAT	CASSVDMGRQPQHF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	9	1	7	9	0	24	36	-1	45	51														CASSVDMGRQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTAGGGGGGGACAGGGCTGAAGCTTTCTTTGGACAA	CASSLGGDRAEAFF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	3	6	8	0	24	35	-1	43	52														CASSLGGDRAEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAAGCCCTACGGGACAGGGGAAACCGGGGAGCTGTTTTTTGGAGAA	CASKPYGTGETGELFF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	10	0	2	5	11	2	24	31	52	42	54														CASKPYGTGETGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCACCACCTCCGGGACAGGGGACTACGAGCAGTACTTCGGGCCG	CASTTSGTGDYEQYF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	0	2	3	11	1	24	31	52	42	53														CASTTSGTGDYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCCTCAAGGCGGGCTAACTATGGCTACACCTTCGGTTCG	CASSPSRRANYGYTF	In	VDJ	1	32	7.202211078801193E-5	8.468834688346883E-5	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	7	4	0	8	0	24	36	-1	44	49						01,02								CASSPSRRANYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGGCCCCTTTCAGGGGCCGAGCAGTACTTCGGGCCG	CASSVGPLSGAEQYF	In	VDJ	1	33	7.427280175013729E-5	8.733485772357724E-5	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	2	6	13	1	24	36	55	49	56														CASSVGPLSGAEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCGCCGTAGTTGAAAAGTATGTGGGTTGCAGCAATCAGCCCCAGCATTTTGGTGAT	CASAVVEKYVGCSNQPQHF	In	VDJ	1	33	7.427280175013729E-5	8.733485772357724E-5	57	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-05	01	10	0	9	1	22	4	24	31	56	53	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASAVVEKYVGCSNQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCGGACAGGGGGCTTTGAATGAGCAGTTCTTCGGGCCA	CASGQGALNEQFF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	1	0	7	2	4	24	31	44	33	48														CASGQGALNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAACTCTGGCTGGAGGAGCTTTCTTTGGACAA		Out	VDJ	1	43	9.677971137139102E-5		38	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	10	1	10	8	0	24	39	-1	47	52														X+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAGGCCTGGGCTACGAGCAGTACTTCGGGCCG	CASSLGLGYEQYF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-07	01	5	0	9	3	8	0	24	36	-1	44	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGLGYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGAGTAGCGGGAACACTTTACAATGAGCAGTTCTTCGGGCCA	CASSVGVAGTLYNEQFF	In	VDJ	1	46	1.0353178425776714E-4	1.2173949864498645E-4	51	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	3	4	7	6	24	36	51	43	57														CASSVGVAGTLYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGCCGGGACAGGGTGTTCGCAGATACGCAGTATTTTGGCCCA	CASSGRDRVFADTQYF	In	VDJ	1	48	1.0803316618201788E-4	1.2703252032520327E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	3	4	4	6	24	36	49	40	55														CASSGRDRVFADTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCATAACAAGGGGGGTGACCTCCTACGAGCAGTACTTCGGGCCG	CASITRGVTSYEQYF	In	VDJ	1	48	1.0803316618201788E-4	1.2703252032520327E-4	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-07	01	10	5	1	0	8	5	24	31	45	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASITRGVTSYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGAGGGGCAGGGGGTCACTGAAGCTTTCTTTGGACAA	CASSVEGQGVTEAFF	In	VDJ	1	57	1.2828938484114622E-4	1.5085111788617887E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	1	4	9	1	24	36	52	45	53														CASSVEGQGVTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGAGGTCAGCCCGGCGAATTCACCCCTCCACTTTGGGAAC	CASSVEVSPANSPLHF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	5	11	1	7	3	11	24	36	43	39	54														CASSVEVSPANSPLHF+TCRBV21-or09_02+TCRBJ01-06	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGGGAACTTAAGGGTAGGTTGGACGAGCAGTACTTCGGGCCG	CASRELKGRLDEQYF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-07	01	6	5	3	5	8	8	24	35	47	43	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRELKGRLDEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCCCGGACTAGCGGCACAGATACGCAGTATTTTGGCCCA	CASSARTSGTDTQYF	In	VDJ	1	60	1.3504145772752236E-4	1.5879065040650406E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	1	6	1	4	0	24	36	-1	40	49						01,02								CASSARTSGTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGAGGGGGCCCCGGGCCTCGATGAGCAGTTCTTCGGGCCA	CASSVEGAPGLDEQFF	In	VDJ	1	62	1.395428396517731E-4	1.6408367208672087E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	5	0	8	4	11	24	36	47	40	58														CASSVEGAPGLDEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGGGAAGACAGATTGGGCAATCAGCCCCAGCATTTTGGTGAT	CASREDRLGNQPQHF	In	VDJ	1	75	1.6880182215940295E-4	1.9848831300813008E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	5	2	4	5	24	35	44	39	49														CASREDRLGNQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTCGACTAGCGGGGGAGCAGATACGCAGTATTTTGGCCCA	CASSSTSGGADTQYF	In	VDJ	1	76	1.710525131215283E-4	2.011348238482385E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	2	2	4	2	2	24	36	50	38	52														CASSSTSGGADTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAGGCGGGACTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLGGTSNQPQHF	In	VDJ	1	81	1.8230596793215517E-4	2.143673780487805E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	7	3	0	4	1	24	36	46	40	47														CASSLGGTSNQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAGGGACAGGGCGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLGTGRTGELFF	In	VDJ	1	87	1.958101137049074E-4	2.302464430894309E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	3	4	3	2	24	36	48	39	50														CASSLGTGRTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGGGAAAATGAGCAGTTCTTCGGGCCA	CASSVGENEQFF	In	VDJ	1	90	2.025621865912835E-4	2.381859756097561E-4	36	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	5	2	7	2	2	24	36	43	38	45														CASSVGENEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCACAGGGGAGGGTCAAGAGACCCAGTACTTCGGGCCA	CASSTGEGQETQYF	In	VDJ	1	91	2.048128775534089E-4	2.408324864498645E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	9	0	2	3	1	24	37	47	40	48														CASSTGEGQETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGGACAGGGTCTGGAAACACCATATATTTTGGAGAG	CASSGTGSGNTIYF	In	VDJ	1	105	2.363225510231641E-4	2.778836382113821E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	3	1	0	0	24	-1	-1	36	45														CASSGTGSGNTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTGGGACACCCGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVGHPSSYNEQFF	In	VDJ	1	113	2.543280787201671E-4	2.990557249322493E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	6	0	2	6	24	36	44	38	50														CASSVGHPSSYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGTCCTTACCGGGACTCCCGCGGGGAATGAGCAGTTCTTCGGGCCA	CASSVVLTGTPAGNEQFF	In	VDJ	2	119	2.6783222449291934E-4	3.149347899728997E-4	54	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	10	7	12	9	24	36	54	48	63						01,02								CASSVVLTGTPAGNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTTGACGGGACACAGAACACTGAAGCTTTCTTTGGACAA	CASSVDGTQNTEAFF	In	VDJ	2	131	2.948405160384238E-4	3.4669292005420053E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	6	1	6	2	24	36	48	42	50														CASSVDGTQNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGCGGGCGGGCGCGACACAGATACGCAGTATTTTGGCCCA	CASSVAGGRDTDTQYF	In	VDJ	3	224	5.041547755160835E-4	5.928184281842818E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	5	4	2	1	9	24	36	44	37	53						01,02								CASSVAGGRDTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTCCTCCGACAGACTTAACAATGAGCAGTTCTTCGGGCCA	CASSSSDRLNNEQFF	In	VDJ	4	338	7.607335451983759E-4	8.945206639566396E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	5	5	7	5	24	35	47	42	52														CASSSSDRLNNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGAAACGACAGGGACTCTGGAAACACCATATATTTTGGAGAG	CASRNDRDSGNTIYF	In	VDJ	5	353	7.944939096302565E-4	9.342183265582656E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	2	3	0	4	1	24	35	46	39	47														CASRNDRDSGNTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAGGTGGAGATACGCAGTATTTTGGCCCA	CASSLGGDTQYF	In	VDJ	9	668	0.0015034615626997488	0.001767869241192412	36	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-03	01	5	5	4	5	2	3	24	36	41	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGGGGGACAGGGCCCTATTCACCCCTCCACTTTGGGAAC	CASSGGTGPYSPLHF	In	VDJ	11	835	0.001879326953374686	0.002209836551490515	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	3	8	3	4	24	36	48	39	52														CASSGGTGPYSPLHF+TCRBV21-or09_02+TCRBJ01-06	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGAGGCAATCAGCCCCAGCATTTTGGTGAT	CASSEGGNQPQHF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	39	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	11	2	2	0	0	23	-1	-1	39	42														CASSEGGNQPQHF+TCRBV06-01+TCRBJ01-05	TCRBV06-01*01	TCRBD02-01*02	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGAAGTTCGGGAACGGGGGGATGAAAAACTGTTTTTTGGCAGT	CASSEVRERGDEKLFF	In	VDJ	1	35	7.877418367438804E-5	9.262787940379404E-5	48	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	1	8	1	6	8	0	23	39	-1	47	54														CASSEVRERGDEKLFF+TCRBV06-01+TCRBJ01-04	TCRBV06-01*01	TCRBD02-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGCTTCGGACTACCTGGGAGACCCAGTACTTCGGGCCA	CASSEALRTTWETQYF	In	VDJ	1	37	8.327556559863878E-5	9.792090108401084E-5	48	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	1	9	5	5	5	23	40	51	45	56						01,02								CASSEALRTTWETQYF+TCRBV06-01+TCRBJ02-05	TCRBV06-01*01	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGCCCTTCGACGGGCGAGCAGTACTTCGGGCCG	CASSEGPSTGEQYF	In	VDJ	1	37	8.327556559863878E-5	9.792090108401084E-5	42	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	8	4	6	9	0	23	39	-1	48	52						01,02								CASSEGPSTGEQYF+TCRBV06-01+TCRBJ02-07	TCRBV06-01*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGGGGGGTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	40	9.00276384850149E-5		43	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	9	1	3	0	1	23	-1	46	40	47														X+TCRBV06-01+TCRBJ02-01	TCRBV06-01*01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGACGGGGGGGGACCCAGTACTTCGGGCCA	CASSEGRGGTQYF	In	VDJ	1	43	9.677971137139102E-5	1.1379996612466124E-4	39	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	8	0	7	2	0	23	39	-1	41	49														CASSEGRGGTQYF+TCRBV06-01+TCRBJ02-05	TCRBV06-01*01	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGCGGAGACAGCTACGAGCAGTACTTCGGGCCG	CASSEGGDSYEQYF	In	VDJ	1	51	1.14785239068394E-4	1.3497205284552846E-4	42	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	5	3	5	0	23	39	-1	44	49														CASSEGGDSYEQYF+TCRBV06-01+TCRBJ02-07	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGCTCCTAGGAAGCGCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSEALLGSASYNEQFF	In	VDJ	1	56	1.2603869387902087E-4	1.4820460704607045E-4	54	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	8	0	4	7	23	40	48	44	55						01,02								CASSEALLGSASYNEQFF+TCRBV06-01+TCRBJ02-01	TCRBV06-01*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGTTCTGTCGGCGGGAGAGACCCAGTACTTCGGGCCA	CASSEVLSAGETQYF	In	VDJ	1	56	1.2603869387902087E-4	1.4820460704607045E-4	45	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	7	4	4	8	0	23	39	-1	47	52						01,02								CASSEVLSAGETQYF+TCRBV06-01+TCRBJ02-05	TCRBV06-01*01	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGATCTAGCGGGGAGGTCCGAGACCCAGTACTTCGGGCCA	CASSEDLAGRSETQYF	In	VDJ	1	70	1.5754836734877608E-4	1.8525575880758808E-4	48	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	4	3	5	2	6	23	39	50	41	56														CASSEDLAGRSETQYF+TCRBV06-01+TCRBJ02-05	TCRBV06-01*01	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCCAAGAGGGGGGCAGCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	76	1.710525131215283E-4		47	TCRBV06	TCRBV06-01	01				TCRBJ02	TCRBJ02-02	01	0	5	1	7	4	4	23	40	50	44	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-01+TCRBJ02-02	TCRBV06-01*01		TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGTAGGGGGACCGGGACTAGCCGAGACCCAGTACTTCGGGCCA	CASSEVGGPGLAETQYF	In	VDJ	1	82	1.8455665889428055E-4	2.1701388888888888E-4	51	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	0	7	5	10	1	23	39	58	49	59						01,02								CASSEVGGPGLAETQYF+TCRBV06-01+TCRBJ02-05	TCRBV06-01*01	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCCGCCGGGACTAGCGGAAACAATGAGCAGTTCTTCGGGCCA	CASSEAAGTSGNNEQFF	In	VDJ	1	103	2.3182116909891337E-4	2.7259061653116533E-4	51	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	5	5	4	2	23	40	55	44	57						01,02								CASSEAAGTSGNNEQFF+TCRBV06-01+TCRBJ02-01	TCRBV06-01*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGTTAGCGGGTCCCTAGCCAGTGAGCAGTTCTTCGGGCCA	CASSEVSGSLASEQFF	In	VDJ	2	118	2.6558153353079396E-4	3.1228827913279135E-4	48	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	5	4	9	1	11	23	39	47	40	58						01,02								CASSEVSGSLASEQFF+TCRBV06-01+TCRBJ02-01	TCRBV06-01*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGCGAGGGTACGATGAGCAGTTCTTCGGGCCA	CASSEARGYDEQFF	In	VDJ	2	178	4.006229912583163E-4	4.710789295392954E-4	42	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	11	0	8	2	4	23	40	47	42	51														CASSEARGYDEQFF+TCRBV06-01+TCRBJ02-01	TCRBV06-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGACRCACAGATACGCAGTATTTTGGCCCA	CASSEGXTDTQYF	In	VDJ	3	228	5.131575393645849E-4	6.034044715447155E-4	39	TCRBV06	TCRBV06-01	01	unresolved			TCRBJ02	TCRBJ02-03	01	1	2	6	2	0	0	23	-1	-1	39	43				TCRBD01,TCRBD02										CASSEGXTDTQYF+TCRBV06-01+TCRBJ02-03	TCRBV06-01*01	unresolved	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGATAAGTACCGATCTAACTATGGCTACACCTTCGGTTCG	CASSEDKYRSNYGYTF	In	VDJ	7	574	0.0012918966122599637	0.0015190972222222222	48	TCRBV06	TCRBV06-01	01				TCRBJ01	TCRBJ01-02	01	1	2	8	0	9	1	23	39	50	48	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEDKYRSNYGYTF+TCRBV06-01+TCRBJ01-02	TCRBV06-01*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTAGACCCACGGGAGACCCAGTACTTCGGGCCA	CASSLDPRETQYF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	39	TCRBV07	TCRBV07-04	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	8	5	5	5	0	22	38	-1	43	46						01,02								CASSLDPRETQYF+TCRBV07-04+TCRBJ02-05	TCRBV07-04*01	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTAAGTAGTGTGATTTCCTTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	35	7.877418367438804E-5		53	TCRBV07	TCRBV07-04	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	5	8	0	2	12	22	37	42	39	54						01,02								X+TCRBV07-04+TCRBJ02-03	TCRBV07-04*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAGAAGCCGGGACAGGGCGGCGAGCAGTACTTCGGGCCG	CAWKKPGQGGEQYF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	3	6	7	3	26	36	52	43	55													Vb 20	CAWKKPGQGGEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGTACAGATCTTCTTAATGAAAAACTGTTTTTTGGCAGT	CAWSGTDLLNEKLFF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	3	5	4	2	7	26	39	45	41	52													Vb 20	CAWSGTDLLNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCCGATAGCGGTCAGGCCAGTTCACCCCTCCACTTTGGGAAC	CAWSADSGQASSPLHF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	48	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	1	5	5	9	4	9	26	39	49	43	58						01,02							Vb 20	CAWSADSGQASSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD02-01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCTCAATGGAACACCATATATTTTGGAGAG	CAWSPQWNTIYF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	36	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-03	01	2	0	10	7	7	0	26	38	-1	45	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSPQWNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01		TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGGAGAACGGGGAGAGCAAAGTACTTCGGGCCG	CAWSVRRTGRAKYF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	8	3	11	8	7	26	40	53	48	60						01,02							Vb 20	CAWSVRRTGRAKYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGGATCGGCCCAGGGGGCGTACCGTGGCTACACCTTCGGTTCG	CAWSVGSAQGAYRGYTF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	51	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	0	7	10	6	26	40	58	50	64													Vb 20	CAWSVGSAQGAYRGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCCGGGACTAGTACCTACTACGAGCAGTACTTCGGGCCG	CASGTSTYYEQYF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	0	8	3	2	6	26	33	43	35	49						01,02							Vb 20	CASGTSTYYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGTCATCTGGGGACTGAAGCTTTCTTTGGACAA	CAWGHLGTEAFF	In	VDJ	1	32	7.202211078801193E-5	8.468834688346883E-5	36	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-01	01	5	6	2	5	8	0	26	35	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWGHLGTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTAGACGGCCTATGGGCAGTACTTCGGGCCG	CAWS*TAYGQYF	Stop	VDJ	1	32	7.202211078801193E-5		36	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-07	01	2	2	7	9	2	9	26	38	43	40	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWS*TAYGQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGAACTGGAAGCCTGGCTACACCTTCGGTTCG		Out	VDJ	1	33	7.427280175013729E-5		37	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-02	01	3	1	8	7	0	10	26	-1	40	37	50			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTACTACGGGATACGAGCAGTACTTCGGGCCG	CAWSTTGYEQYF	In	VDJ	1	33	7.427280175013729E-5	8.733485772357724E-5	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	8	3	4	4	0	26	38	-1	42	47													Vb 20	CAWSTTGYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCCCCACTGACCCAGGGGAAGGATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	35	7.877418367438804E-5		56	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	2	0	12	5	25	36	54	48	59													Vb 20	X+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGACTAGCGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CAWRLAANTGELFF	In	VDJ	1	36	8.10248746365134E-5	9.527439024390244E-5	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	3	5	0	0	0	26	-1	-1	37	45						01,02							Vb 20	CAWRLAANTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*02	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGGACATAGGTGGGGCCTCTGGAAACACCATATATTTTGGAGAG	CAWGDIGGASGNTIYF	In	VDJ	1	37	8.327556559863878E-5	9.792090108401084E-5	48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	6	0	1	10	26	35	42	36	52													Vb 20	CAWGDIGGASGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAATCCCAGGAGTCGGCCGGCTACACCTTCGGTTCG	CAWKSQESAGYTF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	4	4	4	8	5	8	26	36	45	41	53			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWKSQESAGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGAAATCACAGGGGGCACGGCGAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	38	8.552625656076415E-5		50	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	0	2	5	7	26	37	51	42	58			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGCTCAAGAGGGACACTTAACTATGGCTACACCTTCGGTTCG	CAWSVRSRGTLNYGYTF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	51	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	6	1	10	2	26	40	56	50	58			unresolved										Vb 20	CAWSVRSRGTLNYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTCGGGGTGGACTGAAGCTTTCTTTGGACAA	CAWSSGWTEAFF	In	VDJ	1	39	8.777694752288953E-5	1.0321392276422765E-4	36	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	8	3	5	1	3	26	38	44	39	47													Vb 20	CAWSSGWTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTCCCCCAGGGGGCGGAACACCTTCGGTTCG	CAWSSPRGRNTF	In	VDJ	1	39	8.777694752288953E-5	1.0321392276422765E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	0	12	5	3	26	38	51	43	54			unresolved										Vb 20	CAWSSPRGRNTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACTCCGCGGGGGGGCGTACGAGCAGTACTTCGGGCCG	CAWSVLRGGAYEQYF	In	VDJ	1	40	9.00276384850149E-5	1.0586043360433605E-4	45	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	7	0	4	5	2	26	40	54	45	56													Vb 20	CAWSVLRGGAYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTGTCCCTGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	40	9.00276384850149E-5		40	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	4	10	1	5	1	26	38	45	43	46						01,02							Vb 20	X+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCCACAGGGGGCTACACTGAAGCTTTCTTTGGACAA	CAWSPTGGYTEAFF	In	VDJ	1	41	9.227832944714028E-5	1.0850694444444444E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	0	3	3	1	26	38	50	41	51													Vb 20	CAWSPTGGYTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTTTGGGGTAGATTTAAACTTCGGGCCA	CAWSFGVDLNF	In	VDJ	1	41	9.227832944714028E-5	1.0850694444444444E-4	33	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-05	01	2	6	2	15	3	9	26	38	45	41	54			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSFGVDLNF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCAGGGGTCCTCATCTCCTACGAGCAGTACTTCGGGCCG	CAWSPGVLISYEQYF	In	VDJ	1	43	9.677971137139102E-5	1.1379996612466124E-4	45	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	2	0	1	7	26	38	45	39	52													Vb 20	CAWSPGVLISYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGATCGGGTTCTCTAACTATGGCTACACCTTCGGTTCG	CAWSGIGFSNYGYTF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	8	4	0	4	4	26	39	47	43	51						01,02							Vb 20	CAWSGIGFSNYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD02-01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGTTTTTGGGGCACTGAAGCTTTCTTTGGACAA	CACFWGTEAFF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	33	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	6	6	2	4	5	0	26	34	-1	39	43			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CACFWGTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGAAGAGGACAGGGCGCCCCTAGTTCACCCCTCCACTTTGGGAAC	CAWRRGQGAPSSPLHF	In	VDJ	1	56	1.2603869387902087E-4	1.4820460704607045E-4	48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	1	3	9	4	9	26	37	49	41	58			unresolved										Vb 20	CAWRRGQGAPSSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGACAGGGGCTATGGCTACACCTTCGGTTCG	CAWDRGYGYTF	In	VDJ	1	57	1.2828938484114622E-4	1.5085111788617887E-4	33	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	2	4	0	0	26	-1	-1	35	43													Vb 20	CAWDRGYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCAGCCTAGCGCACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	59	1.3279076676539698E-4		43	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	4	6	3	4	1	26	38	48	42	49						01,02							Vb 20	X+TCRBV30-01+TCRBJ02-02	TCRBV30-01*02	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAAGCTGCTGGAAACACCATATATTTTGGAGAG	CAWKAAGNTIYF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	4	6	7	2	1	2	26	36	40	37	42						01,02							Vb 20	CAWKAAGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD02-01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCCCCGGGCGGGGGGGTGAATGAGCAGTTCTTCGGGCCA	CAWSAPGGGVNEQFF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	7	0	7	6	2	26	39	54	45	56													Vb 20	CAWSAPGGGVNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAACAGCGGGAGTCTCCTACAATGAGCAGTTCTTCGGGCCA	CAWSVTAGVSYNEQFF	In	VDJ	1	64	1.4404422157602385E-4	1.6937669376693767E-4	48	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	6	2	0	3	1	26	40	51	43	52			unresolved										Vb 20	CAWSVTAGVSYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCCCCCTCAGGGGTAACGAGCAGTACTTCGGGCCG	CAWTPLRGNEQYF	In	VDJ	1	65	1.462949125381492E-4	1.7202320460704606E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	2	5	7	2	26	36	49	43	51			unresolved										Vb 20	CAWTPLRGNEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCATGGGGGGGGTTTGAACACTGAAGCTTTCTTTGGACAA	CAWSHGGGLNTEAFF	In	VDJ	1	67	1.5079629446239996E-4	1.7731622628726286E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	9	0	0	3	3	26	38	48	41	51													Vb 20	CAWSHGGGLNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGACCTCTAGGGGGTTCGTCTAATGAAAAACTGTTTTTTGGCAGT	CAWRPLGGSSNEKLFF	In	VDJ	1	68	1.5304698542452532E-4	1.7996273712737128E-4	48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	5	1	3	6	5	26	37	49	43	54													Vb 20	CAWRPLGGSSNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTGGTTGGGGGAGCTATGGCTACACCTTCGGTTCG	CAWSVGWGSYGYTF	In	VDJ	1	69	1.552976763866507E-4	1.8260924796747967E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	0	6	1	4	5	2	26	40	50	45	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVGWGSYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTACCCTGTCCCCGAACACTGAAGCTTTCTTTGGACAA	CAWSTLSPNTEAFF	In	VDJ	1	70	1.5754836734877608E-4	1.8525575880758808E-4	42	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-01	01	2	3	7	1	0	9	26	-1	40	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSTLSPNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACTGGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CAWSVLGSGANVLTF	In	VDJ	1	70	1.5754836734877608E-4	1.8525575880758808E-4	45	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-06	01	0	0	9	0	3	0	26	40	-1	43	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVLGSGANVLTF+TCRBV30-01+TCRBJ02-06	TCRBV30-01*01		TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCCTGACAGGCTCTGGAAACACCATATATTTTGGAGAG	CALTGSGNTIYF	In	VDJ	1	75	1.6880182215940295E-4	1.9848831300813008E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	8	2	4	0	2	0	26	32	-1	34	40													Vb 20	CALTGSGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCCGTTTTGGGGCCGAGGCCCCAAGATACGCAGTATTTTGGCCCA	CAWSPVLGPRPQDTQYF	In	VDJ	1	77	1.7330320408365368E-4	2.0378133468834688E-4	51	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	7	0	5	8	10	26	38	51	46	61													Vb 20	CAWSPVLGPRPQDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTAAGGGGTCCTATGGCTACACCTTCGGTTCG	CAWSVKGSYGYTF	In	VDJ	1	79	1.778045860079044E-4	2.0907435636856368E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	2	4	2	2	26	40	47	42	49			unresolved										Vb 20	CAWSVKGSYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCGGGGAACTATGGCTACACCTTCGGTTCG	CAWSAGNYGYTF	In	VDJ	1	80	1.800552769700298E-4	2.117208672086721E-4	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	1	8	3	2	0	0	26	-1	-1	39	44			unresolved										Vb 20	CAWSAGNYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTWAAGGGGTCTCAGCCCCAGCATTTTGGTGAT	CAWSVKGSQPQHF	In	VDJ	1	80	1.800552769700298E-4	2.117208672086721E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	5	2	6	2	2	26	40	47	42	49			unresolved										Vb 20	CAWSVKGSQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGCGGGGGCGGTGGCTACACCTTCGGTTCG	CAWSVRGGGGYTF	In	VDJ	1	86	1.9355942274278205E-4	2.2759993224932248E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	7	2	7	2	3	26	40	49	42	52													Vb 20	CAWSVRGGGGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACAGGGGAGTGGCGATCAGCCCCAGCATTTTGGTGAT	CAWSVQGSGDQPQHF	In	VDJ	1	96	2.1606633236403576E-4	2.5406504065040653E-4	45	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	3	2	5	0	7	26	-1	47	40	54													Vb 20	CAWSVQGSGDQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGATCGGGGGTACGGCGGGCTAGCACAGATACGCAGTATTTTGGCCCA	CAWSVRSGVRRASTDTQYF	In	VDJ	1	98	2.205677142882865E-4	2.593580623306233E-4	57	TCRBV30	TCRBV30-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	8	2	0	5	11	24	38	49	43	60			01,02										Vb 20	CAWSVRSGVRRASTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTCCGGACAGGGCGGAATCCACGAGCAGTACTTCGGGCCG	CAWSSGQGGIHEQYF	In	VDJ	1	98	2.205677142882865E-4	2.593580623306233E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	3	5	3	8	26	38	49	41	57													Vb 20	CAWSSGQGGIHEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGCGGGAGGGACACCGGGGAGCTGTTTTTTGGAGAA	CAWSVRGRDTGELFF	In	VDJ	1	99	2.2281840525041188E-4	2.620045731707317E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	7	0	3	2	0	26	40	-1	42	51			unresolved										Vb 20	CAWSVRGRDTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATCTCCCAACCGGGACAGGGGATTAACACTGAAGCTTTCTTTGGACAA	CAWISQPGQGINTEAFF	In	VDJ	1	101	2.273197871746626E-4	2.672975948509485E-4	51	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	2	2	10	3	26	36	56	46	59													Vb 20	CAWISQPGQGINTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCGAGGGGGCTGGGTGAAGCTTTCTTTGGACAA	CAWSPRGLGEAFF	In	VDJ	1	102	2.29570478136788E-4	2.699441056910569E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	5	0	7	3	4	26	38	48	41	52			unresolved										Vb 20	CAWSPRGLGEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTGGGGACATCCCCCGCCGGGAGCCAAAAACATTCAGTACTTCGGCGCC	CAWSWGHPPPGAKNIQYF	In	VDJ	1	107	2.4082393294741486E-4	2.8317665989159894E-4	54	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	2	0	6	0	2	12	26	38	46	40	58			unresolved										Vb 20	CAWSWGHPPPGAKNIQYF+TCRBV30-01+TCRBJ02-04	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGAAGGGGCAGTCCGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	108	2.4307462390954024E-4		37	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	5	2	6	2	8	26	35	42	37	50													Vb 20	X+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTCCGGGGTGGGCTACAATGAGCAGTTCTTCGGGCCA	CAWSSGVGYNEQFF	In	VDJ	1	109	2.453253148716656E-4	2.884696815718157E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	8	3	3	2	4	26	38	45	40	49			unresolved										Vb 20	CAWSSGVGYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGAACGAGGAACACTGAAGCTTTCTTTGGACAA	CAWSVRTRNTEAFF	In	VDJ	1	114	2.5657876968229244E-4	3.0170223577235774E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	11	2	1	6	0	26	40	-1	46	49			unresolved										Vb 20	CAWSVRTRNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCTAGACTAGCTGAGCAGTTCTTCGGGCCA	CAWSARLAEQFF	In	VDJ	1	116	2.610801516065432E-4	3.069952574525745E-4	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	2	7	9	3	0	26	39	-1	42	49			unresolved			01,02							Vb 20	CAWSARLAEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGCGCAGAGGAGGGAATGAAAAACTGTTTTTTGGCAGT	CAWRRGGNEKLFF	In	VDJ	2	119	2.6783222449291934E-4	3.149347899728997E-4	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	10	0	5	6	0	26	35	-1	41	47			unresolved										Vb 20	CAWRRGGNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*02	TCRBD02-01*02	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTTCAGGGGGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CAWSFRGGSYNEQFF	In	VDJ	2	122	2.745842973792954E-4	3.2287432249322495E-4	45	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-01	01	2	4	1	1	2	3	26	38	47	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSFRGGSYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCAAAGGGGAGTCAGCCCCAGCATTTTGGTGAT	CAWSAKGSQPQHF	In	VDJ	2	125	2.8133637026567156E-4	3.3081385501355015E-4	39	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-05	01	1	5	2	6	3	2	26	39	47	42	49			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSAKGSQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCGATGACGGGCAGCGGTGAGCAGTTCTTCGGGCCA	CASMTGSGEQFF	In	VDJ	2	128	2.880884431520477E-4	3.3875338753387534E-4	36	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	6	5	9	11	0	26	33	-1	44	49			unresolved			01,02							Vb 20	CASMTGSGEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGACGCAGGGGCCGGGGAGCTGTTTTTTGGAGAA	CAWDAGAGELFF	In	VDJ	2	129	2.9033913411417303E-4	3.4139989837398375E-4	36	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	2	6	4	0	26	35	-1	39	45			unresolved										Vb 20	CAWDAGAGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGGGAAGGGGGCCTGGGAAGCTTTCTTTGGACAA		Out	VDJ	2	152	3.421050262430566E-4		43	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	0	8	6	4	26	40	53	46	57			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCTCAGCAGGTTTGATGGCTACACTTTCGGTTCG	CAWSLSRFDGYTF	In	VDJ	2	158	3.556091720158088E-4	4.1814871273712737E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	4	17	5	15	26	38	47	43	62			unresolved										Vb 20	CAWSLSRFDGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACTAGGGACAGGTCCCTACGAGCAGTACTTCGGGCCG	CAWSVLGTGPYEQYF	In	VDJ	2	173	3.893695364476894E-4	4.578463753387534E-4	45	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	4	2	4	2	26	40	52	44	54			unresolved										Vb 20	CAWSVLGTGPYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACTAGGTTCACCCCTCCACTTTGGGAAC	CAWSVLGSPLHF	In	VDJ	2	189	4.253805918416954E-4	5.001905487804878E-4	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	0	3	8	9	0	1	26	-1	45	40	46						01,02							Vb 20	CAWSVLGSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD02-01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACAGATTGAGCAGTTCTTCGGGCCA	CAWSVQIEQFF	In	VDJ	3	215	4.838985568569551E-4	5.689998306233062E-4	33	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	3	5	9	0	2	26	-1	44	40	46			unresolved										Vb 20	CAWSVQIEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCCCAGCCGTTCTGGGGGGCACTGAAGCTTTCTTTGGACAA	CAWTPAVLGGTEAFF	In	VDJ	3	218	4.906506297433312E-4	5.769393631436314E-4	45	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	9	1	4	13	0	26	36	-1	49	55			unresolved										Vb 20	CAWTPAVLGGTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGCCCGTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CACPSNTGELFF	In	VDJ	3	233	5.244109941752118E-4	6.166370257452574E-4	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	8	6	0	2	1	26	34	38	36	39			unresolved			01,02							Vb 20	CACPSNTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGGTAGGGGGAATGAGCAATCAGCCCCAGCATTTTGGTGAT	CAWGVGGMSNQPQHF	In	VDJ	3	259	5.829289591904714E-4	6.854463075880759E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	5	1	1	5	4	26	35	46	40	50			unresolved										Vb 20	CAWGVGGMSNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACTAGCGGGAGAACCTACAATGAGCAGTTCTTCGGGCCA	CAWTSGRTYNEQFF	In	VDJ	5	361	8.124994373272594E-4	9.553904132791328E-4	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	4	2	2	0	2	26	-1	46	36	48			unresolved										Vb 20	CAWTSGRTYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTCGAGAGGGGCCAAAAACATTCAGTACTTCGGCGCC	CAWSSRGAKNIQYF	In	VDJ	5	379	8.530118746455162E-4	0.001003027608401084	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	2	11	0	1	4	0	26	38	-1	42	47			unresolved										Vb 20	CAWSSRGAKNIQYF+TCRBV30-01+TCRBJ02-04	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAAGGGTCTGGAAACACCATATATTTTGGAGAG	CAWKGSGNTIYF	In	VDJ	5	396	8.912736210016475E-4	0.001048018292682927	36	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-03	01	4	5	3	1	1	0	26	36	-1	37	41			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWKGSGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01		TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCCCCTCTAGTCGGGGGCTACGAGCAGTACTTCGGGCCG	CAWSPPLVGGYEQYF	In	VDJ	14	1066	0.002399236565625647	0.0028211805555555555	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	8	2	3	11	0	26	38	-1	49	55			unresolved										Vb 20	CAWSPPLVGGYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAATATAGGTTCCTACAATGAGCAGTTCTTCGGGCCA	CAWNIGSYNEQFF	In	VDJ	80	6281	0.014136589933109464	0.016622734586720866	39	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	4	5	4	1	4	1	26	36	43	40	44			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWNIGSYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATCAGAACATCTTCTACGAGCAGTACTTCGGGCCG	CASSQDQNIFYEQYF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	3	6	3	5	4	23	40	48	45	52														CASSQDQNIFYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGGGTCAGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSQGGQSSYEQYF	In	VDJ	1	24	5.401658309100894E-5	6.351626016260163E-5	45	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-07	01	1	6	2	0	0	6	23	-1	43	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGGQSSYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCGTAGCGGGGGGGGTTCGAATGAGCAGTTCTTCGGGCCA	CASSRSGGGSNEQFF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	5	0	7	1	5	23	36	48	37	53														CASSRSGGGSNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATTGGGCCAAACAGTTCTTCGGGCCA	CASSQDWAKQFF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	36	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	8	0	13	2	4	23	40	46	42	50														CASSQDWAKQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGTAACATTAGGACTAGCTATGGGGAATGAGCAGTTCTTCGGGCCA	CTSSQVTLGLAMGNEQFF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	54	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	1	7	7	8	7	23	39	55	47	62						01,02								CTSSQVTLGLAMGNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATTTTAAGTTCGCGGCTTTCTTTGGACAA	CASSQDFKFAAFF	In	VDJ	1	45	1.0128109329564176E-4	1.1909298780487805E-4	39	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	7	6	11	10	0	23	40	-1	50	53						01,02								CASSQDFKFAAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAAGGATGGGATGAGCAGTTCTTCGGGCCA	CASSQEGWDEQFF	In	VDJ	1	51	1.14785239068394E-4	1.3497205284552846E-4	39	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-01	01	0	0	9	8	5	0	23	40	-1	45	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGWDEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGACTCAGCTGCGTATCTCTGCACCAGCAGCCATTGAACCGAATTGTTAACACGTTGAGGCATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	52	1.1703593003051937E-4		61	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	11	1	4	23	2	20	34	61	57	63														X+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATCAGTACCGCATGAACACTGAAGCTTTCTTTGGACAA	CASSQDQYRMNTEAFF	In	VDJ	1	61	1.372921486896477E-4	1.6143716124661248E-4	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	5	0	1	7	23	40	44	41	51														CASSQDQYRMNTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAATATTAGTGTTCGTCGGGACTAGCGGGAAACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	62	1.395428396517731E-4		61	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	0	3	2	14	2	20	35	62	49	64														X+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCACAGACAGGGGGACACACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	72	1.620497492730268E-4		46	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	1	3	2	4	23	37	48	39	52														X+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAGTCAGCGGGGGCCTACACCGGGGAGCTGTTTTTTGGAGAA	CASSQESAGAYTGELFF	In	VDJ	1	82	1.8455665889428055E-4	2.1701388888888888E-4	51	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	6	2	3	3	3	23	40	51	43	54														CASSQESAGAYTGELFF+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCTCAGTGGCTAGCGGGGTTGGAGCCCGTTACGAGCAGTACTTCGGGCCG	CASSSVASGVGARYEQYF	In	VDJ	1	88	1.9806080466703278E-4	2.328929539295393E-4	54	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	4	3	4	7	11	23	35	51	42	62														CASSSVASGVGARYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTAAGCGGTAGGCACACTGAAGCTTTCTTTGGACAA	CASSQVSGRHTEAFF	In	VDJ	1	89	2.0031149562915816E-4	2.355394647696477E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	6	5	3	2	5	23	39	46	41	51						01,02								CASSQVSGRHTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCTTCAGGAAGGGTATGGCTACACCTTCGGTTCG	CASSLQEGYGYTF	In	VDJ	1	93	2.0931425947765965E-4	2.461255081300813E-4	39	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-02	01	4	4	4	5	2	5	23	36	42	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLQEGYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGCCCCGGGACGAGGGAATGAGCAGTTCTTCGGGCCA	CTSSQAPGRGNEQFF	In	VDJ	1	104	2.3407186006103875E-4	2.752371273712737E-4	45	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-01	01	1	0	7	7	4	5	23	39	48	43	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CTSSQAPGRGNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGACAGGGGGCCCTACGAGCAGTACTTCGGGCCG	CASSQDRGPYEQYF	In	VDJ	2	127	2.858377521899223E-4	3.361068766937669E-4	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	0	2	0	0	23	-1	-1	40	48														CASSQDRGPYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCCGATTTTAGCGGGCACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPDFSGHSYNEQFF	In	VDJ	2	135	3.038432798869253E-4	3.5727896341463414E-4	51	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	5	4	0	7	2	23	36	50	43	52						01,02								CASSPDFSGHSYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCTACCGGGGGCGATGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	139	3.1284604373542677E-4		44	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-03	01	4	6	0	4	4	4	23	36	46	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATCTCTACAGGCTAAACTATGGCTACACCTTCGGTTCG	CASSQDLYRLNYGYTF	In	VDJ	2	164	3.691133177885611E-4	4.3402777777777775E-4	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	4	2	5	3	23	40	50	45	53														CASSQDLYRLNYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTGCGTATCTCTGCACCAGCAGCCAAGATATATCAGGCCCTGGAGTAGCGCCGTACGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	171	3.848681545234387E-4		65	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	5	6	1	17	6	12	29	51	46	57						01,02								X+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCATTTAGCGGGAGGTAGGTTAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	3	258	5.806782682283461E-4		53	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	5	1	2	2	6	23	37	49	39	55														X+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCACCTACCAGGGTACCTAACCGAGCAGTACTTCGGGCCG	CASSHLPGYLTEQYF	In	VDJ	8	593	0.0013346597405403458	0.0015693809281842818	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	3	6	5	8	23	37	47	42	55														CASSHLPGYLTEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGCCGGGAGGACAGATACGCAGTATTTTGGCCCA	CASSQAGRTDTQYF	In	VDJ	14	1113	0.0025050190408455394	0.0029455665650406503	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	8	1	3	1	0	23	39	-1	40	47														CASSQAGRTDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTAGGGTTCGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	22	4.9515201166758194E-5		41	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-05	01	4	5	3	2	2	3	19	31	37	33	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	X+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAAGACCGACCGGGACTAGCGCGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLEDRPGLARSGANVLTF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	63	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	0	0	6	0	10	2	18	34	54	44	56						01,02							Vb 5.1	CASSLEDRPGLARSGANVLTF+TCRBV05-01+TCRBJ02-06	TCRBV05-01*01	TCRBD02-01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCATCAGCGGGGTCACACAGATACGCAGTATTTTGGCCCA	CASSHQRGHTDTQYF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	6	3	2	4	3	19	31	42	35	45													Vb 5.1	CASSHQRGHTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCGGTCGGGGTCATGAACACTGAAGCTTTCTTTGGACAA	CASSPVGVMNTEAFF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	8	3	0	5	3	19	31	41	36	44													Vb 5.1	CASSPVGVMNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTCTCAGGGGACTACACAGATACGCAGTATTTTGGCCCA	CASSLSGDYTDTQYF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	9	2	7	0	19	31	-1	38	45						01,02							Vb 5.1	CASSLSGDYTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTATACGACAGGGAACAATCAGCCCCAGCATTTTGGTGAT	CASSYTTGNNQPQHF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	3	3	4	2	19	32	43	36	45													Vb 5.1	CASSYTTGNNQPQHF+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCGTCAACAGGGGGCGTGGGTGAAGCTTTCTTTGGACAA	CASSSSTGGVGEAFF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	0	7	5	5	19	32	46	37	51													Vb 5.1	CASSSSTGGVGEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGACGTCCTTCGAGGCGAGCAGTACTTCGGGCCG	CASSLDVLRGEQYF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	11	1	6	9	0	19	35	-1	44	48													Vb 5.1	CASSLDVLRGEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTAGGACAGGGGATCACGAGCAGTACTTCGGGCCG	CASSFRTGDHEQYF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	2	5	2	3	19	33	44	35	47													Vb 5.1	CASSFRTGDHEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCCAAGCCGGGACAGGGGACACAGATACGCAGTATTTTGGCCCA	CASQAGTGDTDTQYF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	0	2	2	6	1	19	28	44	34	45													Vb 5.1	CASQAGTGDTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCAGGACAGGGTTTCTACGAGCAGTACTTCGGGCCG	CASSSGQGFYEQYF	In	VDJ	1	24	5.401658309100894E-5	6.351626016260163E-5	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	3	3	2	3	19	32	42	34	45													Vb 5.1	CASSSGQGFYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGGACTAGCGTAGCCCAAGAGACCCAGTACTTCGGGCCA	CASRTSVAQETQYF	In	VDJ	1	24	5.401658309100894E-5	6.351626016260163E-5	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	2	6	1	0	4	19	-1	38	30	42						01,02							Vb 5.1	CASRTSVAQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTCGGAGAGAATAGCTACGAGCAGTACTTCGGGCCG	CASSFGENSYEQYF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	10	2	3	1	7	19	33	38	34	45													Vb 5.1	CASSFGENSYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAAACGCAGGGGGCAGGGTACGAGCAGTACTTCGGGCCG	CASSLETQGAGYEQYF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	0	4	5	4	19	35	48	40	52													Vb 5.1	CASSLETQGAGYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGAAGACAGGGACGACTGGAAACACCATATATTTTGGAGAG	CASSLKTGTTGNTIYF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	2	3	2	2	4	19	34	43	36	47													Vb 5.1	CASSLKTGTTGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGGCCGACAGTAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASRPTVATNEKLFF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	5	0	3	3	19	30	38	33	41													Vb 5.1	CASRPTVATNEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAACAGCCTGACGGGACAGGGAGGGGAGACCCAGTACTTCGGGCCA	CANSLTGQGGETQYF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	3	5	5	4	19	31	45	36	49													Vb 5.1	CANSLTGQGGETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTCAACCCGGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	27	6.076865597738506E-5		44	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	4	8	5	0	7	0	19	31	-1	38	41						01,02							Vb 5.1	X+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD02-01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGACGGGAGCAAGGGAGAACGGAGAGCTGTTTTTTGGAGAA	CASSLTGARENGELFF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	8	2	11	1	14	19	34	41	35	55													Vb 5.1	CASSLTGARENGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAAAGAACCCGCTGCCCCCTACGAGCAGTACTTCGGGCCG	CASKEPAAPYEQYF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-07	01	6	2	8	2	2	11	19	29	33	31	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASKEPAAPYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGGGCGACAGGGGAAAGAGAGACCCAGTACTTCGGGCCA	CASSWATGERETQYF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	2	2	4	4	4	19	32	44	36	48													Vb 5.1	CASSWATGERETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAGGGACCAGTCTCCGTAGGGGAAAAACTGTTTTTTGGCAGT	CASSLEGPVSVGEKLFF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	51	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-04	01	0	0	7	8	1	14	19	35	41	36	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLEGPVSVGEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01		TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTCCAGCCCTAACAGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPALTANTGELFF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	5	0	10	0	19	30	-1	40	44													Vb 5.1	CASSPALTANTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAGATTCGGCAGGGCACAGATACGCAGTATTTTGGCCCA	CASSLEIRQGTDTQYF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	4	1	8	0	19	35	-1	43	47													Vb 5.1	CASSLEIRQGTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTTGGGGGGCATAATACTGGAAACACCATATATTTTGGAGAG	CASSLVGGHNTGNTIYF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	51	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-03	01	0	6	0	2	3	6	19	35	44	38	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLVGGHNTGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01		TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTAGCTAGCGGGGGAACCTACGAGCAGTACTTCGGGCCG	CASSLASGGTYEQYF	In	VDJ	1	32	7.202211078801193E-5	8.468834688346883E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	4	2	2	2	2	19	33	45	35	47													Vb 5.1	CASSLASGGTYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGAATACTTTAGGGGAAAAACTGTTTTTTGGCAGT	CASSLNTLGEKLFF	In	VDJ	1	32	7.202211078801193E-5	8.468834688346883E-5	42	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-04	01	1	5	3	8	8	0	19	34	-1	42	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLNTLGEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01		TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAGCCAGGGGGCAAGGAGCAGTACTTCGGGCCG	CASSLEPGGKEQYF	In	VDJ	1	33	7.427280175013729E-5	8.733485772357724E-5	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	0	7	3	3	19	35	46	38	49													Vb 5.1	CASSLEPGGKEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTCCTGGGGAGTAGCGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSLLGSSGGTDTQYF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	5	3	1	11	0	19	31	-1	42	50													Vb 5.1	CASSLLGSSGGTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCTCGGGGACAGGCTACAATGAGCAGTTCTTCGGGCCA	CASSSSGTGYNEQFF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	4	3	5	0	19	32	-1	37	45													Vb 5.1	CASSSSGTGYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCACCGGGACGGCTACACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	35	7.877418367438804E-5		46	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-05	01	4	0	7	2	4	7	19	31	40	35	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	X+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCGGACAGGGAGGTTCCTACGAGCAGTACTTCGGGCCG	CASSSGQGGSYEQYF	In	VDJ	1	36	8.10248746365134E-5	9.527439024390244E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	3	1	2	4	19	32	42	34	46													Vb 5.1	CASSSGQGGSYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCAAGGACAGGGGTGACCTACGAGCAGTACTTCGGGCCG	CASSPRTGVTYEQYF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	2	2	4	3	19	31	44	35	47													Vb 5.1	CASSPRTGVTYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCCTCCCTAGCACAGATACGCAGTATTTTGGCCCA	CASSLALPSTDTQYF	In	VDJ	1	40	9.00276384850149E-5	1.0586043360433605E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	4	10	0	2	4	19	35	39	37	43						01,02							Vb 5.1	CASSLALPSTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCGGAGGGATTACGAGATACGCAGTATTTTGGCCCA	CASSPEGLRDTQYF	In	VDJ	1	42	9.452902040926564E-5	1.1115345528455284E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	10	0	5	2	6	19	31	39	33	45													Vb 5.1	CASSPEGLRDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGACAGGGTAATCAAGGCACTGAAGCTTTCTTTGGACAA	CASRQGNQGTEAFF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	3	4	0	9	19	-1	36	30	45													Vb 5.1	CASRQGNQGTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCACTAATCCCGGGACGGAGGATGAAAAACTGTTTTTTGGCAGT	CASSTNPGTEDEKLFF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	48	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-04	01	4	0	7	6	9	5	19	31	45	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSTNPGTEDEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01		TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTTCCAGGGTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	44	9.903040233351639E-5		44	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	4	3	3	3	0	19	33	-1	36	41													Vb 5.1	X+TCRBV05-01+TCRBJ02-06	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCGGATCCGCGGGGTTCACAGATACGCAGTATTTTGGCCCA	CASSSGSAGFTDTQYF	In	VDJ	1	45	1.0128109329564176E-4	1.1909298780487805E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	7	3	2	8	2	19	32	46	40	48													Vb 5.1	CASSSGSAGFTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTATTGACAGGGGGCTACGAGCAGTACTTCGGGCCG	CASSLLTGGYEQYF	In	VDJ	1	46	1.0353178425776714E-4	1.2173949864498645E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	1	3	3	0	19	33	-1	36	45													Vb 5.1	CASSLLTGGYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGGGGGCTTTGGCAGATCCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	47	1.057824752198925E-4		47	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	6	0	4	0	12	19	-1	38	32	50													Vb 5.1	X+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGATGTGGGGGGAGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSLDVGGATGELFF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	9	1	4	4	3	19	35	45	39	48													Vb 5.1	CASSLDVGGATGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGGGGACAGGGAGACAATCAGCCCCAGCATTTTGGTGAT	CASSWGQGDNQPQHF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	3	3	1	3	19	32	42	33	45													Vb 5.1	CASSWGQGDNQPQHF+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTAGGCGACAGGGTGTGGAATGAGCAGTTCTTCGGGCCA	CASSLGDRVWNEQFF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	2	3	7	4	5	19	33	44	37	49													Vb 5.1	CASSLGDRVWNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGGGGCGACCGGACAGCGCCGACCTTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	65	1.462949125381492E-4		55	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	1	5	0	8	11	19	27	41	35	52													Vb 5.1	X+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGCTTGGCAGGGTCATGGACGAGCAGTACTTCGGGCCG	CASSLLGRVMDEQYF	In	VDJ	1	72	1.620497492730268E-4	1.9054878048780488E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	3	5	5	6	19	34	44	39	50													Vb 5.1	CASSLLGRVMDEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGGGAGACTACTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASRETTATNEKLFF	In	VDJ	1	105	2.363225510231641E-4	2.778836382113821E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	2	9	0	3	3	19	30	38	33	41						01,02							Vb 5.1	CASRETTATNEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD02-01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTCACAACGGGACCTGGAGAAAAACTGTTTTTTGGCAGT	CASSFTTGPGEKLFF	In	VDJ	1	114	2.5657876968229244E-4	3.0170223577235774E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-04	01	2	0	7	8	6	5	19	33	44	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSFTTGPGEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01		TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGGCACCGGAGCCCGCCAAGAGACCCAGTACTTCGGGCCA	CASSGTGARQETQYF	In	VDJ	2	146	3.286008804703044E-4	3.8639058265582655E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	10	2	1	6	4	19	31	41	37	45													Vb 5.1	CASSGTGARQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTATTCAGGGACAGATACGCAGTATTTTGGCCCA	CASSLYSGTDTQYF	In	VDJ	3	211	4.748957930084536E-4	5.584137872628726E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	4	3	3	4	0	19	34	-1	38	43													Vb 5.1	CASSLYSGTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGAGGGACAACCGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASRGTTATNEKLFF	In	VDJ	3	255	5.7392619534197E-4	6.748602642276423E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	6	0	1	4	19	30	37	31	41													Vb 5.1	CASRGTTATNEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCTGTAAGTGATAGGGGTAATTTCTGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	4	323	7.269731807664953E-4		53	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	5	2	1	10	9	19	28	43	38	52													Vb 5.1	X+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCAAGGTGACTAGCCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSKVTSPNTGELFF	In	VDJ	4	350	7.877418367438804E-4	9.262787940379404E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	2	7	0	5	1	19	31	43	36	44						01,02							Vb 5.1	CASSKVTSPNTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCTAGCGGGGGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLASGGSSYNEQFF	In	VDJ	6	452	0.0010173123148806684	0.0011962228997289973	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	4	2	0	0	3	19	-1	45	35	48													Vb 5.1	CASSLASGGSSYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCGGACCTAATCACCTACGAGCAGTACTTCGGGCCG	CASSPDLITYEQYF	In	VDJ	8	641	0.0014426929067223638	0.001696413448509485	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-07	01	4	1	7	2	2	7	19	31	37	33	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSPDLITYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGGGACTCAGCCGTGTATCTCTACAGTAGCTTCCACAGTTCTGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	YSSFHSSGQSRANVLTF	In	VDJ	2	179	4.028736822204417E-4	4.7372544037940377E-4	51	TCRBV17	TCRBV17-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	6	5	12	5	22	31	48	43	53														YSSFHSSGQSRANVLTF+TCRBV17-01+TCRBJ02-06	TCRBV17-01*01	TCRBD01-01*01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTAGGCTTCAGGGACATGAAGCCCCAGCATTTTGGTGAT	CASSLGFRDMKPQHF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	6	8	10	3	25	37	53	47	56													Vb 3	CASSLGFRDMKPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAACGACTAGCACATCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	23	5.176589212888357E-5		40	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	10	2	7	1	2	3	25	32	41	34	44						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGGCAATTTTATGGCTACACCTTCGGTTCG	CASSRQFYGYTF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	5	9	0	5	1	5	25	37	41	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSRQFYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACAACAGGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLQQAGANVLTF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	3	4	2	2	0	25	40	-1	42	47													Vb 3	CASSLQQAGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGGGCCGACAATGTTGGATACGCAGTATTTTGGCCCA	CASSFGPTMLDTQYF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	3	2	6	6	6	6	25	39	49	45	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFGPTMLDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACAAAAAACGACAGGGCGGAAAGCTCGGGCCG		Out	VDJ	1	24	5.401658309100894E-5		35	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	2	3	17	8	8	25	35	50	43	58													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGAGGGGGCAAGTGCCTACAATGAGCAGTTCTTCGGGCCA	CASSLEGASAYNEQFF	In	VDJ	1	24	5.401658309100894E-5	6.351626016260163E-5	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	5	0	2	1	5	25	40	48	41	53													Vb 3	CASSLEGASAYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACGTTTGGTGGCACCAACAGACATCTATGTACCTCTGTGCCAGCCTCGCCTCGTCCGGGAGAGGCGCTGAAGCTTTCTTTGGACAA	CASLASSGRGAEAFF	In	VDJ	1	24	5.401658309100894E-5	6.351626016260163E-5	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	8	8	2	6	11	5	36	45	62	56	67													Vb 3	CASLASSGRGAEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGGCAGCTAGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSRQLASTDTQYF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	4	7	0	7	1	25	36	48	43	49						01,02							Vb 3	CASSRQLASTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGCACAGGGGGCAGGGGGTGGGTATGGCTACACCTTCGGTTCG	CASSFAQGAGGGYGYTF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	0	5	3	10	25	39	51	42	61													Vb 3	CASSFAQGAGGGYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCATTTCGGGGGAGCAGTACTTCGGGCCG	CASSPISGEQYF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	3	7	7	0	25	37	-1	44	49													Vb 3	CASSPISGEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCAGGTCCGATAGAGACCCAGTACTTCGGGCCA	CASSLSGPIETQYF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	4	4	0	6	25	-1	45	41	51													Vb 3	CASSLSGPIETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAAAAATGACAGGGTCTAGTGGGGAGCAGTACTTCGGGCCG		Out	VDJ	1	27	6.076865597738506E-5		44	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	2	3	7	6	9	25	35	48	41	57													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCAAACAGGTGAAGGGTCCTACGAGCAGTACTTCGGGCCG	CASSQTGEGSYEQYF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	4	1	4	7	25	36	45	40	52													Vb 3	CASSQTGEGSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGTTCAAGGTGGACAGTCGCTCTCCTACGAGCAGTACTTCGGGCCG	CASSVQGGQSLSYEQYF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	5	0	9	5	25	37	52	46	57													Vb 3	CASSVQGGQSLSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGAGGGGGGGACAGGGGATCTACGAGCAGTACTTCGGGCCG	CASRRGGQGIYEQYF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	2	3	6	2	25	36	52	42	54													Vb 3	CASRRGGQGIYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATATGGGGTTAGAGTGAAGACCCAGTACTTCGGGCCA	CASSLYGVRVKTQYF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	1	6	2	6	2	9	25	41	47	43	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLYGVRVKTQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACCTGCGGGGCCAGCTCCTACGAGCAGTACTTCGGGCCG	CATCGASSYEQYF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	10	7	3	0	3	4	25	32	41	35	45													Vb 3	CATCGASSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCTTAACTAGGGCGGGGCAGTACTTCGGGCCG	CASSSLTRAGQYF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	3	8	9	5	6	25	38	48	43	54						01,02							Vb 3	CASSSLTRAGQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCCCCGTTACTATTCTACGAGCAGTACTTCGGGCCG	CASSLSPLLFYEQYF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	3	9	3	7	2	25	41	52	48	54						01,02							Vb 3	CASSLSPLLFYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCTGGGGACAAGGAACCCCCTACTATGGCTACACCTTCGGTTCG	CAWGQGTPYYGYTF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	11	0	6	3	2	11	25	31	39	33	50													Vb 3	CAWGQGTPYYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCTCGATAAATGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	31	6.977141982588655E-5		41	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	6	0	10	3	11	0	25	36	-1	47	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACCCTTAAGGGTTACACCGGGGAGCTGTTTTTTGGAGAA	CATLKGYTGELFF	In	VDJ	1	32	7.202211078801193E-5	8.468834688346883E-5	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-02	01	10	5	3	3	6	2	25	32	42	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CATLKGYTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01		TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGCGGACAGTATGGCTACACCTTCGGTTCG	CASSRGQYGYTF	In	VDJ	1	33	7.427280175013729E-5	8.733485772357724E-5	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	5	5	3	0	25	37	-1	40	46													Vb 3	CASSRGQYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATACGCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	33	7.427280175013729E-5		34	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	1	3	7	5	0	2	25	-1	43	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCTTAAACTAGCGGATCTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	34	7.652349271226266E-5		46	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	3	5	3	6	4	25	37	51	43	55						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGAGGGCGGCCGCTACGAGCAGTACTTCGGGCCG	CASSFEGGRYEQYF	In	VDJ	1	35	7.877418367438804E-5	9.262787940379404E-5	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	11	0	3	1	6	25	39	45	40	51													Vb 3	CASSFEGGRYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTGGGGGGCTCCAGAGACCCAGTACTTCGGGCCA	CASSWGAPETQYF	In	VDJ	1	36	8.10248746365134E-5	9.527439024390244E-5	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	6	6	0	4	3	3	25	36	45	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSWGAPETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGGGGGACACCGAGACCTCTGGAAACACCATATATTTTGGAGAG	CASRGDTETSGNTIYF	In	VDJ	1	36	8.10248746365134E-5	9.527439024390244E-5	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	0	6	0	2	7	25	36	44	38	51													Vb 3	CASRGDTETSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCTGGGACTAGCGGGAGGTATAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	36	8.10248746365134E-5		50	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	0	1	5	4	3	25	37	56	41	59													Vb 3	X+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGACGGGGGGCCCCAGGTGAGAAGCAGTACTTCGGGCCG		Out	VDJ	1	36	8.10248746365134E-5		47	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	8	1	8	3	12	25	39	49	42	61													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAACCCTAGCGGATACAATGAGCAGTTCTTCGGGCCA	CASNPSGYNEQFF	In	VDJ	1	37	8.327556559863878E-5	9.792090108401084E-5	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	4	5	4	3	1	25	35	45	38	46						01,02							Vb 3	CASNPSGYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCAGGGAGCCAAGAGACCCAGTACTTCGGGCCA	CASSPGSQETQYF	In	VDJ	1	37	8.327556559863878E-5	9.792090108401084E-5	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	5	4	3	1	1	2	25	37	43	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPGSQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAATTACGCGGACAGGGCCCTCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	38	8.552625656076415E-5		52	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	7	1	3	0	7	2	25	35	50	42	52													Vb 3	X+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTCAGGGGAGGGGGACAATCAGCCCCAGCATTTTGGTGAT	CASSSGEGDNQPQHF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	9	0	3	5	3	25	36	48	41	51													Vb 3	CASSSGEGDNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTAAAGGGTTATCCGCCCTATGGCTACACCTTCGGTTCG	CASSLKGYPPYGYTF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	5	5	3	4	4	9	25	37	45	41	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLKGYPPYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCCAGCGTTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSPAFSGANVLTF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	4	6	6	0	4	2	25	38	46	42	48						01,02							Vb 3	CASSSPAFSGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD02-01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTTGGAGGGTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLEGYSNQPQHF	In	VDJ	1	40	9.00276384850149E-5	1.0586043360433605E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	10	0	0	3	3	25	36	45	39	48													Vb 3	CASSLEGYSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTTCGACCAATCGGAGGGTCTCTATGGCTACACCTTCGGTTCG	CASSFDQSEGLYGYTF	In	VDJ	1	41	9.227832944714028E-5	1.0850694444444444E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	10	0	4	12	3	25	36	54	48	57													Vb 3	CASSFDQSEGLYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACCGGGGGGGGTGCCAACTATGGCTACACCTTCGGTTCG	CATGGGANYGYTF	In	VDJ	1	42	9.452902040926564E-5	1.1115345528455284E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	10	8	0	2	1	5	25	32	41	33	46													Vb 3	CATGGGANYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCTTACCCGGGGGATCACTGAAGCTTTCTTTGGACAA	CASSLTRGITEAFF	In	VDJ	1	42	9.452902040926564E-5	1.1115345528455284E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	2	4	7	2	25	36	49	43	51													Vb 3	CASSLTRGITEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCGGCGGGGCGTGTTTGGTAAAGCTTTCTTTGGACAA	CASSSRRGVFGKAFF	In	VDJ	1	42	9.452902040926564E-5	1.1115345528455284E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	7	3	9	4	11	25	38	48	42	59													Vb 3	CASSSRRGVFGKAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCGGGACGGTCACAGATACGCAGTATTTTGGCCCA	CASSSGTVTDTQYF	In	VDJ	1	42	9.452902040926564E-5	1.1115345528455284E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	4	0	7	2	2	3	25	38	45	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSGTVTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCGGGGCTAGCGGGAGGCAATGAGCAGTTCTTCGGGCCA	CASSPGLAGGNEQFF	In	VDJ	1	43	9.677971137139102E-5	1.1379996612466124E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	1	6	7	0	25	36	-1	43	54													Vb 3	CASSPGLAGGNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGCCGGGGGGCAGGGTATAATTCACCCCTCCACTTTGGGAAC	CASSRRGAGYNSPLHF	In	VDJ	1	43	9.677971137139102E-5	1.1379996612466124E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	6	8	1	4	4	5	25	36	47	40	52													Vb 3	CASSRRGAGYNSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACCGAGGGAGGGCTGAACACTGAAGCTTTCTTTGGACAA	CATEGGLNTEAFF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	10	9	0	0	4	1	25	32	43	36	44													Vb 3	CATEGGLNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCAGGGACTAGCGGGAGCGGGGGATACGCAGTATTTTGGCCCA	CASSQGLAGAGDTQYF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	0	2	6	3	5	25	36	53	39	58													Vb 3	CASSQGLAGAGDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAACGGGGGAGGGCACTGAAGCTTTCTTTGGACAA	CASSLTGEGTEAFF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	9	0	4	4	0	25	40	-1	44	51													Vb 3	CASSLTGEGTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGACGGGACAGATTAATGAAAAACTGTTTTTTGGCAGT	CASRTGQINEKLFF	In	VDJ	1	45	1.0128109329564176E-4	1.1909298780487805E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	5	4	3	2	25	36	46	39	48													Vb 3	CASRTGQINEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGCCCGAGGGGCTACACCTTCGGTTCG	CASSLGPRGYTF	In	VDJ	1	45	1.0128109329564176E-4	1.1909298780487805E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	11	1	8	5	0	25	40	-1	45	49													Vb 3	CASSLGPRGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCTCAGTGACAGGGGGACTATTCGGGCCG	CASSPSVTGGLF	In	VDJ	1	46	1.0353178425776714E-4	1.2173949864498645E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	1	16	8	4	25	37	54	45	58													Vb 3	CASSPSVTGGLF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCGTGGACAGGCAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASRGQAATNEKLFF	In	VDJ	1	46	1.0353178425776714E-4	1.2173949864498645E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	1	4	0	3	3	25	34	44	37	47													Vb 3	CASRGQAATNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGTCTCCCAGGGGGCGTCACCCCTCCACTTTGGGAAC	CASSLVSQGASPLHF	In	VDJ	1	47	1.057824752198925E-4	1.2438600948509485E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	4	0	10	6	1	25	40	54	46	55													Vb 3	CASSLVSQGASPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCTCTAGGGGAGGGTGAAGAGACCCAGTACTTCGGGCCA	CASSLSLGEGEETQYF	In	VDJ	1	47	1.057824752198925E-4	1.2438600948509485E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	9	0	3	6	2	25	41	54	47	56													Vb 3	CASSLSLGEGEETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGAACATGGACGGAGCACTGAAGCTTTCTTTGGACAA	CASSLEHGRSTEAFF	In	VDJ	1	48	1.0803316618201788E-4	1.2703252032520327E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	3	1	7	4	7	4	25	39	50	46	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLEHGRSTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCAGATAAGAACCTGAATCAGCCCCAGCATTTTGGTGAT	CASSSDKNLNQPQHF	In	VDJ	1	49	1.1028385714414325E-4	1.2967903116531165E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	5	4	0	11	25	-1	41	38	52													Vb 3	CASSSDKNLNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCAAACCATGGGACAGGAGGAAACACCATATATTTTGGAGAG	CASSPNHGTGGNTIYF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	0	4	4	10	1	25	36	54	46	55													Vb 3	CASSPNHGTGGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCAGGACTATGGCTACACCTTCGGTTCG	CASSSQDYGYTF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	4	3	2	0	25	38	-1	40	44													Vb 3	CASSSQDYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTTGGTAGGACAGGGGCAGATACGCAGTATTTTGGCCCA	CASSLFGRTGADTQYF	In	VDJ	1	51	1.14785239068394E-4	1.3497205284552846E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	1	2	4	6	0	25	41	-1	47	56													Vb 3	CASSLFGRTGADTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCAACCCCGGACAGGGGGCATGTAGGGGAGCTGTTTTTTGGAGAA	CASSPTPDRGHVGELFF	In	VDJ	1	52	1.1703593003051937E-4	1.3761856368563685E-4	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	0	8	9	5	25	36	56	45	61													Vb 3	CASSPTPDRGHVGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTCACCCGGATGGAGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	52	1.1703593003051937E-4		46	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-06	01	6	1	8	4	7	4	25	36	46	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01		TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGTTATCCCGACAGATTAACTATGGCTACACCTTCGGTTCG	CASRLSRQINYGYTF	In	VDJ	1	52	1.1703593003051937E-4	1.3761856368563685E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	5	1	3	2	25	41	49	44	51													Vb 3	CASRLSRQINYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACTACCCCCCTGCTAACCTACACAGATACGCAGTATTTTGGCCCA	CASTTPLLTYTDTQYF	In	VDJ	1	53	1.1928662099264474E-4	1.4026507452574526E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	4	9	2	0	16	25	-1	38	35	54						01,02							Vb 3	CASTTPLLTYTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAGTCTGGGGACCTACGAGCAGTACTTCGGGCCG	CASSLSLGTYEQYF	In	VDJ	1	54	1.2153731195477012E-4	1.4291158536585365E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	2	0	8	2	6	0	25	40	-1	46	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLSLGTYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCTAGCTGGTGTGCATGGCTACACCTTCGGTTCG	CASLAGVHGYTF	In	VDJ	1	56	1.2603869387902087E-4	1.4820460704607045E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	8	4	7	6	0	8	25	-1	39	34	47						01,02							Vb 3	CASLAGVHGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTCCGGGACTGGCCCCCTACTGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSSGTGPLLSSYNEQFF	In	VDJ	1	57	1.2828938484114622E-4	1.5085111788617887E-4	57	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	10	0	4	14	24	35	45	39	59						01,02							Vb 3	CASSSGTGPLLSSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCAAGCGGGGTGCCCCAGCATTTTGGTGAT	CASSLSSGVPQHF	In	VDJ	1	58	1.305400758032716E-4	1.5349762872628726E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	1	6	3	9	2	1	25	41	50	43	51													Vb 3	CASSLSSGVPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACAGGGGCGGAACTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASTGAELSYNEQFF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	4	2	0	0	7	25	-1	41	35	48													Vb 3	CASTGAELSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCCCGGGGACTGCGCGCTACGAGCAGTACTTCGGGCCG	CASSPPGTARYEQYF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	10	3	7	5	25	36	49	43	54						01,02							Vb 3	CASSPPGTARYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGGGGATCGAGGAACACTGAAGCTTTCTTTGGACAA	CASSLGGSRNTEAFF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	2	6	1	1	0	6	25	-1	45	40	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLGGSRNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCCAGGGCCTGGCTACACCTTCGGTTCG	CASSFPGPGYTF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	3	7	2	2	25	39	46	41	48													Vb 3	CASSFPGPGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGGGACAGGGGAAAAAACATTCAGTACTTCGGCGCC	CASSRDRGKNIQYF	In	VDJ	1	60	1.3504145772752236E-4	1.5879065040650406E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	0	2	4	1	1	25	37	48	38	49													Vb 3	CASSRDRGKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTCACTCCGGGAGAACTGTTTTTTGGCAGT	CASSLFTPGELFF	In	VDJ	1	60	1.3504145772752236E-4	1.5879065040650406E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	1	8	2	12	6	0	25	41	-1	47	53													Vb 3	CASSLFTPGELFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCCCGGGGCTGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPPGLSYNEQFF	In	VDJ	1	61	1.372921486896477E-4	1.6143716124661248E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-01	01	6	7	0	1	6	2	25	36	47	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPPGLSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCTCGGGACAGCTAAATACAATGAGCAGTTCTTCGGGCCA	CASSLGTAKYNEQFF	In	VDJ	1	61	1.372921486896477E-4	1.6143716124661248E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	5	4	4	5	25	36	47	40	52													Vb 3	CASSLGTAKYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGACCGAGACAGGGGGATACAATGAGCAGTTCTTCGGGCCA	CASRTETGGYNEQFF	In	VDJ	1	61	1.372921486896477E-4	1.6143716124661248E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	1	4	6	1	25	36	51	42	52													Vb 3	CASRTETGGYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCCCCGGGGCTATGGCTACACCTTCGGTTCG	CASSFPRGYGYTF	In	VDJ	1	62	1.395428396517731E-4	1.6408367208672087E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	8	3	4	4	0	25	39	-1	43	48													Vb 3	CASSFPRGYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCTCACTTTGGTCTGGGCCAGGGGAAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLTLVWARGSSYEQYF	In	VDJ	1	63	1.4179353061389847E-4	1.6673018292682928E-4	57	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	2	0	18	3	24	35	59	53	62													Vb 3	CASSLTLVWARGSSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCAATTAGGGGCGGGGACTGAAGCTTTCTTTGGACAA	CASSQLGAGTEAFF	In	VDJ	1	63	1.4179353061389847E-4	1.6673018292682928E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	7	3	5	9	0	25	37	-1	46	52													Vb 3	CASSQLGAGTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGCGAGCGGGGGGACAGATACGCAGTATTTTGGCCCA	CASSLASGGTDTQYF	In	VDJ	1	64	1.4404422157602385E-4	1.6937669376693767E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	6	1	3	3	0	25	40	-1	43	52													Vb 3	CASSLASGGTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTATGCAACAAGCGGGGGTAAGCACAGATACGCAGTATTTTGGCCCA	CASSMQQAGVSTDTQYF	In	VDJ	1	65	1.462949125381492E-4	1.7202320460704606E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	6	2	0	8	2	25	37	53	45	55													Vb 3	CASSMQQAGVSTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACTCCACAGTCAGGTGGCAGGGGAATTGAGCTGTTTTTTGGAGAA	CASTPQSGGRGIELFF	In	VDJ	1	66	1.4854560350027458E-4	1.7466971544715447E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	4	2	11	16	4	25	35	57	51	61													Vb 3	CASTPQSGGRGIELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACCGGACAGGGGGCCATTTCAGCCCCAGCATTTTGGTGAT	CASRPDRGPFQPQHF	In	VDJ	1	67	1.5079629446239996E-4	1.7731622628726286E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	0	6	3	4	25	36	50	39	54													Vb 3	CASRPDRGPFQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGGGGACAGTATGGCTACACCTTCGGTTCG	CASSRGQYGYTF	In	VDJ	1	67	1.5079629446239996E-4	1.7731622628726286E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	5	3	0	25	36	-1	39	46													Vb 3	CASSRGQYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTGCAGGGGTCAATGAGCAGTTCTTCGGGCCA	CASSSAGVNEQFF	In	VDJ	1	70	1.5754836734877608E-4	1.8525575880758808E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	2	6	3	1	25	38	47	41	48													Vb 3	CASSSAGVNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTTTAGGTCAGGACCTCCAAGAGACCCAGTACTTCGGGCCA	CASSFLGQDLQETQYF	In	VDJ	1	71	1.5979905831090146E-4	1.8790226964769647E-4	48	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	3	1	7	1	9	2	25	39	52	48	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFLGQDLQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGCCGATCTTAACACTGAAGCTTTCTTTGGACAA	CASADLNTEAFF	In	VDJ	1	71	1.5979905831090146E-4	1.8790226964769647E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	8	2	8	2	3	4	25	34	39	37	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASADLNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGCCACTAGCGGGGGGACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLCH*RGDSGANVLTF	Stop	VDJ	1	73	1.643004402351522E-4		57	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	0	3	1	0	2	1	24	41	55	43	56													Vb 3	CASSLCH*RGDSGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACAATAACTAGCGGGGGGGCCAGTAGAGATACGCAGTATTTTGGCCCA	CASSTITSGGASRDTQYF	In	VDJ	1	73	1.643004402351522E-4	1.9319529132791327E-4	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	3	0	5	6	7	25	37	56	43	63													Vb 3	CASSTITSGGASRDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCCGGGGACTAGCTCTCCTCAACAGTATTTTGGCCCA	CASSSPGTSSPQQYF	In	VDJ	1	73	1.643004402351522E-4	1.9319529132791327E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	7	12	5	9	25	38	52	43	61						01,02							Vb 3	CASSSPGTSSPQQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAACCCCCGCAATGAACACTGAAGCTTTCTTTGGACAA	CASSLTPAMNTEAFF	In	VDJ	1	73	1.643004402351522E-4	1.9319529132791327E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	2	3	7	0	0	8	25	-1	42	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLTPAMNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAACTCTACCCCCAGCGGGGGGGTGGCAGGAGATACGCAGTATTTTGGCCCA	CANSTPSGGVAGDTQYF	In	VDJ	1	74	1.6655113119727757E-4	1.958418021680217E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	10	6	0	5	11	7	25	32	53	43	60													Vb 3	CANSTPSGGVAGDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCCGCGGGTCGGGCACAGATACGCAGTATTTTGGCCCA	CASSPRGSGTDTQYF	In	VDJ	1	74	1.6655113119727757E-4	1.958418021680217E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	7	4	1	5	4	25	36	46	41	50						01,02							Vb 3	CASSPRGSGTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCTCCAAGGCAGGACTCCTACGAGCAGTACTTCGGGCCG	CASSPPRQDSYEQYF	In	VDJ	1	75	1.6880182215940295E-4	1.9848831300813008E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	4	0	9	1	25	37	50	46	51													Vb 3	CASSPPRQDSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGGACATACACAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSRTYTNTGELFF	In	VDJ	1	75	1.6880182215940295E-4	1.9848831300813008E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	6	2	1	6	25	37	43	38	49													Vb 3	CASSRTYTNTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCTCTGCCGGGGGATACCTACGAGCAGTACTTCGGGCCG	CASSPLPGDTYEQYF	In	VDJ	1	76	1.710525131215283E-4	2.011348238482385E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	8	2	2	8	3	25	36	50	44	53													Vb 3	CASSPLPGDTYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGCGAACCTCAGTTCACCCCTCCACTTTGGGAAC	CASSANLSSPLHF	In	VDJ	1	76	1.710525131215283E-4	2.011348238482385E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-06	01	5	4	5	9	8	0	25	37	-1	45	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSANLSSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01		TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGCCTCCAGGGGGGACCCAGTACTTCGGGCCA	CASSSPPGGTQYF	In	VDJ	1	76	1.710525131215283E-4	2.011348238482385E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	1	7	6	0	25	38	-1	44	51													Vb 3	CASSSPPGGTQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGCAGGGACTTGAAGCTTTCTTTGGACAA	CASSLQGLEAFF	In	VDJ	1	78	1.7555389504577906E-4	2.064278455284553E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	0	10	7	3	0	25	39	-1	42	48						01,02							Vb 3	CASSLQGLEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCGCCGACAGGGAAACTACGAGCAGTACTTCGGGCCG	CASRRQGNYEQYF	In	VDJ	1	78	1.7555389504577906E-4	2.064278455284553E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	2	3	3	4	3	25	34	45	38	48													Vb 3	CASRRQGNYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAAGCGACCAAGAGACCCAGTACTTCGGGCCA	CASRSDQETQYF	In	VDJ	1	79	1.778045860079044E-4	2.0907435636856368E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	6	6	0	1	0	25	36	-1	37	41						01,02							Vb 3	CASRSDQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGCGGACTAGCGGGGCGTTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASRRTSGAFSYNEQFF	In	VDJ	1	80	1.800552769700298E-4	2.117208672086721E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	1	3	0	2	4	25	36	50	38	54													Vb 3	CASRRTSGAFSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACCCACAATCAGCCCCAGCATTTTGGTGAT	CASSTHNQPQHF	In	VDJ	1	80	1.800552769700298E-4	2.117208672086721E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	5	3	7	3	0	3	25	-1	39	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSTHNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTATGACAGGGCTCGAGCAGTACTTCGGGCCG	CASSMTGLEQYF	In	VDJ	1	80	1.800552769700298E-4	2.117208672086721E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	3	6	2	2	25	37	46	39	48													Vb 3	CASSMTGLEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGGTTCCGGGACGTATGGCTACACCTTCGGTTCG	CASGSGTYGYTF	In	VDJ	1	80	1.800552769700298E-4	2.117208672086721E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	4	0	7	5	2	1	25	38	45	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASGSGTYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACGGCTGGAAACACCATATATTTTGGAGAG	CASSTAGNTIYF	In	VDJ	1	81	1.8230596793215517E-4	2.143673780487805E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	8	5	2	1	0	25	37	-1	38	41						01,02							Vb 3	CASSTAGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD02-01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACCTAGGACAGGGGAGCCTGAGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	82	1.8455665889428055E-4		55	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	2	1	4	8	25	40	53	44	61													Vb 3	X+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCTCAGGGGCAGCCCCCAGAGGATCACAGATACGCAGTATTTTGGCCCA	CASSSLRGSPQRITDTQYF	In	VDJ	1	83	1.868073498564059E-4	2.196603997289973E-4	57	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	2	2	4	15	24	37	47	41	62													Vb 3	CASSSLRGSPQRITDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACCAGGGACAGGCCCTACCCCGAGCAGTACTTCGGGCCG	CASSTRDRPYPEQYF	In	VDJ	1	83	1.868073498564059E-4	2.196603997289973E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	4	6	4	8	25	37	49	41	57													Vb 3	CASSTRDRPYPEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCCCGGGACTAGCGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPPGTSGNTGELFF	In	VDJ	1	83	1.868073498564059E-4	2.196603997289973E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	0	5	1	6	0	25	37	-1	43	54						01,02							Vb 3	CASSPPGTSGNTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGACAGTATCAATGAAAAACTGTTTTTTGGCAGT	CASSLDSINEKLFF	In	VDJ	1	83	1.868073498564059E-4	2.196603997289973E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	2	5	5	0	4	25	-1	45	40	49													Vb 3	CASSLDSINEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCAAGGGGGGAAGGGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	86	1.9355942274278205E-4		44	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	6	5	1	1	3	6	25	36	45	39	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGCCGACTACCGGGACAGGCACGGCCGAGCAGTACTTCGGGCCG	CASRPTTGTGTAEQYF	In	VDJ	1	86	1.9355942274278205E-4	2.2759993224932248E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	4	6	10	6	25	36	54	46	60													Vb 3	CASRPTTGTGTAEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGACAGTTTCTTCAGCCCCAGCATTTTGGTGAT	CASSRQFLQPQHF	In	VDJ	1	86	1.9355942274278205E-4	2.2759993224932248E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	5	6	1	5	25	37	43	38	48													Vb 3	CASSRQFLQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGGGCCTATTAGCGGGGGGGGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	86	1.9355942274278205E-4		49	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	5	0	4	8	1	25	37	56	45	57													Vb 3	X+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACGGGGACAGGGTGTGTTCGGCACTGAAGCTTTCTTTGGACAA	CASSLRGQGVFGTEAFF	In	VDJ	1	86	1.9355942274278205E-4	2.2759993224932248E-4	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	3	4	2	9	25	40	51	42	60													Vb 3	CASSLRGQGVFGTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGGACACCAAATCAGCCCCAGCATTTTGGTGAT	CASSLGTPNQPQHF	In	VDJ	1	87	1.958101137049074E-4	2.302464430894309E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	0	6	4	0	3	25	-1	46	40	49													Vb 3	CASSLGTPNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCACCCAGGGGGTTTTTGAGCAGTTCTTCGGGCCA	CASTTQGVFEQFF	In	VDJ	1	88	1.9806080466703278E-4	2.328929539295393E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	4	1	9	5	4	25	35	47	40	51													Vb 3	CASTTQGVFEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGTCCTCCTCAGTCCTGAAGCTTTCTTTGGACAA	CASSLVLLSPEAFF	In	VDJ	1	91	2.048128775534089E-4	2.408324864498645E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	5	6	8	2	25	40	51	48	53													Vb 3	CASSLVLLSPEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTTAGGAACCGGGACTGCCGTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASLGTGTAVSGANVLTF	In	VDJ	1	91	2.048128775534089E-4	2.408324864498645E-4	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	8	0	10	0	9	5	25	34	49	43	54						01,02							Vb 3	CASLGTGTAVSGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD02-01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACCCTGGACAGACATTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLPWTDISNQPQHF	In	VDJ	1	92	2.0706356851553427E-4	2.434789972899729E-4	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	1	5	0	4	4	25	40	50	44	54													Vb 3	CASSLPWTDISNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGTGCTGGAAACACCATATATTTTGGAGAG	CASSLGAGNTIYF	In	VDJ	1	92	2.0706356851553427E-4	2.434789972899729E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-03	01	2	0	10	2	0	2	25	-1	42	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLGAGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01		TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGGCTAGCGAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLGLASTGELFF	In	VDJ	1	93	2.0931425947765965E-4	2.461255081300813E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	4	6	4	3	2	25	40	49	43	51						01,02							Vb 3	CASSLGLASTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCACAGGGCTGGCTACGAGCAGTACTTCGGGCCG	CASSFHRAGYEQYF	In	VDJ	1	95	2.1381564140191038E-4	2.514185298102981E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	3	3	2	4	25	39	47	41	51													Vb 3	CASSFHRAGYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGGTCGAGGACTAGCCTCCCGAGCAGTACTTCGGGCCG		Out	VDJ	1	96	2.1606633236403576E-4		47	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	1	7	6	5	4	25	42	55	47	59						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGAAACAGACCAATGAACACTGAAGCTTTCTTTGGACAA	CASSRNRPMNTEAFF	In	VDJ	1	98	2.205677142882865E-4	2.593580623306233E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	5	0	4	5	25	37	45	41	50													Vb 3	CASSRNRPMNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCGTAACCCTCGGAACCCTCAATCAGCCCCAGCATTTTGGTGAT	CAVTLGTLNQPQHF	In	VDJ	1	99	2.2281840525041188E-4	2.620045731707317E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	11	1	8	3	9	5	25	31	43	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CAVTLGTLNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGTGAGCTCTGGAAACACCATATATTTTGGAGAG	CASSLVSSGNTIYF	In	VDJ	1	100	2.2506909621253726E-4	2.646510840108401E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	3	11	2	0	3	0	25	39	-1	42	45													Vb 3	CASSLVSSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGTATCTACTCTGGGACAGTGAACACTGAAGCTTTCTTTGGACAA	CASIYSGTVNTEAFF	In	VDJ	1	101	2.273197871746626E-4	2.672975948509485E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	0	5	0	10	0	25	33	-1	43	50													Vb 3	CASIYSGTVNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAGTCGGCCGGACTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASKSAGLSNQPQHF	In	VDJ	1	104	2.3407186006103875E-4	2.752371273712737E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	7	1	10	0	8	0	25	35	-1	43	48						01,02							Vb 3	CASKSAGLSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCACGATCGGATGGAAGGGCCTGGAAACACCATATATTTTGGAGAG	CASSHDRMEGPGNTIYF	In	VDJ	1	104	2.3407186006103875E-4	2.752371273712737E-4	51	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-03	01	6	5	3	2	15	1	25	36	55	51	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSHDRMEGPGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01		TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCAGCAGCGGGGGCCCATACACAATGAGCAGTTCTTCGGGCCA	CASQQRGPIHNEQFF	In	VDJ	1	109	2.453253148716656E-4	2.884696815718157E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	6	2	5	4	7	25	34	46	38	53													Vb 3	CASQQRGPIHNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAGGAGAACACAGATACGCAGTATTTTGGCCCA	CASKENTDTQYF	In	VDJ	1	112	2.5207738775804173E-4	2.964092140921409E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	10	2	2	1	2	25	35	40	36	42													Vb 3	CASKENTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGCGGACAGGGGCGAATGAGCAGTACTTCGGGCCG	CASRRTGANEQYF	In	VDJ	1	112	2.5207738775804173E-4	2.964092140921409E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	2	7	2	5	25	36	47	38	52													Vb 3	CASRRTGANEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTATACAGGGAATTAATCAGCCCCAGCATTTTGGTGAT	CASSIQGINQPQHF	In	VDJ	1	112	2.5207738775804173E-4	2.964092140921409E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	3	4	2	4	25	37	45	39	49													Vb 3	CASSIQGINQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCATTGGCCCGACGAACACTGAAGCTTTCTTTGGACAA	CASIGPTNTEAFF	In	VDJ	1	113	2.543280787201671E-4	2.990557249322493E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	7	2	7	1	7	0	25	35	-1	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASIGPTNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCATCTCCCAGGGGCTAGGCTACACCTTCGGTTCG	CASISQGLGYTF	In	VDJ	1	114	2.5657876968229244E-4	3.0170223577235774E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	2	8	5	3	25	35	46	40	49													Vb 3	CASISQGLGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCAGGGGGCGGAACCGGGGAGCTGTTTTTTGGAGAA	CASSSGGGTGELFF	In	VDJ	1	115	2.588294606444178E-4	3.043487466124661E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	0	5	0	3	25	-1	46	38	49													Vb 3	CASSSGGGTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGCTCCAGGACGGGGAATCTATGGCTACACCTTCGGTTCG	CASSAPGRGIYGYTF	In	VDJ	2	125	2.8133637026567156E-4	3.3081385501355015E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	3	4	9	3	25	37	51	46	54													Vb 3	CASSAPGRGIYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCGGGAGCCACTGAAGCTTTCTTTGGACAA	CASSLSGATEAFF	In	VDJ	2	126	2.8358706122779694E-4	3.3346036585365856E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	8	2	4	0	1	25	-1	47	41	48													Vb 3	CASSLSGATEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTGCTAGGTATGGAAGAGACCCAGTACTTCGGGCCA	CASSLLGMEETQYF	In	VDJ	2	130	2.925898250762984E-4	3.440464092140921E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	4	8	3	3	6	25	37	44	40	50						01,02							Vb 3	CASSLLGMEETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTCCCTACGTGGGAGGGCTAATGAGCAGTTCTTCGGGCCA	CASSSLRGRANEQFF	In	VDJ	2	131	2.948405160384238E-4	3.4669292005420053E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	9	0	7	10	2	25	36	53	46	55													Vb 3	CASSSLRGRANEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCCAGGACAGCTAAATGGCTACACCTTCGGTTCG	CASSSPGQLNGYTF	In	VDJ	2	132	2.9709120700054917E-4	3.4933943089430895E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	5	6	5	4	25	38	49	43	53													Vb 3	CASSSPGQLNGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCTCGCCGGCTCCGAGACCCAGTACTTCGGGCCA	CASSLAGSETQYF	In	VDJ	2	135	3.038432798869253E-4	3.5727896341463414E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	6	9	0	5	7	3	25	36	46	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLAGSETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTCTGGGACTGCATGACGATGAGCAGTTCTTCGGGCCA	CASSSLGLHDDEQFF	In	VDJ	2	135	3.038432798869253E-4	3.5727896341463414E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	10	8	4	8	25	38	48	42	56						01,02							Vb 3	CASSSLGLHDDEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCATAGAGGGGGCTAACTATGGCTACACCTTCGGTTCG	CASIEGANYGYTF	In	VDJ	2	137	3.08344661811176E-4	3.6257198509485097E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	5	1	0	3	0	25	35	-1	38	44													Vb 3	CASIEGANYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACCGACAGGTAGGAGGGCAGATACGCAGTATTTTGGCCCA	CASRPTGRRADTQYF	In	VDJ	2	139	3.1284604373542677E-4	3.6786500677506775E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	6	2	4	4	3	8	25	36	45	39	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASRPTGRRADTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCTCGGACTAGCGTGATAGAGACCCAGTACTTCGGGCCA	CASSPRTSVIETQYF	In	VDJ	2	142	3.195981166218029E-4	3.7580453929539294E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	1	6	4	4	4	25	37	50	41	54						01,02							Vb 3	CASSPRTSVIETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCGCAGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPAGSNQPQHF	In	VDJ	2	145	3.26350189508179E-4	3.8374407181571813E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	4	0	4	0	25	37	-1	41	45													Vb 3	CASSPAGSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTCTCGACTAGCGGGAGTGGAGAGACCCAGTACTTCGGGCCA	CASSLSTSGSGETQYF	In	VDJ	2	149	3.353529533566805E-4	3.9433011517615174E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	2	2	4	5	3	25	37	54	42	57													Vb 3	CASSLSTSGSGETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCAAGCGGGCTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPSGLSYNEQFF	In	VDJ	2	151	3.398543352809312E-4	3.9962313685636857E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	6	4	0	4	2	25	36	46	40	48						01,02							Vb 3	CASSPSGLSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCAGGGACAGGGGGCAACACTGAAGCTTTCTTTGGACAA	CASSPGTGGNTEAFF	In	VDJ	2	152	3.421050262430566E-4	4.02269647696477E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	0	2	4	0	25	36	-1	40	52													Vb 3	CASSPGTGGNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCAGACATCTATGTACCTCTGTGCCAGCAGTCTACGCAGAACTTTAGACAGGGAGATTAGGTCCTACGAGCAGTACTTCGGGCCG	CASSLRRTLDREIRSYEQYF	In	VDJ	2	161	3.6236124490218497E-4	4.2608824525745256E-4	60	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	3	1	15	8	21	33	55	48	63													Vb 3	CASSLRRTLDREIRSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGCCCGGGACAGGAAGAGGTGAGCAGTTCTTCGGGCCA	CASSLPGTGRGEQFF	In	VDJ	2	163	3.668626268264357E-4	4.313812669376694E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	4	9	4	6	25	39	51	43	57													Vb 3	CASSLPGTGRGEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCACCGGGACTAGCGGGAGGGCCTTGTGGAATGAGCAGTTCTTCGGGCCA	CASSTGTSGRALWNEQFF	In	VDJ	2	164	3.691133177885611E-4	4.3402777777777775E-4	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	0	0	7	4	8	25	36	56	40	64													Vb 3	CASSTGTSGRALWNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCGCTACTAAGGGGAATCGCAATGAGCAGTTCTTCGGGCCA	CASTATKGNRNEQFF	In	VDJ	2	170	3.8261746356131333E-4	4.499068428184282E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	5	2	6	9	5	25	35	49	44	54													Vb 3	CASTATKGNRNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGGGACAACCTAACACTGAAGCTTTCTTTGGACAA	CASSSGQPNTEAFF	In	VDJ	2	170	3.8261746356131333E-4	4.499068428184282E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	6	2	1	4	25	38	45	39	49													Vb 3	CASSSGQPNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGGACAGGGCCATACGAGCAGTACTTCGGGCCG	CASSLWTGPYEQYF	In	VDJ	2	175	3.938709183719402E-4	4.631393970189702E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	3	4	0	3	25	-1	49	42	52													Vb 3	CASSLWTGPYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACCGGACGGATGGGAGACCCAGTACTTCGGGCCA	CASSLPDGWETQYF	In	VDJ	2	177	3.9837230029619094E-4	4.68432418699187E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	2	1	7	5	2	6	25	40	46	42	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLPDGWETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCATACAGGCTTCTACGGGGGACACTGAAGCTTTCTTTGGACAA	CASSSIQASTGDTEAFF	In	VDJ	2	185	4.163778279931939E-4	4.896045054200542E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	8	2	3	15	0	25	38	-1	53	59													Vb 3	CASSSIQASTGDTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCTCTCTAGCGGCCCCCCAGACCCAGTACTTCGGGCCA	CASSFSLAAPQTQYF	In	VDJ	3	210	4.726451020463282E-4	5.557672764227642E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	4	5	6	4	6	25	39	50	43	56						01,02							Vb 3	CASSFSLAAPQTQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACAGATTAGTACCCCCAATGAGCAGTTCTTCGGGCCA	CASSLQISTPNEQFF	In	VDJ	3	223	5.019040845539581E-4	5.901719173441734E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-01	01	2	4	5	6	0	11	25	-1	43	40	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLQISTPNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGACCGGGACAGGGGGATACAATGAGCARTTCTTCGGGCCA	CASRTGTGGYNEQFF	In	VDJ	3	226	5.086561574403342E-4	5.981114498644986E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	1	4	4	1	25	36	51	40	52													Vb 3	CASRTGTGGYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGGTATCGATTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSSVSISSYNEQFF	In	VDJ	3	251	5.649234314934685E-4	6.642742208672087E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	5	8	0	10	0	25	38	-1	48	51						01,02							Vb 3	CASSSVSISSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTTCCGGGACAACCACCACACTGAAGCTTTCTTTGGACAA	CASSFRDNHHTEAFF	In	VDJ	3	267	6.009344868874745E-4	7.066183943089431E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	6	3	5	6	25	36	47	41	53													Vb 3	CASSFRDNHHTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGATCACTAGCGGCACCGGGGAGCTGTTTTTTGGAGAA	CASRITSGTGELFF	In	VDJ	4	282	6.346948513193551E-4	7.463160569105692E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	3	5	4	4	0	25	36	-1	40	48						01,02							Vb 3	CASRITSGTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGATGGGGCCAATCAGCCCCAGCATTTTGGTGAT	CASSLDGANQPQHF	In	VDJ	4	309	6.954635072967401E-4	8.177718495934959E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	7	0	3	3	0	25	40	-1	43	48													Vb 3	CASSLDGANQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCGTAACCCTYGGAACCCCCAATCAGCCCCAGCATTTTGGTGAT	CAVTLGTPNQPQHF	In	VDJ	4	310	6.977141982588655E-4	8.204183604336044E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	11	1	8	3	9	5	25	31	43	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CAVTLGTPNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCGCCCCCAGGGGGCCCCAGCATTTTGGTGAT	CASTAPRGPQHF	In	VDJ	4	348	7.832404548196296E-4	9.209857723577236E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	4	2	9	7	0	25	35	-1	42	48													Vb 3	CASTAPRGPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCTGGCCGCGGAGTGACTATGGCTACACCTTCGGTTCG	CASSFWPRSDYGYTF	In	VDJ	5	369	8.305049650242625E-4	9.765625E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	7	5	3	6	4	25	39	49	45	53						01,02							Vb 3	CASSFWPRSDYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTTTCGGGGGAGCACTGAAGCTTTCTTTGGACAA	CASSFRGSTEAFF	In	VDJ	5	373	8.39507728872764E-4	9.871485433604337E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	2	4	4	2	25	36	46	40	48													Vb 3	CASSFRGSTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGAGGGCCAGAAGCCCCAGCATTTTGGTGAT	CASSLEGQKPQHF	In	VDJ	5	394	8.867722390773967E-4	0.00104272527100271	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	10	0	8	0	5	25	-1	45	39	50													Vb 3	CASSLEGQKPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTATGAGGGAAGAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	5	400	9.00276384850149E-4		40	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	11	0	5	2	3	25	37	44	39	47													Vb 3	X+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGTCTCCGGCACAGATACGCAGTATTTTGGCCCA	CASSFVSGTDTQYF	In	VDJ	5	421	9.475408950547818E-4	0.001114181063685637	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	4	10	1	3	3	25	39	44	42	47						01,02							Vb 3	CASSFVSGTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGTACCTCTGTGCCAGCAGCCCCTCCCACAGGGAATTTAAGGCGGGCCGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPSHREFKAGRSYNEQFF	In	VDJ	6	477	0.0010735795889338026	0.0012623856707317074	63	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	3	0	8	16	8	19	33	27	49													Vb 3	CASSPSHREFKAGRSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGGAGGGGCTCCCACAATGAGCAGTTCTTCGGGCCA	CASSLGRGSHNEQFF	In	VDJ	6	507	0.0011411003177975638	0.0013417809959349594	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	9	0	5	0	6	25	-1	47	40	53													Vb 3	CASSLGRGSHNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAATGGGGAGCTTCACAGATACGCAGTATTTTGGCCCA	CASSLMGSFTDTQYF	In	VDJ	8	596	0.001341411813426722	0.001577320460704607	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	9	2	2	3	3	25	40	48	43	51													Vb 3	CASSLMGSFTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAGTTACTAGGGTCCCACTACGAGCAGTACTTCGGGCCG	CASKLLGSHYEQYF	In	VDJ	9	706	0.001588987819260513	0.0018684366531165311	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	3	8	3	4	7	25	35	44	39	51						01,02							Vb 3	CASKLLGSHYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTGGACAGGGGAACAGCCCCAGCATTTTGGTGAT	CASSWTGEQPQHF	In	VDJ	11	856	0.0019265914635793189	0.0022654132791327915	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	2	7	2	2	25	36	47	38	49													Vb 3	CASSWTGEQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTTAGGAGCCGGGACTGCCGTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASLGAGTAVSGANVLTF	In	VDJ	12	933	0.0020998946676629724	0.002469194613821138	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	8	0	10	0	9	5	25	34	49	43	54						01,02							Vb 3	CASLGAGTAVSGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD02-01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAAAAAATGACAGGGTCTAGTGGGGAGCAGTACTTCGGGCCG	CASKKMTGSSGEQYF	In	VDJ	12	963	0.0021674153965267336	0.0025485899390243903	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	2	3	7	7	9	25	35	49	42	58													Vb 3	CASKKMTGSSGEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCGGGAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLSGSNQPQHF	In	VDJ	13	1049	0.0023609748192695156	0.0027761898712737126	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	8	3	1	0	0	25	-1	-1	41	46													Vb 3	CASSLSGSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGGCTTCAGGGGGGCTAGGGGAGCTGTTTTTTGGAGAA	CASRASGGLGELFF	In	VDJ	15	1154	0.00259729737029268	0.0030540735094850948	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	1	8	5	4	25	36	48	41	52													Vb 3	CASRASGGLGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGACGGGGGGGCCCCAGGTGAGAAGCAGTACTTCGGGCCG	CASSFDGGAPGEKQYF	In	VDJ	16	1259	0.002833619921315844	0.003331957147696477	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	8	0	8	3	12	25	39	50	42	62													Vb 3	CASSFDGGAPGEKQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCTACAGGGGCAAGTAAACACCATATATTTTGGAGAG	CASSSLQGQVNTIYF	In	VDJ	18	1445	0.0032522484402711634	0.0038242081639566394	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	2	6	4	5	25	38	49	42	54													Vb 3	CASSSLQGQVNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGTTCCTCTGGAGACTACGAGCAGTACTTCGGGCCG	CASSSGDYEQYF	In	VDJ	22	1728	0.003889193982552644	0.004573170731707317	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	9	10	2	3	7	1	25	33	44	40	45													Vb 3	CASSSGDYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGAACGGCGGTGCCACAGATACGCAGTATTTTGGCCCA	CASSLNGGATDTQYF	In	VDJ	24	1882	0.004235800390719951	0.004980733401084011	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	7	5	2	5	3	25	39	48	44	51						01,02							Vb 3	CASSLNGGATDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCACAGGGGAGGGGCCAAAAACATTCAGTACTTCGGCGCC	CASSHRGGAKNIQYF	In	VDJ	66	5142	0.011573052927248665	0.013608358739837399	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-04	01	5	3	2	1	1	4	25	37	45	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSHRGGAKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01		TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCTCGCCTCGTCCGGGAGAGGCGCTGAAGCTTTCTTTGGACAA	CASLASSGRGAEAFF	In	VDJ	93	7242	0.016299503947711947	0.01916603150406504	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	8	8	2	6	11	5	25	34	51	45	56													Vb 3	CASLASSGRGAEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTAAAGTAGCGGGAGGGCCTGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	25	5.6267274053134314E-5		49	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	5	0	5	3	5	18	33	47	36	52														X+TCRBV12-02+TCRBJ02-05	TCRBV12-02*01	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCCCAAGGGCGGGGAGGGTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	27	6.076865597738506E-5		41	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	9	0	9	9	0	18	30	-1	39	46														X+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCACCGAACTAATAGCGGGAGGGCCGTGGGCAGATACGCAGTATTTTGGCCCA	CATELIAGGPWADTQYF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	51	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	12	5	0	4	11	7	18	23	45	34	52														CATELIAGGPWADTQYF+TCRBV12-02+TCRBJ02-03	TCRBV12-02*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGTCAGAAGTCTTACCCTCCCCGGGGGGTCCATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	32	7.202211078801193E-5		50	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	13	8	1	5	19	3	18	22	48	41	51														X+TCRBV12-02+TCRBJ01-05	TCRBV12-02*01	TCRBD02-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCSTGTATSTCTGTGCAAGTCGCTTAAGTTGGTCGGACTAGCGGGAGTCCCGCGGGTTCTACGAGCAGTACTTCGGGCCG	CASRLSWSD*RESRGFYEQYF	Stop	VDJ	1	41	9.227832944714028E-5		63	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	1	2	3	8	11	18	33	54	41	65														CASRLSWSD*RESRGFYEQYF+TCRBV12-02+TCRBJ02-07	TCRBV12-02*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTAGCGGGGCAGCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	43	9.677971137139102E-5		47	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	7	0	0	0	4	18	-1	40	35	44														X+TCRBV12-02+TCRBJ02-03	TCRBV12-02*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCCAATTCGACCGGGGAAGAGGTATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	56	1.2603869387902087E-4		44	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	12	8	3	8	10	7	18	23	38	33	45														X+TCRBV12-02+TCRBJ01-06	TCRBV12-02*01	TCRBD02-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCGCCCTCTTTGAGGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	62	1.395428396517731E-4		46	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	11	2	1	9	0	18	30	-1	39	42														X+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01	TCRBD02-01*02	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCCTCGAAGAAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	68	1.5304698542452532E-4		46	TCRBV12	TCRBV12-02	01				TCRBJ02	TCRBJ02-06	01	5	2	8	5	3	9	18	30	35	33	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-02+TCRBJ02-06	TCRBV12-02*01		TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTCCTAAGTGATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	76	1.710525131215283E-4		43	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	4	9	0	1	5	18	32	36	33	41						01,02								X+TCRBV12-02+TCRBJ01-01	TCRBV12-02*01	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCCAGAGGACCGGGACAGGGGCCGGGGAGCTGTTTTTTGGAGAA	CAQRTGTGAGELFF	In	VDJ	1	77	1.7330320408365368E-4	2.0378133468834688E-4	42	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	12	0	2	6	10	0	18	23	-1	33	43														CAQRTGTGAGELFF+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTAGCGTCGAGGGGATCTCAGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	100	2.2506909621253726E-4		49	TCRBV12	TCRBV12-02	01				TCRBJ02	TCRBJ02-03	01	0	5	2	5	4	7	18	35	44	39	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-02+TCRBJ02-03	TCRBV12-02*01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTAGGACAGGGAGATAGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	259	5.829289591904714E-4		49	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	3	1	0	7	18	-1	41	34	48														X+TCRBV12-02+TCRBJ01-01	TCRBV12-02*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGGACTCGGCCCTGTATCTCTGTGCCAGCAGCCAGGAAGTGAATCAGCCCCAGCATTTTGGTGAT	CASSQEVNQPQHF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	39	TCRBV05	TCRBV05-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	4	4	0	5	20	-1	36	32	41														CASSQEVNQPQHF+TCRBV05-08+TCRBJ01-05	TCRBV05-08*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTCGTCCCGGGACAGGGAACGGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	28	6.301934693951043E-5		49	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	3	4	5	5	22	36	50	41	55														X+TCRBV07-01+TCRBJ01-01	TCRBV07-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCAAGGGCCCCAAAAACATTCAGTACTTCGGCGCC	CASSKGPKNIQYF	In	VDJ	1	40	9.00276384850149E-5	1.0586043360433605E-4	39	TCRBV07	TCRBV07-01	01				TCRBJ02	TCRBJ02-04	01	5	5	3	2	1	2	22	34	39	35	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSKGPKNIQYF+TCRBV07-01+TCRBJ02-04	TCRBV07-01*01		TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCCCCGGAGCCAGCCACAATGAGCAGTTCTTCGGGCCA	CASSPGASHNEQFF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	42	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	10	2	5	3	6	22	34	41	37	47														CASSPGASHNEQFF+TCRBV07-01+TCRBJ02-01	TCRBV07-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAGGTGTTTCCTACGAGCAGTACTTCGGGCCG	CASSLGVSYEQYF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	39	TCRBV07	TCRBV07-01	01				TCRBJ02	TCRBJ02-07	01	4	5	4	1	1	4	22	35	39	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGVSYEQYF+TCRBV07-01+TCRBJ02-07	TCRBV07-01*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCAGGGGGCGCAGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	47	1.057824752198925E-4		38	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	5	0	8	0	4	22	-1	41	34	45														X+TCRBV07-01+TCRBJ01-04	TCRBV07-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAAGTGTGGGAGATACGCAGTATTTTGGCCCA	CASSLSVGDTQYF	In	VDJ	1	64	1.4404422157602385E-4	1.6937669376693767E-4	39	TCRBV07	TCRBV07-01	01				TCRBJ02	TCRBJ02-03	01	4	0	9	5	7	0	22	35	-1	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSVGDTQYF+TCRBV07-01+TCRBJ02-03	TCRBV07-01*01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAGAGTTAAATGAAAAACTGTTTTTTGGCAGT	CASSLELNEKLFF	In	VDJ	1	103	2.3182116909891337E-4	2.7259061653116533E-4	39	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	4	5	8	5	0	5	22	-1	38	35	43						01,02								CASSLELNEKLFF+TCRBV07-01+TCRBJ01-04	TCRBV07-01*01	TCRBD02-01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAGCGGGTGCCGGGGAGCTGTTTTTTGGAGAA	CASSLAGAGELFF	In	VDJ	2	169	3.8036677259918795E-4	4.472603319783198E-4	39	TCRBV07	TCRBV07-01	01				TCRBJ02	TCRBJ02-02	01	0	0	9	6	0	2	22	-1	42	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAGAGELFF+TCRBV07-01+TCRBJ02-02	TCRBV07-01*01		TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTCTACGAGACAAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	4	284	6.391962332436058E-4		43	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	6	1	5	1	22	36	45	41	46														X+TCRBV07-01+TCRBJ01-01	TCRBV07-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCACCGGACAGGGGGCAGGGGAGCAGTACTTCGGGCCG	CASTGQGAGEQYF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	39	TCRBV07	TCRBV07-08		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	0	7	2	4	20	30	43	32	47			01,02											CASTGQGAGEQYF+TCRBV07-08+TCRBJ02-07	TCRBV07-08	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCAGCTTTGGGACTAGCGGGGATCAGTACTTCGGGCCG	CASSFGTSGDQYF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	39	TCRBV07	TCRBV07-08		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	0	3	10	1	2	20	34	48	35	50			01,02											CASSFGTSGDQYF+TCRBV07-08+TCRBJ02-07	TCRBV07-08	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCAGCGTTAGGGGCGAAACTAGCACAGATACGCAGTATTTTGGCCCA	CASSVRGETSTDTQYF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	48	TCRBV07	TCRBV07-08		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	5	2	0	3	7	20	32	40	35	47			01,02											CASSVRGETSTDTQYF+TCRBV07-08+TCRBJ02-03	TCRBV07-08	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCAGCCCCCAGACAGGGATGGGTGGCTACACCTTCGGTTCG	CASSPQTGMGGYTF	In	VDJ	1	35	7.877418367438804E-5	9.262787940379404E-5	42	TCRBV07	TCRBV07-08		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	3	7	5	5	20	32	44	37	49			01,02											CASSPQTGMGGYTF+TCRBV07-08+TCRBJ01-02	TCRBV07-08	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GTGCGCTCCCAGACATCTGTGTATTCTGCGCCAGCAGAAAAAGACCTCATGTTTGACAGGACCTACTACGAGCAGTACTTCGGGCCG	APAEKDLMFDRTYYEQYF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	54	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	19	2	4	3	29	5	27	25	60	54	65													Vb 12	APAEKDLMFDRTYYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGGTGGTAGCGGGGGCAGATACGCAGTATTTTGGCCCA	CASSESVVAGADTQYF	In	VDJ	1	24	5.401658309100894E-5	6.351626016260163E-5	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	5	2	4	5	0	23	40	-1	45	54													Vb 12	CASSESVVAGADTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACTTCGACGGGGTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	26	5.851796501525969E-5		41	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	8	3	0	6	0	23	33	-1	39	44													Vb 12	X+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAATTTATCTGAGCATATGATGGCTACACCTTCGGTTCG	CASSEFI*AYDGYTF	Stop	VDJ	1	28	6.301934693951043E-5		45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	6	7	6	9	5	23	37	49	46	54						01,02							Vb 12	CASSEFI*AYDGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD02-01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCAGGGCCTAATCAGCCCCAGCATTTTGGTGAT	CASSESGPNQPQHF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	42	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-05	01	0	5	3	4	0	3	23	-1	44	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSESGPNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCCTGATGACTAGCGGGAGGCCATCCCAATGAGCAGTTCTTCGGGCCA	CASSES**LAGGHPNEQFF	Stop	VDJ	1	36	8.10248746365134E-5		57	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	2	1	6	5	6	23	40	58	45	64													Vb 12	CASSES**LAGGHPNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTCCCTACCGGGACCCTCGTCCATACGAGCAGTACTTCGGGCCG	CASSPYRDPRPYEQYF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	48	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-07	01	5	0	7	4	7	9	23	35	47	42	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSPYRDPRPYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGACTCGCGGGTTCGGCGCAGATACGCAGTATTTTGGCCCA	CASSESTRGFGADTQYF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	51	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	7	4	4	5	7	23	40	50	45	57						01,02							Vb 12	CASSESTRGFGADTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACCGGACAGGCGTCATCCTACGAGCAGTACTTCGGGCCG	CASTGQASSYEQYF	In	VDJ	1	40	9.00276384850149E-5	1.0586043360433605E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	4	1	2	5	23	33	42	35	47													Vb 12	CASTGQASSYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCTGGGTTCAATCAGCCCCAGCATTTTGGTGAT	CASSESGFNQPQHF	In	VDJ	1	41	9.227832944714028E-5	1.0850694444444444E-4	42	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-05	01	0	0	9	3	1	2	23	40	44	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSESGFNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCACCGGTACATCGGGGGATGAGGGCGAGCAGTACTTCGGGCCG	CATGTSGDEGEQYF	In	VDJ	1	53	1.1928662099264474E-4	1.4026507452574526E-4	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	10	8	2	6	9	7	23	30	45	39	52													Vb 12	CATGTSGDEGEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGGTAGCGGGAGTACAAAGTACGAGCAGTACTTCGGGCCG	CASSGSGSTKYEQYF	In	VDJ	1	54	1.2153731195477012E-4	1.4291158536585365E-4	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	5	2	4	1	7	23	36	46	37	53													Vb 12	CASSGSGSTKYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCATTGCCCGAAGCGGGGGAATCGGCACTGAAGCTTTCTTTGGACAA	CAIARSGGIGTEAFF	In	VDJ	1	57	1.2828938484114622E-4	1.5085111788617887E-4	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	10	6	2	4	8	6	23	30	46	38	52													Vb 12	CAIARSGGIGTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGGGGGCCGTACTGAAGCTTTCTTTGGACAA	CASSGGRTEAFF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	36	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	7	0	5	0	3	23	-1	41	36	44													Vb 12	CASSGGRTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCGGAGGACAGGGGGGCCCTGAAGCTTTCTTTGGACAA	CAGGQGGPEAFF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	36	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	11	1	1	6	3	3	23	29	42	32	45													Vb 12	CAGGQGGPEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCTGGGGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSESGGSGANVLTF	In	VDJ	1	62	1.395428396517731E-4	1.6408367208672087E-4	48	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-06	01	0	6	1	0	1	0	23	40	-1	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSESGGSGANVLTF+TCRBV10-02+TCRBJ02-06	TCRBV10-02*01		TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGGCCGCGGGAAAAGAGACCCAGTACTTCGGGCCA	CASRAAGKETQYF	In	VDJ	1	65	1.462949125381492E-4	1.7202320460704606E-4	39	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	7	3	3	4	1	23	34	44	38	45													Vb 12	CASRAAGKETQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCAGACAAAGCTCTGGAAACACCATATATTTTGGAGAG	CASSRQSSGNTIYF	In	VDJ	1	72	1.620497492730268E-4	1.9054878048780488E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	2	6	0	2	3	23	34	40	36	43													Vb 12	CASSRQSSGNTIYF+TCRBV10-02+TCRBJ01-03	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGACCCGGGACAGCTCAATGAGCAGTTCTTCGGGCCA	CASSDPGQLNEQFF	In	VDJ	1	74	1.6655113119727757E-4	1.958418021680217E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	5	6	3	2	23	37	47	40	49													Vb 12	CASSDPGQLNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCCGGACTATCCGGTTTAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	77	1.7330320408365368E-4		40	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	1	9	5	1	8	23	32	39	33	47						01,02							Vb 12	X+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGGGACAGGGAGAGTCACCCCTCCACTTTGGGAAC	CASRGQGESPLHF	In	VDJ	1	81	1.8230596793215517E-4	2.143673780487805E-4	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	3	10	0	4	23	-1	43	34	47													Vb 12	CASRGQGESPLHF+TCRBV10-02+TCRBJ01-06	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGTTGGAGAGTTGAACACTGAAGCTTTCTTTGGACAA	CASSEVGELNTEAFF	In	VDJ	1	93	2.0931425947765965E-4	2.461255081300813E-4	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	10	2	0	3	3	23	38	45	41	48													Vb 12	CASSEVGELNTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD02-01*02	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGATGATTTGGTCAAGGAGCAGTTCTTCGGGCCA	CASSDDLVKEQFF	In	VDJ	1	98	2.205677142882865E-4	2.593580623306233E-4	39	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-01	01	3	0	10	10	6	5	23	37	45	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSDDLVKEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGGGGACGGGATGAACACTGAAGCTTTCTTTGGACAA	CASSGDGMNTEAFF	In	VDJ	1	103	2.3182116909891337E-4	2.7259061653116533E-4	42	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-01	01	4	0	7	0	0	4	23	-1	41	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSGDGMNTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAATGTGACAGGGGACAGTTGGCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	104	2.3407186006103875E-4		50	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	2	2	3	4	8	23	33	45	37	53													Vb 12	X+TCRBV10-02+TCRBJ01-04	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTTTTCTAGCGGGGGCGCCAGCTCCTACGAGCAGTACTTCGGGCCG	CASSEFSSGGASSYEQYF	In	VDJ	1	106	2.3857324198528948E-4	2.805301490514905E-4	54	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	4	2	0	3	6	23	39	52	42	58													Vb 12	CASSEFSSGGASSYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGGGGCAAAGGGTAGCCCGGATACGCAGTATTTTGGCCCA	CASSGAKGSPDTQYF	In	VDJ	1	116	2.610801516065432E-4	3.069952574525745E-4	45	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-03	01	4	5	3	6	6	7	23	36	46	42	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSGAKGSPDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGTTGGAACAGGGATTTTCAACTGCGGGGAGCTGTTTTTTGGAGAA	CASSVGTGIFNCGELFF	In	VDJ	2	120	2.700829154550447E-4	3.175813008130081E-4	51	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	3	3	7	5	11	23	36	47	41	58													Vb 12	CASSVGTGIFNCGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCATCCAAGAGGGAACAGGAGACAATGAGCAGTTCTTCGGGCCA	CAIQEGTGDNEQFF	In	VDJ	2	135	3.038432798869253E-4	3.5727896341463414E-4	42	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-01	01	10	3	4	5	11	2	23	30	46	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAIQEGTGDNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGAGAGGGAGGCACATTCAGTACTTCGGCGCC	CASSESRGRHIQYF	In	VDJ	2	155	3.4885709912943274E-4	4.102091802168022E-4	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	0	9	1	8	4	1	23	40	50	44	51													Vb 12	CASSESRGRHIQYF+TCRBV10-02+TCRBJ02-04	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCGCCGGGACACCCTACGAGCAGTACTTCGGGCCG	CASAGTPYEQYF	In	VDJ	2	177	3.9837230029619094E-4	4.68432418699187E-4	36	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	0	6	2	3	1	23	32	41	35	42													Vb 12	CASAGTPYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGGGCCTTAATCAGCCCCAGCATTTTGGTGAT	CASSESGLNQPQHF	In	VDJ	3	221	4.974027026297073E-4	5.848788956639567E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	8	0	4	0	3	23	-1	44	40	47													Vb 12	CASSESGLNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCATTAACGGGGGCGGGATGGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	235	5.289123760994625E-4		44	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-07	01	7	6	0	4	5	8	23	33	44	38	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCCCAGACATCTGTGTATTTCTGCGCCAGCGATTAGCCGTTAGGACTAGCGGGTCCTAGGCTCCGAGATACGCAGTATTTTGGCCCA	CASD*PLGLAGPRLRDTQYF	Stop	VDJ	4	287	6.459483061299819E-4		60	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	1	4	5	12	12	21	30	53	42	65						01,02							Vb 12	CASD*PLGLAGPRLRDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGGGGGATGGCTACACCTTCGGTTCG	CAISESGDGYTF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	36	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-02	01	0	6	1	6	0	0	23	-1	-1	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESGDGYTF+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCTATGGCGGGATCCTACAATGAGCAGTTCTTCGGGCCA	CAISESMAGSYNEQFF	In	VDJ	1	37	8.327556559863878E-5	9.792090108401084E-5	48	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	7	3	1	4	0	23	40	-1	44	50													Vb 12	CAISESMAGSYNEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCTGGGAACGAGCAGTACTTCGGGCCG	CAISESGNEQYF	In	VDJ	1	46	1.0353178425776714E-4	1.2173949864498645E-4	36	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-07	01	0	0	8	5	1	0	23	40	-1	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESGNEQYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGAGGTATGAAGAGACCCAGTACTTCGGGCCA	CAISERYEETQYF	In	VDJ	1	55	1.2378800291689549E-4	1.4555809620596207E-4	39	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-05	01	2	5	4	3	0	4	23	-1	41	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISERYEETQYF+TCRBV10-03+TCRBJ02-05	TCRBV10-03*01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGACTCGCGATCAGCCCCAGCATTTTGGTGAT	CAISESTRDQPQHF	In	VDJ	1	67	1.5079629446239996E-4	1.7731622628726286E-4	42	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	2	10	5	0	4	23	-1	44	40	48						01,02							Vb 12	CAISESTRDQPQHF+TCRBV10-03+TCRBJ01-05	TCRBV10-03*01	TCRBD02-01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGACGGGACTAGTCCTCCTCGAGCAGTACTTCGGGCCG	CAISESTGLVLLEQYF	In	VDJ	1	96	2.1606633236403576E-4	2.5406504065040653E-4	48	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	0	8	6	3	7	23	40	51	43	58						01,02							Vb 12	CAISESTGLVLLEQYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTACGACGGACAGGCTCATTCCTACGAGCAGTACTTCGGGCCG	CAISEYDGQAHSYEQYF	In	VDJ	1	106	2.3857324198528948E-4	2.805301490514905E-4	51	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	4	1	5	5	23	39	51	44	56													Vb 12	CAISEYDGQAHSYEQYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGAAGGGAAGGGACACCGGGGAGCTGTTTTTTGGAGAA	CAISESKGRDTGELFF	In	VDJ	2	124	2.790856793035462E-4	3.2816734417344173E-4	48	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-02	01	0	0	8	3	3	4	23	40	47	43	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESKGRDTGELFF+TCRBV10-03+TCRBJ02-02	TCRBV10-03*01		TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGGACCAAACCGGGGAGCTGTTTTTTGGAGAA	CAISESDQTGELFF	In	VDJ	3	222	4.996533935918327E-4	5.875254065040651E-4	42	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-02	01	0	1	7	5	0	3	23	-1	44	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESDQTGELFF+TCRBV10-03+TCRBJ02-02	TCRBV10-03*01		TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCTCCAGGGAGCTCCTACGAGCAGTACTTCGGGCCG	CAISESPGSSYEQYF	In	VDJ	3	245	5.514192857207162E-4	6.483951558265582E-4	45	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-07	01	0	4	3	0	2	2	23	40	47	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESPGSSYEQYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCTGCCTCGGACATCTCTGGAAACACCATATATTTTGGAGAG	CAISESASDISGNTIYF	In	VDJ	9	675	0.0015192163994346265	0.0017863948170731708	51	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	1	6	0	6	1	23	40	51	46	52													Vb 12	CAISESASDISGNTIYF+TCRBV10-03+TCRBJ01-03	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGTCTCACAAGCAATACGATGTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSMSHKQYDVSYNEQFF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	57	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	3	3	6	0	5	13	24	38	46	43	59			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMSHKQYDVSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAAGCCAGTATGCTTGTTGGCTACACCTTCGGTTCG	CASSIEASMLVGYTF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	0	4	5	7	3	9	27	44	50	47	59			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIEASMLVGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGAGATACGCAGTATTTTGGCCCA	CASSIGDTQYF	In	VJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	33	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	1	0	0	5	0	1	27	-1	43	-1	44			01,02										Vb 17	CASSIGDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGACAGATGGAGACCCAGTACTTCGGGCCA	CASSIGQMETQYF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	1	5	5	1	3	27	41	48	42	51			01,02										Vb 17	CASSIGQMETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGTCGGACGGACCCACAGATACGCAGTATTTTGGCCCA	CASSMSDGPTDTQYF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	3	1	7	2	3	5	27	41	48	44	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMSDGPTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCAATAAGACAGGGCCGGGCCACTGAAGCTTTCTTTGGACAA	CASSSIRQGRATEAFF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	3	4	7	6	27	39	53	46	59			01,02										Vb 17	CASSSIRQGRATEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCTCGGCGGGGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASTLGGGSNQPQHF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	7	7	2	0	6	0	27	37	-1	43	50			01,02										Vb 17	CASTLGGGSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGACACCGTGAGGTATGGCTACACCTTCGGTTCG	CASSIDTVRYGYTF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	11	1	5	6	0	27	44	-1	50	54			01,02										Vb 17	CASSIDTVRYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGACGAGGCGCACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	28	6.301934693951043E-5		41	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	11	1	3	4	3	27	40	48	44	51			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCTTCGGGGGAAACTATGGCTACACCTTCGGTTCG	CASSPFGGNYGYTF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	2	2	5	1	27	39	50	44	51			01,02										Vb 17	CASSPFGGNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGCAAGCCACGTTTGGTGCCAAAAGAACCCGACAGCTTCTATCTCTGTGCCAGTAAACAGGGAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	29	6.52700379016358E-5		35	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	25	3	3	2	18	1	46	38	62	56	63			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAAGGGTGGCTACACCTTCGGTTCG	CASSIKGGYTF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	33	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	2	5	3	7	1	0	27	42	-1	43	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIKGGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACAACCAAGAATCAGCCCCAGCATTTTGGTGAT	CASSTTKNQPQHF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	4	3	7	4	2	4	27	40	44	42	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTTKNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGCAGCTATGGCTACACCTTCGGTTCG	CASSSSYGYTF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	5	4	1	0	27	40	-1	41	44			01,02										Vb 17	CASSSSYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACCCCCGGGGCGCGAGCAGTACTTCGGGCCG	CASSIPPGREQYF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	2	7	0	6	5	1	27	42	52	47	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIPPGREQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCCCCCCACTGAAGCTTTCTTTGGACAA	CASSIDPPTEAFF	In	VJ	1	33	7.427280175013729E-5	8.733485772357724E-5	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	0	0	0	4	0	6	27	-1	44	-1	50			01,02										Vb 17	CASSIDPPTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGGGTTCAGGGGGCCCAGCATTTTGGTGAT	CASSMGVQGAQHF	In	VDJ	1	33	7.427280175013729E-5	8.733485772357724E-5	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	1	11	7	0	27	41	-1	48	55			01,02										Vb 17	CASSMGVQGAQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCCGGGTGACTAATGAAAAACTGTTTTTTGGCAGT	CASSSRVTNEKLFF	In	VDJ	1	33	7.427280175013729E-5	8.733485772357724E-5	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	8	4	2	3	2	27	39	46	42	48			01,02			01,02							Vb 17	CASSSRVTNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGAACTCGGTACTCCAGGGGATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	34	7.652349271226266E-5		46	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	9	4	2	5	12	0	27	35	-1	47	53			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCGAACCAGGGTCGCGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASTEPGSRSGANVLTF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	7	4	3	0	6	5	27	37	48	43	53			01,02										Vb 17	CASTEPGSRSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCTCAACAGGACCAACTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	36	8.10248746365134E-5		43	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	3	4	0	5	5	27	35	45	40	50			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGTTGCGGGGGGACCTACAAGAGACCCAGTACTTCGGGCCA	CASSMLRGDLQETQYF	In	VDJ	1	36	8.10248746365134E-5	9.527439024390244E-5	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	7	1	2	3	5	27	41	52	44	57			01,02										Vb 17	CASSMLRGDLQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTGGCTATAGCAGATACGCAGTATTTTGGCCCA	CASSLAIADTQYF	In	VDJ	1	36	8.10248746365134E-5	9.527439024390244E-5	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	5	9	0	4	2	5	27	39	44	41	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSLAIADTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATAGCCAGGGGCTATGGCTACACCTTCGGTTCG	CASIARGYGYTF	In	VDJ	1	36	8.10248746365134E-5	9.527439024390244E-5	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	2	4	4	0	27	37	-1	41	47			01,02										Vb 17	CASIARGYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATCCGCCCAGCGGAAGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASNPPSGRNTGELFF	In	VDJ	1	37	8.327556559863878E-5	9.792090108401084E-5	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	6	5	1	8	3	27	37	50	45	53			01,02			01,02							Vb 17	CASNPPSGRNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCGAGGGACAGGTGAAAAACTGTTTTTTGGCAGT	CASSRGTGEKLFF	In	VDJ	1	37	8.327556559863878E-5	9.792090108401084E-5	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	4	7	4	0	27	38	-1	42	50			01,02										Vb 17	CASSRGTGEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGGGACAGGAACAATCAGCCCCAGCATTTTGGTGAT	CASSRDRNNQPQHF	In	VDJ	1	37	8.327556559863878E-5	9.792090108401084E-5	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	4	3	1	2	27	39	48	40	50			01,02										Vb 17	CASSRDRNNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTGCAAACCGGGACAGGGGCTTCACCCCTCCACTTTGGGAAC	CASSLQTGTGASPLHF	In	VDJ	1	37	8.327556559863878E-5	9.792090108401084E-5	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	2	9	9	1	27	39	58	48	59			01,02										Vb 17	CASSLQTGTGASPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGGGCCCAAAAGACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	38	8.552625656076415E-5		40	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	7	0	3	0	7	27	-1	43	38	50			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGCAAGCCACGTTTGGTGCCAAAAGAACCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGGTATGGCGAGCAGTACTTCGGGCCG	CASSMGYGEQYF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	3	6	2	6	0	5	45	-1	63	59	68			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMGYGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACAAGACAGGGCTAACACCGGGGAGCTGTTTTTTGGAGAA	CASRQDRANTGELFF	In	VDJ	1	39	8.777694752288953E-5	1.0321392276422765E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	3	2	4	2	27	38	49	42	51			01,02										Vb 17	CASRQDRANTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGGGAACTACGAGCAGTACTTCGGGCCG	CASRGNYEQYF	In	VDJ	1	39	8.777694752288953E-5	1.0321392276422765E-4	33	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	6	0	8	3	1	1	27	38	43	39	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRGNYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGCCCAAGGGTCAGGCGAATAATGGCTACACCTTCGGTTCG	CASSRPKGQANNGYTF	In	VDJ	1	39	8.777694752288953E-5	1.0321392276422765E-4	48	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	4	4	4	6	11	6	27	40	55	51	61			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSRPKGQANNGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCTCTGAGGGGCTCGGTGAAAAACTGTTTTTTGGCAGT	CASSLSEGLGEKLFF	In	VDJ	1	39	8.777694752288953E-5	1.0321392276422765E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	5	5	2	7	7	5	27	39	51	46	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSLSEGLGEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCCCAGGGACTAGGGGTGTTCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	39	8.777694752288953E-5		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	0	8	6	4	7	27	36	48	40	55			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGCTTGGGGGGGCACCCACACCGGGGAGCTGTTTTTTGGAGAA	CASSMAWGGTHTGELFF	In	VDJ	1	40	9.00276384850149E-5	1.0586043360433605E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	9	0	3	5	5	27	41	53	46	58			01,02										Vb 17	CASSMAWGGTHTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTAACCCCGCTCGAGAGCTATGGCTACACCTTCGGTTCG	CASSVTPLESYGYTF	In	VDJ	1	40	9.00276384850149E-5	1.0586043360433605E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	11	2	4	12	2	27	39	54	51	56			01,02										Vb 17	CASSVTPLESYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGTGTCGGCAGAGACCCAGTACTTCGGGCCA	CASSMVSAETQYF	In	VDJ	1	41	9.227832944714028E-5	1.0850694444444444E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	3	9	0	4	6	0	27	41	-1	47	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMVSAETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGAGACAGGGGGCCGGGCTTTCTTTGGACAA	CASSETGGRAFF	In	VDJ	1	41	9.227832944714028E-5	1.0850694444444444E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	0	11	2	3	27	39	51	41	54			01,02										Vb 17	CASSETGGRAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCAAATAGGGAGGATTAGCAATCAGCCCCAGCATTTTGGTGAT	CASTQIGRISNQPQHF	In	VDJ	1	42	9.452902040926564E-5	1.1115345528455284E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	7	9	1	0	8	2	27	37	51	45	53			01,02										Vb 17	CASTQIGRISNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGCGTTGCCACTGAAGCTTTCTTTGGACAA	CASSIGVATEAFF	In	VDJ	1	42	9.452902040926564E-5	1.1115345528455284E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	9	0	4	1	5	27	41	45	42	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGVATEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGCAAGCCACGTTTGGTGCCAAAAGAACCCGACAGCTTTTATCTCTGTGCCAGTAGTATGGGGTATGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	43	9.677971137139102E-5		35	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	24	6	2	6	20	5	46	39	63	59	68			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATTGGGGGGACTGGAGGATACAATGAGCAGTTCTTCGGGCCA	CASIGGTGGYNEQFF	In	VDJ	1	45	1.0128109329564176E-4	1.1909298780487805E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	0	10	4	5	6	27	37	48	42	54			01,02			01,02							Vb 17	CASIGGTGGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACATTCGCGCGCGAGGGGGGGGTCCCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	46	1.0353178425776714E-4		56	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	9	0	5	13	6	25	38	58	51	64			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCACCAGGTACTCCTCTGGGAACACTGAAGCTTTCTTTGGACAA	CASTTRYSSGNTEAFF	In	VDJ	1	47	1.057824752198925E-4	1.2438600948509485E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	4	4	1	4	11	27	37	45	41	56			01,02										Vb 17	CASTTRYSSGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCAGGCAAAGACAGGGGCGAAGGGTGGCTACACCTTCGGTTCG	CATQAKTGAKGGYTF	In	VDJ	1	48	1.0803316618201788E-4	1.2703252032520327E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	2	2	7	10	7	27	34	52	44	59			01,02										Vb 17	CATQAKTGAKGGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCCGGGACACACCGCCGAGCAGTACTTCGGGCCG	CASSIPGHTAEQYF	In	VDJ	1	48	1.0803316618201788E-4	1.2703252032520327E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	6	6	3	6	27	41	50	44	56			01,02										Vb 17	CASSIPGHTAEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCAGCCGGGACAGCTCTTACGAGCAGTACTTCGGGCCG	CASSISRDSSYEQYF	In	VDJ	1	49	1.1028385714414325E-4	1.2967903116531165E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	5	4	5	4	27	41	53	46	57			01,02										Vb 17	CASSISRDSSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGATAGGGGCCTACCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	49	1.1028385714414325E-4		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	5	2	3	3	5	27	39	47	42	52			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGGACCAAGCACAGATACGCAGTATTTTGGCCCA	CASRGPSTDTQYF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	6	0	7	0	0	2	27	-1	43	38	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRGPSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGCGTTGTCCGGGACAGGGGTGTAGACGGCTACACCTTCGGTTCG	CASSMGVVRDRGVDGYTF	In	VDJ	1	51	1.14785239068394E-4	1.3497205284552846E-4	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	2	8	11	7	27	41	62	52	69			01,02										Vb 17	CASSMGVVRDRGVDGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGCGGGTGGGATCAGCCCCAGCATTTTGGTGAT	CASSIGGWDQPQHF	In	VDJ	1	52	1.1703593003051937E-4	1.3761856368563685E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	1	7	4	5	0	4	27	-1	48	43	52			01,02			01,02							Vb 17	CASSIGGWDQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCGTTAAAGGCCCCTTATCAGCCCAGCATTTTGGTGAT	CASSAVKGPLSAQHF	In	VDJ	1	52	1.1703593003051937E-4	1.3761856368563685E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	5	4	5	11	19	0	27	39	-1	58	61			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSAVKGPLSAQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGAATAACCCAGGGGGAATCGACTGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	53	1.1928662099264474E-4		46	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	4	1	4	7	9	27	35	49	42	58			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAATCTCAGGAACACTGAAGCTTTCTTTGGACAA	CASSNLRNTEAFF	In	VDJ	1	53	1.1928662099264474E-4	1.4026507452574526E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	5	1	4	0	27	40	-1	44	47			01,02										Vb 17	CASSNLRNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGCTTTCTATCTCTGTGCCAGTAGTATAGATCTAGTCTAGCGGGAGCCGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSIDLV*REPSSYNEQFF	Stop	VDJ	1	53	1.1928662099264474E-4		60	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	4	2	0	6	5	14	31	47	37	52			01,02										Vb 17	CASSIDLV*REPSSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCCTCCACTAGCGGCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSIPPLAASYNEQFF	In	VDJ	1	54	1.2153731195477012E-4	1.4291158536585365E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	3	5	0	6	1	27	41	55	47	56			01,02			01,02							Vb 17	CASSIPPLAASYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCAGAGTGCTAGCGGCCATAGGGGAGCAGTTCTTCGGGCCA	CASSPRVLAAIGEQFF	In	VDJ	1	55	1.2378800291689549E-4	1.4555809620596207E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	5	10	9	8	27	39	55	48	63			01,02			01,02							Vb 17	CASSPRVLAAIGEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCCGGGATGCTGGAGATACGCAGTATTTTGGCCCA	CASSLRDAGDTQYF	In	VDJ	1	55	1.2378800291689549E-4	1.4555809620596207E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	8	3	5	3	6	27	39	47	42	53			01,02										Vb 17	CASSLRDAGDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCGCTAGCGGGACGAACTACAATGAGCAGTTCTTCGGGCCA	CASSTASGTNYNEQFF	In	VDJ	1	57	1.2828938484114622E-4	1.5085111788617887E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	4	3	3	3	4	27	40	52	43	56			01,02										Vb 17	CASSTASGTNYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGCCCGGGGGACGCCTGGAAACACCATATATTTTGGAGAG	CASSIARGTPGNTIYF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	3	8	2	2	4	4	27	41	51	45	55			01,02										Vb 17	CASSIARGTPGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD02-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTTGTCTCCCGCGGTCAGCCCCAGCATTTTGGTGAT	CASSVVSRGQPQHF	In	VDJ	1	60	1.3504145772752236E-4	1.5879065040650406E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	7	5	6	10	0	27	39	-1	49	53			01,02			01,02							Vb 17	CASSVVSRGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAAGCATGAACACTGAAGCTTTCTTTGGACAA	CASRSMNTEAFF	In	VDJ	1	61	1.372921486896477E-4	1.6143716124661248E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	6	7	0	1	1	27	38	42	39	43			01,02			01,02							Vb 17	CASRSMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAAGGGCGGGGAAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	61	1.372921486896477E-4		49	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	7	3	2	3	2	27	44	53	47	55			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCGTTCAGACGGGGAGCTGTTTTTTGGAGAA	CASSIRSDGELFF	In	VDJ	1	61	1.372921486896477E-4	1.6143716124661248E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	5	7	5	1	27	41	49	46	50			01,02										Vb 17	CASSIRSDGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCTGGGACACTGAAGCTTTCTTTGGACAA	CASSAWDTEAFF	In	VDJ	1	61	1.372921486896477E-4	1.6143716124661248E-4	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	5	0	9	3	4	0	27	39	-1	43	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSAWDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCTAGTAGAAAACAGGGGGCGGATGAAGCTTTCTTTGGACAA	CASRKQGADEAFF	In	VDJ	1	61	1.372921486896477E-4	1.6143716124661248E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	0	7	3	3	27	38	50	41	53			01,02										Vb 17	CASRKQGADEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCACAGGGCGAAGCTTTCTTTGGACAA	CASSSQGEAFF	In	VDJ	1	63	1.4179353061389847E-4	1.6673018292682928E-4	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	3	8	2	1	27	39	47	41	48			01,02										Vb 17	CASSSQGEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGTCGATCGTCAAATGAGCAGTTCTTCGGGCCA	CASSSRSSNEQFF	In	VDJ	1	64	1.4404422157602385E-4	1.6937669376693767E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	4	2	8	7	3	6	27	40	45	43	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSSRSSNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGCGACAGAAAACATTCAGTACTTCGGCGCC	CASSIGATENIQYF	In	VDJ	1	65	1.462949125381492E-4	1.7202320460704606E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	2	5	5	4	0	27	43	-1	47	52			01,02										Vb 17	CASSIGATENIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGGGGACGGACAGTACACCATATATTTTGGAGAG	CASSGDGQYTIYF	In	VDJ	1	66	1.4854560350027458E-4	1.7466971544715447E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	1	5	8	7	1	27	38	51	45	52			01,02										Vb 17	CASSGDGQYTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGGTCGGACTAGCGGGTCCCTACAATGAGCAGTTCTTCGGGCCA	CASSRVGLAGPYNEQFF	In	VDJ	1	67	1.5079629446239996E-4	1.7731622628726286E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	1	4	2	5	2	27	40	56	45	58			01,02			01,02							Vb 17	CASSRVGLAGPYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGTCCGGAAATTCACCCCTCCACTTTGGGAAC	CASRSGNSPLHF	In	VDJ	1	68	1.5304698542452532E-4	1.7996273712737128E-4	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-06	01	6	1	8	7	4	0	27	38	-1	42	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRSGNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01		TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCGCGCGACCAAAGGGAGACCCAGTACTTCGGGCCA	CASSIARDQRETQYF	In	VDJ	1	68	1.5304698542452532E-4	1.7996273712737128E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	1	2	7	5	5	6	27	43	51	48	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIARDQRETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCATACAGACAGGAGTAGCTAACTATGGCTACACCTTCGGTTCG	CASSIQTGVANYGYTF	In	VDJ	1	69	1.552976763866507E-4	1.8260924796747967E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	4	0	2	5	27	42	50	44	55			01,02										Vb 17	CASSIQTGVANYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGTGCAGGGGTCTTACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	70	1.5754836734877608E-4		49	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	2	3	4	4	27	42	52	46	56			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGACAGGGGCCTCTTCTATGGCTACACCTTCGGTTCG	CASSIDRGLFYGYTF	In	VDJ	1	70	1.5754836734877608E-4	1.8525575880758808E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	2	4	1	6	27	41	50	42	56			01,02										Vb 17	CASSIDRGLFYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGCAAGCCACGTTTGGTGCCAAAAGAACCCGACAGYTTCTATCTCTGTGCCAGTAGTATGGGGTATGGCGAGCAGTACTTCGGGCCG	CASSMGYGEQYF	In	VDJ	1	70	1.5754836734877608E-4	1.8525575880758808E-4	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	3	6	2	6	0	5	45	-1	63	59	68			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMGYGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACCTAGGGTTTTCGATGGCTACACCTTCGGTTCG	CASRPRVFDGYTF	In	VDJ	1	71	1.5979905831090146E-4	1.8790226964769647E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	6	5	3	6	4	6	27	38	46	42	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRPRVFDGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCCCGGGACAGGGGGCGCGGGACTGAAGCTTTCTTTGGACAA	CASSPRDRGRGTEAFF	In	VDJ	1	72	1.620497492730268E-4	1.9054878048780488E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	0	5	5	5	27	38	55	43	60			01,02										Vb 17	CASSPRDRGRGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGCAGGAACACTGAAGCTTTCTTTGGACAA	CASSIGRNTEAFF	In	VDJ	1	72	1.620497492730268E-4	1.9054878048780488E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	5	1	1	0	27	43	-1	44	47			01,02										Vb 17	CASSIGRNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGCGTCAGCACCTACAATGAGCAGTTCTTCGGGCCA	CASSIGVSTYNEQFF	In	VDJ	1	73	1.643004402351522E-4	1.9319529132791327E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	1	4	5	2	4	2	27	43	50	47	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGVSTYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTACAGGGGACTGCACGGGGCTACACCTTCGGTTCG	CASSIVQGTARGYTF	In	VDJ	1	74	1.6655113119727757E-4	1.958418021680217E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	3	2	8	1	9	27	43	51	44	60			01,02										Vb 17	CASSIVQGTARGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATAAAGGGCTTTCAACGAGCAGTACTTCGGGCCG		Out	VDJ	1	74	1.6655113119727757E-4		37	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	7	5	3	5	3	6	27	37	44	40	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATCACGGCCGAGTGGGTAATGAAAAACTGTTTTTTGGCAGT	CASNHGRVGNEKLFF	In	VDJ	1	75	1.6880182215940295E-4	1.9848831300813008E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	7	0	9	4	13	0	27	37	-1	50	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASNHGRVGNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCGCGGGACACGAGAGAGACCCAGTACTTCGGGCCA	CASSIARDTRETQYF	In	VDJ	1	75	1.6880182215940295E-4	1.9848831300813008E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	1	0	6	4	3	4	27	43	52	46	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIARDTRETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGCTTTCTATCTCTGTGCCAGTAGCCTCCCATGGGGGACAGCTCGTAGCTAAAGGAACACTGAAGCTTTCTTTGGACAA	CASSLPWGTARS*RNTEAFF	Stop	VDJ	1	75	1.6880182215940295E-4		60	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	5	1	10	13	14	25	42	35	55			01,02										Vb 17	CASSLPWGTARS*RNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACGCAGGGCCGGGGCTATGGCTACACCTTCGGTTCG	CASTQGRGYGYTF	In	VDJ	1	77	1.7330320408365368E-4	2.0378133468834688E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	7	4	3	4	2	6	27	37	44	39	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTQGRGYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGCCCACCAACTATGGCTACACCTTCGGTTCG	CASKPTNYGYTF	In	VDJ	1	78	1.7555389504577906E-4	2.064278455284553E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	7	6	7	2	0	5	27	-1	40	37	45			01,02			01,02							Vb 17	CASKPTNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGACTAGCGGGGGGCCGGGAGAGACCCAGTACTTCGGGCCA	CASSIGTSGGPGETQYF	In	VDJ	1	78	1.7555389504577906E-4	2.064278455284553E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	1	1	4	0	5	27	-1	57	43	62			01,02										Vb 17	CASSIGTSGGPGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATCCCAGGGGGCGGTATCAATCAGCCCCAGCATTTTGGTGAT	CASIPGGGINQPQHF	In	VDJ	1	78	1.7555389504577906E-4	2.064278455284553E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	4	0	3	3	5	27	37	48	40	53			01,02										Vb 17	CASIPGGGINQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGTTCAGGGGCTTACGAGCAGTACTTCGGGCCG	CASSSSGAYEQYF	In	VDJ	1	79	1.778045860079044E-4	2.0907435636856368E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	2	4	3	2	27	40	49	43	51			01,02										Vb 17	CASSSSGAYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCAGCGGACAGGGACCCCCAAGAGACCCAGTACTTCGGGCCA	CASSPADRDPQETQYF	In	VDJ	1	79	1.778045860079044E-4	2.0907435636856368E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	3	1	5	4	27	39	52	44	56			01,02										Vb 17	CASSPADRDPQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTGGCTAGCCGATGTGGGTGAGCAGTTCTTCGGGCCA	CASSWLADVGEQFF	In	VDJ	1	80	1.800552769700298E-4	2.117208672086721E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	7	9	3	9	27	39	47	42	56			01,02			01,02							Vb 17	CASSWLADVGEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCTGCACAGGGGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	82	1.8455665889428055E-4		34	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	9	3	2	6	4	0	27	35	-1	39	46			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTCGGACGAATGAACACTGAAGCTTTCTTTGGACAA	CASSVGRMNTEAFF	In	VDJ	1	85	1.9130873178065667E-4	2.249534214092141E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	5	1	7	0	3	3	27	39	46	42	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSVGRMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCCGGGACAGTACTATGGCTACACCTTCGGTTCG	CASSIPGQYYGYTF	In	VDJ	1	86	1.9355942274278205E-4	2.2759993224932248E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	5	3	3	1	27	41	51	44	52			01,02										Vb 17	CASSIPGQYYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGCGATCGGGACTCCACCAGAGGGGCTGTTTTTTGGCAGT		Out	VDJ	1	89	2.0031149562915816E-4		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	7	0	10	14	7	12	27	37	50	44	62			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCCCTCAGAGGGCACGGACTGTTTTTTGGCAGT	CASSIALRGHGLFF	In	VDJ	1	89	2.0031149562915816E-4	2.355394647696477E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	1	11	0	13	6	5	27	43	54	49	59			01,02										Vb 17	CASSIALRGHGLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01*02	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCGCGCGGGAGGCCAAAAACATTCAGTACTTCGGCGCC	CATAREAKNIQYF	In	VDJ	1	91	2.048128775534089E-4	2.408324864498645E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	10	7	2	1	4	0	27	34	-1	38	45			01,02										Vb 17	CATAREAKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD02-01*02	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGTGAGAACACAGATACGCAGTATTTTGGCCCA	CASSIGENTDTQYF	In	VDJ	1	91	2.048128775534089E-4	2.408324864498645E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	11	2	2	4	2	27	41	48	45	50			01,02										Vb 17	CASSIGENTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCAGGCAGGGTATCAGCCCCAGCATTTTGGTGAT	CASSQAGYQPQHF	In	VDJ	1	93	2.0931425947765965E-4	2.461255081300813E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	3	5	4	1	27	39	48	43	49			01,02										Vb 17	CASSQAGYQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAAAGGGGGACTGGCAATGGAGACCCAGTACTTCGGGCCA	CASSIKGGLAMETQYF	In	VDJ	1	101	2.273197871746626E-4	2.672975948509485E-4	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	3	5	1	5	3	10	27	41	50	44	60			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIKGGLAMETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCACTACGGGACCTCTAATGAAAAACTGTTTTTTGGCAGT	CASSHYGTSNEKLFF	In	VDJ	1	103	2.3182116909891337E-4	2.7259061653116533E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	5	0	7	3	6	2	27	39	50	45	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSHYGTSNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGTTCGGACTAGTCCATTTCCAATGAGCAGTTCTTCGGGCCA	CASSISSD*SISNEQFF	Stop	VDJ	1	105	2.363225510231641E-4		51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	1	8	6	5	8	27	42	54	47	62			01,02			01,02							Vb 17	CASSISSD*SISNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGACTAGCGGGAGACACCCGAGGAGCACAGATACGCAGTATTTTGGCCCA	CASSTTSGRHPRSTDTQYF	In	VDJ	1	106	2.3857324198528948E-4	2.805301490514905E-4	57	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	2	2	0	1	10	24	37	50	38	60			01,02										Vb 17	CASSTTSGRHPRSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTAGGACTAGCATACGAGCAGTACTTCGGGCCG	CASSLGLAYEQYF	In	VDJ	1	106	2.3857324198528948E-4	2.805301490514905E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	2	7	4	0	1	27	-1	50	43	51			01,02			01,02							Vb 17	CASSLGLAYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCTCCACGACAGCGGGACTAGCGGGAGCCGGCACCGGGGAGCTGTTTTTTGGAGAA	CASTTAGLAGAGTGELFF	In	VDJ	1	106	2.3857324198528948E-4	2.805301490514905E-4	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	11	0	2	4	11	4	27	33	58	44	62			01,02										Vb 17	CASTTAGLAGAGTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCTGGCGGGAGGGCCGATGAGCAGTTCTTCGGGCCA	CASSIAGGRADEQFF	In	VDJ	1	107	2.4082393294741486E-4	2.8317665989159894E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	7	0	8	3	3	27	43	55	46	58			01,02										Vb 17	CASSIAGGRADEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCAACTTCGTATGGACAGGGTCCGGCAGATACGCAGTATTTTGGCCCA	CASSPTSYGQGPADTQYF	In	VDJ	1	107	2.4082393294741486E-4	2.8317665989159894E-4	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	3	4	12	5	27	39	59	51	64			01,02										Vb 17	CASSPTSYGQGPADTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCATACGTGGGGACACAGATACGCAGTATTTTGGCCCA	CAIRGDTDTQYF	In	VDJ	1	107	2.4082393294741486E-4	2.8317665989159894E-4	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	10	0	8	2	6	0	27	34	-1	40	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CAIRGDTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCCACAGGGGGAACAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	110	2.4757600583379097E-4		46	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	3	1	3	3	2	27	41	52	44	54			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGACGGACTAGCGGGAGGGGGGATGAGCAGTTCTTCGGGCCA	CASSGRTSGRGDEQFF	In	VDJ	1	114	2.5657876968229244E-4	3.0170223577235774E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	1	0	8	4	3	27	39	58	43	61			01,02										Vb 17	CASSGRTSGRGDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGCGGACAGAGACACACCGGGGAGCTGTTTTTTGGAGAA	CASGGQRHTGELFF	In	VDJ	1	114	2.5657876968229244E-4	3.0170223577235774E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	1	5	3	3	4	27	36	45	39	49			01,02										Vb 17	CASGGQRHTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGCCGAAACCGGGGAGCTGTTTTTTGGAGAA	CASAETGELFF	In	VDJ	1	115	2.588294606444178E-4	3.043487466124661E-4	33	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	8	2	8	5	3	1	27	36	41	39	42			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASAETGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCCTCTCCCCATGAGGCGGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	117	2.633308425686686E-4		43	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	10	7	4	5	16	0	27	34	-1	50	55			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCTCAACGGAAGGGAGACAGCCCCAGCATTTTGGTGAT	CASTEGRQPQHF	In	VDJ	1	117	2.633308425686686E-4	3.0964176829268293E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	11	9	2	7	9	1	27	33	47	42	48			01,02										Vb 17	CASTEGRQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGGACACAGGGGAACCCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	118	2.6558153353079396E-4		47	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	2	2	5	5	27	40	52	45	57			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCCGGGACTACGCACCGGGGAGCTGTTTTTTGGAGAA	CASSTPGLRTGELFF	In	VDJ	2	119	2.6783222449291934E-4	3.149347899728997E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	0	9	4	4	2	27	40	51	44	53			01,02			01,02							Vb 17	CASSTPGLRTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCTTAGTCACAGATACGCAGTATTTTGGCCCA	CASSTLVTDTQYF	In	VDJ	2	119	2.6783222449291934E-4	3.149347899728997E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	5	8	2	3	1	27	40	46	43	47			01,02			01,02							Vb 17	CASSTLVTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGACGGTGAGACGAGCAGTACTTCGGGCCG	CASSRR*DEQYF	Stop	VDJ	2	126	2.8358706122779694E-4		36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	4	2	7	5	0	6	27	-1	43	40	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSRR*DEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCGGGATTCCTACGAGCAGTACTTCGGGCCG	CASSIDRDSYEQYF	In	VDJ	2	133	2.9934189796267455E-4	3.5198594173441736E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	8	3	1	1	1	27	44	50	45	51			01,02										Vb 17	CASSIDRDSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTCTCTAGCGGGAACAATGAGCAGTTCTTCGGGCCA	CASSFSSGNNEQFF	In	VDJ	2	136	3.0609397084905063E-4	3.5992547425474255E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	3	5	4	0	27	39	-1	43	52			01,02										Vb 17	CASSFSSGNNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCATTTCCAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	137	3.08344661811176E-4		41	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	4	5	0	9	0	27	37	-1	46	49			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACAACAGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSTTGSYNEQFF	In	VDJ	2	137	3.08344661811176E-4	3.6257198509485097E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	3	1	2	0	27	40	-1	42	48			01,02										Vb 17	CASSTTGSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAAGACAGGGGGCAGGTGAAAAACTGTTTTTTGGCAGT	CASRRQGAGEKLFF	In	VDJ	2	141	3.1734742565967753E-4	3.731580284552846E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	0	7	2	3	27	38	50	40	53			01,02										Vb 17	CASRRQGAGEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGTACTAGCATCTCCTTCAAAGAGCAGTTCTTCGGGCCA	CASSMGTSISFKEQFF	In	VDJ	2	141	3.1734742565967753E-4	3.731580284552846E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	3	7	10	4	12	27	41	51	45	63			01,02			01,02							Vb 17	CASSMGTSISFKEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCCACCAACTATGGCTACACCTTCGGTTCG	CASSTNYGYTF	In	VDJ	2	141	3.1734742565967753E-4	3.731580284552846E-4	33	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	8	3	7	2	3	1	27	36	41	39	42			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCGACTAGCGGTGGTTACAATGAGCAGTTCTTCGGGCCA	CASTPTSGGYNEQFF	In	VDJ	2	146	3.286008804703044E-4	3.8639058265582655E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	2	5	4	4	4	27	37	50	41	54			01,02			01,02							Vb 17	CASTPTSGGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGTGGCAAGCCCCTGAAGCTTTCTTTGGACAA	CASSMWQAPEAFF	In	VDJ	2	146	3.286008804703044E-4	3.8639058265582655E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	9	0	6	2	6	27	41	46	43	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMWQAPEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGGAAGGGCAATGAAGCTTTCTTTGGACAA	CASSIGKGNEAFF	In	VDJ	2	152	3.421050262430566E-4	4.02269647696477E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	0	8	7	1	7	27	41	46	42	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGKGNEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCTCCCAGGGACATCTGGAAACACCATATATTTTGGAGAG	CASLPGTSGNTIYF	In	VDJ	2	152	3.421050262430566E-4	4.02269647696477E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	8	0	6	1	6	0	27	36	-1	42	48			01,02										Vb 17	CASLPGTSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCCTTAAAAGCATTCAGTACTTCGGCGCC	CASSALKSIQYF	In	VDJ	2	157	3.533584810536835E-4	4.1550220189701895E-4	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-04	01	5	5	5	9	9	0	27	39	-1	48	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSALKSIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01		TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCAGGGGGGGGGCCAAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	158	3.556091720158088E-4		44	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	7	4	1	3	3	7	27	37	47	40	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGAAAGTCCACACTACGAGCAGTACTTCGGGCCG	CASSESPHYEQYF	In	VDJ	2	160	3.601105539400596E-4	4.234417344173442E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	6	3	8	0	27	39	-1	47	50			01,02										Vb 17	CASSESPHYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTCTCGGGTGTGTACAATGAGCAGTTCTTCGGGCCA	CASSFSGVYNEQFF	In	VDJ	2	175	3.938709183719402E-4	4.631393970189702E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	8	4	4	4	4	27	39	47	43	51			01,02			01,02							Vb 17	CASSFSGVYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGAGGGGGGCGTTCGTGAAAAACTGTTTTTTGGCAGT	CASSIEGGVREKLFF	In	VDJ	2	178	4.006229912583163E-4	4.710789295392954E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	3	5	1	7	2	7	27	41	49	43	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIEGGVREKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACGACATCCGACAGGGAACACTGAAGCTTTCTTTGGACAA	CASRRHPTGNTEAFF	In	VDJ	2	182	4.096257551068178E-4	4.81664972899729E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	4	1	9	0	27	38	-1	47	53			01,02										Vb 17	CASRRHPTGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTGGGGCGATCGGGGAACAGTGGTTCGCTGAAGCTTTCTTTGGACAA		Out	VDJ	2	186	4.186285189553193E-4		53	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	5	7	0	6	2	20	27	39	46	41	66			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACACATAATACTGGGGGAGCAGTTCTTCGGGCCA	CASRHIILGEQFF	In	VDJ	2	190	4.2763128280382077E-4	5.028370596205962E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	6	6	2	10	12	0	27	38	-1	50	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRHIILGEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGCCACCCCGGGACTAGCGGGGGGGCCATACCAGTTCTTCGGGCCA	CASATPGLAGGPYQFF	In	VDJ	2	192	4.321326647280715E-4	5.081300813008131E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	0	0	13	8	6	27	36	60	44	66			01,02										Vb 17	CASATPGLAGGPYQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGATGGACTCACTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	195	4.388847376144476E-4		47	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	1	10	0	3	4	27	41	49	44	53			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAGCCCGGGCCGGAAGTCCAGTTCTTCGGGCCA	CASSIEPGPEVQFF	In	VDJ	3	199	4.4788750146294913E-4	5.266556571815719E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	0	8	0	13	4	8	27	44	52	48	60			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIEPGPEVQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGACAGGGGGCAGAGACCCAGTACTTCGGGCCA	CASSIGQGAETQYF	In	VDJ	3	200	4.501381924250745E-4	5.293021680216802E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	1	0	4	1	0	27	41	-1	42	53			01,02										Vb 17	CASSIGQGAETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGTAGCGGGGCTCCAAATGAGCAGTTCTTCGGGCCA	CASSMSSGAPNEQFF	In	VDJ	3	201	4.523888833871999E-4	5.319486788617886E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	5	3	7	3	5	27	41	52	44	57			01,02										Vb 17	CASSMSSGAPNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGGACTGTTGGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASRGLLGSNQPQHF	In	VDJ	3	208	4.681437201220775E-4	5.504742547425474E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	0	10	1	0	7	27	-1	44	38	51			01,02			01,02							Vb 17	CASRGLLGSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCCACTAAGGGGGCGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	3	210	4.726451020463282E-4		49	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	5	0	1	8	1	27	40	55	48	56			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCAGGGTTGGGATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	3	211	4.748957930084536E-4		41	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	3	5	0	5	27	-1	46	41	51			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATTCATCGGAGTCAATGAGCAGTTCTTCGGGCCA	CASSIFIGVNEQFF	In	VDJ	3	216	4.861492478190805E-4	5.716463414634146E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	10	2	6	6	1	27	42	52	48	53			01,02										Vb 17	CASSIFIGVNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTCGCCGGTGCTAGCGGCCAAAACATTCAGTACTTCGGCGCC	CASSVAGASGQNIQYF	In	VDJ	3	219	4.929013207054566E-4	5.795858739837398E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	5	4	5	5	10	2	27	39	56	49	58			01,02			01,02							Vb 17	CASSVAGASGQNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD02-01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCCGCAGGCGATGAGCAGTTCTTCGGGCCA	CASSAGDEQFF	In	VDJ	3	226	5.086561574403342E-4	5.981114498644986E-4	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	4	4	8	4	2	27	36	44	40	46			01,02										Vb 17	CASSAGDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATTGACCAGGGCTTTAACTATGGCTACACCTTCGGTTCG	CASIDQGFNYGYTF	In	VDJ	3	231	5.19909612250961E-4	6.113440040650406E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	3	1	5	3	27	37	47	42	50			01,02										Vb 17	CASIDQGFNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCGGGACAGCGCTAACTATGGCTACACCTTCGGTTCG	CASSTRDSANYGYTF	In	VDJ	3	233	5.244109941752118E-4	6.166370257452574E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	5	0	3	2	27	40	50	43	52			01,02										Vb 17	CASSTRDSANYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGGACGAGAGTATACTGAAGCTTTCTTTGGACAA	CASSIGGREYTEAFF	In	VDJ	3	233	5.244109941752118E-4	6.166370257452574E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	1	0	7	5	1	8	27	43	49	44	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGGREYTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGCTGGGTCCCTACGAGCAGTACTTCGGGCCG	CASSMLGPYEQYF	In	VDJ	3	247	5.55920667644967E-4	6.53688177506775E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	3	0	9	2	3	2	27	41	47	44	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMLGPYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATGCGAGGACCGTTCAGCCCCAGCATTTTGGTGAT	CASSIDARTVQPQHF	In	VDJ	4	295	6.639538338269849E-4	7.807206978319783E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	0	1	7	6	5	3	27	44	53	49	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIDARTVQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACTTACAGGGAATTGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	4	308	6.932128163346147E-4		50	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	3	0	3	5	27	40	49	43	54			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGTTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSVYSNQPQHF	In	VDJ	4	318	7.157197259558684E-4	8.415904471544716E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	5	9	0	4	0	27	38	-1	42	44			01,02			01,02							Vb 17	CASSVYSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCAGCCTACGGCCTCGCTGGGTAGCCAGTACTTCGGGCCA	CATQPTASLGSQYF	In	VDJ	4	333	7.49480090387749E-4	8.812881097560976E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	10	0	9	10	19	3	27	34	56	53	59			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CATQPTASLGSQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCAATTTCGGACTTGGTGAAAAACTGTTTTTTGGCAGT	CASNFGLGEKLFF	In	VDJ	4	344	7.742376909711282E-4	9.103997289972899E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	9	1	10	7	7	3	27	35	47	42	50			01,02			01,02							Vb 17	CASNFGLGEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGCGGATGAACACTGAAGCTTTCTTTGGACAA	CASSIGRMNTEAFF	In	VDJ	4	346	7.787390728953788E-4	9.156927506775068E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	7	5	0	1	1	27	43	48	44	49			01,02			01,02							Vb 17	CASSIGRMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCGGGAAGCGGGTGGTATACGAGCAGTACTTCGGGCCG		Out	VDJ	5	391	8.800201661910206E-4		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	6	4	4	8	5	27	37	51	45	56			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCTCGGGACAGGGGTATGATCAGCCCCAGCATTTTGGTGAT	CASSGQGYDQPQHF	In	VDJ	6	459	0.001033067151615546	0.001214748475609756	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	9	0	2	5	3	4	27	35	48	38	52			01,02										Vb 17	CASSGQGYDQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACCGGCACTAGGTAAAAATCAGCCCCAGCATTTTGGTGAT	CASRPALGKNQPQHF	In	VDJ	7	551	0.0012401307201310803	0.001458227472899729	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	3	8	4	6	5	27	38	49	44	54			01,02			01,02							Vb 17	CASRPALGKNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGCAGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSMGRGNTEAFF	In	VDJ	7	585	0.001316654212843343	0.0015482088414634147	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	2	1	3	0	27	41	-1	44	50			01,02										Vb 17	CASSMGRGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGGAGACAGGACTATGGCTACACCTTCGGTTCG	CASSMRRQDYGYTF	In	VDJ	8	629	0.0014156846151768593	0.0016646553184281843	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	4	3	5	0	27	41	-1	46	52			01,02										Vb 17	CASSMRRQDYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGATCGACAGGTTGGGGAGAGACCCAGTACTTCGGGCCA	CASSRSTGWGETQYF	In	VDJ	10	805	0.0018118062245109248	0.002130441226287263	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	4	4	5	6	27	39	50	44	56			01,02										Vb 17	CASSRSTGWGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCTATCGACCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASLSTSGANVLTF	In	VDJ	14	1056	0.0023767296560043933	0.0027947154471544716	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-06	01	8	2	7	0	5	0	27	36	-1	41	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASLSTSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01		TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCACGGGACTAGCGGGAATTGTTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	14	1114	0.002507269731807665		50	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	10	0	3	1	4	5	27	34	51	38	56			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGCAGGGGAAACTACGAGCAGTACTTCGGGCCG	CASSMGRGNYEQYF	In	VDJ	18	1440	0.003240994985460536	0.0038109756097560975	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	2	3	3	3	27	41	50	44	53			01,02										Vb 17	CASSMGRGNYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGGCGTAGGACAGTTTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	23	1824	0.004105260314916679		40	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	9	1	5	4	5	2	27	35	46	40	48			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGCCGGGCATACTACACCGGGGAGCTGTTTTTTGGAGAA	CASSIGRAYYTGELFF	In	VDJ	24	1870	0.004208792099174447	0.00494897527100271	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	1	8	0	3	3	5	27	43	50	46	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGRAYYTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAACAGGGAAACACTGAAGCTTTCTTTGGACAA	CASKQGNTEAFF	In	VDJ	51	4013	0.00903202283100912	0.010620448001355014	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	3	2	1	1	27	37	44	38	45			01,02										Vb 17	CASKQGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGGTATGGCGAGCAGTACTTCGGGCCG	CASSMGYGEQYF	In	VDJ	129	10066	0.022655455224753998	0.026639778116531166	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	3	6	2	6	0	5	27	-1	45	41	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMGYGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGACCCCGGACCGGCTACTGAAGCTTTCTTTGGACAA	CASSDPGPATEAFF	In	VDJ	1	33	7.427280175013729E-5	8.733485772357724E-5	42	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-01	01	3	1	7	5	4	5	23	37	45	41	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSDPGPATEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCACGTCAGATACTAACTATGGCTACACCTTCGGTTCG	CASTSDTNYGYTF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	39	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	5	0	3	3	23	33	39	36	42													Vb 11	CASTSDTNYGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAACTCCGACCCGTGGGTAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	44	9.903040233351639E-5		50	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-01	01	2	0	9	1	11	2	23	38	52	49	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	X+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCGGGCTAGCGGTGAATGAGCAGTTCTTCGGGCCA	CASGLAVNEQFF	In	VDJ	1	45	1.0128109329564176E-4	1.1909298780487805E-4	36	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	4	5	7	3	2	23	32	42	35	44						01,02							Vb 11	CASGLAVNEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGATGGTCCGACAGGGGAAAGGGAGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	47	1.057824752198925E-4		52	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	2	2	5	6	9	23	37	51	43	60													Vb 11	X+TCRBV25-01+TCRBJ02-05	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAGGGGAGAGGTGAAAAACTGTTTTTTGGCAGT	CASSEGRGEKLFF	In	VDJ	1	48	1.0803316618201788E-4	1.2703252032520327E-4	39	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	3	9	2	7	1	3	23	37	43	38	46													Vb 11	CASSEGRGEKLFF+TCRBV25-01+TCRBJ01-04	TCRBV25-01*01	TCRBD02-01*02	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATGAAAAGGGACAGGCGTTCACGTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	49	1.1028385714414325E-4		56	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	4	1	5	8	23	39	52	44	60													Vb 11	X+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGATAGATCAGGGGGCAAGACTGAAGCTTTCTTTGGACAA	CASSDRSGGKTEAFF	In	VDJ	1	61	1.372921486896477E-4	1.6143716124661248E-4	45	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	0	5	5	3	23	37	50	42	53													Vb 11	CASSDRSGGKTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCACATACCTCTCAGTACCTCTGTGCCACCGGCCATGTTGCGGGAGAGGGGAAAGAGACCCAGTACTTCGGGCCA	CATGHVAGEGKETQYF	In	VDJ	1	90	2.025621865912835E-4	2.381859756097561E-4	48	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	10	7	2	3	11	6	23	30	48	41	54													Vb 11	CATGHVAGEGKETQYF+TCRBV25-01+TCRBJ02-05	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAACGGGAAAACTACAGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	98	2.205677142882865E-4		41	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	8	3	6	1	9	23	33	39	34	48													Vb 11	X+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCGGCCGGGACTATAAATGGCAGTACTTCGGGCCG	CASGRDYKWQYF	In	VDJ	1	105	2.363225510231641E-4	2.778836382113821E-4	36	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	0	9	9	4	6	23	32	43	36	49						01,02							Vb 11	CASGRDYKWQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGCGCCGGGTTTAGATACGCAGTATTTTGGCCCA	CASSAPGLDTQYF	In	VDJ	1	111	2.4982669679591635E-4	2.9376270325203255E-4	39	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	8	4	5	3	3	23	36	43	39	46						01,02							Vb 11	CASSAPGLDTQYF+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGAGCGAACAGGGGCGGGGGGAACACTGAAGCTTTCTTTGGACAA	CASRANRGGGNTEAFF	In	VDJ	1	116	2.610801516065432E-4	3.069952574525745E-4	48	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-01	01	6	3	2	1	5	6	23	34	46	39	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASRANRGGGNTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATGGGGCTAGCGGGAGTCGGGATCTAATACGCAGTATTTTGGCCCA	CASSEWG*RESGSNTQYF	Stop	VDJ	2	162	3.6461193586431035E-4		54	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	4	2	7	4	10	23	39	53	43	63													Vb 11	CASSEWG*RESGSNTQYF+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGACCGGACAGGATTGATCTGAAGCTTTCTTTGGACAA		Out	VDJ	2	171	3.848681545234387E-4		43	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	4	6	2	6	23	37	46	39	52													Vb 11	X+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGGAACAGGGTTCACCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	3	201	4.523888833871999E-4		41	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	9	3	3	3	2	5	23	31	39	33	44													Vb 11	X+TCRBV25-01+TCRBJ01-04	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAACAAGAGAGTCACACCGGGGAGCTGTTTTTTGGAGAA	CASSEQESHTGELFF	In	VDJ	5	357	8.03496673478758E-4	9.448043699186992E-4	45	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	11	2	3	3	4	23	38	44	41	48													Vb 11	CASSEQESHTGELFF+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAAATGTGGCAGATACGCAGTATTTTGGCCCA	CASSENVADTQYF	In	VDJ	9	668	0.0015034615626997488	0.001767869241192412	39	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-03	01	2	0	10	4	5	0	23	38	-1	43	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSENVADTQYF+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTAAGGGCAGGGGGCTTCAATCAGCCCCAGCATTTTGGTGAT	CASSLRAGGFNQPQHF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	48	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	0	3	4	2	23	38	50	42	52													Vb 14	CASSLRAGGFNQPQHF+TCRBV27-01+TCRBJ01-05	TCRBV27-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCGAGAGATGACAGGGGGCTGGGGAAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	41	9.227832944714028E-5		50	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	2	0	4	7	6	23	32	49	39	55													Vb 14	X+TCRBV27-01+TCRBJ01-05	TCRBV27-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTGGCAAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTTTATCACTGAATCAGCCCCAGCATTTTGGTGAT	CASSLSLNQPQHF	In	VDJ	1	48	1.0803316618201788E-4	1.2703252032520327E-4	39	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	3	10	4	0	1	42	-1	62	59	63						01,02							Vb 14	CASSLSLNQPQHF+TCRBV27-01+TCRBJ01-05	TCRBV27-01*01	TCRBD02-01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGCCCGAGGAAAGTATGGCTACACCTTCGGTTCG	CSVARGKYGYTF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	11	1	5	5	4	25	33	42	38	46													Vb 4	CSVARGKYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATGCAGGGACTAGCGGGCACGATTCCTACAATGAGCAGTTCTTCGGGCCA	CSVDAGTSGHDSYNEQFF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	54	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	4	1	4	6	25	36	52	40	58						01,02							Vb 4	CSVDAGTSGHDSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGGCCGGACAGGCTCCTACGAGCAGTACTTCGGGCCG	CSVGRTGSYEQYF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	4	0	5	0	25	33	-1	38	45													Vb 4	CSVGRTGSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCCAGGAGGAGAACTGAAGCTTTCTTTGGACAA	CSVARRRTEAFF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	10	1	5	3	3	25	35	43	38	46													Vb 4	CSVARRRTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACTAGCGGGGGGCCACTAGCACAGATACGCAGTATTTTGGCCCA	CSVD*RGATSTDTQYF	Stop	VDJ	1	24	5.401658309100894E-5		48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	4	1	0	0	5	25	-1	47	36	52													Vb 4	CSVD*RGATSTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCGACAGGGTTGGAGTTTGCCGCTTTCTTTGGACAA	CSATGLEFAAFF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	3	11	1	12	25	32	40	33	52													Vb 4	CSATGLEFAAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCTTGAACGGTGAAGCTCCTACGAGCAGTACTTCGGGCCG	CSVEDLER*SSYEQYF	Stop	VDJ	1	28	6.301934693951043E-5		48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	8	5	0	7	5	25	39	49	46	54						01,02							Vb 4	CSVEDLER*SSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGAGCAGGAAAGCAATCAGCCCCAGCATTTTGGTGAT	CSVEEQESNQPQHF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	4	1	1	2	25	39	44	40	46													Vb 4	CSVEEQESNQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGTCTCAGCGGGGAGTACGCAGTATTTTGGCCCA	CSVEVSAGSTQYF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	6	3	8	4	2	25	38	49	42	51													Vb 4	CSVEVSAGSTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCAGGGTGGGGGAAACACCGGGGAGCTGTTTTTTGGAGAA	CSVQGGGNTGELFF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	42	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-02	01	5	4	3	2	0	7	25	-1	39	34	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVQGGGNTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01		TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTACGGGGGGCAAGCAACACTGAAGCTTTCTTTGGACAA	CSVRGASNTEAFF	In	VDJ	1	32	7.202211078801193E-5	8.468834688346883E-5	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	1	2	1	5	25	33	41	34	46													Vb 4	CSVRGASNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAGGGGGACGAAGAGAAAAACTGTTTTTTGGCAGT	CSVGGRREKLFF	In	VDJ	1	32	7.202211078801193E-5	8.468834688346883E-5	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	5	1	8	0	7	25	-1	39	33	46													Vb 4	CSVGGRREKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCCCGTTCAGACGAACACTGAAGCTTTCTTTGGACAA	CSAPVQTNTEAFF	In	VDJ	1	36	8.10248746365134E-5	9.527439024390244E-5	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	7	2	7	1	10	0	25	32	-1	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSAPVQTNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGACCCGGGGTACTCCTACAATGAGCAGTTCTTCGGGCCA	CSVEDPGYSYNEQFF	In	VDJ	1	36	8.10248746365134E-5	9.527439024390244E-5	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	3	0	2	2	25	39	46	41	48													Vb 4	CSVEDPGYSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGAGGAGGCGGGGAGGGAGCAGTACTTCGGGCCG	CSVEEEAGREQYF	In	VDJ	1	36	8.10248746365134E-5	9.527439024390244E-5	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	7	3	7	4	3	25	39	49	43	52						01,02							Vb 4	CSVEEEAGREQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGTACTCCGGGACCTGTTTGAAGCTTTCTTTGGACAA	CSVVLRDLFEAFF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	6	0	7	7	8	5	25	33	46	41	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVVLRDLFEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGCAGGCGGACGACTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSVAGGRLSGANVLTF	In	VDJ	1	39	8.777694752288953E-5	1.0321392276422765E-4	48	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-06	01	6	1	7	0	7	4	25	33	44	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVAGGRLSGANVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01		TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGCCCCCGAGCCGGAACACTGAAGCTTTCTTTGGACAA	CSVEPPSRNTEAFF	In	VDJ	1	42	9.452902040926564E-5	1.1115345528455284E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	6	7	1	7	2	25	36	46	43	48						01,02							Vb 4	CSVEPPSRNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCAGGGACAGGGTAACACCGGGGAGCTGTTTTTTGGAGAA	CSVQGQGNTGELFF	In	VDJ	1	45	1.0128109329564176E-4	1.1909298780487805E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	3	2	2	1	25	34	45	36	46													Vb 4	CSVQGQGNTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGTACAGTTCGATGAACACTGAAGCTTTCTTTGGACAA	CSVGYSSMNTEAFF	In	VDJ	1	46	1.0353178425776714E-4	1.2173949864498645E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	5	0	3	5	25	35	42	38	47													Vb 4	CSVGYSSMNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAGCGGGAGGGGGGCAGATACGCAGTATTTTGGCCCA	CSVSGRGADTQYF	In	VDJ	1	51	1.14785239068394E-4	1.3497205284552846E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	6	0	4	0	3	25	-1	44	34	47													Vb 4	CSVSGRGADTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAACCAACTACAATGAGCAGTTCTTCGGGCCA	CSVETNYNEQFF	In	VDJ	1	51	1.14785239068394E-4	1.3497205284552846E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	2	3	7	3	0	3	25	-1	39	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVETNYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGGACCACAGGGTTGAGAGGTAGCTACGAGCAGTACTTCGGGCCG	CSGTTGLRGSYEQYF	In	VDJ	1	52	1.1703593003051937E-4	1.3761856368563685E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	3	3	3	5	11	25	32	43	37	54													Vb 4	CSGTTGLRGSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCAAGGGGGAGAAAACATTCAGTACTTCGGCGCC	CSVEDQGGENIQYF	In	VDJ	1	53	1.1928662099264474E-4	1.4026507452574526E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	5	1	5	3	2	25	39	48	42	50													Vb 4	CSVEDQGGENIQYF+TCRBV29-01+TCRBJ02-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGCTAGCGGGAGTCTAGGTTTCTTCGGGCCA	CSVGASGSLGFF	In	VDJ	1	53	1.1928662099264474E-4	1.4026507452574526E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	4	2	16	3	7	25	35	48	38	55													Vb 4	CSVGASGSLGFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGAGGGGGGTAGGGACTATGGCTACACCTTCGGTTCG	CSVEEGGRDYGYTF	In	VDJ	1	58	1.305400758032716E-4	1.5349762872628726E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	9	1	3	0	5	25	-1	45	39	50													Vb 4	CSVEEGGRDYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTAGCGGAAGAGCGGGAGACGACCGCCCGATACGCAGTATTTTGGCCCA		Out	VDJ	1	62	1.395428396517731E-4		52	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	6	2	6	9	10	25	35	52	44	62													Vb 4	X+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTGAAGACAGCAGCATATATCTCTGCAGCGTTGCCAATGAGGCGGGCCAGTTGTTTCCAATATTCTGATACGCAGTATTTTGGCCCA		Out	VDJ	1	62	1.395428396517731E-4		58	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	7	4	6	8	20	23	33	46	41	66						01,02							Vb 4	X+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGCGGGGAGGGGCACAGATACGCAGTATTTTGGCCCA	CSVEAGRGTDTQYF	In	VDJ	1	63	1.4179353061389847E-4	1.6673018292682928E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	9	0	1	4	0	25	36	-1	40	47													Vb 4	CSVEAGRGTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGACAGGGCCGCACTGAAGCTTTCTTTGGACAA	CSVGQGRTEAFF	In	VDJ	1	63	1.4179353061389847E-4	1.6673018292682928E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	4	0	3	25	-1	42	35	45													Vb 4	CSVGQGRTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGCGTCCCCGGGAGGGACCCAGTACTTCGGGCCA	CSVEASPGGTQYF	In	VDJ	1	67	1.5079629446239996E-4	1.7731622628726286E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	8	1	7	6	0	25	38	-1	44	51													Vb 4	CSVEASPGGTQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCCTCAGTGGGGGTAGCACAGATACGCAGTATTTTGGCCCA	CSLSGGSTDTQYF	In	VDJ	1	68	1.5304698542452532E-4	1.7996273712737128E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	8	6	1	0	6	1	25	31	42	37	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSLSGGSTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGCAGGGGTCTACGAGCAGTACTTCGGGCCG	CSVEAGVYEQYF	In	VDJ	1	68	1.5304698542452532E-4	1.7996273712737128E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	2	3	0	1	25	-1	44	38	45													Vb 4	CSVEAGVYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGCGGGGGTCCCACAGATACGCAGTATTTTGGCCCA	CSGGGPTDTQYF	In	VDJ	1	72	1.620497492730268E-4	1.9054878048780488E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	7	2	2	0	3	25	-1	39	32	42													Vb 4	CSGGGPTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGCCGCAGGGAATCGTTACGAGCAGTACTTCGGGCCG	CSVEAAGNRYEQYF	In	VDJ	1	72	1.620497492730268E-4	1.9054878048780488E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	3	4	3	6	25	38	46	41	52													Vb 4	CSVEAAGNRYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGACTAGCGGGAGTGCAGATACGCAGTATTTTGGCCCA	CSVETSGSADTQYF	In	VDJ	1	72	1.620497492730268E-4	1.9054878048780488E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	2	2	4	0	2	25	-1	48	36	50													Vb 4	CSVETSGSADTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCGGAAGTTCCGGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	74	1.6655113119727757E-4		37	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-05	01	5	1	8	6	1	8	25	34	38	35	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	X+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGTTTTTGGGAGTAAAGGGACACAGGTCGATGAGCAGTTCTTCGGGCCA	CSVEVFGSKGTQVDEQFF	In	VDJ	1	74	1.6655113119727757E-4	1.958418021680217E-4	54	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	0	6	8	14	7	25	38	58	52	65													Vb 4	CSVEVFGSKGTQVDEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGTATCGCCGGAAGGCACTGAAGCTTTCTTTGGACAA	CSVEVSPEGTEAFF	In	VDJ	1	77	1.7330320408365368E-4	2.0378133468834688E-4	42	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	1	1	8	4	7	3	25	38	48	45	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEVSPEGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGATAGACCGGACAGTCTAGGAGCAGTACTTCGGGCCG		Out	VDJ	1	80	1.800552769700298E-4		40	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	5	7	9	5	25	33	48	42	53													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCAGGCCAGGGGTGGATCTGAAGCTTTCTTTGGACAA	CSVQARGGSEAFF	In	VDJ	1	87	1.958101137049074E-4	2.302464430894309E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	2	6	5	5	25	34	45	39	50													Vb 4	CSVQARGGSEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCAGGACAGGGGGTGACGAGCAGTACTTCGGGCCG	CSARTGGDEQYF	In	VDJ	1	95	2.1381564140191038E-4	2.514185298102981E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	1	5	3	2	25	32	45	35	47													Vb 4	CSARTGGDEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCCCAGAGTCGGAACACTGAAGCTTTCTTTGGACAA	CSVAQSRNTEAFF	In	VDJ	1	97	2.1831702332616114E-4	2.567115514905149E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	4	4	5	1	2	5	25	35	40	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVAQSRNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACCCCCGGGGACTGGTCAATGAGCAGTTCTTCGGGCCA	CSVDPRGLVNEQFF	In	VDJ	1	101	2.273197871746626E-4	2.672975948509485E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	10	6	6	3	25	36	48	42	51						01,02							Vb 4	CSVDPRGLVNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCAAGAGGCGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CSVQEAGNTGELFF	In	VDJ	1	102	2.29570478136788E-4	2.699441056910569E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	7	4	1	7	0	25	33	-1	40	45						01,02							Vb 4	CSVQEAGNTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGCGACAGGGGGCCCCCGCAGATACGCAGTATTTTGGCCCA	CSVRQGAPADTQYF	In	VDJ	1	103	2.3182116909891337E-4	2.7259061653116533E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	0	4	2	5	25	33	45	35	50													Vb 4	CSVRQGAPADTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCAGACCGCAACATCGGTCCAACACACCATATATTTTGGAGAG	CSVEDQTATSVQHTIYF	In	VDJ	1	113	2.543280787201671E-4	2.990557249322493E-4	51	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-03	01	0	2	7	8	3	17	25	39	45	42	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEDQTATSVQHTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01		TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGGCCAGGGGAGCCCCACAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	114	2.5657876968229244E-4		47	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	2	0	4	8	25	33	43	37	51													Vb 4	X+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGAGGGAGCCGTTACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	115	2.588294606444178E-4		40	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	9	2	3	2	6	25	36	43	38	49													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAACCGAGCGGGAGGCAGATACGCAGTATTTTGGCCCA	CSVETEREADTQYF	In	VDJ	2	122	2.745842973792954E-4	3.2287432249322495E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	6	1	4	4	0	25	37	-1	41	50													Vb 4	CSVETEREADTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGACCCCGGGAAGACCCAGTACTTCGGGCCA	CSVEDPGKTQYF	In	VDJ	2	122	2.745842973792954E-4	3.2287432249322495E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	8	3	6	3	0	25	39	-1	42	47													Vb 4	CSVEDPGKTQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAAAAACCGGGACTAGCGAAGCCGGGGAGCTGTTTTTTGGAGAA	CSVKTGTSEAGELFF	In	VDJ	2	140	3.1509673469755215E-4	3.7051151761517616E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	0	6	6	7	3	25	33	50	40	53						01,02							Vb 4	CSVKTGTSEAGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGACTAGCGGGACGGAAACACAGATACGCAGTATTTTGGCCCA	CSVED*RDGNTDTQYF	Stop	VDJ	2	149	3.353529533566805E-4		48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	4	3	2	0	6	25	-1	48	39	54													Vb 4	CSVED*RDGNTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGTATCGGGGGAAGGAGAGACCCAGTACTTCGGGCCA	CSVEVSGEGETQYF	In	VDJ	2	158	3.556091720158088E-4	4.1814871273712737E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	8	2	4	3	4	25	38	47	41	51													Vb 4	CSVEVSGEGETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGTTTGAGTTACGGCTACACCTTCGGTTCG	CSVEGLSYGYTF	In	VDJ	3	196	4.41135428576573E-4	5.187161246612466E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	1	11	2	8	4	4	25	38	45	42	49													Vb 4	CSVEGLSYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGAAGTGGACGGGGGTTGCGGGAGCAGTTCTTCGGGCCA	CSVGSGRGLREQFF	In	VDJ	3	198	4.4563681050082375E-4	5.240091463414634E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	8	2	10	8	6	25	35	49	43	55													Vb 4	CSVGSGRGLREQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGTTTCGGGGGTGAACACTGAAGCTTTCTTTGGACAA	CSVGVSGVNTEAFF	In	VDJ	3	258	5.806782682283461E-4	6.827997967479675E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	8	2	0	6	0	25	35	-1	41	47													Vb 4	CSVGVSGVNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGGCTAGCGGGAGACCCCGAGCAGTACTTCGGGCCG		Out	VDJ	4	284	6.391962332436058E-4		41	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	4	2	6	3	4	25	36	49	39	53													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCATCAGGGGCACTCTACGAGCAGTACTTCGGGCCG	CSASGALYEQYF	In	VDJ	4	311	6.999648892209909E-4	8.230648712737128E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	4	2	3	3	4	25	32	41	35	45													Vb 4	CSASGALYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGTCGGCAGGGAACACCTACGAGCAGTACTTCGGGCCG	CSVGSAGNTYEQYF	In	VDJ	6	433	9.745491866002863E-4	0.0011459391937669377	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	3	2	6	4	25	35	46	41	50													Vb 4	CSVGSAGNTYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCTCGGGCAGGGGTGGTGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	6	467	0.001051072679312549		40	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	4	2	3	5	6	25	31	42	36	48													Vb 4	X+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGACGGGGGGGACTAATGAAAAACTGTTTTTTGGCAGT	CSVGTGGTNEKLFF	In	VDJ	6	471	0.0010600754431610503	0.0012465066056910569	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	4	8	0	2	3	0	25	35	-1	38	46													Vb 4	CSVGTGGTNEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCGAGAGACAGGGGAGCCACTGAAGCTTTCTTTGGACAA	CSARDRGATEAFF	In	VDJ	7	544	0.0012243758833962025	0.0014397018970189702	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	2	4	5	3	25	32	45	37	48													Vb 4	CSARDRGATEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGACAGGGGGCACTAATGAAAAACTGTTTTTTGGCAGT	CSVGTGGTNEKLFF	In	VDJ	9	729	0.0016407537113893966	0.0019293064024390244	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	1	0	2	0	0	25	-1	-1	35	46													Vb 4	CSVGTGGTNEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGGGACAGGGGGAACTAATGAAAAACTGTTTTTTGGCAGT	CSVGTGGTNEKLFF	In	VDJ	12	970	0.0021831702332616113	0.002567115514905149	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	1	1	1	0	25	33	-1	34	45													Vb 4	CSVGTGGTNEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCGGGACACGCCGCCTCCTACCGGGGAGCTGTTTTTTGGAGAA	CSVRDTPPPTGELFF	In	VDJ	31	2398	0.005397156927176643	0.006346332994579946	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	6	5	1	11	25	34	41	35	52													Vb 4	CSVRDTPPPTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGAGGACTCAGCCATGTACTTCTGTGCAGGGGGAGTCGGGCTCAATGAGCAGTTCTTCGGGCCA	CAGGVGLNEQFF	In	VDJ	1	24	5.401658309100894E-5	6.351626016260163E-5	36	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	12	5	1	6	0	9	23	-1	34	28	43													Vb 22	CAGGVGLNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGAGGGGGACAGGGGGCATACGAGCAGTTCTTCGGGCCA	CASRGGQGAYEQFF	In	VDJ	1	24	5.401658309100894E-5	6.351626016260163E-5	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	0	10	3	4	23	34	49	37	53													Vb 22	CASRGGQGAYEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTACCCTCGCCCCCTACAATGAGCAGTTCTTCGGGCCA	CASSTLAPYNEQFF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	42	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-01	01	5	3	7	2	0	8	23	-1	37	35	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSTLAPYNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGCCGGGACAGGCGACACCGGGGAGCTGTTTTTTGGAGAA	CASSAGTGDTGELFF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	4	3	2	2	23	36	46	38	48													Vb 22	CASSAGTGDTGELFF+TCRBV02-01+TCRBJ02-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCACCCCCGCCGGAATCCCGACCTACGAGCAGTACTTCGGGCCG	CASTPAGIPTYEQYF	In	VDJ	1	33	7.427280175013729E-5	8.733485772357724E-5	45	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-07	01	7	1	8	2	8	7	23	33	44	41	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASTPAGIPTYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGACCAGCGGGAAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSDQRENTGELFF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	6	3	2	2	1	23	37	46	39	47													Vb 22	CASSDQRENTGELFF+TCRBV02-01+TCRBJ02-02	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGTCCGAGGGTCTAGTAACGAGCAGTACTTCGGGCCG	CASSVRGSSNEQYF	In	VDJ	1	36	8.10248746365134E-5	9.527439024390244E-5	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	11	0	5	3	7	23	36	44	39	51													Vb 22	CASSVRGSSNEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTAGGGAGGGCTACGATACGCAGTATTTTGGCCCA	CASSREGYDTQYF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	39	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	9	0	6	1	4	23	35	43	36	47													Vb 22	CASSREGYDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCCGGAAGACAAGGGTCCAAGGCTACGAGCAGTACTTCGGGCCG	CASRKTRVQGYEQYF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	45	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-07	01	8	2	6	3	5	11	23	32	41	37	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASRKTRVQGYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTCTCGTGGAATTAGGGACCCAGTACTTCGGGCCA	CASSLVELGTQYF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	39	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-05	01	5	1	8	7	5	6	23	35	43	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSLVELGTQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTACCACAGGGGGCCTGTACAATGAGCAGTTCTTCGGGCCA	CASSTTGGLYNEQFF	In	VDJ	1	61	1.372921486896477E-4	1.6143716124661248E-4	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	0	4	3	3	23	35	47	38	50													Vb 22	CASSTTGGLYNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAACGGGGCAGGACCACTGAAGCTTTCTTTGGACAA	CASSERGRTTEAFF	In	VDJ	1	66	1.4854560350027458E-4	1.7466971544715447E-4	42	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-01	01	2	7	0	4	1	5	23	38	44	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSERGRTTEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGTTAGACTAGCGCACTACGAGCAGTACTTCGGGCCG	CASSVRLAHYEQYF	In	VDJ	1	66	1.4854560350027458E-4	1.7466971544715447E-4	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	2	6	3	3	2	23	36	47	39	49						01,02							Vb 22	CASSVRLAHYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAATCAGTTCGGGACATCGGATCAGCCCCAGCATTTTGGTGAT	CASNQFGTSDQPQHF	In	VDJ	1	72	1.620497492730268E-4	1.9054878048780488E-4	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	0	6	5	8	4	23	33	47	41	51													Vb 22	CASNQFGTSDQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCACCACCCAGGTACCAGGGAACACTGAAGCTTTCTTTGGACAA	CASTTQVPGNTEAFF	In	VDJ	1	72	1.620497492730268E-4	1.9054878048780488E-4	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	4	4	1	5	7	23	33	42	38	49													Vb 22	CASTTQVPGNTEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCTCCCAGACAGAGTACAATGAGCAGTTCTTCGGGCCA	CASSQTEYNEQFF	In	VDJ	1	74	1.6655113119727757E-4	1.958418021680217E-4	39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	2	5	4	5	2	23	32	42	37	44													Vb 22	CASSQTEYNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTTTTAATGGCTACGAGCAGTACTTCGGGCCG	CASSFNGYEQYF	In	VDJ	2	178	4.006229912583163E-4	4.710789295392954E-4	36	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-07	01	5	0	10	3	6	0	23	35	-1	41	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSFNGYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTCCCTTGGAGGCGGTTTCCTACGAGCAGTACTTCGGGCCG	CASSPLEAVSYEQYF	In	VDJ	5	365	8.215022011757609E-4	9.659764566395664E-4	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	10	1	1	5	5	23	35	45	40	50													Vb 22	CASSPLEAVSYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCATCAGTGAGGGAAATGAGCAGTTCTTCGGGCCA	CAISEGNEQFF	In	VDJ	1	86	1.9355942274278205E-4	2.2759993224932248E-4	33	TCRBV06	TCRBV06-04					TCRBJ02	TCRBJ02-01	01	3	0	8	7	0	0	28	-1	-1	42	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISEGNEQFF+TCRBV06-04+TCRBJ02-01	TCRBV06-04		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCTACCCGAAGATACGCAGTATTTTGGCCCA		Out	VDJ	14	1097	0.002469007985451534		32	TCRBV06	TCRBV06-04					TCRBJ02	TCRBJ02-03	01	8	2	8	5	5	0	28	37	-1	42	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-04+TCRBJ02-03	TCRBV06-04		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTCCGCCCACTGCAGGGACAACGATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	22	4.9515201166758194E-5		50	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	6	6	12	3	26	38	56	50	59														X+TCRBV06-07+TCRBJ01-04	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAAAATGAGATAGCGGAGCAGTTCTTCGGGCCA	CASSENEIAEQFF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	39	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	6	10	10	0	26	38	-1	48	53						01,02								CASSENEIAEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCCGATTCTACAATGAGCAGTTCTTCGGGCCA	CASRFYNEQFF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	33	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-01	01	8	2	8	3	1	2	26	35	38	36	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRFYNEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGAGGATTGGGTCCCCTCCACTTTGGGAAC	CASRGLGPLHF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	33	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-06	01	6	0	9	13	6	1	26	37	46	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGLGPLHF+TCRBV06-07+TCRBJ01-06	TCRBV06-07*01		TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGACGGTACCTACGAGCAGTACTTCGGGCCG	CASSDGTYEQYF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	36	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-07	01	5	2	7	2	0	4	26	-1	41	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDGTYEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTCTGCAGGCGCCGGAAGCTTTCTTTGGACAA	CASSLQAPEAFF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	36	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	4	8	3	5	26	38	45	41	50														CASSLQAPEAFF+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCAAGAGTTGGGGAGGCGGGGAGCTGTTTTTTGGAGAA	CASSKSWGGGELFF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	42	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	9	1	7	9	0	26	37	-1	46	52														CASSKSWGGGELFF+TCRBV06-07+TCRBJ02-02	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTTGGACAGGGGCAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLDRGSNQPQHF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	45	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	2	1	1	1	26	39	49	40	50														CASSLDRGSNQPQHF+TCRBV06-07+TCRBJ01-05	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTATTGGGAGACCCAGTACTTCGGGCCA	CASSYWETQYF	In	VDJ	1	40	9.00276384850149E-5	1.0586043360433605E-4	33	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-05	01	3	0	10	5	2	0	26	40	-1	42	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYWETQYF+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTCCCTCGGACCTAGCGATAGGGAGACCCAGTACTTCGGGCCA	CASSYSLGPSDRETQYF	In	VDJ	1	45	1.0128109329564176E-4	1.1909298780487805E-4	51	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	4	6	5	8	5	26	43	57	51	62						01,02								CASSYSLGPSDRETQYF+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTCGGCGGTTGGGTGGCAATGAGCAGTTCTTCGGGCCA	CASSRRLGGNEQFF	In	VDJ	1	46	1.0353178425776714E-4	1.2173949864498645E-4	42	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	7	5	6	2	8	26	38	44	40	52						01,02								CASSRRLGGNEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTGGCAGGGTGAACGGACCGGGGAGCTGTTTTTTGGAGAA	CASSWQGERTGELFF	In	VDJ	1	48	1.0803316618201788E-4	1.2703252032520327E-4	45	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	3	5	2	7	26	39	46	41	53														CASSWQGERTGELFF+TCRBV06-07+TCRBJ02-02	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACAAGACTAGCGGGAGCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	54	1.2153731195477012E-4		47	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	2	2	2	2	1	26	41	55	43	56														X+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGGGACGGGGCGAAGCTTTCTTTGGACAA		Out	VDJ	1	58	1.305400758032716E-4		34	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-01	01	5	0	7	8	0	5	26	-1	43	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCACCAACAGGGACACAGATACGCAGTATTTTGGCCCA	CATNRDTDTQYF	In	VDJ	1	66	1.4854560350027458E-4	1.7466971544715447E-4	36	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	10	3	3	2	3	1	26	33	42	36	43														CATNRDTDTQYF+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTCGTACGAGCAGTACTTCGGGCCG	CASSYSYEQYF	In	VJ	1	77	1.7330320408365368E-4	2.0378133468834688E-4	33	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-07	01	0	0	0	4	0	1	26	-1	43	-1	44														CASSYSYEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTCTTTAAGCGGGTGGAACACAGATACGCAGTATTTTGGCCCA	CASSYSLSGWNTDTQYF	In	VDJ	1	101	2.273197871746626E-4	2.672975948509485E-4	51	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	6	4	2	4	5	26	43	53	47	58						01,02								CASSYSLSGWNTDTQYF+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAGGGCGTCTCAAACTACAATGAGCAGTTCTTCGGGCCA	CASSEGVSNYNEQFF	In	VDJ	2	139	3.1284604373542677E-4	3.6786500677506775E-4	45	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	11	0	3	0	9	26	-1	43	38	52														CASSEGVSNYNEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCTGCAGGGAGGCCAGGGAGCAGTACTTCGGGCCG	CACREAREQYF	In	VDJ	3	198	4.4563681050082375E-4	5.240091463414634E-4	33	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	10	1	7	0	5	26	-1	42	37	47														CACREAREQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTACCCGGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	5	357	8.03496673478758E-4		34	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	8	4	4	3	0	26	38	-1	41	45						01,02								X+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTGCGACAGGGAAACGCACCCGAGCAGTACTTCGGGCCG	CASSLRQGNAPEQYF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	45	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	3	6	2	9	19	33	42	35	51														CASSLRQGNAPEQYF+TCRBV07-07+TCRBJ02-07	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCAGCCATGTATCGCTGTGCCACCCCGAAACAGGGGGCCCTATACAATGAGCAGTTCTTCGGGCCA	CATPKQGALYNEQFF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	45	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	3	0	4	7	4	19	26	42	33	46														CATPKQGALYNEQFF+TCRBV07-07+TCRBJ02-01	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCCGACAGGGGCCACAGATACGCAGTATTTTGGCCCA	CASSPTGATDTQYF	In	VDJ	1	33	7.427280175013729E-5	8.733485772357724E-5	42	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	2	2	2	1	19	31	41	33	42														CASSPTGATDTQYF+TCRBV07-07+TCRBJ02-03	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCCGGACAGGGGACCCTCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	36	8.10248746365134E-5		50	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	1	2	0	2	5	19	31	42	33	47														X+TCRBV07-07+TCRBJ01-03	TCRBV07-07*01	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGAAATAGCGGGACAGGGGGACGGGAGACCCAGTACTTCGGGCCA	CASRNSGTGGRETQYF	In	VDJ	1	37	8.327556559863878E-5	9.792090108401084E-5	48	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	1	5	7	4	19	30	48	37	52														CASRNSGTGGRETQYF+TCRBV07-07+TCRBJ02-05	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCCGGACAGGCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	45	1.0128109329564176E-4		41	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	4	1	2	1	19	31	40	33	41														X+TCRBV07-07+TCRBJ01-01	TCRBV07-07*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTAAAGGGACTAGCGGGAGGAAAGGGTGAGACCCAGTACTTCGGGCCA	CASSLKGLAGGKGETQYF	In	VDJ	2	133	2.9934189796267455E-4	3.5198594173441736E-4	54	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	0	1	5	2	7	19	34	51	36	58														CASSLKGLAGGKGETQYF+TCRBV07-07+TCRBJ02-05	TCRBV07-07*01	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAATCGAACGAGCAGTACTTCGGGCCG	CASSQSNEQYF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	33	TCRBV16	TCRBV16-01					TCRBJ02	TCRBJ02-07	01	0	2	8	5	0	0	29	-1	-1	46	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQSNEQYF+TCRBV16-01+TCRBJ02-07	TCRBV16-01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAGGCCACCCTGGAGGGCTACACCTTCGGTTCG	CASSQATLEGYTF	In	VDJ	1	54	1.2153731195477012E-4	1.4291158536585365E-4	39	TCRBV16	TCRBV16-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	10	2	8	9	0	29	43	-1	52	56			01,02											CASSQATLEGYTF+TCRBV16-01+TCRBJ01-02	TCRBV16-01	TCRBD02-01*02	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAATCGGGAACCGGGGCCGCTTTCTTTGGACAA	CASSQSGTGAAFF	In	VDJ	1	73	1.643004402351522E-4	1.9319529132791327E-4	39	TCRBV16	TCRBV16-01					TCRBJ01	TCRBJ01-01	01	0	7	0	11	7	1	29	46	58	53	59			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQSGTGAAFF+TCRBV16-01+TCRBJ01-01	TCRBV16-01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCTATTTGCGAACACTGAAGCTTTCTTTGGACAA	CASSLFANTEAFF	In	VDJ	1	73	1.643004402351522E-4	1.9319529132791327E-4	39	TCRBV16	TCRBV16-01					TCRBJ01	TCRBJ01-01	01	4	10	0	1	5	0	29	42	-1	47	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLFANTEAFF+TCRBV16-01+TCRBJ01-01	TCRBV16-01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAAAACACAGGGCCCGGGGAGCTGTTTTTTGGAGAA	CASSQNTGPGELFF	In	VDJ	1	85	1.9130873178065667E-4	2.249534214092141E-4	42	TCRBV16	TCRBV16-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	3	3	6	3	1	29	44	53	47	54			01,02											CASSQNTGPGELFF+TCRBV16-01+TCRBJ02-02	TCRBV16-01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAATCTAGGACAGGGTACAATGAGCAGTTCTTCGGGCCA	CASSQSRTGYNEQFF	In	VDJ	4	341	7.67485618084752E-4	9.024601964769648E-4	45	TCRBV16	TCRBV16-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	3	4	2	0	29	46	-1	48	56			01,02											CASSQSRTGYNEQFF+TCRBV16-01+TCRBJ02-01	TCRBV16-01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGCAAGCCACGTTTGGTGGTCAGGGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGAAGGCGGCTACGAGCAGTACTTCGGGCCG	CASSVEGGYEQYF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	39	TCRBV21	TCRBV21-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	7	5	3	7	0	42	54	-1	61	65						01,02								CASSVEGGYEQYF+TCRBV21-01+TCRBJ02-07	TCRBV21-01*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGTGTACAGGGTGGACCCAGTACTTCGGGCCA		Out	VDJ	1	25	5.6267274053134314E-5		37	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	3	3	7	3	2	26	39	48	42	50		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCYATCAGTGATGGAAATGAGCAGTTCTTCGGGCCA	CAISDGNEQFF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	33	TCRBV06	unresolved					TCRBJ02	TCRBJ02-01	01	5	1	8	7	3	0	26	38	-1	41	44		TCRBV06-04,TCRBV06-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISDGNEQFF+TCRBV06-X+TCRBJ02-01	unresolved		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGGGGACTCRGCYGTGTATCTCTGTGCCAGCAGCTTCGCAGCCGCTTACGAGCAGTACTTCGGGCCG	CASSFAAAYEQYF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	39	TCRBV07	unresolved					TCRBJ02	TCRBJ02-07	01	3	4	5	4	2	5	22	36	41	38	46		TCRBV07-02,TCRBV07-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFAAAYEQYF+TCRBV07-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGCCGGGAGCTCTACAATGAGCAGTTCTTCGGGCCA	CASSRELYNEQFF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	8	2	3	0	2	20	-1	38	32	40		TCRBV07-02,TCRBV07-08												CASSRELYNEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCCTCGTCTGGACTAGACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	26	5.851796501525969E-5		46	TCRBV11	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	8	0	7	1	18	30	44	37	45		TCRBV11-01,TCRBV11-03				01,02								X+TCRBV11-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTGAAGACAATCGGCGAGAACTATGGCTACACCTTCGGTTCG	CASSLKTIGENYGYTF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	48	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	6	2	3	9	19	33	40	36	49		TCRBV11-01,TCRBV11-03												CASSLKTIGENYGYTF+TCRBV11-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGCTTAGAGATGTACTACAATGAGCAGTTCTTCGGGCCA	CASSLEMYYNEQFF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	42	TCRBV07	unresolved					TCRBJ02	TCRBJ02-01	01	0	2	8	3	1	4	19	35	38	36	42		TCRBV07-05,TCRBV07-06		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEMYYNEQFF+TCRBV07-X+TCRBJ02-01	unresolved		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTCGTGCGCAGGGAAACTATGGCTACACCTTCGGTTCG	CASSRAQGNYGYTF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	3	2	6	1	23	35	46	41	47		TCRBV06-07,TCRBV06-08												CASSRAQGNYGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCTATACAGCGGGAGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	30	6.752072886376118E-5		56	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	6	0	0	5	2	25	42	57	47	59		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGCCAAGTCGGAGTTGACTTTGGAAACACCATATATTTTGGAGAG	CASSQVGVDFGNTIYF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	48	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	2	10	3	12	1	18	30	46	42	47		TCRBV07-02,TCRBV07-06				01,02								CASSQVGVDFGNTIYF+TCRBV07-X+TCRBJ01-03	unresolved	TCRBD02-01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGCTTGACAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLTATNEKLFF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	2	5	0	0	0	18	-1	-1	32	37		TCRBV07-02,TCRBV07-06												CASSLTATNEKLFF+TCRBV07-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAAGACTAGCGGGAGGGCCTGGTTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	31	6.977141982588655E-5		52	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	2	0	1	1	6	18	28	43	29	49		TCRBV07-02,TCRBV07-06												X+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTACTCGGGGGACAGCAAAAGCAGTACTTCGGGCCG		Out	VDJ	1	33	7.427280175013729E-5		41	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	5	8	2	4	23	40	49	42	53		TCRBV06-05,TCRBV06-06,TCRBV06-08												X+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGAAGACCTTCGACAGGCGTTACTGAAGCTTTCTTTGGACAA	CARRPSTGVTEAFF	In	VDJ	1	33	7.427280175013729E-5	8.733485772357724E-5	42	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	2	4	5	9	4	23	31	46	40	50		TCRBV10-01,TCRBV10-02												CARRPSTGVTEAFF+TCRBV10-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCTTCCGTCTCCTGGTTCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	39	8.777694752288953E-5		47	TCRBV07	unresolved					TCRBJ01	TCRBJ01-01	01	3	0	10	1	9	3	18	32	43	41	46		TCRBV07-01,TCRBV07-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACCTCGGGTCCCGAGAGCTGTTTTTTGGAGAA	CASSYLGSRELFF	In	VDJ	1	40	9.00276384850149E-5	1.0586043360433605E-4	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	8	4	11	2	6	23	38	44	40	50		TCRBV06-07,TCRBV06-08				01,02								CASSYLGSRELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGCGAGGGACCTAATGAGGTCTATGGCTACACCTTCGGTTCG	CASSEGPNEVYGYTF	In	VDJ	1	40	9.00276384850149E-5	1.0586043360433605E-4	45	TCRBV06	unresolved					TCRBJ01	TCRBJ01-02	01	6	0	7	4	3	10	28	39	47	42	57		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGPNEVYGYTF+TCRBV06-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGGACTCMGCCRTGTATCKCTGTGCCAGCAGCCCGGGACTAGCGGGAGGAGGCAATGAGCAGTTCTTCGGGCCA	CASSPGLAGGGNEQFF	In	VDJ	1	41	9.227832944714028E-5	1.0850694444444444E-4	48	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	1	6	2	3	19	31	48	33	51		TCRBV07-07,TCRBV07-08												CASSPGLAGGGNEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCACCATGGCCGACAGAGCCAACGTCCTGACTTTCGGGGCC	CATMADRANVLTF	In	VDJ	1	43	9.677971137139102E-5	1.1379996612466124E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	10	2	5	7	8	1	26	33	46	41	47		TCRBV06-07,TCRBV06-08												CATMADRANVLTF+TCRBV06-X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCACCGCGTCGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASTASGTGELFF	In	VDJ	1	43	9.677971137139102E-5	1.1379996612466124E-4	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	8	4	4	6	0	18	28	-1	34	38		TCRBV07-01,TCRBV07-02				01,02								CASTASGTGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAAAGACAGGGGGAAGGCCTCCACCAATGAGCAGTTCTTCGGGCCA	CASKDRGKASTNEQFF	In	VDJ	1	43	9.677971137139102E-5	1.1379996612466124E-4	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	2	1	6	2	11	28	38	49	40	60		TCRBV06-04,TCRBV06-08												CASKDRGKASTNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGTTCGTTAGCGGGAGGGCCGGAGACCCAGTACTTCGGGCCA	CASSSLAGGPETQYF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	45	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	5	0	5	5	3	18	29	45	34	48		TCRBV07-06,TCRBV07-07												CASSSLAGGPETQYF+TCRBV07-X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGCCGCGACACCCGCACAGATACGCAGTATTTTGGCCCA	CASSRDTRTDTQYF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	42	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	6	1	4	3	23	34	42	38	45		TCRBV10-01,TCRBV10-02												CASSRDTRTDTQYF+TCRBV10-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACGATTCGGGGGGATACAATGAGCAGTTCTTCGGGCCA	CASSYDSGGYNEQFF	In	VDJ	1	45	1.0128109329564176E-4	1.1909298780487805E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	8	1	4	4	1	26	41	52	45	53		TCRBV06-07,TCRBV06-08												CASSYDSGGYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGACCCAGGCAACGCAGCTTTCTTTGGACAA	CASSDPGNAAFF	In	VDJ	1	49	1.1028385714414325E-4	1.2967903116531165E-4	36	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	4	10	4	6	23	35	43	39	49		TCRBV06-07,TCRBV06-08												CASSDPGNAAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACGGGACAGTATCTTACGGCGGGGAGCTGTTTTTTGGAGAA	CASSYGTVSYGGELFF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	0	5	7	0	10	23	-1	45	38	55		TCRBV06-07,TCRBV06-08												CASSYGTVSYGGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGCTTAGACGAGGCAGGATTTAATAATTCACCCCTCCACTTTGGGAAC	CASSLDEAGFNNSPLHF	In	VDJ	1	51	1.14785239068394E-4	1.3497205284552846E-4	51	TCRBV07	unresolved					TCRBJ01	TCRBJ01-06	01	1	4	4	5	6	5	18	34	44	40	49		TCRBV07-05,TCRBV07-06		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDEAGFNNSPLHF+TCRBV07-X+TCRBJ01-06	unresolved		TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGAACAGGGGGCGAATGGCTACACCTTCGGTTCG	CASSEQGANGYTF	In	VDJ	1	52	1.1703593003051937E-4	1.3761856368563685E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	0	6	0	2	24	-1	47	39	49		TCRBV06-01,TCRBV06-08												CASSEQGANGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGGCTGAAAAACAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	59	1.3279076676539698E-4		41	TCRBV10	unresolved					TCRBJ01	TCRBJ01-01	01	4	2	8	2	3	5	23	36	41	39	46		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV10-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTTGGGGCGACATCAGGCTACGAGCAGTACTTCGGGCCG	CASSFGATSGYEQYF	In	VDJ	1	61	1.372921486896477E-4	1.6143716124661248E-4	45	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	7	0	3	1	9	18	32	38	33	47		TCRBV11-01,TCRBV11-03												CASSFGATSGYEQYF+TCRBV11-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAACAGACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSEQTNTGELFF	In	VDJ	1	64	1.4404422157602385E-4	1.6937669376693767E-4	42	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	3	5	0	0	1	26	-1	44	40	45		TCRBV10-01,TCRBV10-02												CASSEQTNTGELFF+TCRBV10-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCTCGAATAGCGTCGCGAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSNSVASTGELFF	In	VDJ	1	65	1.462949125381492E-4	1.7202320460704606E-4	45	TCRBV11	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	8	5	6	4	5	7	18	27	37	32	44		TCRBV11-01,TCRBV11-03				01,02								CASSNSVASTGELFF+TCRBV11-X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGCATAACAGGAGGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	65	1.462949125381492E-4		41	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	10	0	3	7	0	23	34	-1	41	47		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGTCCCGCCGGGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSPAGGSTDTQYF	In	VDJ	1	65	1.462949125381492E-4	1.7202320460704606E-4	45	TCRBV11	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	8	1	0	6	0	19	30	-1	36	43		TCRBV11-01,TCRBV11-03												CASSPAGGSTDTQYF+TCRBV11-X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTCCCTCCTACGACAGCCTTACTACAATGAGCAGTTCTTCGGGCCA	CASSSLLRQPYYNEQFF	In	VDJ	1	68	1.5304698542452532E-4	1.7996273712737128E-4	51	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	5	3	9	5	23	36	50	45	55		TCRBV06-07,TCRBV06-08												CASSSLLRQPYYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTGGCCCCAACTGGATACGCAGTATTTTGGCCCA	CASSEWPQLDTQYF	In	VDJ	1	68	1.5304698542452532E-4	1.7996273712737128E-4	42	TCRBV10	unresolved					TCRBJ02	TCRBJ02-03	01	1	9	0	6	0	8	26	-1	45	42	53		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEWPQLDTQYF+TCRBV10-X+TCRBJ02-03	unresolved		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGCTAGACAGGGAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	69	1.552976763866507E-4		43	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	2	3	2	1	1	18	31	39	32	40		TCRBV07-05,TCRBV07-06												X+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCTTCGGACAGTTAAATGAGCAGTTCTTCGGGCCA	CASSFGQLNEQFF	In	VDJ	1	69	1.552976763866507E-4	1.8260924796747967E-4	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	1	5	7	1	3	18	32	39	33	42		TCRBV07-01,TCRBV07-02												CASSFGQLNEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGCTGCAAAGACTAGCGGGGTCCCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	70	1.5754836734877608E-4		49	TCRBV10	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	2	3	4	7	3	26	37	55	44	58		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCACCCCGAGGGTTGGGGCCAACGTCCTGACTTTCGGGGCC	CASTPRVGANVLTF	In	VDJ	1	70	1.5754836734877608E-4	1.8525575880758808E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	7	11	0	3	4	1	26	36	45	40	46		TCRBV06-07,TCRBV06-08												CASTPRVGANVLTF+TCRBV06-X+TCRBJ02-06	unresolved	TCRBD02-01*02	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCCTCGGGACAGGGCCGCTTAACTATGGCTACACCTTCGGTTCG	CASSLGTGPLNYGYTF	In	VDJ	1	71	1.5979905831090146E-4	1.8790226964769647E-4	48	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	1	3	5	18	30	42	33	47		TCRBV11-01,TCRBV11-03												CASSLGTGPLNYGYTF+TCRBV11-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCATCAGTGAGGGCAACGAGCAGTACTTCGGGCCG	CAISEGNEQYF	In	VDJ	1	73	1.643004402351522E-4	1.9319529132791327E-4	33	TCRBV06	unresolved		unresolved			TCRBJ02	TCRBJ02-07	01	3	8	0	5	0	1	28	-1	46	42	47		TCRBV06-04,TCRBV06-07		TCRBD01,TCRBD02										CAISEGNEQYF+TCRBV06-X+TCRBJ02-07	unresolved	unresolved	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGCGGTGGACAGGCCAACACTGAAGCTTTCTTTGGACAA	CASSGGQANTEAFF	In	VDJ	1	74	1.6655113119727757E-4	1.958418021680217E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	4	2	4	2	23	34	45	38	47		TCRBV06-07,TCRBV06-08												CASSGGQANTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCATCAGAGGAGGGCTTTCCTACAATGAGCAGTTCTTCGGGCCA	CAIRGGLSYNEQFF	In	VDJ	1	76	1.710525131215283E-4	2.011348238482385E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	10	0	1	1	3	28	39	46	40	49		TCRBV06-04,TCRBV06-08												CAIRGGLSYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGTGCCGGCGCCTTGGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	78	1.7555389504577906E-4		49	TCRBV06	unresolved					TCRBJ01	TCRBJ01-02	01	5	1	8	4	13	5	23	35	51	48	56		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTAGCTAAGCTCCGGGGAGCTGTTTTTTGGAGAA	CASSE*LSSGELFF	Stop	VDJ	1	78	1.7555389504577906E-4		42	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	4	9	6	2	4	26	42	47	44	51		TCRBV10-01,TCRBV10-02				01,02								CASSE*LSSGELFF+TCRBV10-X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACTCGAGTCGGGGTAAGGGAAGCTATGGCTACACCTTCGGTTCG	CASSYSSRGKGSYGYTF	In	VDJ	1	81	1.8230596793215517E-4	2.143673780487805E-4	51	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	8	3	4	4	9	23	40	49	44	58		TCRBV06-07,TCRBV06-08												CASSYSSRGKGSYGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTTACTTCCGGGACAGGGATTAGGCACCCCTCCACTTTGGGAAC		Out	VDJ	1	84	1.8905804081853129E-4		49	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	0	3	11	7	6	26	39	55	46	61		TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCCCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAAGCGCTGTATCTGAGAGCGGGGACTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSEALYLRAGTSYNEQFF	In	VDJ	1	84	1.8905804081853129E-4	2.2230691056910568E-4	60	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	6	3	1	17	3	13	25	49	42	52		TCRBV06-01,TCRBV06-07												CASSEALYLRAGTSYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTAGGGTCGCAGGTCCGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLGSQVRTGELFF	In	VDJ	1	85	1.9130873178065667E-4	2.249534214092141E-4	48	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	4	4	4	5	4	19	35	44	40	48		TCRBV11-01,TCRBV11-03												CASSLGSQVRTGELFF+TCRBV11-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGACTCCTGACTAGCGGGGACCGATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	87	1.958101137049074E-4		53	TCRBV10	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	2	3	4	5	5	23	37	53	42	58		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCTTACAGGGGAACAGTCAGCCCCAGCATTTTGGTGAT	CASLQGNSQPQHF	In	VDJ	1	89	2.0031149562915816E-4	2.355394647696477E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	3	2	6	2	5	23	32	41	34	46		TCRBV06-07,TCRBV06-08												CASLQGNSQPQHF+TCRBV06-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGGSGACTYGGCTGTGTATCTCTGTGCCAGCAGCTTAGACGGTTTGGGAGACACCATATATTTTGGAGAG	CASSLDGLGDTIYF	In	VDJ	1	89	2.0031149562915816E-4	2.355394647696477E-4	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	0	9	2	8	7	0	19	35	-1	42	47		TCRBV07-01,TCRBV07-05												CASSLDGLGDTIYF+TCRBV07-X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGTTACTCGACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	98	2.205677142882865E-4		35	TCRBV06	unresolved					TCRBJ02	TCRBJ02-07	01	0	2	8	3	0	0	26	-1	-1	43	45		TCRBV06-05,TCRBV06-06,TCRBV06-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCGCTACCCCTACGGGAGCCCTTTACAATGAGCAGTTCTTCGGGCCA	CASATPTGALYNEQFF	In	VDJ	1	102	2.29570478136788E-4	2.699441056910569E-4	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	8	2	4	10	5	23	32	48	42	53		TCRBV06-07,TCRBV06-08												CASATPTGALYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGAAGTCTAGCGGGAGACTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	104	2.3407186006103875E-4		40	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	2	9	4	2	26	37	51	41	53		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGCTTAGGGAAGGGCTACGAGCAGTACTTCGGGCCG	CASSLGKGYEQYF	In	VDJ	1	114	2.5657876968229244E-4	3.0170223577235774E-4	39	TCRBV07	unresolved					TCRBJ02	TCRBJ02-07	01	1	5	3	3	3	0	18	34	-1	37	41		TCRBV07-02,TCRBV07-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGKGYEQYF+TCRBV07-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGATATCACCGCCGCTACCACAGATACGCAGTATTTTGGCCCA	CASSDITAATTDTQYF	In	VDJ	2	132	2.9709120700054917E-4	3.4933943089430895E-4	48	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	4	9	2	11	1	23	37	51	48	52		TCRBV10-01,TCRBV10-02				01,02								CASSDITAATTDTQYF+TCRBV10-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTCTACCCAGGGGGCCGGATTCACAGATACGCAGTATTTTGGCCCA	CASSSTQGAGFTDTQYF	In	VDJ	2	138	3.105953527733014E-4	3.6521849593495933E-4	51	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	0	2	5	6	23	36	49	41	55		TCRBV06-07,TCRBV06-08												CASSSTQGAGFTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGACACCCGAAGAGACCCAGTACTTCGGGCCA	CASSETPEETQYF	In	VDJ	2	195	4.388847376144476E-4	5.160696138211382E-4	39	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	3	6	3	0	4	23	-1	41	38	45		TCRBV10-01,TCRBV10-02												CASSETPEETQYF+TCRBV10-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCGGCGGTAGCGGGGATAGATGAGCAGTTCTTCGGGCCA	CASSESAVAGIDEQFF	In	VDJ	3	198	4.4563681050082375E-4	5.240091463414634E-4	48	TCRBV10	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	3	8	5	4	23	40	53	45	57		TCRBV10-01,TCRBV10-02												CASSESAVAGIDEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCATCAGTCTAGGGAATGAGCAGTTCTTCGGGCCA	CAISLGNEQFF	In	VDJ	3	242	5.446672128343402E-4	6.404556233062331E-4	33	TCRBV06	unresolved					TCRBJ02	TCRBJ02-01	01	5	5	3	7	2	0	28	40	-1	42	46		TCRBV06-04,TCRBV06-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISLGNEQFF+TCRBV06-X+TCRBJ02-01	unresolved		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCGGGCATGGCACGAACACCGGGGAGCTGTTTTTTGGAGAA	CAGHGTNTGELFF	In	VDJ	5	386	8.687667113803938E-4	0.0010215531842818427	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	11	8	0	0	0	6	22	-1	32	28	38		TCRBV07-01,TCRBV07-02												CAGHGTNTGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTACAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSEYSTGELFF	In	VDJ	5	408	9.18281912547152E-4	0.0010797764227642277	39	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	3	5	4	0	0	26	-1	-1	42	46		TCRBV10-01,TCRBV10-02												CASSEYSTGELFF+TCRBV10-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCTCAGCAGGGGTCACTGAAGCTTTCTTTGGACAA	CASSSAGVTEAFF	In	VDJ	7	527	0.0011861141370400714	0.0013947112127371275	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	2	4	0	1	22	-1	44	39	45		TCRBV07-01,TCRBV07-02												CASSSAGVTEAFF+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGACTAGAGGGGCGACTGGAAACACCATATATTTTGGAGAG		Out	VDJ	7	530	0.0011928662099264474		46	TCRBV06	unresolved					TCRBJ01	TCRBJ01-03	01	1	5	2	2	2	3	23	39	46	41	49		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-X+TCRBJ01-03	unresolved		TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGCGGACAGGGTTAAGAGACCCAGTACTTCGGGCCA	CASSGQG*ETQYF	Stop	VDJ	8	645	0.0014516956705708654		39	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	3	3	1	2	23	34	43	35	45		TCRBV10-01,TCRBV10-02												CASSGQG*ETQYF+TCRBV10-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGAGGCTAGGGGAGACCCAGTACTTCGGGCCA	CASSERLGETQYF	In	VDJ	10	800	0.001800552769700298	0.0021172086720867207	39	TCRBV10	unresolved					TCRBJ02	TCRBJ02-05	01	2	5	3	5	5	0	23	38	-1	43	47		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSERLGETQYF+TCRBV10-X+TCRBJ02-05	unresolved		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTGGGTGGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	11	882	0.0019851094285945783		38	TCRBV10	unresolved					TCRBJ02	TCRBJ02-07	01	1	0	9	4	0	4	23	-1	42	39	46		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV10-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGAAAAAGACCTCATGTTTGACAGGACCTACTACGAGCAGTACTTCGGGCCG		Out	VDJ	51	3982	0.008962251411183232		55	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	4	3	17	5	23	34	57	51	62		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAGCCAAACAGCTTTGTACTTCTGTGCCAGCTTTCTCGAAGTCTTCGGCTACACCTTCGGTTCG	CASFLEVFGYTF	In	VDJ	1	35	7.877418367438804E-5	9.262787940379404E-5	36	TCRBV22	TCRBV22-01	01				TCRBJ01	TCRBJ01-02	01	13	4	5	8	2	16	25	28	33	30	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASFLEVFGYTF+TCRBV22-01+TCRBJ01-02	TCRBV22-01*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCAGCCAAACAGCTTTGTACTTCTGTCCTGGGAGTGTAATAGGAAGCGAGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	2	146	3.286008804703044E-4		49	TCRBV22	TCRBV22-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	6	6	4	10	8	25	36	50	46	58						01,02								X+TCRBV22-01+TCRBJ01-02	TCRBV22-01*01	TCRBD02-01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGTATCTCTGCGCCAGCAGCCAAGATATGTTCGCGGGTTACTAGCGGGAGAGGTCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	22	4.9515201166758194E-5		65	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	3	2	4	14	4	8	25	50	39	54													Vb 7.1	X+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGATCGATACAGGGAAAACACTGAAGCTTTCTTTGGACAA	XASSQDRYRENTEAFF	In	VDJ	1	24	5.401658309100894E-5	6.351626016260163E-5	48	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	3	2	5	2	23	40	51	45	53													Vb 7.1	XASSQDRYRENTEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGACCGGCAGTCCCCTAGCACAGATACGCAGTATTTTGGCCCA	CASSQDRQSPSTDTQYF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	51	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-03	01	0	4	5	0	4	6	23	40	47	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQDRQSPSTDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGCTTGGGCGGGGGGCTGGGGAGAGACCCAGTACTTCGGGCCA	YASSQAWAGGWGETQYF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	51	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	7	1	4	5	6	22	38	51	43	57													Vb 7.1	YASSQAWAGGWGETQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGGGCAGGGGGCATCTAATCAGCCCCAGCATTTTGGTGAT	YASSQGQGASNQPQHF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	48	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	4	0	4	2	4	22	38	48	40	52													Vb 7.1	YASSQGQGASNQPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAGGACAGGCTGATCTCACCCCTCCACTTTGGGAAC	CASSQDRLISPLHF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	42	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	1	4	10	0	6	23	-1	44	37	50													Vb 7.1	CASSQDRLISPLHF+TCRBV04-01+TCRBJ01-06	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCGCCGGACTACCCCTGGGCGAGCAGTACTTCGGGCCG	CASSAGLPLGEQYF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	42	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	9	6	3	8	23	35	44	38	52						01,02							Vb 7.1	CASSAGLPLGEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATCAGGGAGGGTCCTTTGAGCAGTTCTTCGGGCCA	CASSQDQGGSFEQFF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	9	0	9	3	5	23	40	50	43	55													Vb 7.1	CASSQDQGGSFEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCAGACCGCCGGTCCACAGATACGCAGTATTTTGGCCCA	CASSPDRRSTDTQYF	In	VDJ	1	61	1.372921486896477E-4	1.6143716124661248E-4	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	8	5	2	4	2	23	40	47	44	49						01,02							Vb 7.1	CASSPDRRSTDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGATTCTGGGGGGTATAGCCCTGGGGCCAACGTCCTGACTTTCGGGGCC	XASSQDSGGYSPGANVLTF	In	VDJ	1	83	1.868073498564059E-4	2.196603997289973E-4	57	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	0	9	1	2	4	7	22	39	49	43	56													Vb 7.1	XASSQDSGGYSPGANVLTF+TCRBV04-01+TCRBJ02-06	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGTTATGGCGCCGGGGAATAAGCAGTTCTTCGGGCCA	XASSQVMAPGNKQFF	In	VDJ	1	88	1.9806080466703278E-4	2.328929539295393E-4	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	8	3	11	9	4	22	38	52	47	56													Vb 7.1	XASSQVMAPGNKQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAATTTCCAAGCGGGAGAAGGACCGGGGAGCTGTTTTTTGGAGAA	YASSQFPSGRRTGELFF	In	VDJ	1	88	1.9806080466703278E-4	2.328929539295393E-4	51	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	6	2	5	6	4	22	37	51	43	55													Vb 7.1	YASSQFPSGRRTGELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGCTCTAGCGACAGATACGCAGTATTTTGGCCCA	CASSQALATDTQYF	In	VDJ	2	192	4.321326647280715E-4	5.081300813008131E-4	42	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	4	6	3	2	0	23	39	-1	41	47						01,02							Vb 7.1	CASSQALATDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATGTCCCAACGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSQDVPTYTGELFF	In	VDJ	3	202	4.546395743493252E-4	5.34595189701897E-4	48	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-02	01	0	3	7	3	7	2	23	40	49	47	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQDVPTYTGELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01		TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGACGTCAGCTACAATGAGCAGTTCTTCGGGCCA	CASSQDVSYNEQFF	In	VDJ	3	232	5.221603032130864E-4	6.13990514905149E-4	42	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	5	3	3	0	23	40	-1	43	46													Vb 7.1	CASSQDVSYNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGTTTTTTCTACGAGCAGTACTTCGGGCCG	CASSQGFFYEQYF	In	VJ	3	252	5.671741224555939E-4	6.669207317073171E-4	39	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-07	01	1	0	0	3	0	7	23	-1	39	-1	46													Vb 7.1	CASSQGFFYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGCTTCTCTCCCGGGACAGGGGTCCCCTACGAGCAGTACTTCGGGCCG	CASSQGFSPGTGVPYEQYF	In	VDJ	4	280	6.301934693951043E-4	7.410230352303523E-4	57	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	2	2	11	3	23	39	60	50	63													Vb 7.1	CASSQGFSPGTGVPYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGCACGGAGAATGTCCGATACGCAGTATTTTGGCCCA	XASSQARRMSDTQYF	In	VDJ	6	472	0.0010623261341231758	0.0012491531165311654	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	10	2	6	3	7	23	39	46	42	53													Vb 7.1	XASSQARRMSDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTCCCTCCCAGACATCTGTATACTTCTGTGCCAGCAGTTACGAGGGCGGTCGCACCGGGGAGCTGTTTTTTGGAGAA	CASSYEGGRTGELFF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	45	TCRBV06	TCRBV06-09	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	11	0	4	1	6	26	40	46	41	52													Vb 13.1	CASSYEGGRTGELFF+TCRBV06-09+TCRBJ02-02	TCRBV06-09*01	TCRBD02-01*02	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCACCATCCTCACCTTAGCGGGAGAGGGGCGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	40	9.00276384850149E-5		52	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	10	5	2	4	12	7	26	33	54	45	61			01,02										Vb 12	X+TCRBV10-01+TCRBJ02-03	TCRBV10-01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTCGACCAGAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	49	1.1028385714414325E-4		38	TCRBV10	TCRBV10-01					TCRBJ02	TCRBJ02-06	01	0	2	7	10	0	3	26	-1	46	43	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-01+TCRBJ02-06	TCRBV10-01		TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCTAGCGGCATATAGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASS*RHIGQSRANVLTF	Stop	VDJ	1	106	2.3857324198528948E-4		54	TCRBV12	TCRBV12-01	01				TCRBJ02	TCRBJ02-06	01	4	1	6	5	11	5	22	35	51	46	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASS*RHIGQSRANVLTF+TCRBV12-01+TCRBJ02-06	TCRBV12-01*01		TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGACCCAAGAGGACAGTTAATTCACCCCTCCACTTTGGGAAC	CARPKRTVNSPLHF	In	VDJ	4	341	7.67485618084752E-4	9.024601964769648E-4	42	TCRBV12	TCRBV12-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	9	1	5	6	8	1	22	30	44	38	45														CARPKRTVNSPLHF+TCRBV12-01+TCRBJ01-06	TCRBV12-01*01	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGGTATGGCGGGAGGAACAGATACGCAGTATTTTGGCCCA	CATSRGMAGGTDTQYF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	7	1	3	7	1	18	32	47	39	48														CATSRGMAGGTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCACAGACGCCACTGACCGGGACAGGGGGCTTGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	35	7.877418367438804E-5		59	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	0	4	11	3	18	35	58	46	61														X+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGCCGTCAGGCTCTCTGGGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	39	8.777694752288953E-5		49	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	4	4	4	9	18	34	42	38	51														X+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATAACAGGGACTATGGCTACACCTTCGGTTCG	CATSRDNRDYGYTF	In	VDJ	1	46	1.0353178425776714E-4	1.2173949864498645E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	3	3	2	0	18	35	-1	37	43														CATSRDNRDYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATATGGGAGCAGATACGCAGTATTTTGGCCCA	CATSRDMGADTQYF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	9	2	4	3	0	18	35	-1	38	43														CATSRDMGADTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCCAAGCAAAGGGCGCTTACTACGAGCAGTACTTCGGGCCG	CATSSQAKGAYYEQYF	In	VDJ	1	55	1.2378800291689549E-4	1.4555809620596207E-4	48	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-07	01	3	5	3	3	8	6	18	32	44	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSSQAKGAYYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAAGGGGCAGGTTCACCCCTCCACTTTGGGAAC	CATSREGAGSPLHF	In	VDJ	1	58	1.305400758032716E-4	1.5349762872628726E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	5	2	9	0	4	18	-1	40	35	44														CATSREGAGSPLHF+TCRBV15-01+TCRBJ01-06	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTCAGCAGCTTAGGCGGGACAAGTCATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	60	1.3504145772752236E-4		46	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-06	01	14	0	6	5	13	4	18	21	40	34	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV15-01+TCRBJ01-06	TCRBV15-01*01		TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCGAGGAAGTTCTGGCTACACCTTCGGTTCG	CATSRDRGSSGYTF	In	VDJ	1	68	1.5304698542452532E-4	1.7996273712737128E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	11	1	7	2	6	18	35	41	37	47														CATSRDRGSSGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD02-01*02	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTTAATGTGGACACTGAAGCTTTCTTTGGACAA	CATSRVNVDTEAFF	In	VDJ	1	69	1.552976763866507E-4	1.8260924796747967E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-01	01	1	0	10	3	7	0	18	34	-1	41	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRVNVDTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATGGCCAGGGCTACGAGCAGTACTTCGGGCCG	CATSRDGQGYEQYF	In	VDJ	1	73	1.643004402351522E-4	1.9319529132791327E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	3	4	0	18	35	-1	39	44														CATSRDGQGYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCCTAACAGGGTTTCCCTGGGCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	82	1.8455665889428055E-4		50	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	3	3	7	4	10	18	32	42	36	52														X+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTGAAGGGGTCGGGCGAAAACATTCAGTACTTCGGCGCC	CATSRVKGSGENIQYF	In	VDJ	1	85	1.9130873178065667E-4	2.249534214092141E-4	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	5	2	5	3	7	18	34	42	37	49														CATSRVKGSGENIQYF+TCRBV15-01+TCRBJ02-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCATCCGTGTGCGGGTCACAGATACGCAGTATTTTGGCCCA	CATSIRVRVTDTQYF	In	VDJ	1	85	1.9130873178065667E-4	2.249534214092141E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	7	4	2	7	1	18	31	43	38	44						01,02								CATSIRVRVTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGTCGTAAGCAACCAGTAGGAGACCCAGTACTTCGGGCCA	CATSVVSNQ*ETQYF	Stop	VDJ	1	94	2.11564950439785E-4		45	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-05	01	5	4	5	5	12	3	18	30	45	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSVVSNQ*ETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAAAGGACTATGAACACTGAAGCTTTCTTTGGACAA	CATSRERTMNTEAFF	In	VDJ	1	97	2.1831702332616114E-4	2.567115514905149E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	1	9	0	2	0	18	35	-1	37	43						01,02								CATSRERTMNTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGGCCTAGCGGACATCACAGATACGCAGTATTTTGGCCCA	CATSRGLADITDTQYF	In	VDJ	1	98	2.205677142882865E-4	2.593580623306233E-4	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	4	5	2	4	4	18	32	43	36	47						01,02								CATSRGLADITDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCCCCGGACAGACGAATCAGCCCCAGCATTTTGGTGAT	CATSPGQTNQPQHF	In	VDJ	1	99	2.2281840525041188E-4	2.620045731707317E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	5	4	3	3	18	30	39	33	42														CATSPGQTNQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGCAGGGAATCCCTACGAGCAGTACTTCGGGCCG	CATSRAGNPYEQYF	In	VDJ	1	104	2.3407186006103875E-4	2.752371273712737E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	3	2	0	4	18	-1	39	34	43														CATSRAGNPYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCACACCGGACAGGGCCGGAGAGACCCAGTACTTCGGGCCA	CATTPDRAGETQYF	In	VDJ	1	106	2.3857324198528948E-4	2.805301490514905E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	1	3	4	4	4	18	28	40	32	44														CATTPDRAGETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCCAAGCGGGGGCTGGGGGGGCCAACGTCCTGACTTTCGGGGCC	CATSSQAGAGGANVLTF	In	VDJ	1	107	2.4082393294741486E-4	2.8317665989159894E-4	51	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	3	6	2	4	3	5	18	32	43	35	48														CATSSQAGAGGANVLTF+TCRBV15-01+TCRBJ02-06	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCTAAGTGGAGAGACCCAGTACTTCGGGCCA	CATSRDLSGETQYF	In	VDJ	1	110	2.4757600583379097E-4	2.9111619241192413E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	4	9	4	1	5	18	35	39	36	44						01,02								CATSRDLSGETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGCCCGAGCAGGGGCAATGAAGACCCAGTACTTCGGGCCA	CATSRARAGAMKTQYF	In	VDJ	2	120	2.700829154550447E-4	3.175813008130081E-4	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	2	6	6	6	18	34	46	40	52														CATSRARAGAMKTQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGGGGACGCGGGGGCACACTGAAGCTTTCTTTGGACAA	CATSREGTRGHTEAFF	In	VDJ	2	128	2.880884431520477E-4	3.3875338753387534E-4	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	7	2	3	6	1	18	35	48	41	49														CATSREGTRGHTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATAGGGTCCCCTCGGAAGGCTACACCTTCGGTTCG	CATSRDRVPSEGYTF	In	VDJ	2	128	2.880884431520477E-4	3.3875338753387534E-4	45	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-02	01	0	5	3	8	1	11	18	35	40	36	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDRVPSEGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGATTAGCGGGAACAAACTACGAGCAGTACTTCGGGCCG	CATSRLAGTNYEQYF	In	VDJ	2	139	3.1284604373542677E-4	3.6786500677506775E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	5	3	3	1	5	18	33	42	34	47														CATSRLAGTNYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTCTCTGTTATTACAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	2	148	3.3310226239455514E-4		47	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-06	01	1	3	7	7	11	0	18	34	-1	45	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV15-01+TCRBJ01-06	TCRBV15-01*01		TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATGGGGAAAGCAACCATCAGTTTTTTGGCAGT	CATSRDGESNHQFF	In	VDJ	2	149	3.353529533566805E-4	3.9433011517615174E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-04	01	0	0	8	16	2	12	18	35	41	37	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDGESNHQFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01		TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGGAGGGATTCCTACGAGCAGTACTTCGGGCCG	CATSRGRDSYEQYF	In	VDJ	2	152	3.421050262430566E-4	4.02269647696477E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	10	0	1	0	2	18	-1	40	34	42														CATSRGRDSYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCCCTCGACCCAGTCAAGTTCGCAATCAGCCCCAGCATTTTGGTGAT	CATSPRPSQVRNQPQHF	In	VDJ	2	171	3.848681545234387E-4	4.525533536585366E-4	51	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-05	01	5	2	7	2	4	12	18	30	37	34	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSPRPSQVRNQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGGGGACGGATTTAACTATGGCTACACCTTCGGTTCG	CATSRGDGFNYGYTF	In	VDJ	2	176	3.9612160933406556E-4	4.657859078590786E-4	45	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-02	01	3	0	7	1	2	5	18	32	39	34	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRGDGFNYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGATTGGCCCAGGAGACCCAGTACTTCGGGCCA	CATSRGLAQETQYF	In	VDJ	2	181	4.073750641446924E-4	4.790184620596206E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	5	5	8	0	18	34	-1	42	45														CATSRGLAQETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATAAAGGGGGCCTATTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	182	4.096257551068178E-4		47	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	5	0	6	3	4	18	35	45	38	49														X+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGAGTCGGGAGCAGCTCCTACGAGCAGTACTTCGGGCCG	CATSRGVGSSSYEQYF	In	VDJ	2	192	4.321326647280715E-4	5.081300813008131E-4	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	8	2	0	4	3	18	34	44	38	47														CATSRGVGSSSYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGGCCGGGGGACGGTGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	192	4.321326647280715E-4		50	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	8	2	0	3	6	18	30	39	33	45														X+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD02-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATAGGGGTGGCACTGAAGCTTTCTTTGGACAA	CATSRDRGGTEAFF	In	VDJ	3	207	4.658930291599521E-4	5.478277439024391E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	2	4	1	3	18	35	41	36	44														CATSRDRGGTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATGCTTGGGACCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	3	248	5.581713586070924E-4		47	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-03	01	0	0	7	2	5	0	18	35	-1	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV15-01+TCRBJ01-03	TCRBV15-01*01		TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAAAGTAGCGGGAGGGGTTACAATGAGCAGTTCTTCGGGCCA	CATSRESSGRGYNEQFF	In	VDJ	3	272	6.121879416981013E-4	7.198509485094851E-4	51	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	5	0	4	3	2	18	35	49	38	51														CATSRESSGRGYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCTACTTCACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	4	349	7.85491145781755E-4		44	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	3	10	2	3	3	18	35	41	38	44						01,02								X+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCATCCACAGGTAGATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	18	1410	0.0031734742565967754		41	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	4	5	3	3	18	31	39	34	42														X+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCACCCTTTCCCCCCAGAGACCCAGTACTTCGGGCCA		Out	VDJ	24	1877	0.004224546935909324		41	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	4	10	4	2	8	18	31	35	33	43						01,02								X+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCGGTAAGGACAGGACGGGAGAGACCCAGTACTTCGGGCCA	CASSGKDRTGETQYF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	45	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	4	4	5	5	18	30	42	35	47														CASSGKDRTGETQYF+TCRBV07-02+TCRBJ02-05	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTTTTTAAAGGTACTGAAGCTTTCTTTGGACAA	CASSFFKGTEAFF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	39	TCRBV07	TCRBV07-02	01				TCRBJ01	TCRBJ01-01	01	3	5	4	5	6	1	18	32	41	38	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFFKGTEAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGACCCTCGACTGCTCTGAACACTGAAGCTTTCTTTGGACAA	CASRPSTALNTEAFF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	2	10	0	6	4	18	29	39	35	43						01,02								CASRPSTALNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCACCTGGCTGGGACCCGTGCAGATACGCAGTATTTTGGCCCA	CASSHLAGTRADTQYF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	0	7	4	9	5	18	30	44	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHLAGTRADTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCACAGGTTTCTGGAAACACCATATATTTTGGAGAG	CASSSQVSGNTIYF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	4	1	1	2	18	31	37	32	39														CASSSQVSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCAGCTGGGGACAGGGACCGAGTATGGCTACACCTTCGGTTCG	CASSPQLGTGTEYGYTF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	5	9	6	18	30	48	39	54														CASSPQLGTGTEYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACGGGAGAAGTGGAGGGACACCCGTTACCCAGGCAGTATTTTGGCCCA	CASSLTGEVEGHPLPRQYF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	57	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	2	0	6	11	14	12	18	33	53	47	65				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTGEVEGHPLPRQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTAAGACAGCTCTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFKTALNTGELFF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	2	5	1	3	4	18	32	40	35	44														CASSFKTALNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTAGAGGGGGAGGGGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	24	5.401658309100894E-5		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	9	0	3	2	2	18	35	44	37	46														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAATTAGCGGGGGGGCGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	25	5.6267274053134314E-5		47	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	5	0	2	4	2	18	31	46	35	48														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACAGGGTTCCGATCACGAGCAGTACTTCGGGCCG	CASSLQGSDHEQYF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	3	5	0	8	18	-1	38	33	46														CASSLQGSDHEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCCGCTGGGGACTAGCTAAAGAGACCCAGTACTTCGGGCCA	CASTRWGLAKETQYF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	7	0	7	3	7	2	18	28	44	35	46						01,02								CASTRWGLAKETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGACTAGCGGGGGGCGGTACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	26	5.851796501525969E-5		53	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	0	1	0	0	4	18	-1	47	32	51														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTAAGGCGTCGTCCTGAGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	26	5.851796501525969E-5		53	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	3	5	4	0	2	12	18	32	37	34	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGCGTGACAGGGGTTCCCTACAATGAGCAGTTCTTCGGGCCA	CASSVTGVPYNEQFF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	2	2	2	3	18	30	40	32	43														CASSVTGVPYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACTCTGGACCGTTCCTCCTACGAGCAGTACTTCGGGCCG	CASSTLDRSSYEQYF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	5	1	7	0	5	5	18	30	39	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTLDRSSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGACCGGGACAGGCGATACGAGCAGTACTTCGGGCCG	CASSDRDRRYEQYF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	4	4	4	3	18	30	42	34	45														CASSDRDRRYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGGGGTGGGTCCCAGCCCCAGCATTTTGGTGAT	CASSSGGGSQPQHF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	4	8	2	7	1	7	18	31	38	32	45														CASSSGGGSQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCGGGACAGGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSAGTGGNTEAFF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	1	1	3	0	18	30	-1	33	44														CASSAGTGGNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGCGGCGGGGTACAAGAGACCCAGTACTTCGGGCCA	CASSLSGGVQETQYF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	7	3	2	4	2	18	33	43	37	45														CASSLSGGVQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCGAGGCGGGGGCCTCTCCTACGAGCAGTACTTCGGGCCG	CASSPRGGGLSYEQYF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	7	2	0	7	3	18	30	44	37	47														CASSPRGGGLSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTATGGGGGGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSLWGASTDTQYF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	6	0	0	5	1	18	30	41	35	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLWGASTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGAAGGGACAGGGCTCTACGAGCAGTACTTCGGGCCG	CASSEGTGLYEQYF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	3	3	2	18	30	42	33	44														CASSEGTGLYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGCCCCTCCACAAGAGAGGGGGCAACACTGAAGCTTTCTTTGGACAA	CASSLGPLHKRGGNTEAFF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	57	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	5	0	2	16	0	18	34	-1	50	57														CASSLGPLHKRGGNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTAAGACAGGGGCCTATGGCTACACCTTCGGTTCG	CASSFKTGAYGYTF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	2	4	3	1	18	32	43	35	44														CASSFKTGAYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTAGACGGGGTTCTGAACACTGAAGCTTTCTTTGGACAA	CASSLDGVLNTEAFF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	8	3	0	0	3	18	-1	40	35	43														CASSLDGVLNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGAGTGGGCCCTCTGATGAGCAGTTCTTCGGGCCA	CASSLGSGPSDEQFF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	1	8	0	8	5	6	18	34	43	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGSGPSDEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGTACAGGGGATGGGCACTGAAGCTTTCTTTGGACAA	CASSSVQGMGTEAFF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	2	4	4	5	18	31	42	35	47														CASSSVQGMGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACGGGCCGAGGGGAGACCCAGTACTTCGGGCCA	CASSLTGRGETQYF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	11	0	5	7	0	18	33	-1	40	45														CASSLTGRGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACGTCGTCGACGCGACCCAGTACTTCGGGCCA	CASSLDVVDATQYF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	0	2	7	7	7	2	18	35	45	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDVVDATQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTCGGGCGGGGGGCACCTACGAGCAGTACTTCGGGCCG	CASSPRAGGTYEQYF	In	VDJ	1	33	7.427280175013729E-5	8.733485772357724E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	7	1	2	6	2	18	30	44	36	46														CASSPRAGGTYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTCCTACTAGCGGGAGAAGATACGCAGTATTTTGGCCCA	CASSVLLAGEDTQYF	In	VDJ	1	33	7.427280175013729E-5	8.733485772357724E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	3	2	5	5	1	18	30	46	35	47														CASSVLLAGEDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGACAGGGCCCGGGAAACATCATATATTTTGGAGAG		Out	VDJ	1	33	7.427280175013729E-5		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	1	3	12	1	12	18	31	40	32	52														X+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCTAGACTAGCGTGGCCTACGAGCAGTACTTCGGGCCG	CASSF*TSVAYEQYF	Stop	VDJ	1	33	7.427280175013729E-5		45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	2	6	2	3	3	18	32	43	35	46						01,02								CASSF*TSVAYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGACCCCGGGAGGGAGACCCAGTACTTCGGGCCA	CASSLDPGRETQYF	In	VDJ	1	33	7.427280175013729E-5	8.733485772357724E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	8	1	5	6	0	18	32	-1	38	45														CASSLDPGRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAGAGCGAGCTGGGAGGGCGAGCAGTACTTCGGGCCG	CASSRASWEGEQYF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	9	0	6	10	0	18	30	-1	40	47														CASSRASWEGEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCACCGACTAAGCGGTAGTGCGGAAAATGAGCAGTTCTTCGGGCCA	CASSHRLSGSAENEQFF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	9	7	4	15	18	30	39	34	54						01,02								CASSHRLSGSAENEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTATCGACAGGCGAACACTGAAGCTTTCTTTGGACAA	CASSYRQANTEAFF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	4	1	3	1	18	31	40	34	41														CASSYRQANTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGTCAAGGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	34	7.652349271226266E-5		41	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	0	5	4	6	5	0	18	35	-1	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCGGACAGTACTCACACTATGGCTACACCTTCGGTTCG	CASSLVGQYSHYGYTF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	1	5	3	2	7	18	34	42	36	49														CASSLVGQYSHYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCGCGCAAGCGGTTCGCACAGATACGCAGTATTTTGGCCCA	CASAQAVRTDTQYF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	6	5	1	5	3	18	27	37	32	40						01,02								CASAQAVRTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGACAGGGGATGGGAACACTGAAGCTTTCTTTGGACAA	CASSLTGDGNTEAFF	In	VDJ	1	35	7.877418367438804E-5	9.262787940379404E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	2	1	0	4	18	-1	40	32	44														CASSLTGDGNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCGTCGGACAGGGGACCTACAATGAGCAGTTCTTCGGGCCA	CASTVGQGTYNEQFF	In	VDJ	1	36	8.10248746365134E-5	9.527439024390244E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	1	2	2	5	1	18	28	42	33	43														CASTVGQGTYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGCGGACCCAGGGGGCACTGAAGCTTTCTTTGGACAA	CASSQADPGGTEAFF	In	VDJ	1	36	8.10248746365134E-5	9.527439024390244E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	1	4	10	0	18	30	-1	40	47														CASSQADPGGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAAAAAGATCCAGAGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	36	8.10248746365134E-5		46	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	3	4	5	2	10	2	18	32	45	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATTCGGCCCCGGCTACGAGCAGTACTTCGGGCCG	CASSLFGPGYEQYF	In	VDJ	1	37	8.327556559863878E-5	9.792090108401084E-5	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	2	9	0	3	3	5	18	33	39	36	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLFGPGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCTTAGGACTAGCGGGGGTTCTCGAGCAGTACTTCGGGCCG	CASSFLGLAGVLEQYF	In	VDJ	1	37	8.327556559863878E-5	9.792090108401084E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	1	2	6	4	4	18	32	49	36	53														CASSFLGLAGVLEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAAGCAGGGACCTATGGCTACACCTTCGGTTCG	CASSLEAGTYGYTF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	3	0	7	4	7	0	18	32	-1	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEAGTYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTCTATACTTCTCGGGTTGTCACCCCTCCACTTTGGGAAC	CASSSILLGLSPLHF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	6	8	4	10	12	3	18	29	45	41	48						01,02								CASSSILLGLSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD02-01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGCACGGATGGGGGTCTCTATGGCTACACCTTCGGTTCG	CASSRTDGGLYGYTF	In	VDJ	1	39	8.777694752288953E-5	1.0321392276422765E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	5	6	1	4	9	3	18	30	44	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRTDGGLYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCTCGGGGGGCCCAGAGACCCAGTACTTCGGGCCA	CASSSSGGPETQYF	In	VDJ	1	39	8.777694752288953E-5	1.0321392276422765E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	8	1	4	3	3	18	31	41	34	44														CASSSSGGPETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGCAGGTACTTTCACAGATACGCAGTATTTTGGCCCA	CASSLGAGTFTDTQYF	In	VDJ	1	39	8.777694752288953E-5	1.0321392276422765E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	4	4	2	3	6	18	34	41	37	47														CASSLGAGTFTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCCCGGGAAGAGGCGACGAGCAGTACTTCGGGCCG	CASSLVPGRGDEQYF	In	VDJ	1	39	8.777694752288953E-5	1.0321392276422765E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	8	3	5	3	7	18	34	42	37	49														CASSLVPGRGDEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCTCACAGGGGGCAGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSTSQGAGSTDTQYF	In	VDJ	1	40	9.00276384850149E-5	1.0586043360433605E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	0	0	5	4	18	30	44	35	48														CASSTSQGAGSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCTAGGCGGGGCTGTCACTGAAGCTTTCTTTGGACAA	CASSPLGGAVTEAFF	In	VDJ	1	40	9.00276384850149E-5	1.0586043360433605E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	7	3	4	7	4	18	30	43	37	47														CASSPLGGAVTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGAGGTACCGGGAGGGGTTATTACTCGGTGAGCAGTTCTTCGGGCCA	CASSLGRYREGLLLGEQFF	In	VDJ	1	42	9.452902040926564E-5	1.1115345528455284E-4	57	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	8	0	9	8	12	18	34	50	42	62														CASSLGRYREGLLLGEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAGGAGGGGGACCGGGGAGTCACCCCTCCACTTTGGGAAC	CASSRRGTGESPLHF	In	VDJ	1	43	9.677971137139102E-5	1.1379996612466124E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-06	01	5	5	1	10	3	9	18	30	39	33	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRRGTGESPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01		TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGAAAGGGGGCGCGGGTTCAGGCTTTCTTTGGACAA	CASSSGKGARVQAFF	In	VDJ	1	43	9.677971137139102E-5	1.1379996612466124E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	5	0	11	6	10	18	31	44	37	54														CASSSGKGARVQAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCCCGCTAGCGGGAGGTACCAAGAGACCCAGTACTTCGGGCCA	CASSPASGRYQETQYF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	4	1	0	4	1	18	30	45	34	46														CASSPASGRYQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTACAGGGGATCAATCAGCCCCAGCATTTTGGTGAT	CASSLQGINQPQHF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	2	3	2	2	18	30	39	32	41														CASSLQGINQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGTATGGGTCAAAGCATCCTTACGAGCAGTACTTCGGGCCG	CASSLGYGSKHPYEQYF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	51	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	1	0	9	4	5	12	18	34	42	39	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGYGSKHPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCCGGGAGTTACCTAGCGGCTCCTACGAGCAGTACTTCGGGCCG	CASRELPSGSYEQYF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	4	5	0	10	0	18	27	-1	37	44						01,02								CASRELPSGSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGAACCCCCTCGAGGTGGGAGGGCGGTAGCTATGGCTACACCTTCGGTTCG	CASS*TPSRWEGGSYGYTF	Stop	VDJ	1	45	1.0128109329564176E-4		57	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	9	0	4	15	6	18	31	53	46	59														CASS*TPSRWEGGSYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAACCCGGGGCAAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLNPGQSSYNEQFF	In	VDJ	1	45	1.0128109329564176E-4	1.1909298780487805E-4	51	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	2	7	0	0	5	4	18	33	43	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLNPGQSSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCAACCCGCCCGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	45	1.0128109329564176E-4		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	8	5	4	9	0	18	32	-1	41	44						01,02								X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCAAGGGGCCGGGACTCATCTACGAGCAGTACTTCGGGCCG	CASTKGPGLIYEQYF	In	VDJ	1	46	1.0353178425776714E-4	1.2173949864498645E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	0	10	3	10	3	18	28	44	38	47						01,02								CASTKGPGLIYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTACCGACAGGGTTTGAACACTGAAGCTTTCTTTGGACAA	CASSYRQGLNTEAFF	In	VDJ	1	47	1.057824752198925E-4	1.2438600948509485E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	0	3	2	18	31	41	34	43														CASSYRQGLNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGATGGAGGGACAGGTGAACACTGAAGCTTTCTTTGGACAA	CASRMEGQVNTEAFF	In	VDJ	1	47	1.057824752198925E-4	1.2438600948509485E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	4	0	6	0	18	29	-1	35	43														CASRMEGQVNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCGACTGGCGGGAGGGCCGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSSRLAGGPGTGELFF	In	VDJ	1	48	1.0803316618201788E-4	1.2703252032520327E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	7	0	5	8	6	18	31	48	39	54														CASSSRLAGGPGTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATCCGACAGGGGAAGATGAAAAACTGTTTTTTGGCAGT	CASSLDPTGEDEKLFF	In	VDJ	1	48	1.0803316618201788E-4	1.2703252032520327E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	2	2	6	3	3	18	35	46	38	49														CASSLDPTGEDEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTAGGGGGGACAGCGCGGGAAGCTTTCTTTGGACAA	CASSLVGGTAREAFF	In	VDJ	1	49	1.1028385714414325E-4	1.2967903116531165E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	5	8	7	5	18	32	46	39	51														CASSLVGGTAREAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTATGACTAGCGGGAGGACCGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	50	1.1253454810626863E-4		49	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	2	1	2	2	4	18	31	46	33	50														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTCCCGGGGGACAGGGGGCTAACGAGCAGTACTTCGGGCCG	CASSSPGGQGANEQYF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	0	5	7	2	18	31	50	38	52														CASSSPGGQGANEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACCCGTGGGTTCCCAAGAGACCCAGTACTTCGGGCCA	CASSLPVGSQETQYF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	2	0	9	1	5	3	18	33	41	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLPVGSQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGAGGAGCTAATGAAAAACTGTTTTTTGGCAGT	CASSLGGANEKLFF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	1	10	2	3	2	0	18	34	-1	36	40														CASSLGGANEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGCCGCAGCCGAATTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGRSRISYNEQFF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	8	0	1	0	12	18	-1	36	32	48														CASSLGRSRISYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTACTAGCGGGGGGGTCAATGAGCAGTTCTTCGGGCCA	CASSTSGGVNEQFF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	3	0	6	1	1	18	29	43	30	44														CASSTSGGVNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCACCGGGGTGGAGGAAAAGGCAGGGGATACGCAGTATTTTGGCCCA	CASSPTGVEEKAGDTQYF	In	VDJ	1	51	1.14785239068394E-4	1.3497205284552846E-4	54	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	4	3	6	22	0	18	30	-1	52	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPTGVEEKAGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGTAGCGGTTTCGGCTCCTACGAGCAGTACTTCGGGCCG	CASSRSGFGSYEQYF	In	VDJ	1	51	1.14785239068394E-4	1.3497205284552846E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	5	0	2	6	18	30	38	32	44						01,02								CASSRSGFGSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCCCGATGGGGCGACCACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	51	1.14785239068394E-4		43	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	8	7	0	0	5	4	18	27	37	32	41														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCGCCCCGACAAGGCAATCTTGAACACTGAAGCTTTCTTTGGACAA	CASSSRPDKAILNTEAFF	In	VDJ	1	52	1.1703593003051937E-4	1.3761856368563685E-4	54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	6	0	8	9	18	31	43	39	52														CASSSRPDKAILNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACAGGGGGCGCGTGAGACCCAGTACTTCGGGCCA	CASSLQGARETQYF	In	VDJ	1	52	1.1703593003051937E-4	1.3761856368563685E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	0	5	0	4	18	-1	41	33	45														CASSLQGARETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGCCGACTTGGAAGGGGCGACAGTGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	52	1.1703593003051937E-4		55	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	2	5	5	17	2	18	34	56	51	58														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTAGCGGGAGACCAAGAGACCCAGTACTTCGGGCCA	CASSLVAGDQETQYF	In	VDJ	1	52	1.1703593003051937E-4	1.3761856368563685E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	5	2	0	0	0	18	-1	-1	34	43														CASSLVAGDQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGGACAGGTGGAAACACCATATATTTTGGAGAG	CASSFGTGGNTIYF	In	VDJ	1	52	1.1703593003051937E-4	1.3761856368563685E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	0	4	3	1	0	18	32	-1	33	41														CASSFGTGGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCAGGGGTGCCTCCTCCAATGAGCAGTTCTTCGGGCCA	CASSFRGASSNEQFF	In	VDJ	1	54	1.2153731195477012E-4	1.4291158536585365E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	2	6	0	9	18	-1	38	32	47														CASSFRGASSNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGGATACGGGAACACTGAAGCTTTCTTTGGACAA	CASSLGGYGNTEAFF	In	VDJ	1	55	1.2378800291689549E-4	1.4555809620596207E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	9	1	1	0	6	18	-1	38	32	44														CASSLGGYGNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATGCAGGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLDAGSSYEQYF	In	VDJ	1	56	1.2603869387902087E-4	1.4820460704607045E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	0	4	3	0	2	2	18	35	42	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDAGSSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTAGGAGGGTTGGATACGAGCAGTACTTCGGGCCG	CASSLVRRVGYEQYF	In	VDJ	1	56	1.2603869387902087E-4	1.4820460704607045E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	10	0	4	3	5	18	34	43	37	48														CASSLVRRVGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCCCCAGGGGGGCGGAAAAATCGAGTTCTTCGGGCCA	CASSFPQGGGKIEFF	In	VDJ	1	56	1.2603869387902087E-4	1.4820460704607045E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	1	14	4	12	18	32	43	36	55														CASSFPQGGGKIEFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGACGGGGTTCTTGAACACTGAAGCTTTCTTTGGACAA	CASRTGFLNTEAFF	In	VDJ	1	56	1.2603869387902087E-4	1.4820460704607045E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	3	0	2	4	18	29	36	31	40														CASRTGFLNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCATGGGAGGGGCTGGAAACACCATATATTTTGGAGAG	CASTMGGAGNTIYF	In	VDJ	1	57	1.2828938484114622E-4	1.5085111788617887E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	7	9	0	2	4	1	18	28	39	32	40														CASTMGGAGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTAGAGACAGCCTTATACAATGAGCAGTTCTTCGGGCCA	CASSVETALYNEQFF	In	VDJ	1	57	1.2828938484114622E-4	1.5085111788617887E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	2	5	4	0	5	18	-1	40	35	45														CASSVETALYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCACAGGGGGCGGGCGGGGAGCTGTTTTTGGAGAA		Out	VDJ	1	58	1.305400758032716E-4		41	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	0	18	2	13	18	30	41	32	54														X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGCCCGGGACAGGGGGATCTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	58	1.305400758032716E-4		55	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	1	0	4	4	18	35	50	39	54														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGGACTAGCGGGGGCCAACAGCAGTTCTTCGGGCCA	CASSFGTSGGQQQFF	In	VDJ	1	58	1.305400758032716E-4	1.5349762872628726E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	0	2	11	1	5	18	32	47	33	52														CASSFGTSGGQQQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGCTTCATTCTAGCGGGAGTGGAGAGCAGTTCTTCGGGCCA	CASRLHSSGSGEQFF	In	VDJ	1	58	1.305400758032716E-4	1.5349762872628726E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	2	10	8	4	18	29	47	37	51														CASRLHSSGSGEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCACAAGCGGGAGGTGGAGATACGCAGTATTTTGGCCCA	CASSPQAGGGDTQYF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	6	1	5	5	3	18	30	44	35	47														CASSPQAGGGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCCTTTCTACGGGTGAGCAGTTCTTCGGGCCA	CASSLALSTGEQFF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	8	4	9	11	0	18	32	-1	43	47						01,02								CASSLALSTGEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCATCTTGACTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	60	1.3504145772752236E-4		43	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	4	2	8	0	6	0	18	31	-1	37	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGGTTCCTGGGGCAAGAGACCCAGTACTTCGGGCCA	CASSFGFLGQETQYF	In	VDJ	1	62	1.395428396517731E-4	1.6408367208672087E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	3	6	2	2	9	0	18	32	-1	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGFLGQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCCGGACGGTGGGGTGGAATGGCTACACCTTCGGTTCG	CASSARTVGWNGYTF	In	VDJ	1	63	1.4179353061389847E-4	1.6673018292682928E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	5	1	7	6	4	11	18	30	38	34	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSARTVGWNGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCACGGACAGGGAGCGTACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSHGQGAYSGANVLTF	In	VDJ	1	63	1.4179353061389847E-4	1.6673018292682928E-4	57	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	1	3	0	5	6	18	31	44	36	50														CASSSHGQGAYSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCCACGGGGGACTAGCGGGGGCCACGGGGAATGAGCAGTTCTTCGGGCCA	CASHGGLAGATGNEQFF	In	VDJ	1	63	1.4179353061389847E-4	1.6673018292682928E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	0	2	7	5	8	18	27	46	32	54														CASHGGLAGATGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCGGACAGGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSTGQATGELFF	In	VDJ	1	64	1.4404422157602385E-4	1.6937669376693767E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	4	4	3	1	18	30	40	33	41														CASSTGQATGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGCAGGGGGCCGGCGGGGAGCTGTTTTTTGGAGAA	CASSPQGAGGELFF	In	VDJ	1	64	1.4404422157602385E-4	1.6937669376693767E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	0	7	3	3	18	30	41	33	44														CASSPQGAGGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGCTTCACATGACTAGCGGGAGGGCTCCGGACGAGCAGTACTTCGGGCCG	CASSSLHMTSGRAPDEQYF	In	VDJ	1	64	1.4404422157602385E-4	1.6937669376693767E-4	57	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	2	0	5	10	6	18	31	55	41	61														CASSSLHMTSGRAPDEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGAGCGGGAGGGTCTCCGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLGSGRVSGANVLTF	In	VDJ	1	64	1.4404422157602385E-4	1.6937669376693767E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	1	6	0	4	2	5	18	34	46	36	51														CASSLGSGRVSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTAGCGGGGCCTCCTACGAGCAGTACTTCGGGCCG	CASSLGSGASYEQYF	In	VDJ	1	64	1.4404422157602385E-4	1.6937669376693767E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	5	3	0	1	1	18	34	43	35	44														CASSLGSGASYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCACTTAGTCGGAGGGGGTTGAACACTGAAGCTTTCTTTGGACAA	CASSSLSRRGLNTEAFF	In	VDJ	1	66	1.4854560350027458E-4	1.7466971544715447E-4	51	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	4	5	1	0	11	1	18	31	48	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSLSRRGLNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCAGGGGCCCCTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	67	1.5079629446239996E-4		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	2	0	2	4	18	30	38	32	42														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCGGGCAGGACGGAACACTGAAGCTTTCTTTGGACAA	CASSLRAGRNTEAFF	In	VDJ	1	67	1.5079629446239996E-4	1.7731622628726286E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	7	4	1	0	7	18	-1	37	32	44						01,02								CASSLRAGRNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTTGGACAGGCTGACACAAATACGCAGTATTTTGGCCCA	CASSLGQADTNTQYF	In	VDJ	1	68	1.5304698542452532E-4	1.7996273712737128E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	4	7	3	9	18	30	40	33	49														CASSLGQADTNTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGACCTTCTAGGACAGGGCGGACTGAAGCTTTCTTTGGACAA	CASRPSRTGRTEAFF	In	VDJ	1	72	1.620497492730268E-4	1.9054878048780488E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	3	5	8	3	18	29	45	37	48														CASRPSRTGRTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCTTGGGACAGGAGACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	74	1.6655113119727757E-4		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	4	2	4	3	18	31	43	35	46														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCACCCGGACTAGCGGGGGGGCGTGAGCAGTTCTTCGGGCCA	CASSPPGLAGGREQFF	In	VDJ	1	76	1.710525131215283E-4	2.011348238482385E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	1	0	9	6	2	18	30	51	36	53														CASSPPGLAGGREQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGACAGGCAGTACCGGAAACACCATATATTTTGGAGAG	CASSLGTGSTGNTIYF	In	VDJ	1	76	1.710525131215283E-4	2.011348238482385E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	1	4	4	0	7	18	-1	41	34	48														CASSLGTGSTGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTACTATCGGCTAGCGGGGGACTACAATGAGCAGTTCTTCGGGCCA	CASSYYRLAGDYNEQFF	In	VDJ	1	79	1.778045860079044E-4	2.0907435636856368E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	4	2	3	8	1	18	31	49	39	50														CASSYYRLAGDYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGACAGGGGGATGAAAAACTGTTTTTTGGCAGT	CASSPGQGDEKLFF	In	VDJ	1	80	1.800552769700298E-4	2.117208672086721E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	1	6	2	0	18	30	-1	32	43														CASSPGQGDEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTCTGGACAGGGGCCCTCCTACGAGCAGTACTTCGGGCCG	CASSSGQGPSYEQYF	In	VDJ	1	85	1.9130873178065667E-4	2.249534214092141E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	2	0	4	2	18	29	42	33	44														CASSSGQGPSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTTACCGGGACAGGGGATCTCCTCGAGGGTTACTGAAGCTTTCTTTGGACAA	CASSLPGQGISSRVTEAFF	In	VDJ	1	87	1.958101137049074E-4	2.302464430894309E-4	57	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	2	5	2	15	18	33	45	35	60														CASSLPGQGISSRVTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAGGGGTGCAGGGATCCTACGAGCAGTACTTCGGGCCG	CASSPGVQGSYEQYF	In	VDJ	1	89	2.0031149562915816E-4	2.355394647696477E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	2	1	1	8	18	30	37	31	45														CASSPGVQGSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGACCCGAGGGGGGGATATGGCTACACCTTCGGTTCG	CASSPDPRGGYGYTF	In	VDJ	1	89	2.0031149562915816E-4	2.355394647696477E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	9	0	5	10	1	18	30	47	40	48														CASSPDPRGGYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGTCAAGGTCACACAGGCGACCTTAGGGACACTGAAGCTTTCTTTGGACAA	CASSQGQGHTGDLRDTEAFF	In	VDJ	1	95	2.1381564140191038E-4	2.514185298102981E-4	60	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	4	3	15	11	18	30	50	45	61														CASSQGQGHTGDLRDTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCACAGGGGCGGTATACCCCCACCGGGGAGCTGTTTTTTGGAGAA	CASSPQGRYTPTGELFF	In	VDJ	1	96	2.1606633236403576E-4	2.5406504065040653E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	2	4	2	11	18	30	39	32	50														CASSPQGRYTPTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAAGGCCGACGGGGGATAGGGAGACCCAGTACTTCGGGCCA	CASSSRPTGDRETQYF	In	VDJ	1	96	2.1606633236403576E-4	2.5406504065040653E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	8	2	5	9	5	18	31	46	40	51														CASSSRPTGDRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTTGGGACAGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSWDRNTGELFF	In	VDJ	1	100	2.2506909621253726E-4	2.646510840108401E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	5	1	3	0	18	31	-1	34	41														CASSSWDRNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAAATTAGCGGGTCCTACGCGGCGATCTTCGGGCCA	CASSLEISGSYAAIF	In	VDJ	1	100	2.2506909621253726E-4	2.646510840108401E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	5	4	17	3	13	18	35	45	38	58						01,02								CASSLEISGSYAAIF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGATTCGCCCGGGACAGGGGGCGGTACAATGAGCAGTTCTTCGGGCCA	CASRFARDRGRYNEQFF	In	VDJ	1	104	2.3407186006103875E-4	2.752371273712737E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	0	4	8	2	18	29	49	37	51														CASRFARDRGRYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGTATAGCGGGGGCGACCTACGAGCAGTACTTCGGGCCG	CASSRIAGATYEQYF	In	VDJ	1	105	2.363225510231641E-4	2.778836382113821E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	5	2	2	4	3	18	30	43	34	46														CASSRIAGATYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGACAGGGGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSSDRGSSYEQYF	In	VDJ	1	107	2.4082393294741486E-4	2.8317665989159894E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	1	0	2	2	18	31	42	33	44														CASSSDRGSSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGAGAACCCCGACGGACAGGAAAAACTGTTTTTTGGCAGT	CASSENPDGQEKLFF	In	VDJ	1	109	2.453253148716656E-4	2.884696815718157E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	1	5	8	12	0	18	30	-1	42	48														CASSENPDGQEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACGGGGTCGGGCACTGAAGCTTTCTTTGGACAA	CASSLTGSGTEAFF	In	VDJ	1	110	2.4757600583379097E-4	2.9111619241192413E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	8	3	4	1	5	18	33	39	34	44														CASSLTGSGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGGAGCGGAGAGCGACGAGCAGTACTTCGGGCCG	CASSSGAESDEQYF	In	VDJ	1	112	2.5207738775804173E-4	2.964092140921409E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	8	2	5	0	9	18	-1	37	31	46														CASSSGAESDEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGACAGGGTTTGGTCAGCCCCAGCATTTTGGTGAT	CASSLGTGFGQPQHF	In	VDJ	1	113	2.543280787201671E-4	2.990557249322493E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	1	3	6	0	5	18	-1	42	34	47														CASSLGTGFGQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAGGGCCCCTAGTATAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	114	2.5657876968229244E-4		46	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	10	0	5	0	10	18	-1	38	32	48														X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGGACAGCAACAAGCCATTCAATACTTCGGCGCC	CASSLGGQQQAIQYF	In	VDJ	1	115	2.588294606444178E-4	3.043487466124661E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	0	5	16	1	15	18	34	42	35	57														CASSLGGQQQAIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCGCTCATATAAATGACAGGGAATGAGTTAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	122	2.745842973792954E-4		50	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	2	3	8	12	8	18	27	46	39	54														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATGGAAGGACTAGCGGGGATAAATGAGCAGTTCTTCGGGCCA	CASSMEGLAGINEQFF	In	VDJ	2	125	2.8133637026567156E-4	3.3081385501355015E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	1	3	7	6	3	18	30	48	36	51														CASSMEGLAGINEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCTGCCCCGGGGCGGGGGTAGGAAACACCATATATTTTGGAGAG	CASCPGAGVGNTIYF	In	VDJ	2	126	2.8358706122779694E-4	3.3346036585365856E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	8	7	2	4	9	2	18	27	43	36	45														CASCPGAGVGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGATCGACAAGGGTGAACACTGAAGCTTTCTTTGGACAA	CASRSTRVNTEAFF	In	VDJ	2	132	2.9709120700054917E-4	3.4933943089430895E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	6	2	6	0	3	4	18	29	36	32	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRSTRVNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGCGCCCTGGGGACACCGGGCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	134	3.015925889247999E-4		53	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	6	1	10	6	18	30	46	40	52														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCATCCGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPSGNTGELFF	In	VDJ	2	135	3.038432798869253E-4	3.5727896341463414E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	8	5	1	5	0	18	30	-1	35	38						01,02								CASSPSGNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTCGCGGAGGCCATACCTTACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	136	3.0609397084905063E-4		52	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	10	1	0	5	10	18	31	41	36	51														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCACGGGGCTTAGACAAAAACATTCAGTACTTCGGCGCC	CASSSRGLDKNIQYF	In	VDJ	2	143	3.218488075839283E-4	3.7845105013550135E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-04	01	4	7	0	3	3	5	18	31	39	34	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRGLDKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01		TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTTGGGACTAGCGGGCACAGATACGCAGTATTTTGGCCCA	CASSFLGLAGTDTQYF	In	VDJ	2	147	3.3085157143242976E-4	3.8903709349593496E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	0	5	1	3	0	18	32	-1	35	46						01,02								CASSFLGLAGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAAAAACCCCGGGACTAGCGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSPKTPGLAAYNEQFF	In	VDJ	2	149	3.353529533566805E-4	3.9433011517615174E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	5	2	11	0	18	30	-1	41	52						01,02								CASSPKTPGLAAYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGATGCGGGGGGCAGGGATGAGCAGTTCTTCGGGCCA	CASSDAGGRDEQFF	In	VDJ	2	152	3.421050262430566E-4	4.02269647696477E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	1	8	3	5	18	30	41	33	46														CASSDAGGRDEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATATCGGGGGACCGGGAGAGACCCAGTACTTCGGGCCA	CASSLDIGGPGETQYF	In	VDJ	2	164	3.691133177885611E-4	4.3402777777777775E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	8	2	4	3	6	18	35	44	38	50														CASSLDIGGPGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTAGGGACCCGCTCACCCCTCCACTTTGGGAAC	CASSLVGTRSPLHF	In	VDJ	2	168	3.7811608163706257E-4	4.4461382113821136E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-06	01	3	0	7	10	4	4	18	32	41	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVGTRSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01		TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACTGACTAGCGGACACAATGAGCAGTTCTTCGGGCCA	CASSLLTSGHNEQFF	In	VDJ	2	169	3.8036677259918795E-4	4.472603319783198E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	2	5	5	2	2	18	33	44	35	46						01,02								CASSLLTSGHNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAACGACCTAGGGACTAATGAAAAACTGTTTTTTGGCAGT	CASSNDLGTNEKLFF	In	VDJ	2	170	3.8261746356131333E-4	4.499068428184282E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	5	5	3	2	8	0	18	30	-1	38	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSNDLGTNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAACATTGAAACTAAAGGGGGCCCAATCAGGGGACGCATTCAGTACTTCGGCGCC	CASNIETKGGPIRGRIQYF	In	VDJ	2	179	4.028736822204417E-4	4.7372544037940377E-4	57	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	7	5	0	9	13	14	18	28	48	41	62														CASNIETKGGPIRGRIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACCCAGGGGACCCCTCACAGATACGCAGTATTTTGGCCCA	CASSLPRGPLTDTQYF	In	VDJ	2	193	4.343833556901969E-4	5.107765921409214E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	2	2	2	6	18	33	41	35	47														CASSLPRGPLTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTGTCCGGGGCAGGCCGCGAGCAGTACTTCGGGCCG	CASSLVSGAGREQYF	In	VDJ	2	193	4.343833556901969E-4	5.107765921409214E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	3	7	0	6	7	6	18	32	44	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVSGAGREQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGACGGACTAGCGGGAGGGGGGACGAGCAGTACTTCGGGCCG	CASSRRTSGRGDEQYF	In	VDJ	3	196	4.41135428576573E-4	5.187161246612466E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	1	0	5	4	3	18	30	49	34	52														CASSRRTSGRGDEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCCTAGGGGTCAGTAGGAACACTGAAGCTTTCTTTGGACAA	CASSLLGVSRNTEAFF	In	VDJ	3	196	4.41135428576573E-4	5.187161246612466E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	2	1	5	7	18	30	40	35	47														CASSLLGVSRNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTCCCAATCCCTACAATGAGCAGTTCTTCGGGCCA	CASSPPNPYNEQFF	In	VDJ	3	209	4.703944110842029E-4	5.531207655826558E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	5	4	6	2	5	3	18	30	37	35	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPPNPYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGCTCGGGGAGGGAGACCCAGTACTTCGGGCCA	CASSLGSGRETQYF	In	VDJ	3	214	4.816478658948297E-4	5.663533197831979E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	9	1	5	7	0	18	32	-1	39	45														CASSLGSGRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATTCGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLFGSSYNEQFF	In	VDJ	3	216	4.861492478190805E-4	5.716463414634146E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	8	2	0	2	0	18	33	-1	35	41														CASSLFGSSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAGGGACAGATCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSRDRSGANVLTF	In	VDJ	3	219	4.929013207054566E-4	5.795858739837398E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	0	5	1	1	1	18	30	38	31	39														CASSRDRSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCGACTAGCGGTTACTACAATGAGCAGTTCTTCGGGCCA	CASSATSGYYNEQFF	In	VDJ	3	220	4.951520116675819E-4	5.822323848238483E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	5	3	2	3	18	30	41	32	44						01,02								CASSATSGYYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGAGGGACTAGCGGGAGGGCCAGCCCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	4	274	6.16689323622352E-4		55	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	0	0	5	2	7	18	31	49	33	56														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATGAGGGCGAGAAACGTACGAGCAGTACTTCGGGCCG		Out	VDJ	4	282	6.346948513193551E-4		47	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	11	0	4	1	9	18	35	41	36	50														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTGGGACTAGCGGAATACAATGAGCAGTTCTTCGGGCCA	CASSLGLAEYNEQFF	In	VDJ	4	285	6.414469242057312E-4	7.542555894308943E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	5	4	2	2	18	30	43	32	45						01,02								CASSLGLAEYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAGGGGGCGGGCGGGAGACCCAGTACTTCGGGCCA	CASSSGGGRETQYF	In	VDJ	4	306	6.88711434410364E-4	8.098323170731707E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	0	5	0	6	18	-1	39	31	45														CASSSGGGRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGCTCTTTTACAGGACACTTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	4	339	7.629842361605013E-4		50	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	6	1	12	2	18	30	47	42	49														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATGAACACCCAAGAGACCCAGTACTTCGGGCCA	CASSLMNTQETQYF	In	VDJ	5	383	8.620146384940177E-4	0.0010136136517615176	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	3	6	1	4	1	18	33	40	37	41														CASSLMNTQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGAATGGGACCGCCCATGAACACTGAAGCTTTCTTTGGACAA	CASSLGMGPPMNTEAFF	In	VDJ	5	388	8.732680933046446E-4	0.0010268462059620596	51	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	1	0	7	0	4	6	18	34	43	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGMGPPMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGGGACCCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	5	396	8.912736210016475E-4		44	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	0	0	7	1	1	2	18	35	41	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATGGGGGCAAGGCTACGAGCAGTACTTCGGGCCG	CASSLWGQGYEQYF	In	VDJ	5	405	9.115298396607758E-4	0.0010718368902439025	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	6	0	3	1	4	18	33	40	34	44														CASSLWGQGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGCGCTAGCGGGGGAGAGACCCAGTACTTCGGGCCA	CASSLGASGGETQYF	In	VDJ	5	420	9.452902040926564E-4	0.0011115345528455284	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	4	2	4	3	0	18	34	-1	37	47														CASSLGASGGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGCAGGGCCTGGAAACACCATATATTTTGGAGAG	CASSLGAGPGNTIYF	In	VDJ	5	428	9.632957317896594E-4	0.0011327066395663958	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	6	0	2	0	5	18	-1	38	32	43														CASSLGAGPGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGCGGGACAGGGGTTGGCTACACCTTCGGTTCG	CASSLSGTGVGYTF	In	VDJ	6	450	0.0010128109329564177	0.0011909298780487805	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	2	7	3	1	18	33	46	36	47														CASSLSGTGVGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATTAGGCGGGGGAGGAGATACGCAGTATTTTGGCCCA	CASSLLGGGGDTQYF	In	VDJ	6	475	0.0010690782070095519	0.0012570926490514905	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	7	2	5	4	3	18	33	44	37	47														CASSLLGGGGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGACAGGGGGCCGGGACGAGCAGTACTTCGGGCCG	CASSPTGGRDEQYF	In	VDJ	6	498	0.0011208440991384355	0.0013179623983739838	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	0	5	2	4	18	30	42	32	46														CASSPTGGRDEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAGGGACTAGCGGCAAGAGACCCAGTACTTCGGGCCA	CASSRD*RQETQYF	Stop	VDJ	6	499	0.001123094790100561		42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	5	2	1	0	18	30	-1	31	42						01,02								CASSRD*RQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGCTAGCGGAATACAATGAGCAGTTCTTCGGGCCA	CASSLGLAEYNEQFF	In	VDJ	8	656	0.0014764532711542444	0.001736111111111111	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	4	5	4	2	2	18	34	43	36	45						01,02								CASSLGLAEYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTGGTCTAGCCGGGACGAGCAGTACTTCGGGCCG	CASSLWSSRDEQYF	In	VDJ	9	700	0.0015754836734877607	0.0018525575880758809	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	4	7	5	5	4	18	32	42	37	46						01,02								CASSLWSSRDEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTGGACAGGGAAATTCACCCCTCCACTTTGGGAAC	CASSPGQGNSPLHF	In	VDJ	9	720	0.001620497492730268	0.0019054878048780487	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	3	7	3	1	18	30	41	33	42														CASSPGQGNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGTGACCCGGGGCGAGGCGGCTACACCTTCGGTTCG	CASSQGDPGRGGYTF	In	VDJ	10	765	0.0017217785860259099	0.002024580792682927	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	5	7	0	8	11	5	18	30	46	41	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGDPGRGGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACATTCTATAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASTFYSSYNEQFF	In	VDJ	11	886	0.00199411219244308	0.0023448086043360433	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	4	9	0	4	3	18	28	35	32	38						01,02								CASTFYSSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCCGACAGGGAGAGTCCTACGAGCAGTACTTCGGGCCG	CASTRQGESYEQYF	In	VDJ	13	978	0.0022011757609586144	0.0025882876016260162	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	2	3	1	3	4	18	28	38	31	42														CASTRQGESYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGCTGGGGGACCCCACCGGGGAGCTGTTTTTTGGAGAA	CASSWLGDPTGELFF	In	VDJ	21	1638	0.0036866317959613603	0.004334984756097561	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	4	0	7	4	6	2	18	31	42	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWLGDPTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGATCTAGCGGGAGAGCGGCGAATGAGCAGTTCTTCGGGCCA	CASSQGSSGRAANEQFF	In	VDJ	23	1772	0.00398822438488616	0.004689617208672087	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	2	7	7	7	18	30	47	37	54														CASSQGSSGRAANEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGACGAATACTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSQGRILAKNIQYF	In	VDJ	26	2066	0.00464992752775102	0.005467691395663957	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-04	01	5	1	7	0	3	7	18	30	37	33	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGRILAKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01		TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGATCTTCCGCCCGAGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	37	2900	0.00652700379016358		49	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	11	2	4	15	0	18	30	-1	45	48														X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGCCCCCTAGCGGCGGAAACATTCAGTACTTCGGCGCC	CASSPPPSGGNIQYF	In	VDJ	54	4245	0.009554183134222207	0.011234438516260162	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	5	4	5	6	7	3	18	30	44	37	47						01,02								CASSPPPSGGNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD02-01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCACAGGGGGCGGGCGGGGAGCTGTTTTTTGGAGAA	CASSPQGAGGELFF	In	VDJ	176	13778	0.031010020076163384	0.03646362635501355	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	0	7	2	3	18	30	41	32	44														CASSPQGAGGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCGGGCTCGGGACTTCGCAGTTCTTCGGGCCA	CASGLGTSQFF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	33	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	12	0	10	12	10	2	26	31	47	41	49						01,02								CASGLGTSQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTAGACTAGCGGGAGAGGGGCGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	39	8.777694752288953E-5		52	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	2	2	5	1	7	26	43	56	44	63														X+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGACCTACTAGTTCTCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	42	9.452902040926564E-5		47	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	3	8	1	4	4	26	41	50	45	54						01,02								X+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGCTTATTTAAAACAGGGTAGTTCTTCTTCGAGCAGTACTTCGGGCCG		Out	VDJ	1	46	1.0353178425776714E-4		55	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	3	6	10	11	26	41	57	51	68														X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGCTGTGTATTTTTGTGCCAGCTACGGGACTAGCGGGAGTAAAAACCTACGGGAACTCAATGAGCAGTTCTTCGGGCCA	CASYGTSGSKNLRELNEQFF	In	VDJ	1	46	1.0353178425776714E-4	1.2173949864498645E-4	60	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	12	0	2	6	7	18	15	20	41	27	59														CASYGTSGSKNLRELNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGCCTTAGGGACCAGTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASGLALGTSSSYNEQFF	In	VDJ	1	47	1.057824752198925E-4	1.2438600948509485E-4	54	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-01	01	1	0	7	0	5	6	26	42	52	47	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLALGTSSSYNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGCCAAGGACAGGGGGCCCACACCATATATTTTGGAGAG	CASQGQGAHTIYF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	9	1	0	8	4	2	26	34	49	38	51														CASQGQGAHTIYF+TCRBV12-05+TCRBJ01-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGCCCAATTCGGACCGGATAACTATGGCTACACCTTCGGTTCG	CASAQFGPDNYGYTF	In	VDJ	1	51	1.14785239068394E-4	1.3497205284552846E-4	45	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-02	01	7	1	7	1	8	4	26	36	48	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASAQFGPDNYGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACTTCGGGCAATCAGCCCCAGCATTTTGGTGAT	CASTSGNQPQHF	In	VDJ	1	65	1.462949125381492E-4	1.7202320460704606E-4	36	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-05	01	12	4	5	2	0	8	26	-1	34	31	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTSGNQPQHF+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACTACATGGGGGGGGACAGATACGCAGTATTTTGGCCCA	CASTTWGGTDTQYF	In	VDJ	1	66	1.4854560350027458E-4	1.7466971544715447E-4	42	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	12	9	0	3	11	1	26	31	49	42	50														CASTTWGGTDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGCCCCCCAGGCTAGCAGGAATGAGCAGTTCTTCGGGCCA	CASAPQASRNEQFF	In	VDJ	1	70	1.5754836734877608E-4	1.8525575880758808E-4	42	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	4	7	7	9	3	26	36	50	45	53						01,02								CASAPQASRNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCCTGGGGGTCAACCCCGGACTGTTTTTTGGCAGT	CASLGVNPGLFF	In	VDJ	1	105	2.363225510231641E-4	2.778836382113821E-4	36	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-04	01	12	6	1	13	6	10	26	31	42	37	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASLGVNPGLFF+TCRBV12-05+TCRBJ01-04	TCRBV12-05*01		TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGTACTCAGGGGTTGACACTGAAGCTTTCTTTGGACAA	CASGLYSGVDTEAFF	In	VDJ	1	112	2.5207738775804173E-4	2.964092140921409E-4	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	2	3	4	3	26	41	51	45	54														CASGLYSGVDTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTACTCAAGTTCCGGGCACTGAAGCTTTCTTTGGACAA	CASTQVPGTEAFF	In	VDJ	2	120	2.700829154550447E-4	3.175813008130081E-4	39	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	8	8	4	4	10	0	26	35	-1	45	49						01,02								CASTQVPGTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTAAAGGACTAGCGGGGGTACTCACAGATACGCAGTATTTTGGCCCA	CASGKGLAGVLTDTQYF	In	VDJ	2	120	2.700829154550447E-4	3.175813008130081E-4	51	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	1	2	2	3	4	26	38	54	41	58														CASGKGLAGVLTDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTCCCCGGACAAAAACGGAAGCTAATACTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	142	3.195981166218029E-4		47	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	11	1	6	3	4	16	26	32	41	36	57														X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGAAGAAACTGGGGCCCAGACGGGGGATCATGGGAAACTGTTTTTTGGCAGT	CEETGAQTGDHGKLFF	In	VDJ	2	152	3.421050262430566E-4	4.02269647696477E-4	48	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	13	8	2	11	18	8	26	30	54	48	62														CEETGAQTGDHGKLFF+TCRBV12-05+TCRBJ01-04	TCRBV12-05*01	TCRBD02-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGGACAGTTCACTGAAGCTTTCTTTGGACAA	CASGLGQFTEAFF	In	VDJ	2	153	3.44355717205182E-4	4.0491615853658535E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	5	4	0	2	26	-1	47	42	49														CASGLGQFTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCCTAGCAGGGCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASLAGPNTGELFF	In	VDJ	2	169	3.8036677259918795E-4	4.472603319783198E-4	42	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-02	01	12	4	3	0	8	1	26	31	44	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASLAGPNTGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01		TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTGGCCCACCAGCTAGGAGGCGGTATCCCAATCGTACTTCGGGCCA		Out	VDJ	2	171	3.848681545234387E-4		55	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	10	1	13	13	13	26	43	61	56	74														X+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGTGGGGCGGAAACATTCAGTACTTCGGCGCC	CASGLWGGNIQYF	In	VDJ	2	177	3.9837230029619094E-4	4.68432418699187E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	2	7	0	6	1	2	26	41	47	42	49														CASGLWGGNIQYF+TCRBV12-05+TCRBJ02-04	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAATTCCCAGGGGGCCACCGGGGAGCTGTTTTTTGGAGAA	CASNSQGATGELFF	In	VDJ	3	263	5.91931723038973E-4	6.960323509485095E-4	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	12	4	0	4	10	0	26	31	-1	41	49														CASNSQGATGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTTCGTCAGGGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	23	1768	0.003979221621037659		41	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	3	4	4	0	26	40	-1	44	49														X+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCTACCTGTTCTCTGGAAACACCATATATTTTGGAGAG	CASYLFSGNTIYF	In	VDJ	27	2079	0.00467918651025865	0.0055020960365853655	39	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-03	01	12	4	5	0	0	9	26	-1	34	31	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASYLFSGNTIYF+TCRBV12-05+TCRBJ01-03	TCRBV12-05*01		TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAAGAGGACAGGGCCTAGATTTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	22	4.9515201166758194E-5		52	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	1	3	1	2	8	20	35	45	37	53														X+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGATTACCAGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASRLPGGNQPQHF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	42	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	2	2	5	0	20	31	-1	36	42														CASRLPGGNQPQHF+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTGTCGGTGAACACTGAAGCTTTCTTTGGACAA	CASSLSVNTEAFF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	39	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	8	5	0	5	0	20	31	-1	36	39						01,02								CASSLSVNTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTCGACCTCTGGAAACACCATATATTTTGGAGAG	CASSSTSGNTIYF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	39	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-03	01	6	2	7	0	3	0	20	31	-1	34	37				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSTSGNTIYF+TCRBV23-01+TCRBJ01-03	TCRBV23-01*01		TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACACGGCACTGTATCTCTGCGCCAGCAAAGGCAGCGTGGTGATAGGGAGCTAGCGGGAGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASKGSVVIGS*REGTGELFF	Stop	VDJ	1	28	6.301934693951043E-5		63	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	4	0	4	22	0	18	28	-1	50	62														CASKGSVVIGS*REGTGELFF+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCCACGCCGGGAGGGGACCCATAACAATGAGCAGTTCTTCGGGCCA	CASSPRREGTHNNEQFF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	51	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	8	0	5	7	8	20	31	46	38	54														CASSPRREGTHNNEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTGTTCTCCCAAACCGAAGCTTTCTTTGGACAA	CASSLFSQTEAFF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	39	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-01	01	6	3	7	8	13	1	20	31	46	44	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLFSQTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGATGGTTCCACTGAAGCTTTCTTTGGACAA	CASSQDGSTEAFF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	39	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-01	01	2	0	10	4	3	3	20	35	40	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDGSTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCCTTCAACAGGGTTTGGCTACACCTTCGGTTCG	CASSPSTGFGYTF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	39	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	3	7	7	2	20	31	44	38	46														CASSPSTGFGYTF+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAACTCTTGAAGTAGGGGGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	38	8.552625656076415E-5		47	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	7	5	2	1	11	0	20	30	-1	41	46														X+TCRBV23-01+TCRBJ02-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTGAATGGTGTCACTGAAGCTTTCTTTGGACAA	CASSLNGVTEAFF	In	VDJ	1	40	9.00276384850149E-5	1.0586043360433605E-4	39	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-01	01	6	0	10	4	7	3	20	31	40	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLNGVTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCTTAGTCAGTCAACTATGGCTACACCTTCGGTTCG	CASSQS*SVNYGYTF	Stop	VDJ	1	41	9.227832944714028E-5		45	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-02	01	0	4	5	2	5	2	20	37	45	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQS*SVNYGYTF+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTGGTCGGGGGGAGTACGTACCGGGGAGCTGTTTTTTGGAGAA	CASSWSGGVRTGELFF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	48	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	8	1	5	5	7	20	31	43	36	50														CASSWSGGVRTGELFF+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCGCGATGGGGTAGGGTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSRDGVGSYNSPLHF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	51	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-06	01	4	5	3	1	10	0	20	33	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDGVGSYNSPLHF+TCRBV23-01+TCRBJ01-06	TCRBV23-01*01		TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTGGGACCGAGCCTACGAGCAGTACTTCGGGCCG	CASSWDRAYEQYF	In	VDJ	1	49	1.1028385714414325E-4	1.2967903116531165E-4	39	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-07	01	6	0	7	2	2	4	20	31	38	33	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWDRAYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCACCCAGGGGGCGGGTATCGGGGAGCTGTTTTTTGGAGAA	CASTQGAGIGELFF	In	VDJ	1	51	1.14785239068394E-4	1.3497205284552846E-4	42	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	4	0	7	2	6	20	30	40	32	46														CASTQGAGIGELFF+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGAATCGGCAGGGGGAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQESAGGNTGELFF	In	VDJ	1	53	1.1928662099264474E-4	1.4026507452574526E-4	51	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	1	2	7	1	20	35	49	42	50														CASSQESAGGNTGELFF+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGATGGTGGACACACCTGGAACACTGAAGCTTTCTTTGGACAA	CASSQDGGHTWNTEAFF	In	VDJ	1	56	1.2603869387902087E-4	1.4820460704607045E-4	51	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	6	1	6	6	20	35	46	41	52														CASSQDGGHTWNTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGGGTGGGGCCAAGCGCGGGACGAGCAGTACTTCGGGCCG	CASSQGWGQARDEQYF	In	VDJ	1	60	1.3504145772752236E-4	1.5879065040650406E-4	48	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-07	01	2	7	0	5	4	10	20	35	44	39	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGWGQARDEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTAGGGACAGGATATGAGCAGTTCTTCGGGCCA	CASSLGTGYEQFF	In	VDJ	1	63	1.4179353061389847E-4	1.6673018292682928E-4	39	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	4	8	4	2	20	31	43	35	45														CASSLGTGYEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCCCTTTTTTGACGGAGACTCTGGAAACACCATATATTTTGGAGAG	CASSPFFDGDSGNTIYF	In	VDJ	1	78	1.7555389504577906E-4	2.064278455284553E-4	51	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	6	10	2	0	13	1	20	31	48	44	49														CASSPFFDGDSGNTIYF+TCRBV23-01+TCRBJ01-03	TCRBV23-01*01	TCRBD02-01*02	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCTTCCCGAGCGGTCGTCTACAGGGAGGTGAGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	83	1.868073498564059E-4		59	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-05	01	4	3	3	4	17	7	20	33	56	50	63				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCCCTGACAATAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	85	1.9130873178065667E-4		40	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	8	2	6	0	3	2	20	29	36	32	38														X+TCRBV23-01+TCRBJ02-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGGGGAACTTAGTAGACAGGACCCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	107	2.4082393294741486E-4		62	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	2	4	0	13	3	19	36	55	49	58														X+TCRBV23-01+TCRBJ01-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTGGGACAAGGCCTACGAGCAGTACTTCGGGCCG	CASSWDKAYEQYF	In	VDJ	1	108	2.4307462390954024E-4	2.858231707317073E-4	39	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	6	2	2	3	20	31	39	33	42														CASSWDKAYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCACTTGACAGCGACGTTGGCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	113	2.543280787201671E-4		46	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	2	5	3	3	9	20	30	38	33	47														X+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGAGCAGGGGACTCGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	142	3.195981166218029E-4		47	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-04	01	6	4	2	0	2	5	20	31	39	33	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ01-04	TCRBV23-01*01		TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCACCCCCCGGGACAGGGGGAAGACAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	157	3.533584810536835E-4		50	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	1	7	6	4	20	34	51	40	55														X+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAAACTACAGGGGGAAGCTACGAGCAGTACTTCGGGCCG	CASSQTTGGSYEQYF	In	VDJ	2	158	3.556091720158088E-4	4.1814871273712737E-4	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	1	3	3	3	20	35	46	38	49														CASSQTTGGSYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCACTCCGCGACAGGGGAATCCTACGAGCAGTACTTCGGGCCG	CASSHSATGESYEQYF	In	VDJ	2	180	4.05124373182567E-4	4.763719512195122E-4	48	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	2	1	9	2	20	31	48	40	50														CASSHSATGESYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGGTGGGGGACCCACAGATACGCAGTATTTTGGCCCA	CASSQGGGPTDTQYF	In	VDJ	2	189	4.253805918416954E-4	5.001905487804878E-4	45	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-03	01	2	0	7	2	5	1	20	35	45	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGGGPTDTQYF+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAACACGATCTCGATTAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	219	4.929013207054566E-4		43	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-01	01	2	2	8	7	3	8	20	35	40	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAACCCATCTTTTAATATGGCTACACCTTCGGTTCG	CASSQPIF*YGYTF	Stop	VDJ	3	262	5.896810320768476E-4		42	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-02	01	2	4	6	5	2	8	20	35	39	37	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQPIF*YGYTF+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCTCACCGACTACAGGAAGGGGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	4	309	6.954635072967401E-4		52	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-03	01	4	3	4	3	10	6	20	33	48	43	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCCCATTCCGGGACAGGGTTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPHSGTGFSNQPQHF	In	VDJ	5	426	9.587943498654087E-4	0.001127413617886179	54	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	3	0	8	2	20	33	50	41	52														CASSPHSGTGFSNQPQHF+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCTCTCCAGTATGCCACAAGAAAAACTGTTTTTTGGCAGT	CASSLSSMPQEKLFF	In	VDJ	8	649	0.0014606984344193667	0.0017175855352303522	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	6	8	13	1	20	33	49	46	50														CASSLSSMPQEKLFF+TCRBV23-01+TCRBJ01-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCGGGACAAATGGCTACACCTTCGGTTCG	CASSPGTNGYTF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	36	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	6	6	3	1	26	38	47	41	48		TCRBV12-03,TCRBV12-04												CASSPGTNGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCGACAGGTGTGTTCACTGAAGCTTTCTTTGGACAA	CASSPTGVFTEAFF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	4	4	2	6	26	38	46	40	52		TCRBV12-03,TCRBV12-04												CASSPTGVFTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTGGGGTATCAATCAGCCCCAGCATTTTGGTGAT	CASSWGINQPQHF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	39	TCRBV12						TCRBJ01	TCRBJ01-05	01	4	6	2	3	0	3	26	-1	43	39	46		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWGINQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCCTGAGGTCGGGCGAGCAGTACTTCGGGCCG	CASSLRSGEQYF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	8	4	6	6	0	26	39	-1	45	49	TCRBV03,TCRBV12					01,02								CASSLRSGEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGCGGGGGAACAATGAGCAGTTCTTCGGGCCA	CSAPRGNNEQFF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	2	5	2	1	26	35	44	37	45		TCRBV20-01,TCRBV20-or09_02												CSAPRGNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CMCCARCCARACAGCTYTKTACTTCTGTGCCAGCAGAGGGACAGTTAACACTGAAGCTTTCTTTGGACAA	CASRGTVNTEAFF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	5	2	1	2	24	35	43	36	45	TCRBV22,TCRBV24													CASRGTVNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGGCGGGGGCCAGGAGACCCAGTACTTCGGGCCA	CASSLAGGGQETQYF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	45				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	7	2	5	2	4	18	35	44	37	48	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAGGGQETQYF+X+TCRBJ02-05		TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCTTAGTTGCGTGGAATAAAGCTTTCTTTGGACAA	CASSLVAWNKAFF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	39	unresolved						TCRBJ01	TCRBJ01-01	01	6	1	8	9	11	3	20	31	45	42	48	TCRBV07,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVAWNKAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTCAACCCCGACCATCGGCGGGAGCTCAAATGAGCAGTTCTTCGGGCCA	CASSSTPTIGGSSNEQFF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	7	2	7	15	4	19	32	54	47	58	TCRBV05,TCRBV11													CASSSTPTIGGSSNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGCTTAGCTAGCGGGGGGGCCAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLASGGASTGELFF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	4	0	4	0	4	23	-1	51	39	55	TCRBV13,TCRBV21													CASSLASGGASTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAACATAGCTAACTATGGCTACACCTTCGGTTCG	CASNIANYGYTF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	36	unresolved						TCRBJ01	TCRBJ01-02	01	6	3	6	0	0	3	23	-1	36	33	39	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNIANYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGGGCCCGCCGCAACCGGGGAGCTGTTTTTTGGAGAA	CASSGPAATGELFF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	8	0	5	1	8	23	34	39	35	47	TCRBV09,TCRBV12													CASSGPAATGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTGGGGACAGGGGGATTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLGTGGFSNQPQHF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	1	0	2	3	26	39	52	41	55		TCRBV03-01,TCRBV03-02												CASSLGTGGFSNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGTCCCCCCCGGGACAGTCCTAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	23	5.176589212888357E-5		50	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	5	0	9	5	26	34	50	43	55		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGTCGGGACTAGCGGGAGTTGGATTCGGAGATACGCAGTATTTTGGCCCA	CSAKSGLAGVGFGDTQYF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	0	2	5	4	10	26	36	54	40	64		TCRBV20-01,TCRBV20-or09_02												CSAKSGLAGVGFGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGCCCCCTCAGGGAGTAGTACAGACCCAGTACTTCGGGCCA	CSATPPQGVVQTQYF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	45	TCRBV20						TCRBJ02	TCRBJ02-05	01	4	4	3	6	8	8	26	36	49	44	57		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATPPQGVVQTQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAATAGATTACCTGGAAGCTTTCTTTGGACAA	CSARIDYLEAFF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	5	8	8	1	8	26	38	42	39	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARIDYLEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCATTCAGAGACCCAGTACTTCGGGCCA	CSARDHSETQYF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	6	4	1	3	26	40	43	41	46		TCRBV20-01,TCRBV20-or09_02												CSARDHSETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCCCCGGGGGCCCCTCCTACGAGCAGTACTTCGGGCCG	CSASPGGPSYEQYF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	42	TCRBV20						TCRBJ02	TCRBJ02-07	01	5	6	0	0	6	2	26	35	47	41	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASPGGPSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCACGCGGGAGGGAACCAATGAGCAGTTCTTCGGGCCA	CASTREGTNEQFF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	7	0	6	1	3	22	32	42	33	45		TCRBV12-03,TCRBV12-04												CASTREGTNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAATCTGGTACCTATGGCTACACCTTCGGTTCG	CASSESGTYGYTF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	39	TCRBV12						TCRBJ01	TCRBJ01-02	01	5	0	10	4	6	3	22	34	42	40	45		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSESGTYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTAACTAGCACAGATACGCAGTATTTTGGCCCA	CASSLLTSTDTQYF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	3	10	0	6	0	24	36	-1	42	45		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLLTSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCGACCGAAAGGGCAATGAGCAGTTCTTCGGGCCA	CASSFDRKGNEQFF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	42	TCRBV24						TCRBJ02	TCRBJ02-01	01	6	5	3	6	10	0	24	36	-1	46	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFDRKGNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATAGAGTAAAGGCGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSQDRVKASSYEQYF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	51							TCRBJ02	TCRBJ02-07	01	0	5	4	0	8	4	18	35	46	43	50	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDRVKASSYEQYF+X+TCRBJ02-07			TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCTGACAGGGGTCGGGACACTGAAGCTTTCTTTGGACAA	CASSPDRGRDTEAFF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	2	3	3	5	18	30	41	33	46	TCRBV07,TCRBV11													CASSPDRGRDTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAAACCCCAGCGGGGGGGTCAATAACACAGATACGCAGTATTTTGGCCCA	CASSLNPSGGVNNTDTQYF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	57	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	6	0	2	6	7	18	33	49	39	56	TCRBV07,TCRBV11													CASSLNPSGGVNNTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGGCGGAGTGAGACAGGGGGAAGGGTCCTACGAGTAGTACTTCGGGCCG	CASSLGGVRQGEGSYE*YF	Stop	VDJ	1	23	5.176589212888357E-5		57	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	1	11	9	15	18	34	52	43	67	TCRBV07,TCRBV11													CASSLGGVRQGEGSYE*YF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGGGTCGGACAGGGGGCGCGTCAACACTGAAGCTTTCTTTGGACAA	CASSLGSDRGRVNTEAFF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	54	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	0	2	6	5	19	33	50	39	55		TCRBV05-06,TCRBV05-07												CASSLGSDRGRVNTEAFF+TCRBV05-X+TCRBJ01-01	TCRBV05	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAACGTAGGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASNVGGNTGELFF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	42	unresolved			unresolved			TCRBJ02	TCRBJ02-02	01	0	6	2	1	0	0	23	-1	-1	39	43	TCRBV09,TCRBV12			TCRBD01,TCRBD02										CASNVGGNTGELFF+X+TCRBJ02-02	unresolved	unresolved	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTTCCACACCGGGACAGGGCGGTGAAAAACTGTTTTTTGGCAGT	CASSSTPGQGGEKLFF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	3	7	9	3	23	34	52	43	55	TCRBV09,TCRBV21													CASSSTPGQGGEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGTAMSCTCYCAGACATCTGTGTACTTCTGTGCCAGCAGTGACTCGAGCGGGGGGGCAAATGAGCAGTTCTTCGGGCCA	CASSDSSGGANEQFF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	6	0	7	1	2	28	45	56	46	58	TCRBV06,TCRBV10													CASSDSSGGANEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGACAATTAATTCACCCCTCCACTTTGGGAAC	CASSQETINSPLHF	In	VDJ	1	24	5.401658309100894E-5	6.351626016260163E-5	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	2	6	6	0	2	26	-1	47	43	49		TCRBV03-01,TCRBV03-02												CASSQETINSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTCGCACGGGGAACCAGTACTTCGGGCCA	CASSQGRTGNQYF	In	VDJ	1	24	5.401658309100894E-5	6.351626016260163E-5	39	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	8	3	10	6	2	26	42	53	48	55		TCRBV03-01,TCRBV03-02												CASSQGRTGNQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCAGGGAAGGGGCCCGAGCAGTACTTCGGGCCG	CSARDPGKGPEQYF	In	VDJ	1	24	5.401658309100894E-5	6.351626016260163E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	6	2	8	26	40	47	42	55		TCRBV20-01,TCRBV20-or09_02												CSARDPGKGPEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCCCTCGGGGGAGATCAAAGCTTTCTTTGGACAA	CSAPPSGEIKAFF	In	VDJ	1	24	5.401658309100894E-5	6.351626016260163E-5	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	2	9	7	6	26	35	48	42	54		TCRBV20-01,TCRBV20-or09_02												CSAPPSGEIKAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGGGGACTAGAATACGAGCAGTACTTCGGGCCG	CSGGLEYEQYF	In	VDJ	1	24	5.401658309100894E-5	6.351626016260163E-5	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	0	8	4	1	2	26	33	42	34	44		TCRBV20-01,TCRBV20-or09_02				01,02								CSGGLEYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCTTAATTAAGGGAAACGAGCAGTACTTCGGGCCG	CASSLIKGNEQYF	In	VDJ	1	24	5.401658309100894E-5	6.351626016260163E-5	39	unresolved						TCRBJ02	TCRBJ02-07	01	2	0	8	5	5	1	22	37	46	42	47	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLIKGNEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCACCCGGGTTGGGGTCAGCAATCAGCCCCAGCATTTTGGTGAT	CASTRVGVSNQPQHF	In	VDJ	1	24	5.401658309100894E-5	6.351626016260163E-5	45	unresolved						TCRBJ01	TCRBJ01-05	01	7	6	2	1	8	2	23	33	45	41	47	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTRVGVSNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTAGGGCAACGCGACGAGCAGTACTTCGGGCCG	CASSLLGQRDEQYF	In	VDJ	1	24	5.401658309100894E-5	6.351626016260163E-5	42	TCRBV24						TCRBJ02	TCRBJ02-07	01	6	5	3	5	5	7	24	36	45	41	52		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLLGQRDEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTGGACAGGGGGGTTGAGGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	24	5.401658309100894E-5		52	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	1	3	5	7	24	36	51	41	58		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ASGACTCGGCYSTGTATCTCTGTGCCAGCAGCCTAGGGGGCGCAGTAAATACGCAGTATTTTGGCCCA	CASSLGGAVNTQYF	In	VDJ	1	24	5.401658309100894E-5	6.351626016260163E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	7	0	7	0	7	19	-1	40	35	47	TCRBV05,TCRBV07													CASSLGGAVNTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGACGTAACTAGCGGACCCTCGGAGCAGTACTTCGGGCCG	CASSQDVTSGPSEQYF	In	VDJ	1	24	5.401658309100894E-5	6.351626016260163E-5	48				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	3	5	7	4	7	18	35	47	39	54	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03				01,02								CASSQDVTSGPSEQYF+X+TCRBJ02-07		TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTATATGTCGGGACAGTATTAGCTGAAGCTTTCTTTGGACAA	CASSLYVGTVLAEAFF	In	VDJ	1	24	5.401658309100894E-5	6.351626016260163E-5	48	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	5	6	7	6	19	33	47	40	53		TCRBV05-06,TCRBV05-07												CASSLYVGTVLAEAFF+TCRBV05-X+TCRBJ01-01	TCRBV05	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCTGGGGGCGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLGAGTGELFF	In	VDJ	1	24	5.401658309100894E-5	6.351626016260163E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	6	0	4	2	3	24	36	44	38	47	TCRBV09,TCRBV21													CASSLGAGTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGCCAACGGGATCAGCGGGGCATACGTTCTTCGGGCCA	CASRPTGSAGHTFF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	6	3	15	12	5	26	37	56	49	61		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRPTGSAGHTFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGACAGGGGGGGATACGCAGTATTTTGGCCCA	CASSRTGGDTQYF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	1	1	6	0	1	26	-1	49	39	50		TCRBV03-01,TCRBV03-02												CASSRTGGDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGGCGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	25	5.6267274053134314E-5		35	TCRBV03						TCRBJ02	TCRBJ02-03	01	4	8	0	5	0	2	26	-1	43	39	45		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAGGGCCCATCCCCGAGAGACCCAGTACTTCGGGCCA	CSARAHPRETQYF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	11	0	4	0	10	26	-1	39	34	49		TCRBV20-01,TCRBV20-or09_02												CSARAHPRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACGCCGCGGACAGGGGGCAGGTCGGGGAGCTGTTTTTTGGAGAA	CSANAADRGQVGELFF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	1	0	7	7	4	26	36	54	43	58		TCRBV20-01,TCRBV20-or09_02												CSANAADRGQVGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCCTAGCGGCACTACCGGGGAGCTGTTTTTTGGAGAA	CSARDPSGTTGELFF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	4	5	5	2	4	26	40	49	42	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDPSGTTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACGTGACAGGGAACACTGAAGCTTTCTTTGGACAA	CSARDVTGNTEAFF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	4	1	3	0	26	40	-1	43	49		TCRBV20-01,TCRBV20-or09_02												CSARDVTGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTTAAAAAAACTCCTGAGGTATTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	25	5.6267274053134314E-5		46	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	11	1	9	15	3	26	37	56	52	59		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCAGGTCCGGGGTACAATGAGCAGTTCTTCGGGCCA	CSASGPGYNEQFF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	3	4	7	0	26	35	-1	42	47		TCRBV20-01,TCRBV20-or09_02												CSASGPGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCAACGGGGGAGAGCGATGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	25	5.6267274053134314E-5		46	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	7	8	2	3	3	9	24	35	44	38	53		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTCCCAAACGGGGAACTATGGCTACACCTTCGGTTCG	CASSSQTGNYGYTF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	8	3	2	7	0	24	36	-1	43	48	TCRBV06,TCRBV24													CASSSQTGNYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCGGGGGACTAGCGGGTACCGGGGAGCTGTTTTTTGGAGAA	CASSGGLAGTGELFF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	0	4	5	2	1	18	30	44	32	45	TCRBV05,TCRBV11					01,02								CASSGGLAGTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCGATACTAGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	XASSDTRSSYNEQFF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	3	8	0	3	3	22	34	42	37	45	TCRBV04,TCRBV07,TCRBV17					01,02								XASSDTRSSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCAGGACAGGGCAGGGGGAGACCTAGTACTTCGGGCCA	CASSRTGQGET*YF	Stop	VDJ	1	25	5.6267274053134314E-5		42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	1	3	12	1	13	19	31	40	32	53		TCRBV05-06,TCRBV05-07												CASSRTGQGET*YF+TCRBV05-X+TCRBJ02-05	TCRBV05	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGTCACAAGACAAGGCTCTGGAAACACCATATATTTTGGAGAG	CASSLVTRQGSGNTIYF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	2	6	0	8	3	19	33	45	41	48	TCRBV05,TCRBV11													CASSLVTRQGSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCATTCGTCGGGGGGAAGATACTTTCTTTGGACAA	CASSPIRRGEDTFF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	1	12	9	6	26	38	54	47	60		TCRBV12-03,TCRBV12-04												CASSPIRRGEDTFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCCCTCGCCGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSPSPGNQPQHF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	8	5	2	7	0	24	36	-1	43	46	TCRBV06,TCRBV10					01,02								CASSPSPGNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACTTTGTTCTGAACACTGAAGCTTTCTTTGGACAA	CASSQDFVLNTEAFF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	4	10	0	0	6	26	-1	45	43	51		TCRBV03-01,TCRBV03-02				01,02								CASSQDFVLNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCATATTCCGACAGAGCTCCTACGAGCAGTACTTCGGGCCG	CSAIFRQSSYEQYF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	5	0	8	2	26	34	47	42	49		TCRBV20-01,TCRBV20-or09_02												CSAIFRQSSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGGACTAGCGGCCTACAATGAGCAGTTCTTCGGGCCA	CSAGLAAYNEQFF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	5	2	0	0	26	-1	-1	34	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSAGLAAYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCGGGACAGGGAGGAGATACGCAGTATTTTGGCCCA	CASSPGQGGDTQYF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	3	5	1	3	23	36	46	37	49	TCRBV01,TCRBV04													CASSPGQGGDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCCCCCGGGACACAGACTCTGGAAACACCATATATTTTGGAGAG	CASSPRDTDSGNTIYF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	0	6	0	5	4	22	33	44	38	48		TCRBV12-03,TCRBV12-04												CASSPRDTDSGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTAAACCAGGGGGTGCAGATACGCAGTATTTTGGCCCA	CATSKPGGADTQYF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	1	4	4	2	24	36	47	40	49		TCRBV24-01,TCRBV24-or09_02												CATSKPGGADTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCAAGCCACGTTTGSYSMMMSMSASASCTCTKTACYTCTGTGCCAGCCCGTGACTAGCGGGAGCCTGCTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	26	5.851796501525969E-5		43	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	11	2	2	9	6	5	24	31	49	37	54	TCRBV24,TCRBV25,TCRBV27,TCRBV28													X+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCGCCAACTCACAGATGAGCCCAGATACGCAGTATTTTGGCCCA	CASANSQMSPDTQYF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	11	3	5	4	10	7	24	31	45	41	52	TCRBV24,TCRBV27													CASANSQMSPDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTCGAGCGGGGGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	26	5.851796501525969E-5		44	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	6	1	1	2	0	18	31	-1	33	42	TCRBV05,TCRBV11													X+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCRTGTATCTCTGTGCCAGCAGCTTAGGTCCAGCGGGGGGCAGCTACGAGCAGTACTTCGGGCCG	CASSLGPAGGSYEQYF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	6	1	3	4	3	19	35	48	39	51	TCRBV07,TCRBV11													CASSLGPAGGSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCCTGGGGGGCGGGAGGGCCGATCAATGAGCAGTTCTTCGGGCCA	CASSPWGAGGPINEQFF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	51	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	7	0	6	9	5	19	31	49	40	54		TCRBV05-06,TCRBV05-07												CASSPWGAGGPINEQFF+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTGAGGTCAGGGGTGATCAATGAGCAGTTCTTCGGGCCA	CASSLRSGVINEQFF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	45	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	4	2	6	4	4	19	34	44	38	48		TCRBV05-06,TCRBV05-07												CASSLRSGVINEQFF+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACTACCGCGACAGGGGTTTCGGGCAAAAAGTCAGCCCCAGCATTTTGGTGAT	CASSELPRQGFRAKSQPQHF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	60	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	2	2	6	7	14	21	36	51	43	65		TCRBV06-01,TCRBV06-08												CASSELPRQGFRAKSQPQHF+TCRBV06-X+TCRBJ01-05	TCRBV06	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGCCAAAAGGGGGCGGGAGGCGGCGGCAAAAACATTCAGTACTTCGGCGCC	CASSQKGAGGGGKNIQYF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	54				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	6	7	1	3	10	6	24	35	53	45	59	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSQKGAGGGGKNIQYF+X+TCRBJ02-04		TCRBD02-01*02	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGATGACTAGCGCGACCTACGGGGGGGCACGAGCAGTACTTCGGGCCG	CASR*LARPTGGHEQYF	Stop	VDJ	1	27	6.076865597738506E-5		51	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	2	6	5	2	16	26	37	47	39	63		TCRBV03-01,TCRBV03-02				01,02								CASR*LARPTGGHEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGCTAAAGTATTTGGCTACACCTTCGGTTCG	CASSQAKVFGYTF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	39	TCRBV03						TCRBJ01	TCRBJ01-02	01	3	9	0	7	0	9	26	-1	43	40	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQAKVFGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGGCTGATCCGGACAGCGCTTGAAGCTTTCTTTGGACAA	CASRLIRTALEAFF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	5	7	8	4	26	37	51	45	55		TCRBV03-01,TCRBV03-02												CASRLIRTALEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCAGGACAGGTCAATCAGCCCCAGCATTTTGGTGAT	CSASGQVNQPQHF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	4	3	4	1	26	34	45	38	46		TCRBV20-01,TCRBV20-or09_02												CSASGQVNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCCTAGCGGGGGACAATGAGCAGTTCTTCGGGCCA	CSARDPLAGDNEQFF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	4	2	5	4	0	26	40	-1	44	54		TCRBV20-01,TCRBV20-or09_02												CSARDPLAGDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCGTATAGACTCTATGGCTACACCTTCGGTTCG	CSARDPYRLYGYTF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	2	10	4	8	0	26	40	-1	48	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDPYRLYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTGGGACAGCAAGGCTACACCTTCGGTTCG	CSARDLGQQGYTF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	5	8	3	3	26	40	50	43	53		TCRBV20-01,TCRBV20-or09_02												CSARDLGQQGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCCCCGCTTCAAAAGGTGTCGGAAGAGACCCAGTACTTCGGGCCA	CSARSPLQKVSEETQYF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	51	TCRBV20						TCRBJ02	TCRBJ02-05	01	2	5	4	3	13	6	26	38	54	51	60		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARSPLQKVSEETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCAGCGGGGCCATACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	27	6.076865597738506E-5		41	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	6	3	3	2	5	26	37	46	39	51		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGAAGGGGGGACGGGGGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	27	6.076865597738506E-5		44	TCRBV20						TCRBJ02	TCRBJ02-02	01	5	5	1	5	3	8	26	35	44	38	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGACGCTAAGGGGTATCGCCGGGGGACCCAGTACTTCGGGCCA	CSADAKGYRRGTQYF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	45	TCRBV20						TCRBJ02	TCRBJ02-05	01	5	5	2	7	7	11	26	35	47	42	58		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSADAKGYRRGTQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCACCACTAGCGGGGCGACCGCTACGCAGTATTTTGGCCCA	CASTTSGATATQYF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	3	3	8	2	7	22	32	44	34	51		TCRBV12-03,TCRBV12-04												CASTTSGATATQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCGGCCTTACTAGCGGCTCGACTGCAGATACGCAGTATTTTGGCCCA	CAGLTSGSTADTQYF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	11	3	5	4	6	8	22	28	42	34	50	TCRBV09,TCRBV12					01,02								CAGLTSGSTADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCACGTTTGGTGGTCAGGAGCACAGCACGGTATTTCTGTGCCAGCAGCGTAGGGGGTGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSVGGGSNQPQHF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	45	TCRBV21			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	5	1	1	2	4	36	48	56	50	60		TCRBV21-or09_02,TCRBV21-01												CASSVGGGSNQPQHF+TCRBV21-X+TCRBJ01-05	TCRBV21	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACACAGGGGCCACTGAAGCTTTCTTTGGACAA	CATSDTGATEAFF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	2	4	1	1	24	38	46	39	47		TCRBV24-01,TCRBV24-or09_02												CATSDTGATEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCATTACTTTGGGAGGGCCCCCCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	27	6.076865597738506E-5		47	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	7	9	0	6	10	5	24	35	52	45	57		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*02	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAAACAGGGACTAATTCACCCCTCCACTTTGGGAAC	CAISETGTNSPLHF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	3	3	6	0	2	23	-1	44	38	46	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-08,TCRBV10-03												CAISETGTNSPLHF+X+TCRBJ01-06		TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGRGACWCRGCMSTGTATCTCTRCGCCAGCAGCCAAGGTCCGGGGGGTACTTACAATAAGCAGTTCTTCGGGCCA	XASSQGPGGTYNKQFF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	8	1	11	4	11	20	35	46	39	57	TCRBV04,TCRBV23													XASSQGPGGTYNKQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGCAAGCCACGTTTGGTGGTCAGGAGCACAGCACGGTATTTCTGTGCCAGCAGCGTAGAAGGCGGCTACGAGCAGTACTTCGGGCCG	CASSVEGGYEQYF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	39	TCRBV21			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	7	5	3	7	0	42	54	-1	61	65		TCRBV21-or09_02,TCRBV21-01				01,02								CASSVEGGYEQYF+TCRBV21-X+TCRBJ02-07	TCRBV21	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCTGTGCCACCAGTGATTTGCAATGCGCGGTACCCGGATTCGGACTTAGGGCTGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	27	6.076865597738506E-5		70	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	1	10	3	21	9	2	20	46	41	55		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCTTGGAGGCGAGCAGTACTTCGGGCCG	CASSHLGGEQYF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	36	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	10	1	6	4	0	26	40	-1	44	49		TCRBV03-01,TCRBV03-02												CASSHLGGEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCCGCCGGGGGGCGGGGTCTGGCACAGATACGCAGTATTTTGGCCCA	CSATRRGAGSGTDTQYF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	8	1	1	5	9	26	36	48	41	57		TCRBV20-01,TCRBV20-or09_02												CSATRRGAGSGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGGGACAGGGGACCAGCTATGGCTACACCTTCGGTTCG	CSATGQGTSYGYTF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	2	4	1	5	26	36	47	37	52		TCRBV20-01,TCRBV20-or09_02												CSATGQGTSYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGGGGGGGAGGAATGAAGCTTTCTTTGGACAA	CSARVGGRNEAFF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	9	0	7	1	5	26	39	47	40	52		TCRBV20-01,TCRBV20-or09_02												CSARVGGRNEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTAACCGGTCCCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	28	6.301934693951043E-5		38	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	8	5	6	5	3	26	39	47	44	50		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGACGCCCGACAGGCTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	28	6.301934693951043E-5		46	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	4	0	8	1	26	37	51	45	52		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCGCAGACAGCTTACAATGAGCAGTTCTTCGGGCCA	CATSDPQTAYNEQFF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	2	5	4	5	2	24	39	49	44	51		TCRBV24-01,TCRBV24-or09_02												CATSDPQTAYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTCAGCCGGGACTAGCGGCAATGAGCAGTTCTTCGGGCCA	CASSSAGTSGNEQFF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	5	6	1	0	18	35	-1	36	47	TCRBV05,TCRBV07,TCRBV11					01,02								CASSSAGTSGNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGTCGCACGGCAGACAGATACGCAGTATTTTGGCCCA	CASSLVARQTDTQYF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	45	unresolved						TCRBJ02	TCRBJ02-03	01	1	4	5	3	8	0	18	34	-1	42	45	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVARQTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GRGACWCGGCMCTSTATCTCTGYGCCAGCAGCCAAGATCAACGGGGGGAGACCCAGTACTTCGGGCCA	CASSQDQRGETQYF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	8	2	5	9	0	19	31	-1	40	46	TCRBV05,TCRBV23													CASSQDQRGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGCTTAGGTCAGGGAAAAAAACTGTTTTTTGGCAGT	CASSLGQGKKLFF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	3	9	1	2	23	40	46	41	48	TCRBV13,TCRBV21													CASSLGQGKKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGGTCAAGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASRSRSSYEQYF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	10	2	0	5	0	23	34	-1	39	43	TCRBV02,TCRBV09													CASRSRSSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGTATCGTCAGGGGATGGGGTGGCGAGCAGTACTTCGGGCCG	CASSIVRGWGGEQYF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	2	6	5	9	26	38	49	43	58	TCRBV09,TCRBV12													CASSIVRGWGGEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCCCCCAGAAGTGGGCAGCATCTATGGCTACACCTTCGGTTCG	CASSPPEVGSIYGYTF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	8	0	4	11	5	24	36	51	47	56	TCRBV06,TCRBV10													CASSPPEVGSIYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACAGGGGGGGGGACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSHRGGDSYNEQFF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	48	TCRBV03						TCRBJ02	TCRBJ02-01	01	3	4	1	0	0	5	26	-1	47	40	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHRGGDSYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGTGCGGAACAGTACTTCGGGCCG	CASSQGAEQYF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	33	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	7	5	10	4	2	26	40	48	44	50		TCRBV03-01,TCRBV03-02				01,02								CASSQGAEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGGGGGGACAGGGAGTCGGCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	29	6.52700379016358E-5		38	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	9	0	3	7	2	6	26	31	42	33	48		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCAGGAGCTCCTACGAGCAGTACTTCGGGCCG	CSARDPRSSYEQYF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	42	TCRBV20						TCRBJ02	TCRBJ02-07	01	0	4	4	0	3	2	26	40	47	43	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDPRSSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCCGGGACAGGAGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSARSGTGGSGANVLTF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	0	4	0	3	3	26	38	49	41	52		TCRBV20-01,TCRBV20-or09_02												CSARSGTGGSGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD01-01*01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGGGGGGTAATCCGGAGCACTGAAGCTTTCTTTGGACAA	CASRGVIRSTEAFF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	6	6	1	4	0	10	22	-1	38	33	48		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGVIRSTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGCTCCGGACGTCTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSGRLSGANVLTF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	48							TCRBJ02	TCRBJ02-06	01	3	1	7	0	2	4	33	46	52	48	56	TCRBV05,TCRBV07,TCRBV13,TCRBV25,TCRBV27,TCRBV28	TCRBV05-04,TCRBV05-05,TCRBV05-08,TCRBV07-01,TCRBV13-01,TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGRLSGANVLTF+X+TCRBJ02-06			TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGCCCCTGGTCGAGGGGGGGGGCGAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLAPGRGGGRTNEKLFF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	60	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	0	9	0	1	10	4	18	35	52	45	56	TCRBV07,TCRBV11													CASSLAPGRGGGRTNEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGCACGGACACCAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	29	6.52700379016358E-5		47				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	6	2	4	3	18	35	44	39	47	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												X+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGGGACTCRGCCSTKTATCTYTRCGCCAGCAGCCAACCACTAGCGGGGGGGCGGAAGGAGACCCAGTACTTCGGGCCA	XASSQPLAGGRKETQYF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	3	0	5	2	6	22	37	52	39	58	TCRBV04,TCRBV05													XASSQPLAGGRKETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGGGGACTCRGCYKTGTATYTCTGTGCCAGCAGCTTACTCGGGGGGGAGACCCAGTACTTCGGGCCA	CASSLLGGETQYF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	8	1	5	5	0	23	35	-1	40	47	TCRBV07,TCRBV09													CASSLLGGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTAATGTCTGAGGGCAACGAGCAGTACTTCGGGCCG	CASSLMSEGNEQYF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	11	0	5	6	2	26	41	52	47	54		TCRBV12-03,TCRBV12-04												CASSLMSEGNEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGTCCCCTGCAAAACGCAGTATTTTGGCCCA	CASSQDVPCKTQYF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	42	TCRBV03						TCRBJ02	TCRBJ02-03	01	0	4	6	9	9	2	26	43	54	52	56		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDVPCKTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGCAGGGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQGAGYSNQPQHF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	4	3	0	3	2	26	42	50	45	52		TCRBV03-01,TCRBV03-02												CASSQGAGYSNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCGGACTAGTTTGGGGCCCAGATACGCAGTATTTTGGCCCA	CASSPGLVWGPDTQYF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	1	8	4	2	9	26	39	48	41	57		TCRBV03-01,TCRBV03-02				01,02								CASSPGLVWGPDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGRKGACTCYGCYGTGTATYTCTGTGCCAGCAGCTTCCTGAGGGACAATGAGCAGTTCTTCGGGCCA	CASSFLRDNEQFF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	11	0	5	3	0	20	34	-1	37	42	TCRBV03,TCRBV07													CASSFLRDNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTAGGAACAGACCAAGAGACCCAGTACTTCGGGCCA	CSALGTDQETQYF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	39	TCRBV20						TCRBJ02	TCRBJ02-05	01	6	3	5	0	7	0	26	34	-1	41	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSALGTDQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCAGGTCCAAGAGACCCAGTACTTCGGGCCA	CSAQVQETQYF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	4	1	1	1	26	34	39	35	40		TCRBV20-01,TCRBV20-or09_02												CSAQVQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGACAGGGGACATTCACCCCTCCACTTTGGGAAC	CSAREDRGHSPLHF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	1	2	8	0	2	26	-1	49	40	51		TCRBV20-01,TCRBV20-or09_02												CSAREDRGHSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCGGATTATCATATAACACTGAAGCTTTCTTTGGACAA	CGLSYNTEAFF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	33	TCRBV20						TCRBJ01	TCRBJ01-01	01	11	1	8	2	0	9	26	-1	32	29	41		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CGLSYNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CASCWSCCARACAKCTKTGTACTTCTGTGCCAGCAGTTTAGTCGGACCCAGGTCGTTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	30	6.752072886376118E-5		46	unresolved						TCRBJ01	TCRBJ01-06	01	13	1	7	9	15	8	25	28	47	43	55	TCRBV06,TCRBV22			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGAGGCGGGAGCATGGGATACGAGCAGTACTTCGGGCCG	CASRGGSMGYEQYF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	7	2	4	2	7	22	33	42	35	49	TCRBV09,TCRBV12													CASRGGSMGYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCGGACTTTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPDFNTGELFF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	1	10	2	2	2	24	36	43	38	45		TCRBV24-01,TCRBV24-or09_02				01,02								CASSPDFNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATGCCTACGAGCGGGAGATTAGACAGATACGCAGTATTTTGGCCCA	CASSLCLRAGD*TDTQYF	Stop	VDJ	1	30	6.752072886376118E-5		54	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	6	2	3	11	5	24	36	55	47	60		TCRBV24-01,TCRBV24-or09_02												CASSLCLRAGD*TDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTAGTAGAGAGTTGGGAGACCCAGTACTTCGGGCCA	CASSLVESWETQYF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	5	8	5	0	8	19	-1	38	35	46	TCRBV07,TCRBV11					01,02								CASSLVESWETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCCTTTCCAGGGCTCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	30	6.752072886376118E-5		40	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	3	4	5	2	19	31	41	36	43	TCRBV05,TCRBV11													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCTCCCGGGTTCTAGGAAAGGGTTAGCCAGTACTTCGGGCCA		Out	VDJ	1	30	6.752072886376118E-5		46	unresolved						TCRBJ02	TCRBJ02-05	01	3	5	3	10	15	4	19	32	51	47	55	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGATTCGGGGGGGACCAAGAGACCCAGTACTTCGGGCCA	CASRFGGDQETQYF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	0	0	3	0	26	37	-1	40	48		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRFGGDQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCGGAGGGCTTTCTAGCACAGATACGCAGTATTTTGGCCCA	CASGGLSSTDTQYF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	12	10	0	0	4	6	26	31	41	35	47	TCRBV02,TCRBV12													CASGGLSSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTCCTACTAGTTTTTCGGCAGATACGCAGTATTTTGGCCCA	CASSPTSFSADTQYF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	45				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	3	8	4	3	8	36	48	56	51	64	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01				01,02								CASSPTSFSADTQYF+X+TCRBJ02-03		TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAACCCTACCGGTAGCTCGTACGAGCAGTACTTCGGGCCG	CASNPTGSSYEQYF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	42				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	5	7	4	10	3	24	34	48	44	51	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03				01,02								CASNPTGSSYEQYF+X+TCRBJ02-07		TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCGGGACAGGGAAACCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	31	6.977141982588655E-5		50	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	0	3	2	1	4	26	42	52	43	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCATCCGGGAAATGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSPIREMGNQPQHF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	4	8	3	2	5	5	26	39	49	44	54		TCRBV03-01,TCRBV03-02												CASSPIREMGNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD02-01*02	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTAGAGGGGCGGACAGGGAACTATGGCTACACCTTCGGTTCG	CASSLEGRTGNYGYTF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	3	2	5	0	26	43	-1	48	56		TCRBV03-01,TCRBV03-02												CASSLEGRTGNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCGAGCTTTACGATATACGCAGTATTTTGGCCCA		Out	VDJ	1	31	6.977141982588655E-5		38	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	6	7	7	3	8	26	36	42	39	50		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACTCAGGAAGGGGGGGACCACGAGCAGTACTTCGGGCCG	CSARTQEGGDHEQYF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	9	0	5	9	3	26	38	54	47	57		TCRBV20-01,TCRBV20-or09_02												CSARTQEGGDHEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACAACATACAAGAGACCCAGTACTTCGGGCCA	CSARDNIQETQYF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	3	6	2	2	2	26	40	45	42	47		TCRBV20-01,TCRBV20-or09_02												CSARDNIQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAAGCGCCTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSARDQAPSSYNEQFF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	8	0	8	0	26	40	-1	48	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDQAPSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTCTGGCAGCTCGAACACTGAAGCTTTCTTTGGACAA	CSARSGSSNTEAFF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	4	5	1	6	3	26	37	46	43	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARSGSSNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCTCCCGGGGGTCGGGATACCCAGTACTTCGGGCCA	CSAPPGGRDTQYF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	2	8	5	7	26	35	46	40	53		TCRBV20-01,TCRBV20-or09_02												CSAPPGGRDTQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCCCAACCGGGACTAGCGGGAATTGGGTAACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	31	6.977141982588655E-5		58	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	0	3	3	9	9	23	34	56	43	65		TCRBV12-03,TCRBV12-04,TCRBV12-05												X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAACCAAGCGGGAAATAATCGAATGAACAATGAGCAGTTCTTCGGGCCA	CASNQAGNNRMNNEQFF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	51	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	11	6	3	5	7	13	24	31	45	38	58		TCRBV24-01,TCRBV24-or09_02												CASNQAGNNRMNNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTCTATTACCGGGACAGGGGGCGGAAGATGAGCAGTTCTTCGGGCCA	CASSLLPGQGAEDEQFF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	0	8	8	5	23	35	55	43	60	TCRBV06,TCRBV24													CASSLLPGQGAEDEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACKCRGCCATGTAYCKSTGTGCCAGCAAGTATTTACAGGGATTCAATGAGCAGTTCTTCGGGCCA	CASKYLQGFNEQFF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	3	3	6	7	3	18	28	41	35	44	TCRBV07,TCRBV15													CASKYLQGFNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGGCAGGGGAGCGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	31	6.977141982588655E-5		44				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	2	5	3	4	18	35	44	38	48	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												X+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACKCRGCCRTGTAYSTSTGTGCCAGCAGCTTCGAGGGTCGGGTGCTAAGGTAGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	31	6.977141982588655E-5		53	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	3	11	0	4	1	15	18	32	38	33	53	TCRBV11,TCRBV15													X+X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCACAACTAGCGTTGGGGAGACCCAGTACTTCGGGCCA	CASSTTSVGETQYF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	3	6	5	3	5	19	31	41	34	46	TCRBV05,TCRBV11					01,02								CASSTTSVGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCACCAGCAGCGCCTGTAGCTTGTGCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	32	7.202211078801193E-5		50	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	5	7	4	5	13	23	35	44	40	57	TCRBV01,TCRBV04					01,02								X+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACAGAGCCTACGAGCAGTACTTCGGGCCG	CSARDRAYEQYF	In	VDJ	1	32	7.202211078801193E-5	8.468834688346883E-5	36	TCRBV20						TCRBJ02	TCRBJ02-07	01	0	4	5	2	0	2	26	-1	43	40	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDRAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGGAGGGCTAGCACAGATACGCAGTATTTTGGCCCA	CSARDRRASTDTQYF	In	VDJ	1	32	7.202211078801193E-5	8.468834688346883E-5	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	10	0	0	2	2	26	40	48	42	50		TCRBV20-01,TCRBV20-or09_02												CSARDRRASTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGGACAGGGGAACATATGGCTACACCTTCGGTTCG	CSAGDRGTYGYTF	In	VDJ	1	32	7.202211078801193E-5	8.468834688346883E-5	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	2	5	1	4	26	35	46	36	50		TCRBV20-01,TCRBV20-or09_02												CSAGDRGTYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTTCCCGTCTACGAGCAGTACTTCGGGCCG	CASSFPVYEQYF	In	VDJ	1	32	7.202211078801193E-5	8.468834688346883E-5	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	8	6	3	3	1	23	37	42	40	43	TCRBV24,TCRBV27					01,02								CASSFPVYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCAAGATTACGAGGGGGGTGGGAATGAGCAGTTCTTCGGGCCA	CASSQDYEGGGNEQFF	In	VDJ	1	32	7.202211078801193E-5	8.468834688346883E-5	48	unresolved						TCRBJ02	TCRBJ02-01	01	5	5	1	7	10	5	18	30	46	40	51	TCRBV04,TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDYEGGGNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACKCRGCCATGTAYCKSTGTGCCAGCAGCCCATGGACAGGAAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSPWTGSTGELFF	In	VDJ	1	32	7.202211078801193E-5	8.468834688346883E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	4	4	4	3	18	30	41	34	44	TCRBV07,TCRBV15													CASSPWTGSTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATCTCTGTGCCAGCAGCTTCCCTAGGACGGGACAGGGTTACGAAAAACTGTTTTTTGGCAGT	CASSFPRTGQGYEKLFF	In	VDJ	1	32	7.202211078801193E-5	8.468834688346883E-5	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	3	8	9	4	18	32	50	41	54	TCRBV05,TCRBV07													CASSFPRTGQGYEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGACTCGGCYGTGTATSTCTGTGCAAGTCCGCGCTTGCCGCTCAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASPRLPLNSNQPQHF	In	VDJ	1	32	7.202211078801193E-5	8.468834688346883E-5	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	7	7	6	0	1	12	18	28	32	29	44	TCRBV07,TCRBV12					01,02								CASPRLPLNSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAAAGGCAGGGTGCCGGGGAGCTGTTTTTTGGAGAA	CASSQERQGAGELFF	In	VDJ	1	32	7.202211078801193E-5	8.468834688346883E-5	45				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	4	3	6	4	2	18	35	44	39	46	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQERQGAGELFF+X+TCRBJ02-02		TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAGCCGCAACGGGGCGAGACCCAGTACTTCGGGCCA	CASSQEPQRGETQYF	In	VDJ	1	32	7.202211078801193E-5	8.468834688346883E-5	45							TCRBJ02	TCRBJ02-05	01	0	7	0	5	8	0	18	35	-1	43	48	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEPQRGETQYF+X+TCRBJ02-05			TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGCTTAGGACAGGCAGTCTACGAGCAGTACTTCGGGCCG	CASSLGQAVYEQYF	In	VDJ	1	32	7.202211078801193E-5	8.468834688346883E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	4	3	0	4	19	-1	41	35	45	TCRBV07,TCRBV11													CASSLGQAVYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCTTACTTACAGGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSLLTGANTEAFF	In	VDJ	1	32	7.202211078801193E-5	8.468834688346883E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	2	1	4	1	19	33	44	37	45	TCRBV05,TCRBV07													CASSLLTGANTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGGRGACWYGGCWSTGTATCTCTGYGCCAGCAGGCTCTCAGGGTCGTCTGAGCAGTACTTCGGGCCG	CASRLSGSSEQYF	In	VDJ	1	32	7.202211078801193E-5	8.468834688346883E-5	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	3	7	5	6	22	33	43	38	49	TCRBV07,TCRBV23													CASRLSGSSEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGACAGGGTCCAAGCTATGGCTACACCTTCGGTTCG	CASSQGQGPSYGYTF	In	VDJ	1	33	7.427280175013729E-5	8.733485772357724E-5	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	3	4	0	6	26	-1	49	42	55		TCRBV03-01,TCRBV03-02												CASSQGQGPSYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTCGTCCTACGAGCAGTACTTCGGGCCG	CSARSSYEQYF	In	VDJ	1	33	7.427280175013729E-5	8.733485772357724E-5	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	8	6	1	2	0	26	37	-1	39	41		TCRBV20-01,TCRBV20-or09_02				01,02								CSARSSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAAGGAGATTTATGGCTACACCTTCGGTTCG	CSASKEIYGYTF	In	VDJ	1	33	7.427280175013729E-5	8.733485772357724E-5	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	10	2	5	3	3	26	37	44	40	47		TCRBV20-01,TCRBV20-or09_02												CSASKEIYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGGGGGGACAGAGCTAATGGAGCAGTTCTTCGGGCCA	CASSGGTELMEQFF	In	VDJ	1	33	7.427280175013729E-5	8.733485772357724E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	5	10	3	8	22	34	44	37	52	TCRBV02,TCRBV12													CASSGGTELMEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCGACAGGGGGAATTTGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	33	7.427280175013729E-5		49	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	1	3	1	6	24	40	50	41	56		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAACAACGGAGTCGGGGATACCACCTTCGGTTCG	CASNNGVGDTTF	In	VDJ	1	33	7.427280175013729E-5	8.733485772357724E-5	36	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	7	8	3	13	10	4	23	33	48	43	52	TCRBV06,TCRBV10													CASNNGVGDTTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACKCRGCCATGTAYCKSTGTGCCAGCAGCTTAGTTGGTAGCGGGAGGGCCAAAACCTGATTCTTCGGGCCA	CASSLVGSGRAKT*FF	Stop	VDJ	1	33	7.427280175013729E-5		48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	5	0	16	4	11	18	34	49	38	60	TCRBV07,TCRBV15													CASSLVGSGRAKT*FF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCTTTGGAGGGGCGCGAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSFGGARSNQPQHF	In	VDJ	1	33	7.427280175013729E-5	8.733485772357724E-5	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	10	0	1	1	6	18	32	39	33	45	TCRBV11,TCRBV23													CASSFGGARSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGGTTCCGGGACAGCCACCTCCAATGAGCAGTTCTTCGGGCCA	CSAGSGTATSNEQFF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	5	6	7	7	26	34	48	41	55		TCRBV20-01,TCRBV20-or09_02												CSAGSGTATSNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACAAAGGCCCCTTACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	34	7.652349271226266E-5		43	TCRBV20						TCRBJ01	TCRBJ01-02	01	0	5	4	3	3	6	26	40	46	43	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGGGTCAGCCCCAGCATTTTGGTGAT	CSARDGGQPQHF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	36	TCRBV20						TCRBJ01	TCRBJ01-05	01	0	6	1	6	1	0	26	40	-1	41	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDGGQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTGTCGCCGGCAGGGGGATTCACTGAAGCTTTCTTTGGACAA	CSARDLSPAGGFTEAFF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	1	4	11	3	26	40	58	51	61		TCRBV20-01,TCRBV20-or09_02												CSARDLSPAGGFTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGTCCGCGGGTAGCGGGAGTAGAAGAGACCCAGTACTTCGGGCCA	CSGPRVAGVEETQYF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	5	2	3	9	3	26	33	51	42	54		TCRBV20-01,TCRBV20-or09_02												CSGPRVAGVEETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGGGACCGGACAGACTCTAATCAGCCCCAGCATTTTGGTGAT	CASRDRTDSNQPQHF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	5	4	5	5	22	33	44	38	49		TCRBV12-03,TCRBV12-04												CASRDRTDSNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTACTGGACTAGCGGGGGGGATGAGCAGTTCTTCGGGCCA	CASSYWTSGGDEQFF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	1	0	8	3	0	18	31	-1	34	49	TCRBV07,TCRBV11													CASSYWTSGGDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGTCCGGGACAGGTCTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLASGTGLSGANVLTF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	57				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	0	4	0	4	3	18	35	47	39	50	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLASGTGLSGANVLTF+X+TCRBJ02-06		TCRBD01-01*01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCCAGCAGCTCCAAAGCCCGGGACTAGCGGGAGTCACGGTAGGGGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	34	7.652349271226266E-5		74				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	0	2	0	10	13	-1	9	33	19	46	TCRBV03,TCRBV09,TCRBV12,TCRBV21	TCRBV03-01,TCRBV03-02,TCRBV09-01,TCRBV12-01,TCRBV21-01												X+X+TCRBJ02-06		TCRBD02-01*02	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTTATAAAGAGGCCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	34	7.652349271226266E-5		47	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	2	11	1	0	6	1	19	33	43	39	44		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ01-03	TCRBV05	TCRBD02-01*02	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCATCGTATTTCGTGGGGGACCCTACGAGCAGTACTTCGGGCCG	CASIVFRGGPYEQYF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	45	unresolved						TCRBJ02	TCRBJ02-07	01	7	0	7	2	13	0	22	32	-1	45	50	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASIVFRGGPYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCGTAGGGTTAGGGACTTTCAATGAGCAGTTCTTCGGGCCA	CASSVGLGTFNEQFF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	10	6	9	2	24	36	51	45	53	TCRBV12,TCRBV21					01,02								CASSVGLGTFNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTCCAGACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPDSGANVLTF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	4	5	0	2	1	24	35	40	37	41	TCRBV09,TCRBV21													CASSPDSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTCCGGACATCCAAGAGACCCAGTACTTCGGGCCA	CASSPDIQETQYF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	6	1	3	1	24	35	43	38	44	TCRBV09,TCRBV21													CASSPDIQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCCTTGGGTCGGGCGGGAGAGTGTACGAGAGACCCAGTACTTCGGGCCA	CSAPPWVGRESVRETQYF	In	VDJ	1	35	7.877418367438804E-5	9.262787940379404E-5	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	7	2	4	14	8	26	35	56	49	64		TCRBV20-01,TCRBV20-or09_02												CSAPPWVGRESVRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTGACTAGCGGCTACACAGATACGCAGTATTTTGGCCCA	CSALTSGYTDTQYF	In	VDJ	1	35	7.877418367438804E-5	9.262787940379404E-5	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	2	5	2	2	3	26	35	46	37	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSALTSGYTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACTATATCCGGGACAGCAACTACGAGCAGTACTTCGGGCCG	CATSDYIRDSNYEQYF	In	VDJ	1	35	7.877418367438804E-5	9.262787940379404E-5	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	5	3	8	3	24	38	53	46	56		TCRBV24-01,TCRBV24-or09_02												CATSDYIRDSNYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCCTGGGCGACTAGCTCTCGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	35	7.877418367438804E-5		47	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	2	7	6	2	5	19	35	44	37	49	TCRBV05,TCRBV07					01,02								X+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTTGCCTTTAGGCTGGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	35	7.877418367438804E-5		50	TCRBV05						TCRBJ01	TCRBJ01-02	01	2	1	8	4	12	5	19	33	48	45	53		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV05-X+TCRBJ01-02	TCRBV05		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCGGGAGGGATCCATACAATGAGCAGTTCTTCGGGCCA	CASGRDPYNEQFF	In	VDJ	1	35	7.877418367438804E-5	9.262787940379404E-5	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	9	0	4	0	5	23	-1	39	32	44	TCRBV02,TCRBV12													CASGRDPYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCCGGGACAGGGGCCCTACGAGCAGTACTTCGGGCCG	CASSHPGQGPYEQYF	In	VDJ	1	36	8.10248746365134E-5	9.527439024390244E-5	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	2	2	3	1	26	40	53	43	54		TCRBV03-01,TCRBV03-02												CASSHPGQGPYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACGGGACAGCTAACTATGGCTACACCTTCGGTTCG	CSARDGTANYGYTF	In	VDJ	1	36	8.10248746365134E-5	9.527439024390244E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	5	0	1	0	26	40	-1	41	48		TCRBV20-01,TCRBV20-or09_02												CSARDGTANYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCTTCGACTAGCGGGGGGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	36	8.10248746365134E-5		44	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	2	0	4	4	0	22	33	-1	37	51		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTCGGGGAGGTAGGCGAAAAACTGTTTTTTGGCAGT	CASSLFGEVGEKLFF	In	VDJ	1	36	8.10248746365134E-5	9.527439024390244E-5	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	6	9	1	8	7	5	24	36	49	43	54		TCRBV24-01,TCRBV24-or09_02												CASSLFGEVGEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD02-01*02	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGGAGATAGCGGGAGGTGGGAGACCCAGTACTTCGGGCCA	CASSLGDSGRWETQYF	In	VDJ	1	36	8.10248746365134E-5	9.527439024390244E-5	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	5	1	5	4	3	19	35	49	39	52	TCRBV07,TCRBV11													CASSLGDSGRWETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGAACACACAGATACGCAGTATTTTGGCCCA	CASSLEHTDTQYF	In	VDJ	1	36	8.10248746365134E-5	9.527439024390244E-5	39				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	3	6	2	1	0	18	34	-1	35	38	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02												CASSLEHTDTQYF+X+TCRBJ02-03		TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATGCAGGCCGTCGCACTGAAGCTTTCTTTGGACAA	CASSQDAGRRTEAFF	In	VDJ	1	36	8.10248746365134E-5	9.527439024390244E-5	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	4	4	2	6	18	35	41	37	47	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDAGRRTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGTTCGAGCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSLFELAKNIQYF	In	VDJ	1	36	8.10248746365134E-5	9.527439024390244E-5	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	3	6	7	0	5	1	18	32	40	37	41	TCRBV05,TCRBV11					01,02								CASSLFELAKNIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGGGGACAGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGGQDTGELFF	In	VDJ	1	37	8.327556559863878E-5	9.792090108401084E-5	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	0	4	3	1	0	26	42	-1	43	51		TCRBV12-03,TCRBV12-04												CASSLGGQDTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGCCGACAGGATTAGACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	37	8.327556559863878E-5		47	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	4	3	3	5	26	42	51	45	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCGACAGGTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	37	8.327556559863878E-5		41	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	4	1	2	0	26	40	-1	42	48		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAACTCGCACCTCATCCCTGAACACTGAAGCTTTCTTTGGACAA	CSATRTSSLNTEAFF	In	VDJ	1	37	8.327556559863878E-5	9.792090108401084E-5	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	3	10	0	1	13	26	34	38	35	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSATRTSSLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCACCCGGGACAGGGGTAGGTGAAGCTTTCTTTGGACAA	CSAPPGTGVGEAFF	In	VDJ	1	37	8.327556559863878E-5	9.792090108401084E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	2	7	7	4	26	34	51	41	55		TCRBV20-01,TCRBV20-or09_02												CSAPPGTGVGEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTTCCGGAGGCGGAGCACCTTCGGTTCG		Out	VDJ	1	37	8.327556559863878E-5		35	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	1	10	1	13	5	5	26	39	49	44	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGGACGCTGACTACGAGCAGTACTTCGGGCCG	CSARGDADYEQYF	In	VDJ	1	37	8.327556559863878E-5	9.792090108401084E-5	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	3	0	7	3	2	5	26	37	44	39	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGDADYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTAGGGTACGAGCAGTACTTCGGGCCG	CASSLLGYEQYF	In	VDJ	1	37	8.327556559863878E-5	9.792090108401084E-5	36	TCRBV24						TCRBJ02	TCRBJ02-07	01	6	5	3	4	5	0	24	36	-1	41	45		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLLGYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTACCTCCCTCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	37	8.327556559863878E-5		37	TCRBV24						TCRBJ01	TCRBJ01-01	01	6	3	7	6	3	6	24	36	41	39	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGACCGCCTGAAGGATGGCTACACCTTCGGTTCG	CAISDRLKDGYTF	In	VDJ	1	37	8.327556559863878E-5	9.792090108401084E-5	39	unresolved						TCRBJ01	TCRBJ01-02	01	5	2	7	6	0	10	23	-1	38	35	48	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISDRLKDGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACGGGGGCCGTGGCACGAGAGCTGGGACCCCACAGATACGCAGTATTTTGGCCCA	CASSLRGPWHESWDPTDTQYF	In	VDJ	1	37	8.327556559863878E-5	9.792090108401084E-5	63							TCRBJ02	TCRBJ02-03	01	2	6	0	2	1	22	18	33	40	34	62	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRGPWHESWDPTDTQYF+X+TCRBJ02-03			TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCATCCGACAGGGACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	37	8.327556559863878E-5		41	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	3	3	5	1	19	31	43	36	44		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ02-07	TCRBV05	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGGAACGGTCTGGTTCCTGAAGCTTTCTTTGGACAA	CASRNGLVPEAFF	In	VDJ	1	37	8.327556559863878E-5	9.792090108401084E-5	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	8	5	6	3	8	23	34	40	37	48	TCRBV02,TCRBV09					01,02								CASRNGLVPEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGGGGGATTCAGGGGCTGGAAGATACGCAGTATTTTGGCCCA	CASRGIQGLEDTQYF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	2	5	7	5	24	35	48	42	53	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASRGIQGLEDTQYF+X+TCRBJ02-03		TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAACGCCATTTCTTTCTCTGAGACCCAGTACTTCGGGCCA	CASSNAISFSETQYF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	45	TCRBV03						TCRBJ02	TCRBJ02-05	01	5	3	7	5	1	15	26	38	41	39	56		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSNAISFSETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGTAGGGGAAGCGGGGGGGCCCACTGAGCAGTTCTTCGGGCCA	CASSVGEAGGPTEQFF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	6	0	9	8	5	26	38	56	46	61		TCRBV03-01,TCRBV03-02												CASSVGEAGGPTEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGCAAATTAAGCGGGAGGGGAGCGGAGACCCAGTACTTCGGGCCA	CSARSKLSGRGAETQYF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	6	0	5	9	5	26	38	57	47	62		TCRBV20-01,TCRBV20-or09_02												CSARSKLSGRGAETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGTTATACTAGCGGGTTACGAGCAGTACTTCGGGCCG	CSARDVILAGYEQYF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	3	4	4	6	1	26	40	55	46	56		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDVILAGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCCAGGGGCACAGATACGCAGTATTTTGGCCCA	CSARSRGTDTQYF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	3	1	2	0	26	38	-1	40	45		TCRBV20-01,TCRBV20-or09_02												CSARSRGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATTCCCAGGGGTTGTCACTGAAGCTTTCTTTGGACAA	CSARFPGVVTEAFF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	2	4	4	4	26	38	48	42	52		TCRBV20-01,TCRBV20-or09_02												CSARFPGVVTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCGGGAAACGAGCGGACCCGAGTTATACGAGCAGTACTTCGGGCCG	CSASRETSGPELYEQYF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	6	5	4	10	10	26	37	52	47	62		TCRBV20-01,TCRBV20-or09_02				01,02								CSASRETSGPELYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCTCCGGACTAGCATTGATACGCAGTATTTTGGCCCA	CSAPLRTSIDTQYF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	1	7	6	7	3	26	35	50	42	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPLRTSIDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTTCGACCGCTAGCGGGCTCACCTACGAGCAGTACTTCGGGCCG	CASSSTASGLTYEQYF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	4	4	2	6	4	22	35	49	41	53	TCRBV09,TCRBV12					01,02								CASSSTASGLTYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAATTCGGACTAAACAATGAGCAGTTCTTCGGGCCA	CASSQEFGLNNEQFF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	45				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	1	9	5	4	1	18	35	45	39	46	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03				01,02								CASSQEFGLNNEQFF+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTAGTAGTTAGGACTAGGGCTAGAGGAGTGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	38	8.552625656076415E-5		58	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	1	8	4	6	13	18	34	47	40	60	TCRBV07,TCRBV11					01,02								X+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGGCCGGGTCAATATACGAGCAGTACTTCGGGCCG	CASSLAGSIYEQYF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	8	4	4	3	6	18	32	39	35	45	TCRBV05,TCRBV11					01,02								CASSLAGSIYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTTAGGGGCCCGAGCACAGATACGCAGTATTTTGGCCCA	CASSFRGPSTDTQYF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	5	2	0	1	4	18	32	38	33	42	TCRBV05,TCRBV11													CASSFRGPSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCCCCCAGCGGGGGTCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	38	8.552625656076415E-5		40	TCRBV05			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	6	2	5	4	2	19	28	40	32	42		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGCGGATCACGCGGGAGCGAGGCGCAGTATTTTGGCCCA	CASSGSRGSEAQYF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	7	2	10	7	5	24	36	50	43	55	TCRBV02,TCRBV21													CASSGSRGSEAQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATCCGGGAGGGACGGGGAGCTGTTTTTTGGAGAA	CASSQSGRDGELFF	In	VDJ	1	39	8.777694752288953E-5	1.0321392276422765E-4	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	8	0	7	2	1	26	41	51	43	52		TCRBV03-01,TCRBV03-02												CASSQSGRDGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*02	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACACTCCTAAGGGTGAGCAGTTCTTCGGGCCA	CASSHTPKGEQFF	In	VDJ	1	39	8.777694752288953E-5	1.0321392276422765E-4	39	TCRBV03						TCRBJ02	TCRBJ02-01	01	3	5	3	9	8	0	26	40	-1	48	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHTPKGEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCTCTCCGGGGGGCGCGGATACGCAGTATTTTGGCCCA	CASSPGGADTQYF	In	VDJ	1	39	8.777694752288953E-5	1.0321392276422765E-4	39	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	8	1	6	4	4	26	35	46	39	50		TCRBV03-01,TCRBV03-02												CASSPGGADTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTGAGAGCGGAGACCCAGTACTTCGGGCCA	CSARDLRAETQYF	In	VDJ	1	39	8.777694752288953E-5	1.0321392276422765E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	6	6	5	6	0	26	40	-1	46	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLRAETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTCCAGGGACAGGCCGAGGGCAATGAGCAGTTCTTCGGGCCA	CSVQGQAEGNEQFF	In	VDJ	1	39	8.777694752288953E-5	1.0321392276422765E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	0	4	6	4	7	26	33	45	37	52		TCRBV20-01,TCRBV20-or09_02												CSVQGQAEGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGCTATGACGCGGCAACAACACAAGAGACCCAGTACTTCGGGCCA	CASSQGYDAATTQETQYF	In	VDJ	1	39	8.777694752288953E-5	1.0321392276422765E-4	54	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	7	5	2	8	8	23	39	51	47	59	TCRBV01,TCRBV04					01,02								CASSQGYDAATTQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCACTTATGGGGGCAGGGGAGAGACCCAGTACTTCGGGCCA	CASTYGGRGETQYF	In	VDJ	1	39	8.777694752288953E-5	1.0321392276422765E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	4	2	4	10	0	22	32	-1	42	48	TCRBV02,TCRBV12													CASTYGGRGETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTACCGGGACAGGGACTTTGGGGGTTGCGGAGACCCAGTACTTCGGGCCA	CASSTGTGTLGVAETQYF	In	VDJ	1	39	8.777694752288953E-5	1.0321392276422765E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	3	5	3	15	22	34	46	37	61	TCRBV09,TCRBV12													CASSTGTGTLGVAETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCCGGACCCCGGGGCTCTGGCTACACCTTCGGTTCG	CATSDSGPRGSGYTF	In	VDJ	1	39	8.777694752288953E-5	1.0321392276422765E-4	45	TCRBV24						TCRBJ01	TCRBJ01-02	01	2	7	0	7	9	2	24	40	54	49	56		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDSGPRGSGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGGAGACTCCCGGGGACACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	39	8.777694752288953E-5		46	TCRBV24						TCRBJ01	TCRBJ01-04	01	9	0	7	2	11	0	24	33	-1	44	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-04	TCRBV24		TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGACGCTTGGGGACAGGTTTGAACACTGAAGCTTTCTTTGGACAA	CASRRLGTGLNTEAFF	In	VDJ	1	39	8.777694752288953E-5	1.0321392276422765E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	4	0	7	2	24	35	50	42	52		TCRBV24-01,TCRBV24-or09_02												CASRRLGTGLNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTCATCGCCGGACACAGTTCTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSSPDTVLSGANVLTF	In	VDJ	1	39	8.777694752288953E-5	1.0321392276422765E-4	57	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	1	6	0	7	7	19	32	44	39	51	TCRBV07,TCRBV11													CASSSSPDTVLSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCCCCCGCCCCCAGGGCGAGAGCAGTACTTCGGGCCG		Out	VDJ	1	39	8.777694752288953E-5		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	3	7	11	3	23	35	51	46	54	TCRBV09,TCRBV21													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAGGGACAGGGCGAATCTACACCTTCGGTTCG		Out	VDJ	1	40	9.00276384850149E-5		40	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	3	10	1	5	26	41	51	42	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAAACTTAGGCTTTCAAGCTTTCTTTGGACAA	CASSPNLGFQAFF	In	VDJ	1	40	9.00276384850149E-5	1.0586043360433605E-4	39	TCRBV03						TCRBJ01	TCRBJ01-01	01	4	5	4	9	7	5	26	39	49	46	54		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPNLGFQAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAGGGATTCGGCTTGATGAGCAGTTCTTCGGGCCA	CSAREGIRLDEQFF	In	VDJ	1	40	9.00276384850149E-5	1.0586043360433605E-4	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	0	0	8	8	1	9	26	40	45	41	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREGIRLDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTTCAGGTTTGAACACTGAAGCTTTCTTTGGACAA	CSARGSGLNTEAFF	In	VDJ	1	40	9.00276384850149E-5	1.0586043360433605E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	4	0	3	2	26	39	46	42	48		TCRBV20-01,TCRBV20-or09_02												CSARGSGLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCACCCAGGTTACGGAGCAGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	40	9.00276384850149E-5		41	unresolved						TCRBJ02	TCRBJ02-07	01	10	4	4	2	2	11	23	30	36	32	47	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGACACAATCGTCCCCGGACCCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	40	9.00276384850149E-5		50							TCRBJ01	TCRBJ01-06	01	9	1	7	2	14	1	18	26	44	40	45	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-06			TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCGAAGGGGGTGGGGACGCAGATACGCAGTATTTTGGCCCA	CASSEGGGDADTQYF	In	VDJ	1	40	9.00276384850149E-5	1.0586043360433605E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	5	1	4	2	8	18	30	38	32	46	TCRBV05,TCRBV11													CASSEGGGDADTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTATCAGGGATGAACACTGAAGCTTTCTTTGGACAA	CASSLSGMNTEAFF	In	VDJ	1	40	9.00276384850149E-5	1.0586043360433605E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	3	0	1	1	18	33	39	34	40	TCRBV07,TCRBV11													CASSLSGMNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTCTATTCCGGGACAGATACGACAAACGAGGACCGGGGAGCTGTTTTTTGGAGAA	CASSFSIPGQIRQTRTGELFF	In	VDJ	1	40	9.00276384850149E-5	1.0586043360433605E-4	63				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	5	5	9	15	18	32	48	41	63	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02,TCRBV11-03												CASSFSIPGQIRQTRTGELFF+X+TCRBJ02-02		TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCAAGTCCCCATAGCGGGAGGGCAGTACTTCGGGCCG	CASSQVPIAGGQYF	In	VDJ	1	40	9.00276384850149E-5	1.0586043360433605E-4	42	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	5	1	9	10	0	19	31	-1	41	51		TCRBV05-06,TCRBV05-07												CASSQVPIAGGQYF+TCRBV05-X+TCRBJ02-07	TCRBV05	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGAACTAGCGGGGGGTACCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLELAGGTSYNEQFF	In	VDJ	1	40	9.00276384850149E-5	1.0586043360433605E-4	54	TCRBV05			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	3	1	0	3	3	19	33	48	36	51		TCRBV05-06,TCRBV05-07												CASSLELAGGTSYNEQFF+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTAACCTCCGGTCGGCGGAGACCCAGTACTTCGGGCCA	CASSNLRSAETQYF	In	VDJ	1	40	9.00276384850149E-5	1.0586043360433605E-4	42	unresolved						TCRBJ02	TCRBJ02-05	01	5	9	0	5	12	1	23	34	49	46	50	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSNLRSAETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGAGGAGACAGGGGCCGATCTGGAAACACCATATATTTTGGAGAG	CASRGDRGRSGNTIYF	In	VDJ	1	41	9.227832944714028E-5	1.0850694444444444E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	2	2	1	4	4	26	37	49	41	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRGDRGRSGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCGGACAGGCTCCTTCACCCCTCCACTTTGGGAAC	CASSPGQAPSPLHF	In	VDJ	1	41	9.227832944714028E-5	1.0850694444444444E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	4	9	3	4	26	38	48	41	52		TCRBV12-03,TCRBV12-04												CASSPGQAPSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGACCCTACTAGACGGGGAGCTGTTTTTTGGAGAA	CASSQGTLLDGELFF	In	VDJ	1	41	9.227832944714028E-5	1.0850694444444444E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	3	8	7	7	1	26	42	54	49	55		TCRBV03-01,TCRBV03-02				01,02								CASSQGTLLDGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCCCTAGTTGGGCAGGAGCAGTTCTTCGGGCCA	CSARPLVGQEQFF	In	VDJ	1	41	9.227832944714028E-5	1.0850694444444444E-4	39	TCRBV20						TCRBJ02	TCRBJ02-01	01	2	8	0	10	9	2	26	38	51	47	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARPLVGQEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCAAGACAGGGGGCGCGCAATGAGCAGTTCTTCGGGCCA	CSAPRQGARNEQFF	In	VDJ	1	41	9.227832944714028E-5	1.0850694444444444E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	0	6	4	3	26	35	49	39	52		TCRBV20-01,TCRBV20-or09_02												CSAPRQGARNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CACCWMCCAGACATCTRTGTACYTSTGTGCCAGCAGTGAAGGACTAGCGGGAGTATATGAGCAGTTCTTCGGGCCA	CASSEGLAGVYEQFF	In	VDJ	1	41	9.227832944714028E-5	1.0850694444444444E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	2	2	8	0	3	23	-1	51	39	54	TCRBV06,TCRBV28													CASSEGLAGVYEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCACCCCACCTTGGGACAGGGAAACTAGCACAGATACGCAGTATTTTGGCCCA	CASSTPPWDRETSTDTQYF	In	VDJ	1	41	9.227832944714028E-5	1.0850694444444444E-4	57	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	3	0	10	5	18	30	49	40	54	TCRBV05,TCRBV11													CASSTPPWDRETSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCTCCGACAGGGGCTTCTCCTACGAGCAGTACTTCGGGCCG	CASSSDRGFSYEQYF	In	VDJ	1	41	9.227832944714028E-5	1.0850694444444444E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	2	0	2	3	18	31	41	33	44	TCRBV11,TCRBV23													CASSSDRGFSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCAACCGGGGCCACAGATACGCAGTATTTTGGCCCA	CASSLATGATDTQYF	In	VDJ	1	41	9.227832944714028E-5	1.0850694444444444E-4	45							TCRBJ02	TCRBJ02-03	01	0	7	0	2	4	0	18	35	-1	39	44	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLATGATDTQYF+X+TCRBJ02-03			TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGGTGACCGCGTAGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLGDRVGSNQPQHF	In	VDJ	1	41	9.227832944714028E-5	1.0850694444444444E-4	51	TCRBV05						TCRBJ01	TCRBJ01-05	01	2	2	7	0	4	8	19	33	40	37	48		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGDRVGSNQPQHF+TCRBV05-X+TCRBJ01-05	TCRBV05		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCACGAACAGGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASTNRGTGELFF	In	VDJ	1	41	9.227832944714028E-5	1.0850694444444444E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	3	1	5	3	0	23	33	-1	36	44	TCRBV02,TCRBV12													CASTNRGTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTTAGATGGTCCCAAAAGAGATCAGCCCCAGCATTTTGGTGAT	CASSLDGPKRDQPQHF	In	VDJ	1	42	9.452902040926564E-5	1.1115345528455284E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	11	2	5	12	0	26	42	-1	54	57	TCRBV12,TCRBV21					unresolved								CASSLDGPKRDQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCAAAAGTTTATTCCAGACTAGCGGAAGGTCCCAGATACGCAATATTTTGGCCCA		Out	VDJ	1	42	9.452902040926564E-5		61	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	2	5	15	16	18	20	32	57	48	75		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGCTAACTAGCGGGAGGTTCGAGACCCAGTACTTCGGGCCA	CSATLTSGRFETQYF	In	VDJ	1	42	9.452902040926564E-5	1.1115345528455284E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	3	1	5	5	3	26	36	53	41	56		TCRBV20-01,TCRBV20-or09_02												CSATLTSGRFETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTAGGGGACTAGGCCCTCTCGGGCGGGACTAAAGCTTTCTTTGGACAA	CATSDLGD*ALSGGTKAFF	Stop	VDJ	1	42	9.452902040926564E-5		57	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	0	8	9	2	19	24	41	51	43	70		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDLGD*ALSGGTKAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATCAGGGAGGAAGCGAGCAGTACTTCGGGCCG	CASSQDQGGSEQYF	In	VDJ	1	42	9.452902040926564E-5	1.1115345528455284E-4	42				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	9	1	6	3	3	18	35	44	38	47	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDQGGSEQYF+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTTTGACAGGGAGAATGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	42	9.452902040926564E-5		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	2	3	5	2	5	18	32	41	34	46	TCRBV05,TCRBV11													X+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCTCTTACAGCTCACTTAATCAGCCCCAGCATTTTGGTGAT	CASSYSSLNQPQHF	In	VDJ	1	42	9.452902040926564E-5	1.1115345528455284E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	3	5	4	4	7	23	32	40	36	47	TCRBV02,TCRBV09													CASSYSSLNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCTCTGGACAGGGCTACCGGGGAGCTGTTTTTTGGAGAA	CASSPLDRATGELFF	In	VDJ	1	43	9.677971137139102E-5	1.1379996612466124E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	3	5	6	2	26	37	51	43	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPLDRATGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCCCTACGGACAGGGGCCTACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	43	9.677971137139102E-5		49	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	2	3	6	4	26	40	55	46	59		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGTAGAGAGGGATGAAAAACTGTTTTTTGGCAGT	CAISVERDEKLFF	In	VDJ	1	43	9.677971137139102E-5	1.1379996612466124E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	4	11	0	6	4	0	24	37	-1	41	46	TCRBV06,TCRBV10													CAISVERDEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGAAACAGGGTCAGGGCCCTATGGGGAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	43	9.677971137139102E-5		49	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	3	8	2	16	26	37	45	39	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACCCGGGACCGCGTCCTACGAGCAGTACTTCGGGCCG	CSAPGTASYEQYF	In	VDJ	1	43	9.677971137139102E-5	1.1379996612466124E-4	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	6	0	7	1	4	4	26	34	43	38	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPGTASYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCATCAGGGACTTAGCCAAAAACATTCAGTACTTCGGCGCC	CSASIRDLAKNIQYF	In	VDJ	1	43	9.677971137139102E-5	1.1379996612466124E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	3	0	10	0	5	1	26	37	48	42	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSASIRDLAKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTCCCGGACAGGGCAACCTACGAGCAGTACTTCGGGCCG	CSVPDRATYEQYF	In	VDJ	1	43	9.677971137139102E-5	1.1379996612466124E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	3	2	4	3	26	33	45	37	48		TCRBV20-01,TCRBV20-or09_02												CSVPDRATYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTTCCCAGGGGGGACGGCTCAATCAGCCCCAGCATTTTGGTGAT	CSSQGGRLNQPQHF	In	VDJ	1	43	9.677971137139102E-5	1.1379996612466124E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	4	1	3	3	7	26	32	42	35	49		TCRBV20-01,TCRBV20-or09_02												CSSQGGRLNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTGATAGGACAGGGGTAAGGGATGAGCAGTTCTTCGGGCCA	CASSDRTGVRDEQFF	In	VDJ	1	43	9.677971137139102E-5	1.1379996612466124E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	2	8	4	6	22	34	47	38	53		TCRBV12-03,TCRBV12-04												CASSDRTGVRDEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCTACGGAGCGGGAGGGCCCCGGAGCAGTACTTCGGGCCG		Out	VDJ	1	43	9.677971137139102E-5		46	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	6	0	7	7	5	24	36	53	43	58		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCAGGGAGACAGGGCAACACTGAAGCTTTCTTTGGACAA	CASSSGRQGNTEAFF	In	VDJ	1	43	9.677971137139102E-5	1.1379996612466124E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	2	6	1	18	31	44	37	45	TCRBV07,TCRBV11													CASSSGRQGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTGACAGGGTCAGAGACCCAGTACTTCGGGCCA	CASSVTGSETQYF	In	VDJ	1	43	9.677971137139102E-5	1.1379996612466124E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	2	3	4	0	2	23	-1	44	37	46	TCRBV09,TCRBV12													CASSVTGSETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTTGGACTAGCGGGGTACAATGAGCAGTTCTTCGGGCCA	CASSVGLAGYNEQFF	In	VDJ	1	43	9.677971137139102E-5	1.1379996612466124E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	1	3	4	1	0	23	37	-1	38	50	TCRBV09,TCRBV21													CASSVGLAGYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ACGACTCGGCYSTGTATCTCTGTGCCAGCAGCCAAGATGGCGGGGGGGCCGCGTTCGGGGAGCTGTTTTTTGGAGAA	CASSQDGGGAAFGELFF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	51				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	7	0	7	2	7	20	37	48	39	55	TCRBV04,TCRBV05	TCRBV04-02,TCRBV05-04												CASSQDGGGAAFGELFF+X+TCRBJ02-02		TCRBD02-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGACCGAAACCGGGGAGCTGTTTTTTGGAGAA	CSATTETGELFF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	36	TCRBV20						TCRBJ02	TCRBJ02-02	01	4	2	7	5	1	4	26	36	40	37	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATTETGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCCCGGGACAGGGGTATCAGCCCCAGCATTTTGGTGAT	CSARAPGQGYQPQHF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	0	2	5	4	1	26	39	53	43	54		TCRBV20-01,TCRBV20-or09_02												CSARAPGQGYQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGCTAGCGGGGGGGACTCCTACGAGCAGTACTTCGGGCCG	CSARGASGGDSYEQYF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	4	0	0	3	1	26	39	54	42	55		TCRBV20-01,TCRBV20-or09_02												CSARGASGGDSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCCCCCGCTAGCGGGAGTTTGAATGAGCAGTTCTTCGGGCCA	CSAAPASGSLNEQFF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	2	7	7	4	26	35	52	42	56		TCRBV20-01,TCRBV20-or09_02												CSAAPASGSLNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTCACTAGCGGGGGGGCCATGTACAATGAGCAGTTCTTCGGGCCA	CSAFTSGGAMYNEQFF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	3	0	4	3	5	26	35	51	38	56		TCRBV20-01,TCRBV20-or09_02												CSAFTSGGAMYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCGGACAGTAGAACTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSRTVELAKNIQYF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	1	5	0	1	7	24	36	43	37	50		TCRBV24-01,TCRBV24-or09_02												CASSRTVELAKNIQYF+TCRBV24-X+TCRBJ02-04	TCRBV24	TCRBD01-01*01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCARCCAGACMKMTCTKTACYWCTGTGCCAGCAGTTTAACCCCTGCCTACGAGCAGTACTTCGGGCCG	CASSLTPAYEQYF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	39	unresolved						TCRBJ02	TCRBJ02-07	01	6	3	7	2	3	5	24	36	41	39	46	TCRBV08,TCRBV24			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTPAYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGGATGAACACTGAAGCTTTCTTTGGACAA	CASSVGMNTEAFF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	39	unresolved						TCRBJ01	TCRBJ01-01	01	0	1	8	0	0	0	23	-1	-1	39	42	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGMNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQDSNQPQHF	In	VJ	1	45	1.0128109329564176E-4	1.1909298780487805E-4	39	TCRBV03						TCRBJ01	TCRBJ01-05	01	0	0	0	0	0	0	26	-1	-1	-1	43		TCRBV03-01,TCRBV03-02												CASSQDSNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGAACTACAATGAGCAGTTCTTCGGGCCA	CASSQNYNEQFF	In	VDJ	1	45	1.0128109329564176E-4	1.1909298780487805E-4	36	TCRBV03						TCRBJ02	TCRBJ02-01	01	3	2	8	3	0	1	26	-1	42	40	43		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQNYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACCGAACCCTGGGACACATACAATGAGCAGTTCTTCGGGCCA	CSATEPWDTYNEQFF	In	VDJ	1	45	1.0128109329564176E-4	1.1909298780487805E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	6	4	11	2	26	34	51	45	53		TCRBV20-01,TCRBV20-or09_02												CSATEPWDTYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAATCAGGGGGCGCCCACTGAAGCTTTCTTTGGACAA	CSANQGAPTEAFF	In	VDJ	1	45	1.0128109329564176E-4	1.1909298780487805E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	0	4	2	3	26	36	46	38	49		TCRBV20-01,TCRBV20-or09_02												CSANQGAPTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGACTAGCGGGGACCTACGAGCAGTACTTCGGGCCG	CSARDRLAGTYEQYF	In	VDJ	1	45	1.0128109329564176E-4	1.1909298780487805E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	2	3	2	2	1	26	40	53	42	54		TCRBV20-01,TCRBV20-or09_02												CSARDRLAGTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTTGATCGCGTTTCCTACGAGCAGTACTTCGGGCCG	CSARDLDRVSYEQYF	In	VDJ	1	45	1.0128109329564176E-4	1.1909298780487805E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	7	6	1	8	2	26	40	51	48	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLDRVSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATTTATCGACAGAGCACAGATACGCAGTATTTTGGCCCA	CSAIYRQSTDTQYF	In	VDJ	1	45	1.0128109329564176E-4	1.1909298780487805E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	5	0	6	0	26	36	-1	42	47		TCRBV20-01,TCRBV20-or09_02												CSAIYRQSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAGCCCGTGGCCAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	45	1.0128109329564176E-4		40	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	9	0	6	6	1	23	37	46	43	47	TCRBV04,TCRBV07,TCRBV17													X+X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCGGAGGGACAGCGTCACAGATACGCAGTATTTTGGCCCA	CATRRDSVTDTQYF	In	VDJ	1	45	1.0128109329564176E-4	1.1909298780487805E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	9	0	5	2	4	3	24	33	44	37	47		TCRBV24-01,TCRBV24-or09_02												CATRRDSVTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTATCGGGTAGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSYRVGGNQPQHF	In	VDJ	1	45	1.0128109329564176E-4	1.1909298780487805E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	5	2	2	8	0	24	36	-1	44	49		TCRBV24-01,TCRBV24-or09_02												CASSYRVGGNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGCTTAGATCCCTCTGGAAACACCATATATTTTGGAGAG	CASSLDPSGNTIYF	In	VJ	1	45	1.0128109329564176E-4	1.1909298780487805E-4	42	unresolved						TCRBJ01	TCRBJ01-03	01	1	0	0	0	0	4	18	-1	34	-1	38	TCRBV07,TCRBV11													CASSLDPSGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCCCGTTCGGGGGAGGGGAAATTAGGGCAGTACTTCGGGCCG		Out	VDJ	1	45	1.0128109329564176E-4		43	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	8	9	0	9	8	9	18	27	42	35	51	TCRBV07,TCRBV11													X+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGCGGGGGACAGTCGAAGCTTTCTTTGGACAA	CASSQRGTVEAFF	In	VDJ	1	46	1.0353178425776714E-4	1.2173949864498645E-4	39	TCRBV03						TCRBJ01	TCRBJ01-01	01	3	0	5	8	4	2	26	40	51	44	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQRGTVEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGATCGAGCGGGAGTTTATACGAGCAGTACTTCGGGCCG	CSARDRSSGSLYEQYF	In	VDJ	1	46	1.0353178425776714E-4	1.2173949864498645E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	6	2	4	7	4	26	40	55	47	59		TCRBV20-01,TCRBV20-or09_02												CSARDRSSGSLYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTTATTAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CSAFISSYNSPLHF	In	VDJ	1	46	1.0353178425776714E-4	1.2173949864498645E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	5	5	8	0	5	0	26	35	-1	40	43		TCRBV20-01,TCRBV20-or09_02				01,02								CSAFISSYNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD02-01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGACGGGGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSDGGSSYNEQFF	In	VDJ	1	46	1.0353178425776714E-4	1.2173949864498645E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	1	0	2	2	22	34	43	36	45		TCRBV12-03,TCRBV12-04												CASSDGGSSYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTCCTCGGAGTCTGGAACATTCAGTACTTCGGCGCC	CASSFLGVWNIQYF	In	VDJ	1	46	1.0353178425776714E-4	1.2173949864498645E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	2	10	2	7	4	5	19	33	41	37	46	TCRBV07,TCRBV11													CASSFLGVWNIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01*02	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGGACAGGGACGTTAATGAAAAACTGTTTTTTGGCAGT	CASSLDRDVNEKLFF	In	VDJ	1	46	1.0353178425776714E-4	1.2173949864498645E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	1	3	4	0	4	18	-1	40	32	44	TCRBV05,TCRBV11													CASSLDRDVNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTGGCAAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCACCAGTGATTCGACAGAAGGCGAGCAGTACTTCGGGCCG	CATSDSTEGEQYF	In	VDJ	1	46	1.0353178425776714E-4	1.2173949864498645E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	5	6	1	4	42	58	64	59	68		TCRBV24-01,TCRBV24-or09_02												CATSDSTEGEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCGCCCGGGGGAGCGGGAGAGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSARGSGRGNTGELFF	In	VDJ	1	46	1.0353178425776714E-4	1.2173949864498645E-4	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	6	2	1	9	3	19	31	48	40	51	TCRBV05,TCRBV07													CASSARGSGRGNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGCTGTGTATTTCTGTGCCAGCAGCCAAGGGAAAATGTCGGGACACCAAAGGGCCAAGAACACTGAAGCTTTCTTTGGACAA	CASSQGKMSGHQRAKNTEAFF	In	VDJ	1	46	1.0353178425776714E-4	1.2173949864498645E-4	63	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	6	1	10	12	13	29	45	39	57		TCRBV03-01,TCRBV03-02												CASSQGKMSGHQRAKNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGGGACTGGGAGGGGGACCCAGTACTTCGGGCCA	CASSGTGRGTQYF	In	VDJ	1	47	1.057824752198925E-4	1.2438600948509485E-4	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	9	0	7	7	1	26	37	51	44	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSGTGRGTQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTTAGGCGGGACAGGGATTTCAGAGACCCAGTACTTCGGGCCA	CASSLGGTGISETQYF	In	VDJ	1	47	1.057824752198925E-4	1.2438600948509485E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	0	3	4	2	5	26	42	53	44	58	TCRBV12,TCRBV21													CASSLGGTGISETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAGAGATGCCGGGACCTATGGCTACACCTTCGGTTCG	CSARDAGTYGYTF	In	VDJ	1	47	1.057824752198925E-4	1.2438600948509485E-4	39	TCRBV20						TCRBJ01	TCRBJ01-02	01	0	0	7	4	4	0	26	40	-1	44	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDAGTYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCATCTGGCGGGGGAGACCCAGTACTTCGGGCCA	CSAHLAGETQYF	In	VDJ	1	47	1.057824752198925E-4	1.2438600948509485E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	7	3	5	7	0	26	34	-1	41	47		TCRBV20-01,TCRBV20-or09_02												CSAHLAGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGACAGAACTGGGGCCAACGTCCTGACTTTCGGGGCC	CSADRTGANVLTF	In	VDJ	1	47	1.057824752198925E-4	1.2438600948509485E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	2	5	2	1	2	26	34	40	35	42		TCRBV20-01,TCRBV20-or09_02												CSADRTGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD01-01*01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTAGCTAGCGGCGAGCAGTACTTCGGGCCG	CSARDLASGEQYF	In	VDJ	1	47	1.057824752198925E-4	1.2438600948509485E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	4	5	6	5	0	26	40	-1	45	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLASGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGGTCGGTAGGACTGAAGCTTTCTTTGGACAA	CSARGVGRTEAFF	In	VDJ	1	47	1.057824752198925E-4	1.2438600948509485E-4	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	6	1	5	0	8	26	-1	42	37	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGVGRTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTATCTAGCGGGAGAGGCAATGAGCAGTTCTTCGGGCCA	CSALSSGRGNEQFF	In	VDJ	1	47	1.057824752198925E-4	1.2438600948509485E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	2	6	4	3	26	35	49	39	52		TCRBV20-01,TCRBV20-or09_02												CSALSSGRGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTGGTCGGACAGCTAATTCACCCCTCCACTTTGGGAAC	CASSGRTANSPLHF	In	VDJ	1	47	1.057824752198925E-4	1.2438600948509485E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	5	6	3	1	24	37	46	40	47	TCRBV24,TCRBV27													CASSGRTANSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGGACAGGGGCCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	47	1.057824752198925E-4		53				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	1	2	0	5	2	24	36	50	41	52	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												X+X+TCRBJ02-06		TCRBD01-01*01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCGGGACAGAAAATTCACCCCTCCACTTTGGGAAC	CASGTENSPLHF	In	VDJ	1	47	1.057824752198925E-4	1.2438600948509485E-4	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	11	0	5	7	2	2	24	31	40	33	42		TCRBV24-01,TCRBV24-or09_02												CASGTENSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCTGGGGGCGAACTACTGAACTATCGTCTTATCTCAACGTCCTGACTTTCGGGGCC	CASWGRTTELSSYLNVLTF	In	VDJ	1	47	1.057824752198925E-4	1.2438600948509485E-4	57	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	8	6	0	9	2	25	19	27	35	29	60	TCRBV05,TCRBV07													CASWGRTTELSSYLNVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCACTGGACAGGGTCCGGAGACCCAGTACTTCGGGCCA	CASTGQGPETQYF	In	VDJ	1	47	1.057824752198925E-4	1.2438600948509485E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	1	3	5	2	4	23	33	43	35	47	TCRBV02,TCRBV12													CASTGQGPETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTTTGAACGGCGGTGCCACAGATACGCAGTATTTTGGCCCA	CASSLNGGATDTQYF	In	VDJ	1	48	1.0803316618201788E-4	1.2703252032520327E-4	45				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	7	5	2	5	3	36	50	59	55	62	TCRBV27,TCRBV28	TCRBV27-01,TCRBV28-01				01,02								CASSLNGGATDTQYF+X+TCRBJ02-03		TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGCCACAGGGAATTTGGGCACAGATACGCAGTATTTTGGCCCA	CASSATGNLGTDTQYF	In	VDJ	1	48	1.0803316618201788E-4	1.2703252032520327E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	3	3	1	2	7	24	37	45	39	52	TCRBV06,TCRBV10													CASSATGNLGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAAATACCGGGACTGGAATGAGCAGTTCTTCGGGCCA	CASSKYRDWNEQFF	In	VDJ	1	48	1.0803316618201788E-4	1.2703252032520327E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	10	7	7	2	26	38	51	45	53		TCRBV03-01,TCRBV03-02				01,02								CASSKYRDWNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACTTGAAGGGGACACTGAAGCTTTCTTTGGACAA	CASSQLEGDTEAFF	In	VDJ	1	48	1.0803316618201788E-4	1.2703252032520327E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	5	2	3	5	0	26	41	-1	46	51		TCRBV03-01,TCRBV03-02												CASSQLEGDTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGCCTTCACAGATACGCAGTATTTTGGCCCA	CSARDAFTDTQYF	In	VDJ	1	48	1.0803316618201788E-4	1.2703252032520327E-4	39	TCRBV20						TCRBJ02	TCRBJ02-03	01	0	10	0	2	1	3	26	40	43	41	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDAFTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCGTCTCCGGGGGGGTCCAAGAGACCCAGTACTTCGGGCCA	CSARVVSGGVQETQYF	In	VDJ	1	48	1.0803316618201788E-4	1.2703252032520327E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	8	0	1	7	1	26	39	54	46	55		TCRBV20-01,TCRBV20-or09_02												CSARVVSGGVQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTCGTACGGGGGAATGGCTACACCTTCGGTTCG	CSALVRGNGYTF	In	VDJ	1	48	1.0803316618201788E-4	1.2703252032520327E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	2	6	6	1	26	35	47	41	48		TCRBV20-01,TCRBV20-or09_02												CSALVRGNGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGCGAAGGGACAGGTTCTTCGAGCAGTACTTCGGGCCG	CSAGRRDRFFEQYF	In	VDJ	1	48	1.0803316618201788E-4	1.2703252032520327E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	4	6	7	5	26	35	50	42	55		TCRBV20-01,TCRBV20-or09_02												CSAGRRDRFFEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGCTGGTTACGTTGGGACAGGGATTGGCTACACCTTCGGTTCG	CASSQAGYVGTGIGYTF	In	VDJ	1	48	1.0803316618201788E-4	1.2703252032520327E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	3	7	11	2	23	39	59	50	61	TCRBV01,TCRBV04													CASSQAGYVGTGIGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCTCCGGACAGGGGGAATTTATGGCTACACCTTCGGTTCG	CASSLRTGGIYGYTF	In	VDJ	1	48	1.0803316618201788E-4	1.2703252032520327E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	1	5	4	4	24	36	50	40	54		TCRBV24-01,TCRBV24-or09_02												CASSLRTGGIYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCAAAACTAGCGGAGGGTACCCCCGTGGGGAGCAGTTCTTCGGGCCA	CASSKTSGGYPRGEQFF	In	VDJ	1	48	1.0803316618201788E-4	1.2703252032520327E-4	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	3	5	10	3	16	19	31	42	34	58	TCRBV07,TCRBV11					01,02								CASSKTSGGYPRGEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGGGGCACATATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	48	1.0803316618201788E-4		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	8	0	0	0	5	18	-1	38	34	43	TCRBV05,TCRBV11													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTCTGGGGGGGAGGCCGCTATGGCTACACCTTCGGTTCG	CASSFWGGGRYGYTF	In	VDJ	1	48	1.0803316618201788E-4	1.2703252032520327E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	9	0	4	2	6	18	32	41	34	47	TCRBV05,TCRBV11													CASSFWGGGRYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGGGACTCRGCCSTKTATCTYTRCGCCAGCAGCCGACCGGGACAGGTAATTAATGAGCAGTTCTTCGGGCCA	XASSRPGQVINEQFF	In	VDJ	1	48	1.0803316618201788E-4	1.2703252032520327E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	4	7	5	5	22	34	47	39	52	TCRBV05,TCRBV07,TCRBV17													XASSRPGQVINEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCACCTTGGGCAGTAATAATGAAAAACTGTTTTTTGGCAGT	CASTLGSNNEKLFF	In	VDJ	1	48	1.0803316618201788E-4	1.2703252032520327E-4	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	5	4	1	3	19	35	39	36	42		TCRBV05-06,TCRBV05-07												CASTLGSNNEKLFF+TCRBV05-X+TCRBJ01-04	TCRBV05	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGATCCAGCGGGGGGGCGTACGAGCAGTACTTCGGGCCG	CASRSSGGAYEQYF	In	VDJ	1	49	1.1028385714414325E-4	1.2967903116531165E-4	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	6	0	4	4	2	26	37	51	41	53		TCRBV03-01,TCRBV03-02												CASRSSGGAYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCTGTCCGCCAGGGAAGGTGAAAAACTGTTTTTTGGCAGT	CASSQDLSAREGEKLFF	In	VDJ	1	49	1.1028385714414325E-4	1.2967903116531165E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	3	7	9	4	23	40	54	49	58	TCRBV01,TCRBV04													CASSQDLSAREGEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTGAGTGAGGAAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLSEESSYNEQFF	In	VDJ	1	49	1.1028385714414325E-4	1.2967903116531165E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	11	1	0	4	4	23	37	45	41	49	TCRBV24,TCRBV27													CASSLSEESSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCAGGGGCGTCCTAGGCACAGATACGCAGTATTTTGGCCCA	CASSSRGVLGTDTQYF	In	VDJ	1	49	1.1028385714414325E-4	1.2967903116531165E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	2	1	2	8	24	36	44	38	52		TCRBV24-01,TCRBV24-or09_02												CASSSRGVLGTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCGCCCTGGCTCACACAGATACGCAGTATTTTGGCCCA	CASALAHTDTQYF	In	VDJ	1	49	1.1028385714414325E-4	1.2967903116531165E-4	39	unresolved			unresolved			TCRBJ02	TCRBJ02-03	01	8	9	0	2	5	3	23	32	40	37	43	TCRBV06,TCRBV10			TCRBD01,TCRBD02										CASALAHTDTQYF+X+TCRBJ02-03	unresolved	unresolved	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAGCTGCGACCGTTTGGGAAGAAAACACCATATATTTTGGAGAG	CASSVAATVWEENTIYF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	51	TCRBV12						TCRBJ01	TCRBJ01-03	01	6	0	8	6	17	3	26	37	58	54	61		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVAATVWEENTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12		TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCTCCGACAGGGCCCAAGAGGCTACACCTTCGGTTCG	CASSLRQGPRGYTF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	3	8	4	7	26	38	49	42	56		TCRBV12-03,TCRBV12-04												CASSLRQGPRGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGTAGGGACAGGGGTCTCAAAGACCCAGTACTTCGGGCCA	CASSQVGTGVSKTQYF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	0	2	6	2	6	23	39	51	41	57	TCRBV01,TCRBV04													CASSQVGTGVSKTQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGGACTAGCGGCCAATGAGCAGTTCTTCGGGCCA	CASSQEGLAANEQFF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	1	5	6	1	1	26	43	54	44	55		TCRBV03-01,TCRBV03-02				01,02								CASSQEGLAANEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCTCGGGACTAGCGGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	50	1.1253454810626863E-4		47	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	0	5	3	3	0	26	42	-1	45	56		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGTTTCCCCAGATGACAGATACGCAGTATTTTGGCCCA	CSARRFPQMTDTQYF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	45	TCRBV20						TCRBJ02	TCRBJ02-03	01	2	4	5	3	9	3	26	38	50	47	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRFPQMTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGGAGGATACCAAATCAGCCCCAGCATTTTGGTGAT	CSGRIPNQPQHF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	7	10	1	4	0	6	26	-1	38	33	44		TCRBV20-01,TCRBV20-or09_02												CSGRIPNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*02	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTCCCTTGACCTCCGGGACAGGGCGTTTTGGTGAAGCTTTCTTTGGACAA	CASSPLTSGTGRFGEAFF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	54	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	3	7	12	8	22	34	55	46	63		TCRBV12-03,TCRBV12-04												CASSPLTSGTGRFGEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTGGGACAGACCTACGAGCAGTACTTCGGGCCG	CASSLGQTYEQYF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	5	2	0	1	22	-1	43	36	44		TCRBV12-03,TCRBV12-04												CASSLGQTYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGCGGTGGGGATCGAACACCGGGGAGCTGTTTTTTGGAGAA	CATSDLRWGSNTGELFF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	51	TCRBV24						TCRBJ02	TCRBJ02-02	01	0	0	8	0	5	1	24	42	51	47	52		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDLRWGSNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCGGGCAGGGGGGACAGTCCTCTGGAAACACCATATATTTTGGAGAG	CASSGQGGQSSGNTIYF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	5	0	8	2	18	30	45	38	47	TCRBV11,TCRBV23													CASSGQGGQSSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTTATCTATCTATGGGGACAGGATTAGCGGGGAGCTGTTTTTTGGAGAA	CASSLSIYGDRISGELFF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	4	7	14	5	24	35	57	49	62	TCRBV12,TCRBV21													CASSLSIYGDRISGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCTAGCAGCACAGATACGCAGTATTTTGGCCCA	CASSSSSTDTQYF	In	VDJ	1	51	1.14785239068394E-4	1.3497205284552846E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	4	7	0	0	0	26	-1	-1	39	44		TCRBV12-03,TCRBV12-04				01,02								CASSSSSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGGCGGGAGGGTTTTCGGATACGCAGTATTTTGGCCCA	CSAKAGGFSDTQYF	In	VDJ	1	51	1.14785239068394E-4	1.3497205284552846E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	7	0	6	2	6	26	36	47	38	53		TCRBV20-01,TCRBV20-or09_02												CSAKAGGFSDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCCCCCTAGCGGGTTCAGAGACCCAGTACTTCGGGCCA	CSATPLAGSETQYF	In	VDJ	1	51	1.14785239068394E-4	1.3497205284552846E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	4	4	4	5	3	26	36	49	41	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSATPLAGSETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTCCCGGCAGCATCCCCAATCAGCCCCAGCATTTTGGTGAT	CSATPGSIPNQPQHF	In	VDJ	1	51	1.14785239068394E-4	1.3497205284552846E-4	45	TCRBV20						TCRBJ01	TCRBJ01-05	01	4	4	5	3	7	6	26	36	46	43	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATPGSIPNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGCGGGGGAGCCTACAATGAGCAGTTCTTCGGGCCA	CSARSGGAYNEQFF	In	VDJ	1	51	1.14785239068394E-4	1.3497205284552846E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	6	2	2	0	2	26	-1	46	38	48		TCRBV20-01,TCRBV20-or09_02												CSARSGGAYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTAGGCGGATGGGGCACAGATACGCAGTATTTTGGCCCA	CSARDLGGWGTDTQYF	In	VDJ	1	51	1.14785239068394E-4	1.3497205284552846E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	4	8	1	1	9	26	40	45	41	54		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLGGWGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTCCCAGGGGAAAATAGCGGGAGGACCAAGCACAGATACGCAGTATTTTGGCCCA	CASSSQGKIAGGPSTDTQYF	In	VDJ	1	51	1.14785239068394E-4	1.3497205284552846E-4	60	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	5	1	0	12	4	18	31	53	43	57	TCRBV05,TCRBV11													CASSSQGKIAGGPSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCCCGGGGGAGGGGGACTACAATGAGCAGTTCTTCGGGCCA	CASSLAPGEGDYNEQFF	In	VDJ	1	51	1.14785239068394E-4	1.3497205284552846E-4	51				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	9	0	3	5	3	18	35	47	40	50	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAPGEGDYNEQFF+X+TCRBJ02-01		TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGTGTACTTCTGTGCCAGCAGTGCATCCGGGGCAACTCAACTCCGGGTCGTGTTGCAACACTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	51	1.14785239068394E-4		64	TCRBV06						TCRBJ02	TCRBJ02-01	01	4	7	0	9	5	28	10	23	33	28	61		TCRBV06-01,TCRBV06-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-X+TCRBJ02-01	TCRBV06		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCCGTGACCTTAACTATAATTCACCCCTCCACTTTGGGAAC	CASSSRDLNYNSPLHF	In	VDJ	1	52	1.1703593003051937E-4	1.3761856368563685E-4	48	TCRBV12						TCRBJ01	TCRBJ01-06	01	4	2	7	3	5	5	26	39	47	44	52		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRDLNYNSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12		TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTTGGGGGGAATTCACCCCTCCACTTTGGGAAC	CASSFGGNSPLHF	In	VDJ	1	52	1.1703593003051937E-4	1.3761856368563685E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	3	9	1	7	1	0	23	37	-1	38	44	TCRBV24,TCRBV27													CASSFGGNSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCATGTATCKCTGTGCCAGCAGCTTAGATTGGGGGGTCGGTTACGAGCAGTACTTCGGGCCG	CASSLDWGVGYEQYF	In	VDJ	1	52	1.1703593003051937E-4	1.3761856368563685E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	9	1	4	3	5	18	34	43	37	48	TCRBV07,TCRBV11													CASSLDWGVGYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCCGCAGGGGATGGTGGCTGGAACAGATACGCAGTATTTTGGCCCA	CASSPQGMVAGTDTQYF	In	VDJ	1	52	1.1703593003051937E-4	1.3761856368563685E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	2	3	3	12	18	30	39	33	51	TCRBV07,TCRBV11													CASSPQGMVAGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGCTTAGGGGGCTTAGAATGGCTACACCTTCGGTTCG		Out	VDJ	1	52	1.1703593003051937E-4		40	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	7	0	6	0	5	19	-1	40	35	45	TCRBV07,TCRBV11													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTGAAGAGGGTGGCAATCAGCCCCAGCATTTTGGTGAT	CASSEEGGNQPQHF	In	VDJ	1	52	1.1703593003051937E-4	1.3761856368563685E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	11	0	2	4	2	23	34	43	38	45	TCRBV09,TCRBV21													CASSEEGGNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAACCCCGGGGGGAGGCACACAGATACGCAGTATTTTGGCCCA	CASNPGGRHTDTQYF	In	VDJ	1	53	1.1928662099264474E-4	1.4026507452574526E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	12	8	1	2	9	5	26	31	47	40	52	TCRBV09,TCRBV12													CASNPGGRHTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGATCCCGGGGTTAGGGAGACCCAGTACTTCGGGCCA	XASSQDPGVRETQYF	In	VDJ	1	53	1.1928662099264474E-4	1.4026507452574526E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	8	3	5	3	5	23	40	48	43	53	TCRBV01,TCRBV04													XASSQDPGVRETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTACTTACGGGCAGCAAGAGACCCAGTACTTCGGGCCA	CSTYGQQETQYF	In	VDJ	1	53	1.1928662099264474E-4	1.4026507452574526E-4	36	TCRBV20						TCRBJ02	TCRBJ02-05	01	8	8	0	2	6	2	26	32	42	38	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSTYGQQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCCCCCACTAGCGGGGGATTTCTACGAGCAGTACTTCGGGCCG	CASSPPLAGDFYEQYF	In	VDJ	1	53	1.1928662099264474E-4	1.4026507452574526E-4	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	3	2	3	6	4	24	35	52	41	56		TCRBV24-01,TCRBV24-or09_02												CASSPPLAGDFYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGCATCAGCCGGGGGGCTCAAGGCATGAGCAGTTCTTCGGGCCA	CASSLHQPGGSRHEQFF	In	VDJ	1	53	1.1928662099264474E-4	1.4026507452574526E-4	51	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	1	8	10	8	24	36	53	46	61		TCRBV24-01,TCRBV24-or09_02												CASSLHQPGGSRHEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGAAACACTGAAGCTTTCTTTGGACAA	CASSLGNTEAFF	In	VDJ	1	54	1.2153731195477012E-4	1.4291158536585365E-4	36	TCRBV12						TCRBJ01	TCRBJ01-01	01	1	2	8	2	0	0	26	-1	-1	42	44		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTGGGGCTAACTATGGCTACACCTTCGGTTCG	CASSQGGANYGYTF	In	VDJ	1	54	1.2153731195477012E-4	1.4291158536585365E-4	42	TCRBV03						TCRBJ01	TCRBJ01-02	01	1	6	2	0	2	0	26	42	-1	44	48		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGGANYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCCCCGGGACGCCCGCCTATGGCTACACCTTCGGTTCG	CATSPGTPAYGYTF	In	VDJ	1	54	1.2153731195477012E-4	1.4291158536585365E-4	42	TCRBV24						TCRBJ01	TCRBJ01-02	01	7	0	7	4	4	6	24	35	44	39	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSPGTPAYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACTATGACACCTTTGAATGAGCAGTTCTTCGGGCCA	CATMTPLNEQFF	In	VDJ	1	54	1.2153731195477012E-4	1.4291158536585365E-4	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	2	6	7	3	6	24	32	39	35	45		TCRBV24-01,TCRBV24-or09_02												CATMTPLNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTCCCTCCGGTAACTACGAGCAGTACTTCGGGCCG	CASSPSGNYEQYF	In	VDJ	1	54	1.2153731195477012E-4	1.4291158536585365E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	8	5	3	5	3	23	35	43	40	46	TCRBV06,TCRBV24					01,02								CASSPSGNYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAGGGGGGCGCGGGTGAGCAGTTCTTCGGGCCA	CASSQEGGAGEQFF	In	VDJ	1	54	1.2153731195477012E-4	1.4291158536585365E-4	42							TCRBJ02	TCRBJ02-01	01	0	6	0	9	1	5	18	35	42	36	47	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGGAGEQFF+X+TCRBJ02-01			TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGTTTAAGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLAFKSSYNEQFF	In	VDJ	1	54	1.2153731195477012E-4	1.4291158536585365E-4	48				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	11	2	0	6	0	18	35	-1	41	44	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAFKSSYNEQFF+X+TCRBJ02-01		TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGGAGGTAGGGCAGGGGCGAACACAGATACACAGTATTTTGGCCCA	CASSGGRAGANTDTQYF	In	VDJ	1	54	1.2153731195477012E-4	1.4291158536585365E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	2	12	11	14	23	34	51	45	65	TCRBV02,TCRBV09													CASSGGRAGANTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTCACCCGGGGGGGCCGGCACAGATACGCAGTATTTTGGCCCA	CASSSPGGAGTDTQYF	In	VDJ	1	55	1.2378800291689549E-4	1.4555809620596207E-4	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	8	0	1	6	3	26	37	51	43	54		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSSPGGAGTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTCCCGCTTAAGCGGGACCGGGGATACGCAGTATTTTGGCCCA	CASSSRLSGTGDTQYF	In	VDJ	1	55	1.2378800291689549E-4	1.4555809620596207E-4	48	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	6	3	6	8	5	26	39	54	47	59		TCRBV12-03,TCRBV12-04												CASSSRLSGTGDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCCGGGACAGGGGGCAGCTATGGCTACACCTTCGGTTCG	CASSLAGTGGSYGYTF	In	VDJ	1	55	1.2378800291689549E-4	1.4555809620596207E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	0	4	1	2	26	43	56	44	58		TCRBV12-03,TCRBV12-04												CASSLAGTGGSYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGACAGGGAAGCTCTGGAAACACCATATATTTTGGAGAG	CSARDGQGSSGNTIYF	In	VDJ	1	55	1.2378800291689549E-4	1.4555809620596207E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	1	3	0	1	3	26	40	49	41	52		TCRBV20-01,TCRBV20-or09_02												CSARDGQGSSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTTCCGGGAGAGTTCTACGAGCAGTACTTCGGGCCG	CSAFPGEFYEQYF	In	VDJ	1	55	1.2378800291689549E-4	1.4555809620596207E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	8	2	3	4	4	26	35	45	39	49		TCRBV20-01,TCRBV20-or09_02												CSAFPGEFYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGAAGATGCCGGGACTAGCGGTTTAGGAATGAGCAGTTCTTCGGGCCA	CASRRCRD*RFRNEQFF	Stop	VDJ	1	55	1.2378800291689549E-4		51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	5	7	8	6	23	34	53	42	59	TCRBV24,TCRBV27					01,02								CASRRCRD*RFRNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTACCAGCACCCCGACTAGCGGGATAGAGACCCAGTACTTCGGGCCA	CTSTPTSGIETQYF	In	VDJ	1	56	1.2603869387902087E-4	1.4820460704607045E-4	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	2	3	4	4	1	26	36	51	40	52		TCRBV03-01,TCRBV03-02												CTSTPTSGIETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGAGGACTAGCGGGAAAGGGAGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSRGLAGKGGTGELFF	In	VDJ	1	56	1.2603869387902087E-4	1.4820460704607045E-4	54	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	1	3	4	2	8	26	39	53	41	61		TCRBV03-01,TCRBV03-02												CASSRGLAGKGGTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*02	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGACTAGCCTGGCAGATACGCAGTATTTTGGCCCA	CASSRTSLADTQYF	In	VDJ	1	56	1.2603869387902087E-4	1.4820460704607045E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	1	7	4	0	4	26	-1	47	39	51		TCRBV03-01,TCRBV03-02				01,02								CASSRTSLADTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTGGGGGCGGAGCACAATGAGCAGTTCTTCGGGCCA	CSARDLGAEHNEQFF	In	VDJ	1	56	1.2603869387902087E-4	1.4820460704607045E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	6	0	5	3	5	26	40	49	43	54		TCRBV20-01,TCRBV20-or09_02												CSARDLGAEHNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCCGCGGGCGTGGGCACAGATACGCAGTATTTTGGCCCA	CASSLSAGVGTDTQYF	In	VDJ	1	56	1.2603869387902087E-4	1.4820460704607045E-4	48				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	7	4	1	6	5	24	36	47	42	52	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01				01,02								CASSLSAGVGTDTQYF+X+TCRBJ02-03		TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTATCTCGAGCATCTAGCTACACCTTCGGTTCG	CASSLSRASSYTF	In	VDJ	1	56	1.2603869387902087E-4	1.4820460704607045E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	4	9	9	13	0	24	36	-1	49	52	TCRBV06,TCRBV24,TCRBV27					01,02								CASSLSRASSYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGGGGCAGGCAATGGGCAGTTCTTCGGGCCA	CAISGAGNGQFF	In	VDJ	1	56	1.2603869387902087E-4	1.4820460704607045E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	7	0	12	0	9	23	-1	40	35	49	TCRBV06,TCRBV10													CAISGAGNGQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCCCGGACAGGGGGCTAATTCTTCACCCCTCCACTTTGGGAAC	CASSPGQGANSSPLHF	In	VDJ	1	56	1.2603869387902087E-4	1.4820460704607045E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	1	0	9	3	6	19	31	45	34	51	TCRBV07,TCRBV11													CASSPGQGANSSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCAGTGGCAATCAGCCCCAGCATTTTGGTGAT	CASSLASGNQPQHF	In	VDJ	1	56	1.2603869387902087E-4	1.4820460704607045E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	5	2	0	2	18	-1	38	35	40	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLASGNQPQHF+X+TCRBJ01-05		TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAGGATTTCGAGGTCGGGGAGCTGTTTTTTGGAGAA	XASSQDFEVGELFF	In	VDJ	1	56	1.2603869387902087E-4	1.4820460704607045E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	11	1	7	7	1	22	36	47	43	48	TCRBV01,TCRBV04,TCRBV07,TCRBV17													XASSQDFEVGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCGCAGTCTTAAGCTCTGGAAACACCATATATTTTGGAGAG	CASSAVLSSGNTIYF	In	VDJ	1	56	1.2603869387902087E-4	1.4820460704607045E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	4	5	0	1	7	19	31	35	32	42	TCRBV05,TCRBV11													CASSAVLSSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTAGACAGGGGAGGGTCTTCCTATGGCTACACCTTCGGTTCG	CASSLDRGGSSYGYTF	In	VDJ	1	57	1.2828938484114622E-4	1.5085111788617887E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	2	4	3	9	26	38	49	41	58		TCRBV03-01,TCRBV03-02												CASSLDRGGSSYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGGCGCAAAACACTGAAGCTTTCTTTGGACAA	CSARRAQNTEAFF	In	VDJ	1	57	1.2828938484114622E-4	1.5085111788617887E-4	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	2	5	3	2	0	5	26	-1	42	38	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRAQNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATTCTTGGAAGTGAGCAGTTCTTCGGGCCA	CSAILGSEQFF	In	VDJ	1	57	1.2828938484114622E-4	1.5085111788617887E-4	33	TCRBV20						TCRBJ02	TCRBJ02-01	01	4	1	8	9	5	2	26	36	44	41	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAILGSEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTAAGCCCCGAGGGGGCCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	57	1.2828938484114622E-4		47	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	5	0	5	9	2	24	36	52	45	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAGATGCGGGCGAGGTCTACAATGAGCAGTTCTTCGGGCCA	CASSEDAGEVYNEQFF	In	VDJ	1	57	1.2828938484114622E-4	1.5085111788617887E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	7	4	3	7	6	23	34	46	41	52	TCRBV02,TCRBV09					01,02								CASSEDAGEVYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCGTGGGCAGGGCGCCACAATGAGCAGTTCTTCGGGCCA	CSARDPWAGRHNEQFF	In	VDJ	1	58	1.305400758032716E-4	1.5349762872628726E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	3	5	8	4	26	40	53	48	57		TCRBV20-01,TCRBV20-or09_02												CSARDPWAGRHNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGATCTAGGGACAGGGGCTTACAATGAGCAGTTCTTCGGGCCA	CASSQDLGTGAYNEQFF	In	VDJ	1	58	1.305400758032716E-4	1.5349762872628726E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	2	4	4	2	23	40	54	44	56	TCRBV04,TCRBV23													CASSQDLGTGAYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGCCGCCGGGACAGGGGTCGACGAGCAGTACTTCGGGCCG	CATSDAAGTGVDEQYF	In	VDJ	1	58	1.305400758032716E-4	1.5349762872628726E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	2	5	6	3	24	39	55	45	58		TCRBV24-01,TCRBV24-or09_02												CATSDAAGTGVDEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGACGGCGAACACTGAAGCTTTCTTTGGACAA	CASRTANTEAFF	In	VDJ	1	58	1.305400758032716E-4	1.5349762872628726E-4	36	TCRBV24						TCRBJ01	TCRBJ01-01	01	7	2	7	1	0	3	24	-1	38	35	41		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRTANTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCGCATGGACAGGCTCTGGCAATCAGCCCCAGCATTTTGGTGAT	CAAWTGSGNQPQHF	In	VDJ	1	58	1.305400758032716E-4	1.5349762872628726E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	12	1	4	2	4	5	24	30	41	34	46		TCRBV24-01,TCRBV24-or09_02												CAAWTGSGNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGAACATTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSEHYSNQPQHF	In	VDJ	1	58	1.305400758032716E-4	1.5349762872628726E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	6	0	3	3	23	34	40	37	43	TCRBV09,TCRBV12													CASSEHYSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCGGGGGACAGGAAACACCATATATTTTGGAGAG	CASSQDRGTGNTIYF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	45	unresolved						TCRBJ01	TCRBJ01-03	01	0	0	6	4	4	0	23	40	-1	44	50	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDRGTGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGGGCTAGCCGGAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	59	1.3279076676539698E-4		46	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	7	5	3	4	26	43	51	46	55		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGCTTAGAAGGGGCTTCGAAGGCTTTCTTTGGACAA	CASSLEGASKAFF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	5	2	11	1	8	20	36	42	37	50	TCRBV07,TCRBV11													CASSLEGASKAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCGATAGCACAGATACGCAGTATTTTGGCCCA	CSAPDSTDTQYF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	36	TCRBV20						TCRBJ02	TCRBJ02-03	01	6	2	8	0	4	1	26	34	40	38	41		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPDSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTTATCCCAGGGTACCAGCTTCTTCGGGCCA		Out	VDJ	1	59	1.3279076676539698E-4		34	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	3	16	8	7	26	34	47	42	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCCGGGACTAGCGGTCAACAGGGTACAAGAGACCCAGTACTTCGGGCCA	CSAPGLAVNRVQETQYF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	0	5	2	3	11	26	34	48	37	59		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPGLAVNRVQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTAGGACTAGCGGGAGGCCAGTCCCCCTTCGAGCAGTACTTCGGGCCG	CSARVGLAGGQSPFEQYF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	1	1	6	2	12	26	39	55	41	67		TCRBV20-01,TCRBV20-or09_02												CSARVGLAGGQSPFEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCCCAGGACACCTTCGATCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	59	1.3279076676539698E-4		46	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	6	4	5	9	26	37	47	42	56		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCTCCCGACTAGCGGCAAGCGTAGATTGAGGTCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	59	1.3279076676539698E-4		59	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	2	5	4	5	17	22	33	47	38	64		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGGACAGCGGAAGACACCGGGGAGCTGTTTTTTGGAGAA	CATRTAEDTGELFF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	42	TCRBV24						TCRBJ02	TCRBJ02-02	01	7	2	5	3	0	6	24	-1	40	35	46		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATRTAEDTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCAACGGGGCTCTTAGGGACCCAGTACTTCGGGCCA	CASSSTGLLGTQYF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	42	unresolved						TCRBJ02	TCRBJ02-05	01	4	7	0	7	4	7	18	31	40	35	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSTGLLGTQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCAGCTGTGTATTTTTGTGCCAGCAGTCCCAGAGCTTCCCTTGGACTGAAGGCGGTCGGCTACGAGCAGTACTTCGGGCCG	CASSPRASLGLKAVGYEQYF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	60	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	10	3	15	12	15	27	47	42	59		TCRBV12-03,TCRBV12-04				01,02								CASSPRASLGLKAVGYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTTAGCGGCGGGGAGGTAGGTGAGCAGTTCTTCGGGCCA	CASSVSGGEVGEQFF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	5	9	2	12	24	36	44	38	56	TCRBV09,TCRBV21					01,02								CASSVSGGEVGEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAGGTATCCGGCGGGGCTACACCTTCGGTTCG	CASSEGIRRGYTF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	7	5	8	7	0	23	39	-1	46	50	TCRBV02,TCRBV09					01,02								CASSEGIRRGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGCAACAAAAATGAGCAGTTCTTCGGGCCA	CASSLGNKNEQFF	In	VDJ	1	60	1.3504145772752236E-4	1.5879065040650406E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	8	0	7	0	6	26	-1	44	40	50		TCRBV12-03,TCRBV12-04												CASSLGNKNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATAAACTAGCGGGAGAAGATGGGTACGCAGTATTTTGGCCCA		Out	VDJ	1	60	1.3504145772752236E-4		52	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	3	2	8	3	8	26	43	57	46	65		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGACAGCTAACTATGGCTACACCTTCGGTTCG	CSARGTANYGYTF	In	VDJ	1	60	1.3504145772752236E-4	1.5879065040650406E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	1	5	0	0	0	26	-1	-1	39	45		TCRBV20-01,TCRBV20-or09_02												CSARGTANYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAACACCTGGGGGGGTACAACCGATAGAATTCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	60	1.3504145772752236E-4		52	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	11	9	0	4	6	16	24	31	44	37	60		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCCAAGGCAGGGTTGGCGAAAAACTGTTTTTTGGCAGT	CASSQGRVGEKLFF	In	VDJ	1	60	1.3504145772752236E-4	1.5879065040650406E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	3	8	5	5	18	30	40	35	45	TCRBV11,TCRBV23													CASSQGRVGEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTCCGGCACTAGCGGGGTTAACTACGAGCAGTACTTCGGGCCG	CASSSGTSGVNYEQYF	In	VDJ	1	60	1.3504145772752236E-4	1.5879065040650406E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	3	3	3	5	4	18	31	46	36	50	TCRBV05,TCRBV11													CASSSGTSGVNYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTTTCGGACTAGTGACAGATACGCAGTATTTTGGCCCA	CASSFGLVTDTQYF	In	VDJ	1	60	1.3504145772752236E-4	1.5879065040650406E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	1	8	3	3	2	23	35	45	38	47	TCRBV02,TCRBV12					01,02								CASSFGLVTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACGGCAGGGCTAAGTTCGGGCCG	CASSQDGRAKF	In	VDJ	1	61	1.372921486896477E-4	1.6143716124661248E-4	33	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	16	3	5	26	43	51	46	56		TCRBV03-01,TCRBV03-02												CASSQDGRAKF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGCGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSQGGDTGELFF	In	VDJ	1	61	1.372921486896477E-4	1.6143716124661248E-4	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	7	3	3	0	0	26	-1	-1	42	48		TCRBV03-01,TCRBV03-02												CASSQGGDTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCACCCGGGGGACGAGCGAAAAACTGTTTTTTGGCAGT	CSASTRGTSEKLFF	In	VDJ	1	61	1.372921486896477E-4	1.6143716124661248E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	8	2	8	4	6	26	37	47	41	53		TCRBV20-01,TCRBV20-or09_02												CSASTRGTSEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTTCCGGGAGGCTAGCTGGCTACAATGAGCAGTTCTTCGGGCCA	CASSSGRLAGYNEQFF	In	VDJ	1	61	1.372921486896477E-4	1.6143716124661248E-4	48				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	1	3	1	8	33	46	54	47	62	TCRBV27,TCRBV28	TCRBV27-01,TCRBV28-01												CASSSGRLAGYNEQFF+X+TCRBJ02-01		TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAAGTCAGCACCTACGAGCAGTACTTCGGGCCG	CASSQEVSTYEQYF	In	VDJ	1	61	1.372921486896477E-4	1.6143716124661248E-4	42							TCRBJ02	TCRBJ02-07	01	0	4	5	2	3	2	18	35	41	38	43	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEVSTYEQYF+X+TCRBJ02-07			TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCTTAGGTACAGGGAATCAGCCCCAGCATTTTGGTGAT	CASSLGTGNQPQHF	In	VDJ	1	61	1.372921486896477E-4	1.6143716124661248E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	3	4	4	0	19	33	-1	37	43	TCRBV05,TCRBV07													CASSLGTGNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCCCAAAGCGGGAGAGGTGAGCAGTACTTCGGGCCG	CASSQAQSGRGEQYF	In	VDJ	1	62	1.395428396517731E-4	1.6408367208672087E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	6	2	7	5	4	26	42	55	47	59		TCRBV03-01,TCRBV03-02												CASSQAQSGRGEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGCGGACGCCCTGAAGCTTTCTTTGGACAA	CASSQGGRPEAFF	In	VDJ	1	62	1.395428396517731E-4	1.6408367208672087E-4	39	TCRBV03						TCRBJ01	TCRBJ01-01	01	3	1	7	6	4	3	26	40	48	44	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGGRPEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAAACACCTACCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	62	1.395428396517731E-4		37	TCRBV20						TCRBJ01	TCRBJ01-02	01	4	3	6	4	2	6	26	36	41	38	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCAAATATGCACAGATACGCAGTATTTTGGCCCA	CATQICTDTQYF	In	VDJ	1	62	1.395428396517731E-4	1.6408367208672087E-4	36	TCRBV24						TCRBJ02	TCRBJ02-03	01	9	4	6	1	0	5	24	-1	35	33	40		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATQICTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGGAGACAGGGGAAATGAGCAGTTCTTCGGGCCA	CATGDRGNEQFF	In	VDJ	1	62	1.395428396517731E-4	1.6408367208672087E-4	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	9	2	2	7	3	1	24	33	44	36	45		TCRBV24-01,TCRBV24-or09_02												CATGDRGNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTTGGGACAGCTTCCTACGAGCAGTACTTCGGGCCG	CASSLFGTASYEQYF	In	VDJ	1	62	1.395428396517731E-4	1.6408367208672087E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	5	1	6	2	24	36	49	42	51		TCRBV24-01,TCRBV24-or09_02												CASSLFGTASYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GMGACWCGGCWSTGTATCTCTGYGCCAGCAGCTTGGATGTCATGCATCAGCCCCAGCATTTTGGTGAT	CASSLDVMHQPQHF	In	VDJ	1	62	1.395428396517731E-4	1.6408367208672087E-4	42	unresolved						TCRBJ01	TCRBJ01-05	01	2	1	8	5	0	8	19	-1	36	33	44	TCRBV07,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDVMHQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCCGTACCCCACAGAAGATGAGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	62	1.395428396517731E-4		47				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	5	7	8	8	18	30	42	38	50	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												X+X+TCRBJ02-01		TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCATGGGGGCAGGCTGAACACTGAAGCTTTCTTTGGACAA	CASSHGGRLNTEAFF	In	VDJ	1	62	1.395428396517731E-4	1.6408367208672087E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	6	0	0	3	4	18	30	39	33	43	TCRBV07,TCRBV11													CASSHGGRLNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCGGGACAGGGGGCCGGGATGGCTACACCTTCGGTTCG	CASSGTGGRDGYTF	In	VDJ	1	62	1.395428396517731E-4	1.6408367208672087E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	0	6	0	4	18	-1	42	30	46	TCRBV05,TCRBV11													CASSGTGGRDGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTACAGGCGGACTCCTACGAGCAGTACTTCGGGCCG	CASSLQADSYEQYF	In	VDJ	1	62	1.395428396517731E-4	1.6408367208672087E-4	42	unresolved			unresolved			TCRBJ02	TCRBJ02-07	01	2	4	4	0	0	4	18	-1	37	33	41	TCRBV05,TCRBV11			TCRBD01,TCRBD02										CASSLQADSYEQYF+X+TCRBJ02-07	unresolved	unresolved	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGAAAATTAAAGAGACTAGCGGGGAGGGCAAGGACATTCAGTACTTCGGCGCC		Out	VDJ	1	62	1.395428396517731E-4		56	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	6	2	3	8	11	9	25	36	58	47	67		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD02-01*01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTGATGTCGGGGGGGCAGATAATGAGCAGTTCTTCGGGCCA	CASSDVGGADNEQFF	In	VDJ	1	62	1.395428396517731E-4	1.6408367208672087E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	8	0	7	3	5	23	37	48	40	53	TCRBV02,TCRBV21													CASSDVGGADNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCGACTAGCGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSRLAGSYNEQFF	In	VDJ	1	62	1.395428396517731E-4	1.6408367208672087E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	2	3	1	1	0	23	35	-1	36	47	TCRBV09,TCRBV21													CASSRLAGSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSLGTGELFF	In	VDJ	1	63	1.4179353061389847E-4	1.6673018292682928E-4	36	TCRBV12						TCRBJ02	TCRBJ02-02	01	3	6	2	5	0	0	26	-1	-1	40	44		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCCCCTGGAAGCGGGTGCCAATGAGCAGTTCTTCGGGCCA	CASSPLEAGANEQFF	In	VDJ	1	63	1.4179353061389847E-4	1.6673018292682928E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	6	4	6	9	3	26	37	52	46	55		TCRBV03-01,TCRBV03-02				01,02								CASSPLEAGANEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAGCGGGAACTAGCCCCCCACGAGCAGTACTTCGGGCCG	CSAQRELAPHEQYF	In	VDJ	1	63	1.4179353061389847E-4	1.6673018292682928E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	6	3	5	2	11	26	34	43	36	54		TCRBV20-01,TCRBV20-or09_02												CSAQRELAPHEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGATGATGGGAGATTGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSADDGRLSSYNEQFF	In	VDJ	1	63	1.4179353061389847E-4	1.6673018292682928E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	9	2	0	7	6	26	34	46	41	52		TCRBV20-01,TCRBV20-or09_02												CSADDGRLSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGGACAGGGGGGTTATGAACACTGAAGCTTTCTTTGGACAA	CSAPDRGVMNTEAFF	In	VDJ	1	63	1.4179353061389847E-4	1.6673018292682928E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	1	0	2	4	26	35	47	37	51		TCRBV20-01,TCRBV20-or09_02												CSAPDRGVMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTCGGGGGAAGGGAAGCAGATACGCAGTATTTTGGCCCA	CSVGGREADTQYF	In	VDJ	1	63	1.4179353061389847E-4	1.6673018292682928E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	8	2	4	1	8	26	33	40	34	48		TCRBV20-01,TCRBV20-or09_02												CSVGGREADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCCATGACAGGGAGCAAGAGACCCAGTACTTCGGGCCA	CASSHDREQETQYF	In	VDJ	1	63	1.4179353061389847E-4	1.6673018292682928E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	3	2	4	2	20	31	42	35	44	TCRBV11,TCRBV23													CASSHDREQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATACCGGTGAAAAACTGTTTTTTGGCAGT	CSARDTGEKLFF	In	VDJ	1	64	1.4404422157602385E-4	1.6937669376693767E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	8	5	7	3	0	26	40	-1	43	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDTGEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAATTTATACGGGAGGAGCAGTACTTCGGGCCG		Out	VDJ	1	64	1.4404422157602385E-4		38	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	8	2	7	9	0	26	37	-1	46	52		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGCGTACAGGGGCGGCGAGACCCAGTACTTCGGGCCA	CASSQAYRGGETQYF	In	VDJ	1	64	1.4404422157602385E-4	1.6937669376693767E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	3	2	5	3	4	23	39	49	42	53	TCRBV01,TCRBV04													CASSQAYRGGETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCCCGGGCAGGGTGGATCACCCCTCCACTTTGGGAAC	CASSPGQGGSPLHF	In	VDJ	1	64	1.4404422157602385E-4	1.6937669376693767E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	7	4	3	10	7	4	24	35	47	42	51		TCRBV24-01,TCRBV24-or09_02												CASSPGQGGSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTGGACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSWTNTGELFF	In	VDJ	1	64	1.4404422157602385E-4	1.6937669376693767E-4	39	TCRBV24						TCRBJ02	TCRBJ02-02	01	6	1	8	0	1	0	24	36	-1	37	40		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWTNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGCCTGCGAATTCCTATGGCTACACCTTCGGTTCG	CASSLSPANSYGYTF	In	VDJ	1	64	1.4404422157602385E-4	1.6937669376693767E-4	45				TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	7	6	4	9	5	24	36	48	45	53	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01				01,02								CASSLSPANSYGYTF+X+TCRBJ01-02		TCRBD02-01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGAGGCTAGCGGGAGTCTACGAGCAGTACTTCGGGCCG	CASSLRLAGVYEQYF	In	VDJ	1	64	1.4404422157602385E-4	1.6937669376693767E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	4	2	3	6	1	24	36	52	42	53		TCRBV24-01,TCRBV24-or09_02												CASSLRLAGVYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCAACACAGGGGATCGAACACTGAAGCTTTCTTTGGACAA	CASSQHRGSNTEAFF	In	VDJ	1	64	1.4404422157602385E-4	1.6937669376693767E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	2	1	4	3	18	30	41	34	44	TCRBV05,TCRBV11													CASSQHRGSNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCAGGGGGCGTCTTCTACGAGCAGTACTTCGGGCCG	CASSSGGVFYEQYF	In	VDJ	1	64	1.4404422157602385E-4	1.6937669376693767E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	0	3	0	5	18	-1	39	31	44	TCRBV07,TCRBV11													CASSSGGVFYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCAGGCGGCGCATATGATACGCAGTATTTTGGCCCA	CASSLAGGAYDTQYF	In	VDJ	1	64	1.4404422157602385E-4	1.6937669376693767E-4	45				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	7	5	6	2	7	18	35	41	37	48	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLAGGAYDTQYF+X+TCRBJ02-03		TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAACAGGGGGATTGGCCCAAGAGACCCAGTACTTCGGGCCA	CSATGGLAQETQYF	In	VDJ	1	65	1.462949125381492E-4	1.7202320460704606E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	3	1	1	1	6	26	34	43	35	49		TCRBV20-01,TCRBV20-or09_02												CSATGGLAQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTCAACAGGGGAGGGCAGATACGCAGTATTTTGGCCCA	CASSQQGRADTQYF	In	VDJ	1	65	1.462949125381492E-4	1.7202320460704606E-4	42	unresolved						TCRBJ02	TCRBJ02-03	01	6	3	2	4	2	4	24	36	45	38	49	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQQGRADTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGGGGACAGGGAACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	65	1.462949125381492E-4		40	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	3	2	0	2	23	-1	43	34	45	TCRBV06,TCRBV10													X+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCKGCYRTGTATYKCTGTGCCAGCAGCTTCCAGGGGGCGCGTTTCATGGTTGAGCAGTTCTTCGGGCCA	CASSFQGARFMVEQFF	In	VDJ	1	65	1.462949125381492E-4	1.7202320460704606E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	0	9	1	12	18	32	41	33	53	TCRBV03,TCRBV07													CASSFQGARFMVEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGAGCCACAGGGGGCTCGAGCACTGAAGCTTTCTTTGGACAA	CASRATGGSSTEAFF	In	VDJ	1	66	1.4854560350027458E-4	1.7466971544715447E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	0	4	4	5	26	37	50	41	55		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRATGGSSTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAATAAGGGGTCTGGGAAAACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	66	1.4854560350027458E-4		49	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	5	2	3	3	9	26	40	48	43	57		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATACAGCCACTAACTATGGCTACACCTTCGGTTCG	CSARDTATNYGYTF	In	VDJ	1	66	1.4854560350027458E-4	1.7466971544715447E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	5	0	1	3	26	40	45	41	48		TCRBV20-01,TCRBV20-or09_02												CSARDTATNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAACGGGAGGACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	66	1.4854560350027458E-4		38	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	11	8	1	0	4	1	24	31	42	35	43		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCAAGGGCGTTTGGGGCGAGCAGTACTTCGGGCCG	CASSPKGVWGEQYF	In	VDJ	1	66	1.4854560350027458E-4	1.7466971544715447E-4	42	TCRBV24						TCRBJ02	TCRBJ02-07	01	6	5	3	6	4	9	24	36	44	40	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPKGVWGEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCACGAGGAACGGCAATCAGCCCCAGCATTTTGGTGAT	CASSSTRNGNQPQHF	In	VDJ	1	66	1.4854560350027458E-4	1.7466971544715447E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	11	1	2	5	4	24	36	45	41	49		TCRBV24-01,TCRBV24-or09_02												CASSSTRNGNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD02-01*02	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTAAGTAAGTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	66	1.4854560350027458E-4		43	TCRBV24						TCRBJ02	TCRBJ02-01	01	6	5	5	4	6	5	24	36	44	42	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ASCTCCCAGACATCTGTGTACTTSTGTTCCAAAACTAGCCTTATGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	66	1.4854560350027458E-4		37	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	10	3	7	6	2	6	23	30	38	32	44	TCRBV06,TCRBV10					01,02								X+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTAGGCCGGGACTAGCGGGGGTCAAATCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	66	1.4854560350027458E-4		58	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	0	2	0	7	6	23	35	56	42	62		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTACGAGACAGGGGCGCGAGGGGGACTAGCCTATATACGCAGTATTTTGGCCCA	CASSLRDRGARGTSLYTQYF	In	VDJ	1	67	1.5079629446239996E-4	1.7731622628726286E-4	60	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	7	7	21	4	21	33	63	54	67		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLRDRGARGTSLYTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCGACAGGGGGGTAATCAGCCCCAGCATTTTGGTGAT	CASSRQGGNQPQHF	In	VDJ	1	67	1.5079629446239996E-4	1.7731622628726286E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	1	4	2	2	26	37	48	39	50		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSRQGGNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGACTGGACTTAAACACCGGGGAGCTGTTTTTTGGAGAA	CASRLDLNTGELFF	In	VDJ	1	67	1.5079629446239996E-4	1.7731622628726286E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	1	10	2	3	2	26	37	45	40	47		TCRBV03-01,TCRBV03-02				01,02								CASRLDLNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGCCAGCGGGGGGGCAGATACGCAGTATTTTGGCCCA	CSASASGGADTQYF	In	VDJ	1	67	1.5079629446239996E-4	1.7731622628726286E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	6	0	4	4	0	26	37	-1	41	51		TCRBV20-01,TCRBV20-or09_02												CSASASGGADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTAAGGCGGGGAACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	67	1.5079629446239996E-4		38	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	7	3	2	4	2	26	35	45	39	47		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAATATAACGGGGGCATAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	67	1.5079629446239996E-4		43	TCRBV24						TCRBJ01	TCRBJ01-02	01	11	6	0	1	10	1	24	31	47	41	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGACTCGGCYGTGTATCTCTGTGCCAGCAGCTTGGACAGTTCTAACTATGGCTACACCTTCGGTTCG	CASSLDSSNYGYTF	In	VDJ	1	67	1.5079629446239996E-4	1.7731622628726286E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	1	5	0	0	2	19	-1	39	33	41	TCRBV05,TCRBV07													CASSLDSSNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCAAGATCAGGGTAATCAGCCCCAGCATTTTGGTGAT	CASSQDQGNQPQHF	In	VDJ	1	67	1.5079629446239996E-4	1.7731622628726286E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	3	4	1	1	18	35	41	36	42	TCRBV04,TCRBV05,TCRBV11													CASSQDQGNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATCGATTTAGGGGCACAGATACGCAGTATTTTGGCCCA	CASSQDRFRGTDTQYF	In	VDJ	1	67	1.5079629446239996E-4	1.7731622628726286E-4	48							TCRBJ02	TCRBJ02-03	01	0	5	3	1	7	0	18	35	-1	42	46	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDRFRGTDTQYF+X+TCRBJ02-03			TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCAGGCTTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSRLATNEKLFF	In	VDJ	1	67	1.5079629446239996E-4	1.7731622628726286E-4	42	TCRBV05						TCRBJ01	TCRBJ01-04	01	4	5	4	0	0	4	19	-1	34	31	38		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRLATNEKLFF+TCRBV05-X+TCRBJ01-04	TCRBV05		TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCGCCGGGACAGGGGTCTCGGGGGAGCTGTTTTTTGGAGAA	CASSAGTGVSGELFF	In	VDJ	1	67	1.5079629446239996E-4	1.7731622628726286E-4	45	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	2	8	3	5	19	31	44	34	49		TCRBV05-06,TCRBV05-07												CASSAGTGVSGELFF+TCRBV05-X+TCRBJ02-02	TCRBV05	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTGCATACAGGGATCTACGAGCAGTACTTCGGGCCG	CASSLHTGIYEQYF	In	VDJ	1	67	1.5079629446239996E-4	1.7731622628726286E-4	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	3	3	3	3	2	19	34	43	37	45		TCRBV05-06,TCRBV05-07												CASSLHTGIYEQYF+TCRBV05-X+TCRBJ02-07	TCRBV05	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTAACGTAGATAGCGGGAGACCAGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	67	1.5079629446239996E-4		50	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	5	2	8	9	4	22	35	53	44	57	TCRBV07,TCRBV11													X+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAGGGATTTTAGCGGGGATTCCTACGAGCAGTACTTCGGGCCG	CSARDFSGDSYEQYF	In	VDJ	1	68	1.5304698542452532E-4	1.7996273712737128E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	5	3	1	9	2	26	34	51	43	53		TCRBV20-01,TCRBV20-or09_02												CSARDFSGDSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGACAGGCAGGAACTAATGAAAAACTGTTTTTTGGCAGT	CASRQAGTNEKLFF	In	VDJ	1	68	1.5304698542452532E-4	1.7996273712737128E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	4	1	0	4	22	-1	38	33	42		TCRBV12-03,TCRBV12-04												CASRQAGTNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCRTGTATCTCTGTGCCAGCAGCTCGCCAGGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSSPGGNTEAFF	In	VDJ	1	68	1.5304698542452532E-4	1.7996273712737128E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	1	1	3	0	18	31	-1	34	41	TCRBV07,TCRBV11													CASSSPGGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCGTCAGCGGGAGTGGACCGGGGAGCTGTTTTTTGGAGAA	CASSRQREWTGELFF	In	VDJ	1	69	1.552976763866507E-4	1.8260924796747967E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	6	2	5	5	3	26	37	50	42	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSRQREWTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*02	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAACCCCGGAGCATTCCTGCAAGAGACCCAGTACTTCGGGCCA	CASNPGAFLQETQYF	In	VDJ	1	69	1.552976763866507E-4	1.8260924796747967E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	10	2	2	5	8	26	36	45	41	53		TCRBV03-01,TCRBV03-02												CASNPGAFLQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGTGGGGGCACGTCACTGAAGCTTTCTTTGGACAA	CSARGWGHVTEAFF	In	VDJ	1	69	1.552976763866507E-4	1.8260924796747967E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	6	0	4	3	4	26	39	48	42	52		TCRBV20-01,TCRBV20-or09_02												CSARGWGHVTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCCAGACAGGATCGTTACAATGAGCAGTTCTTCGGGCCA	CSARSRQDRYNEQFF	In	VDJ	1	69	1.552976763866507E-4	1.8260924796747967E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	2	4	4	4	5	26	38	48	42	53		TCRBV20-01,TCRBV20-or09_02												CSARSRQDRYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCCGGGGACGGGTGAATACTGAAGCTTTCTTTGGACAA	CASSRGRVNTEAFF	In	VDJ	1	69	1.552976763866507E-4	1.8260924796747967E-4	42	unresolved						TCRBJ01	TCRBJ01-01	01	5	0	7	5	2	8	18	30	37	32	45	TCRBV11,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRGRVNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCCCCGAATGGGTGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	69	1.552976763866507E-4		43	TCRBV05						TCRBJ02	TCRBJ02-05	01	4	0	9	3	9	2	19	31	43	40	45		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV05-X+TCRBJ02-05	TCRBV05		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCTTAGAAAGGGGCATGAAGCCCCAGCATTTTGGTGAT	CASSLERGMKPQHF	In	VDJ	1	69	1.552976763866507E-4	1.8260924796747967E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	5	2	8	4	5	19	33	42	37	47	TCRBV05,TCRBV07													CASSLERGMKPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCTTCGGGGTCACCCCTCCACTTTGGGAAC	CASSQASGSPLHF	In	VDJ	1	70	1.5754836734877608E-4	1.8525575880758808E-4	39	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	1	8	3	10	3	0	26	42	-1	45	50		TCRBV03-01,TCRBV03-02												CASSQASGSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD02-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGAGGACAGGGCGCCCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSRRTGRPGANVLTF	In	VDJ	1	70	1.5754836734877608E-4	1.8525575880758808E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	1	3	2	3	4	26	39	50	42	54		TCRBV03-01,TCRBV03-02												CASSRRTGRPGANVLTF+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD01-01*01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCCCGGGACTAGAAGAACAGATACGCAGTATTTTGGCCCA	CASSPGTRRTDTQYF	In	VDJ	1	70	1.5754836734877608E-4	1.8525575880758808E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	8	3	4	4	26	37	49	41	53		TCRBV03-01,TCRBV03-02				01,02								CASSPGTRRTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCTAGGTTTAGGAGTTATGAGCAGTTCTTCGGGCCA	CSASPRFRSYEQFF	In	VDJ	1	70	1.5754836734877608E-4	1.8525575880758808E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	8	8	2	11	26	37	43	39	54		TCRBV20-01,TCRBV20-or09_02				01,02								CSASPRFRSYEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGACTGGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	70	1.5754836734877608E-4		37	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	1	10	4	0	3	26	-1	42	37	45		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCAAGTCCGGGGAGGGGGCAGGGAGCAGTTCTTCGGGCCA	CASSQVRGGGREQFF	In	VDJ	1	70	1.5754836734877608E-4	1.8525575880758808E-4	45	unresolved						TCRBJ02	TCRBJ02-01	01	5	5	0	10	11	3	18	30	48	41	51	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVRGGGREQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTGCCTTAAGGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	70	1.5754836734877608E-4		41	unresolved						TCRBJ01	TCRBJ01-01	01	3	5	3	3	6	0	18	32	-1	38	42	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTTATTTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQVISNTGELFF	In	VDJ	1	71	1.5979905831090146E-4	1.8790226964769647E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	5	9	0	1	3	26	42	45	43	48		TCRBV03-01,TCRBV03-02				01,02								CASSQVISNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACCCCTGGGGCCTACGAGCAGTACTTCGGGCCG	CSATPGAYEQYF	In	VDJ	1	71	1.5979905831090146E-4	1.8790226964769647E-4	36	TCRBV20						TCRBJ02	TCRBJ02-07	01	6	6	2	2	7	0	26	34	-1	41	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATPGAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGTCCGGGTTCACTGAAGCTTTCTTTGGACAA	CSARDGSGFTEAFF	In	VDJ	1	71	1.5979905831090146E-4	1.8790226964769647E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	8	4	4	6	2	26	40	50	46	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDGSGFTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGAGGGGAATGGACCTACGAGCAGTACTTCGGGCCG	CSARGGEWTYEQYF	In	VDJ	1	71	1.5979905831090146E-4	1.8790226964769647E-4	42	TCRBV20						TCRBJ02	TCRBJ02-07	01	1	5	2	2	1	6	26	39	45	40	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGGEWTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTACCTCTCGGGACAGGACAAGATACGCAGTATTTTGGCCCA	CSALPLGTGQDTQYF	In	VDJ	1	71	1.5979905831090146E-4	1.8790226964769647E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	4	5	9	3	26	35	52	44	55		TCRBV20-01,TCRBV20-or09_02												CSALPLGTGQDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGTTCTCATACGGACAGACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	71	1.5979905831090146E-4		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	1	5	0	9	1	23	31	46	40	47	TCRBV06,TCRBV10													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCACCCCAGGGCCAGGGACGAACATTCAGTACTTCGGCGCC	CASTPGPGTNIQYF	In	VDJ	1	71	1.5979905831090146E-4	1.8790226964769647E-4	42	unresolved						TCRBJ02	TCRBJ02-04	01	10	0	7	7	14	1	24	31	50	45	51	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTPGPGTNIQYF+X+TCRBJ02-04	unresolved		TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCTCCCCTGGCAGGGGCGGGATAGATACGCAGTATTTTGGCCCA	CATSPGRGGIDTQYF	In	VDJ	1	72	1.620497492730268E-4	1.9054878048780488E-4	45	TCRBV24						TCRBJ02	TCRBJ02-03	01	9	4	2	5	8	6	24	33	47	41	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSPGRGGIDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCCAACCTACAGGGTTTAACACTGAAGCTTTCTTTGGACAA	CASSSQPTGFNTEAFF	In	VDJ	1	73	1.643004402351522E-4	1.9319529132791327E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	3	2	8	3	26	39	53	47	56		TCRBV12-03,TCRBV12-04												CASSSQPTGFNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGTAGGGACTTCGTCGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	73	1.643004402351522E-4		38	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	9	0	10	5	2	7	23	31	39	33	46	TCRBV01,TCRBV17					01,02								X+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTGGGACGGGACCCTACGAGCAGTACTTCGGGCCG	CASSGTGPYEQYF	In	VDJ	1	73	1.643004402351522E-4	1.9319529132791327E-4	39	TCRBV03						TCRBJ02	TCRBJ02-07	01	6	0	7	2	1	5	26	37	43	38	48		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGTGPYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCTGGGACAGGGTGGGACGAGCAGTACTTCGGGCCG	CSARAGTGWDEQYF	In	VDJ	1	73	1.643004402351522E-4	1.9319529132791327E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	3	5	2	4	26	39	50	41	54		TCRBV20-01,TCRBV20-or09_02												CSARAGTGWDEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTATGCCAGGCGGGAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CSASMPGGSSYNSPLHF	In	VDJ	1	73	1.643004402351522E-4	1.9319529132791327E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	3	7	2	0	8	0	26	37	-1	45	52		TCRBV20-01,TCRBV20-or09_02												CSASMPGGSSYNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD02-01*02	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGCGGGGGAGCGGGGCTCAAGAGACCCAGTACTTCGGGCCA	CSAPRGSGAQETQYF	In	VDJ	1	73	1.643004402351522E-4	1.9319529132791327E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	6	3	2	9	2	26	35	51	44	53		TCRBV20-01,TCRBV20-or09_02												CSAPRGSGAQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCATCCCCCCAGGGGGCGTAAAAGGATCGGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	73	1.643004402351522E-4		58	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	0	5	9	14	23	35	52	44	66		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTAGACAGGGCCTATGGCTACACCTTCGGTTCG	CASSLDRAYGYTF	In	VDJ	1	73	1.643004402351522E-4	1.9319529132791327E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	4	3	1	24	36	46	39	47	TCRBV24,TCRBV27													CASSLDRAYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATGGAGTAGCAGCAATGAGCAGTTCTTCGGGCCA	CASSLWSSSNEQFF	In	VDJ	1	73	1.643004402351522E-4	1.9319529132791327E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	5	7	6	8	2	24	36	48	44	50		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLWSSSNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCCGTTGACAGGGGGCTCTGAAGAGACCCAGTACTTCGGGCCA	CASSPLTGGSEETQYF	In	VDJ	1	73	1.643004402351522E-4	1.9319529132791327E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	0	3	5	4	18	30	45	35	49	TCRBV07,TCRBV11													CASSPLTGGSEETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGGGACTAGCGGACTTAATGAGCAGTTCTTCGGGCCA	CASSLGTSGLNEQFF	In	VDJ	1	73	1.643004402351522E-4	1.9319529132791327E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	1	5	7	0	4	18	-1	44	34	48	TCRBV05,TCRBV11					01,02								CASSLGTSGLNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCTCCTTGAGGACTCAGCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	74	1.6655113119727757E-4		41	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	9	1	10	7	8	3	24	33	46	41	49		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCCGGGCAGCTAACTATGGCTACACCTTCGGTTCG	CASSSRAANYGYTF	In	VDJ	1	74	1.6655113119727757E-4	1.958418021680217E-4	42	TCRBV24						TCRBJ01	TCRBJ01-02	01	6	8	0	0	4	2	24	36	44	40	46		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRAANYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCGGAAGCAGGGATGGGACAGATACGCAGTATTTTGGCCCA	CAGSRDGTDTQYF	In	VDJ	1	74	1.6655113119727757E-4	1.958418021680217E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	11	4	3	3	5	5	23	29	39	34	44	TCRBV06,TCRBV10													CAGSRDGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTCACGTTTTACCCCCGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	74	1.6655113119727757E-4		44	unresolved						TCRBJ02	TCRBJ02-07	01	2	3	7	3	6	5	22	37	45	43	50	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGGCTAGGGGAGAGACCCAGTACTTCGGGCCA	CSARGARGETQYF	In	VDJ	1	75	1.6880182215940295E-4	1.9848831300813008E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	6	0	4	0	6	26	-1	43	37	49		TCRBV20-01,TCRBV20-or09_02												CSARGARGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACGGATTCCTGGCTGGCTACACCTTCGGTTCG	CATSDGFLAGYTF	In	VDJ	1	75	1.6880182215940295E-4	1.9848831300813008E-4	39	TCRBV24						TCRBJ01	TCRBJ01-02	01	4	1	8	7	1	8	24	38	42	39	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDGFLAGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGTCGGGACAGGGTGCCTACGAGCAGTACTTCGGGCCG	CASSLSSGQGAYEQYF	In	VDJ	1	75	1.6880182215940295E-4	1.9848831300813008E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	2	8	2	24	36	53	44	55	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSSGQGAYEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGACCCCGACAGCTCTTGAACACTGAAGCTTTCTTTGGACAA	CASRPRQLLNTEAFF	In	VDJ	1	75	1.6880182215940295E-4	1.9848831300813008E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	5	0	5	4	23	34	44	39	48	TCRBV06,TCRBV10													CASRPRQLLNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTTCTGTGCCAGCAGCCCCTAATAAGACGTGGACAGGGTTTTTTCCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	75	1.6880182215940295E-4		64	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	1	3	2	13	7	4	17	38	30	45		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD01-01*01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTAGGCACAGGGGGTGCGGAGTGCTTTCTTTGGACAA		Out	VDJ	1	76	1.710525131215283E-4		35	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	3	1	11	4	8	26	32	44	36	52		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCGACTAGCGGGGACAATGAGCAGTTCTTCGGGCCA	CSAPTSGDNEQFF	In	VDJ	1	76	1.710525131215283E-4	2.011348238482385E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	2	3	5	3	0	26	34	-1	37	48		TCRBV20-01,TCRBV20-or09_02												CSAPTSGDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGTCCCTAGCACGTAGCACCGGGGAGCTGTTTTTTGGAGAA	CSARRSLARSTGELFF	In	VDJ	1	76	1.710525131215283E-4	2.011348238482385E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	4	7	4	6	6	26	38	49	44	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSARRSLARSTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAGGACAGGGGTGCGCAATGAGCAGTTCTTCGGGCCA	CASSERTGVRNEQFF	In	VDJ	1	76	1.710525131215283E-4	2.011348238482385E-4	45	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	1	2	6	1	4	23	38	48	39	52		TCRBV06-01,TCRBV06-08												CASSERTGVRNEQFF+TCRBV06-X+TCRBJ02-01	TCRBV06	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTAGACGGCGGCACAGATACGCAGTATTTTGGCCCA	CASSLDGGTDTQYF	In	VDJ	1	76	1.710525131215283E-4	2.011348238482385E-4	42	unresolved						TCRBJ02	TCRBJ02-03	01	0	9	0	1	1	1	18	35	39	36	40	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDGGTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGAAGTGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSQGSGTGELFF	In	VDJ	1	77	1.7330320408365368E-4	2.0378133468834688E-4	42	TCRBV03						TCRBJ02	TCRBJ02-02	01	1	0	10	4	5	0	26	42	-1	47	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGSGTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGAAACGCACAGGGGAATAACCTACAATGAGCAGTTCTTCGGGCCA	CSAETHRGITYNEQFF	In	VDJ	1	77	1.7330320408365368E-4	2.0378133468834688E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	2	2	8	5	26	34	49	42	54		TCRBV20-01,TCRBV20-or09_02												CSAETHRGITYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAACCATTTCGAAAAGACCCAGTACTTCGGGCCA	CASNHFEKTQYF	In	VDJ	1	78	1.7555389504577906E-4	2.064278455284553E-4	36	TCRBV03						TCRBJ02	TCRBJ02-05	01	3	2	8	6	4	2	26	40	46	44	48		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNHFEKTQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAGTGCCCAGTACGAGCAGTACTTCGGGCCG	CASSQSAQYEQYF	In	VDJ	1	78	1.7555389504577906E-4	2.064278455284553E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	5	4	6	0	26	41	-1	47	50		TCRBV03-01,TCRBV03-02												CASSQSAQYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTAAAGGCATTCGGGGTCTATGGCTACACCTTCGGTTCG	CASSLKAFGVYGYTF	In	VDJ	1	78	1.7555389504577906E-4	2.064278455284553E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	4	8	3	4	10	1	26	39	54	49	55		TCRBV03-01,TCRBV03-02												CASSLKAFGVYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCGGACTAGCGGGAGGGTCCACAGATACGCAGTATTTTGGCCCA	CASSLGLAGGSTDTQYF	In	VDJ	1	78	1.7555389504577906E-4	2.064278455284553E-4	51	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	1	0	2	2	2	26	39	56	41	58		TCRBV03-01,TCRBV03-02												CASSLGLAGGSTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTACAGGTTAGCAATCAGCCCCAGCATTTTGGTGAT	CSALQVSNQPQHF	In	VDJ	1	78	1.7555389504577906E-4	2.064278455284553E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	4	0	2	1	26	35	42	37	43		TCRBV20-01,TCRBV20-or09_02												CSALQVSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGGGAGACTAGCGGGGTCCAATGAGCAGTTCTTCGGGCCA	CASSLGRLAGSNEQFF	In	VDJ	1	78	1.7555389504577906E-4	2.064278455284553E-4	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	2	3	6	7	2	24	36	54	43	56		TCRBV24-01,TCRBV24-or09_02												CASSLGRLAGSNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCAGAGTCGATTATTAAGCTACGAGCAGTACTTCGGGCCG	CASSQSRLLSYEQYF	In	VDJ	1	78	1.7555389504577906E-4	2.064278455284553E-4	45	unresolved						TCRBJ02	TCRBJ02-07	01	5	4	5	3	0	14	18	-1	33	30	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQSRLLSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCGCCCGAATGGACAGGGGGATGTATTCCACTGAAGCTTTCTTTGGACAA	CASSARMDRGMYSTEAFF	In	VDJ	1	78	1.7555389504577906E-4	2.064278455284553E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	1	4	8	8	18	30	48	38	56	TCRBV05,TCRBV11													CASSARMDRGMYSTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTGAAGGGACCCACGAGCAGTACTTCGGGCCG	CASSEGTHEQYF	In	VDJ	1	78	1.7555389504577906E-4	2.064278455284553E-4	36	unresolved						TCRBJ02	TCRBJ02-07	01	5	0	7	5	4	2	23	34	43	38	45	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGTHEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTCGGGGGCTCCGGGTTGAAGCTTTCTTTGGACAA	CASSFRGLRVEAFF	In	VDJ	1	79	1.778045860079044E-4	2.0907435636856368E-4	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	3	6	0	7	2	7	26	40	48	42	55		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFRGLRVEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAATTGTTATGGGGGGCCAGCCCCAGCATTTTGGTGAT	CSAREIVMGGQPQHF	In	VDJ	1	79	1.778045860079044E-4	2.0907435636856368E-4	45	TCRBV20						TCRBJ01	TCRBJ01-05	01	0	6	0	7	10	0	26	40	-1	50	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREIVMGGQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCCTAATCGGGCTGAAGCTTTCTTTGGACAA	CSARDPNRAEAFF	In	VDJ	1	79	1.778045860079044E-4	2.0907435636856368E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	8	4	6	7	0	26	40	-1	47	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDPNRAEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTCTCACAGGGCTCTGGGAACACTGAAGCTTTCTTTGGACAA	CSVSQGSGNTEAFF	In	VDJ	1	79	1.778045860079044E-4	2.0907435636856368E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	3	1	4	6	26	33	43	37	49		TCRBV20-01,TCRBV20-or09_02												CSVSQGSGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCAAGGAGGGACCCCCTCCACTTTGGGAAC	CASSLSRRDPLHF	In	VDJ	1	79	1.778045860079044E-4	2.0907435636856368E-4	39				TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	6	10	0	13	7	2	24	36	49	43	51	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSRRDPLHF+X+TCRBJ01-06		TCRBD02-01*02	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCCGGTCCGGGCCGTTGAACACTGAAGCTTTCTTTGGACAA	CASSFRSGPLNTEAFF	In	VDJ	1	80	1.800552769700298E-4	2.117208672086721E-4	48	TCRBV12						TCRBJ01	TCRBJ01-01	01	3	8	0	0	7	3	26	40	51	47	54		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFRSGPLNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTCAGCGGGGACAGGGGACGTCGGGGAGCTGTTTTTTGGAGAA	CSARDSAGTGDVGELFF	In	VDJ	1	80	1.800552769700298E-4	2.117208672086721E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	0	2	7	7	4	26	40	57	47	61		TCRBV20-01,TCRBV20-or09_02												CSARDSAGTGDVGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATTCCCCCGCCTGGGTACTCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	80	1.800552769700298E-4		47	TCRBV20						TCRBJ02	TCRBJ02-05	01	4	0	9	1	11	4	26	36	50	47	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCGGACAGGGAACTATGGCTACACCTTCGGTTCG	CASSRTGNYGYTF	In	VDJ	1	80	1.800552769700298E-4	2.117208672086721E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	1	3	2	2	0	24	35	-1	37	45		TCRBV24-01,TCRBV24-or09_02												CASSRTGNYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGTGGACAGATAGAGTGAGTCACGAGCAGTACTTCGGGCCG	CASSLAWTDRVSHEQYF	In	VDJ	1	80	1.800552769700298E-4	2.117208672086721E-4	51				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	5	5	2	12	18	35	43	37	55	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAWTDRVSHEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCAGGACAGGCCGTTGGGAGTAGTACTTCGGGCCG	CASSRTGRWE*YF	Stop	VDJ	1	81	1.8230596793215517E-4		39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	4	11	2	11	26	37	46	39	57		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSRTGRWE*YF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTTCCAGGACGGGCACTGAAGCTTTCTTTGGACAA	CSATSRTGTEAFF	In	VDJ	1	81	1.8230596793215517E-4	2.143673780487805E-4	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	4	1	7	4	6	3	26	36	46	42	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATSRTGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATCGGACTAGTTGGATCACCCCTCCACTTTGGGAAC	CSAIGLVGSPLHF	In	VDJ	1	81	1.8230596793215517E-4	2.143673780487805E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	4	1	8	10	2	5	26	36	45	38	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSAIGLVGSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD02-01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGCGGGAGTACGCAGATACGCAGTATTTTGGCCCA	CSAGREYADTQYF	In	VDJ	1	81	1.8230596793215517E-4	2.143673780487805E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	7	2	4	2	4	26	35	44	37	48		TCRBV20-01,TCRBV20-or09_02												CSAGREYADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAACAGGGGGGGAAACATTCAGTACTTTGGCGCC	CASNRGGNIQYF	In	VDJ	1	81	1.8230596793215517E-4	2.143673780487805E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	7	3	1	22	0	18	23	-1	41	33	59	TCRBV06,TCRBV10													CASNRGGNIQYF+X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGGGTAGCGGGAGAGTTGGGGGAGATACGCAGTATTTTGGCCCA	CSAGGSGRVGGDTQYF	In	VDJ	1	82	1.8455665889428055E-4	2.1701388888888888E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	5	2	5	5	9	26	35	49	40	58		TCRBV20-01,TCRBV20-or09_02												CSAGGSGRVGGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGGCGTTACGGTGGGGGCGGCTGAAGCTTTCTTTGGACAA	CASSLGVTVGAAEAFF	In	VDJ	1	82	1.8455665889428055E-4	2.1701388888888888E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	6	0	6	10	2	18	34	50	44	52	TCRBV07,TCRBV11													CASSLGVTVGAAEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGGGAAGGGGAGACAAGAGACCCAGTACTTCGGGCCA	CASSQGGKGRQETQYF	In	VDJ	1	83	1.868073498564059E-4	2.196603997289973E-4	48	TCRBV03						TCRBJ02	TCRBJ02-05	01	1	5	2	2	6	3	26	42	53	48	56		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGGKGRQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCTCCTACGGGAACACTGAAGCTTTCTTTGGACAA	CASSSYGNTEAFF	In	VDJ	1	83	1.868073498564059E-4	2.196603997289973E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	7	4	9	1	3	3	24	35	41	38	44		TCRBV24-01,TCRBV24-or09_02				01,02								CASSSYGNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCGTCGCCGGACAGGTCCAAGAGACCCAGTACTTCGGGCCA	CSVAGQVQETQYF	In	VDJ	1	84	1.8905804081853129E-4	2.2230691056910568E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	9	1	4	1	7	1	26	31	45	38	46		TCRBV20-01,TCRBV20-or09_02												CSVAGQVQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCTCGACCACTAGAGACAGATACGCAGTATTTTGGCCCA	CSAPRPLETDTQYF	In	VDJ	1	84	1.8905804081853129E-4	2.2230691056910568E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	3	8	3	8	2	26	35	48	43	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPRPLETDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGCATTGACAGGGGGCTTCACTGAAGCTTTCTTTGGACAA	CASSALTGGFTEAFF	In	VDJ	1	84	1.8905804081853129E-4	2.2230691056910568E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	0	4	4	2	24	37	51	41	53		TCRBV24-01,TCRBV24-or09_02												CASSALTGGFTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCTTGTGCTGGGAGAGGGTGGCTACACCTTCGGTTCG	CASSLVLGEGGYTF	In	VDJ	1	84	1.8905804081853129E-4	2.2230691056910568E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	9	2	7	8	4	23	35	48	43	52	TCRBV06,TCRBV10													CASSLVLGEGGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GRGACWCRGCMMTGTATCKCTGYGCCAGCAGCTTGTTGTTGAGCGGGAGGGAATCCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	84	1.8905804081853129E-4		58	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	6	0	0	10	6	20	31	51	41	57	TCRBV07,TCRBV23													X+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAATGAGGCCGCACTTTACAATGAGCAGTTCTTCGGGCCA	CASNEAALYNEQFF	In	VDJ	1	84	1.8905804081853129E-4	2.2230691056910568E-4	42	unresolved			unresolved			TCRBJ02	TCRBJ02-01	01	6	11	1	4	2	8	23	33	39	35	47	TCRBV02,TCRBV09			TCRBD01,TCRBD02										CASNEAALYNEQFF+X+TCRBJ02-01	unresolved	unresolved	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCACAGCTGGACAGGCGAATCCTACGAGCAGTACTTCGGGCCG	CASSHSWTGESYEQYF	In	VDJ	1	85	1.9130873178065667E-4	2.249534214092141E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	4	1	5	4	23	37	49	42	53	TCRBV01,TCRBV23													CASSHSWTGESYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCATGAACCCGGGAGAAAAACTGTTTTTTGGCAGT	CASMNPGEKLFF	In	VDJ	1	85	1.9130873178065667E-4	2.249534214092141E-4	36	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	7	8	3	8	6	0	26	36	-1	42	47		TCRBV03-01,TCRBV03-02												CASMNPGEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD02-01*02	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCTCGGCGCAGGGGATAGATACGCAGTATTTTGGCCCA	CSARASAQGIDTQYF	In	VDJ	1	85	1.9130873178065667E-4	2.249534214092141E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	4	2	5	8	2	26	39	53	47	55		TCRBV20-01,TCRBV20-or09_02												CSARASAQGIDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAATTAAGACAGGGGGCTACGGATACGCAGTATTTTGGCCCA	CASSQLRQGATDTQYF	In	VDJ	1	85	1.9130873178065667E-4	2.249534214092141E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	2	0	6	4	4	23	38	52	42	56	TCRBV01,TCRBV04													CASSQLRQGATDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCTAGGACAGCGCAAGAGACCCAGTACTTCGGGCCA	CATSDSRTAQETQYF	In	VDJ	1	85	1.9130873178065667E-4	2.249534214092141E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	1	5	2	3	2	24	40	49	43	51		TCRBV24-01,TCRBV24-or09_02												CATSDSRTAQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCTCCCGACAGGGAGATGAAAAACTGTTTTTTGGCAGT	CASSRQGDEKLFF	In	VDJ	1	85	1.9130873178065667E-4	2.249534214092141E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	11	2	3	6	6	2	24	31	44	37	46		TCRBV24-01,TCRBV24-or09_02												CASSRQGDEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCGGACAGGGGTGTTTACTGAAGCTTTCTTTGGACAA	CASSRTGVFTEAFF	In	VDJ	1	86	1.9355942274278205E-4	2.2759993224932248E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	2	5	2	5	26	37	48	39	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSRTGVFTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCAAGGGACAGGGACGGAGACCCAGTACTTCGGGCCA	CASSQDQGTGTETQYF	In	VDJ	1	86	1.9355942274278205E-4	2.2759993224932248E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	0	3	5	4	3	26	43	56	47	59		TCRBV03-01,TCRBV03-02												CASSQDQGTGTETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAATCCTAACGGGGGTTCAGATACGCAGTATTTTGGCCCA	CSANPNGGSDTQYF	In	VDJ	1	86	1.9355942274278205E-4	2.2759993224932248E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	8	2	4	7	2	26	36	49	43	51		TCRBV20-01,TCRBV20-or09_02												CSANPNGGSDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCATCAGGACATGCAGAGACCCAGTACTTCGGGCCA	CSARASGHAETQYF	In	VDJ	1	86	1.9355942274278205E-4	2.2759993224932248E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	1	6	4	7	3	26	37	49	44	52		TCRBV20-01,TCRBV20-or09_02												CSARASGHAETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTGAAGGGGAGCTCCTACGAGCAGTACTTCGGGCCG	CSALKGSSYEQYF	In	VDJ	1	86	1.9355942274278205E-4	2.2759993224932248E-4	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	5	5	2	0	4	2	26	35	44	39	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSALKGSSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAGGGCCCGCCGGAAGTCATCTACGAGCAGTACTTCGGGCCG	CASSQEGPPEVIYEQYF	In	VDJ	1	86	1.9355942274278205E-4	2.2759993224932248E-4	51				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	8	0	3	0	14	18	-1	39	35	53	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQEGPPEVIYEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCTCCGCGAGGGTGAACACTGAAGCTTTCTTTGGACAA	CASSARVNTEAFF	In	VDJ	1	86	1.9355942274278205E-4	2.2759993224932248E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	7	11	0	0	5	0	23	32	-1	37	42	TCRBV09,TCRBV21													CASSARVNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCGGGGCTAGCGGGTACTCCGCCTACAATGAGCAGTTCTTCGGGCCA	CASSRGASGYSAYNEQFF	In	VDJ	1	87	1.958101137049074E-4	2.302464430894309E-4	54	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	4	4	2	6	7	26	39	53	45	60		TCRBV03-01,TCRBV03-02				01,02								CASSRGASGYSAYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGGACAGGGGCTGAAAAACTGTTTTTTGGCAGT	CSASGTGAEKLFF	In	VDJ	1	87	1.958101137049074E-4	2.302464430894309E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	2	7	1	1	26	37	48	38	49		TCRBV20-01,TCRBV20-or09_02												CSASGTGAEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGGGCAGGGGGGCGATACGCAGTATTTTGGCCCA	CASSGQGGDTQYF	In	VDJ	1	87	1.958101137049074E-4	2.302464430894309E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	1	6	2	2	24	37	46	39	48		TCRBV24-01,TCRBV24-or09_02												CASSGQGGDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGACCTAGGGTGGCTTAATCAGCCCCAGCATTTTGGTGAT	CASSQDLGWLNQPQHF	In	VDJ	1	87	1.958101137049074E-4	2.302464430894309E-4	48							TCRBJ01	TCRBJ01-05	01	0	5	3	4	3	6	18	35	42	38	48	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDLGWLNQPQHF+X+TCRBJ01-05			TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGAAAGACAGGGTTTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	88	1.9806080466703278E-4		41	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	3	1	3	2	26	37	47	40	49		TCRBV12-03,TCRBV12-04,TCRBV12-05												X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCGTAGCTTTGCAGGGAATGGGGGAGCTGTTTTTTGGAGAA	CASSVALQGMGELFF	In	VDJ	1	88	1.9806080466703278E-4	2.328929539295393E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	3	8	10	4	26	37	52	47	56	TCRBV12,TCRBV21													CASSVALQGMGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCACTGGGTGAGCCAAGAGACCCAGTACTTCGGGCCA	CSAHWVSQETQYF	In	VDJ	1	88	1.9806080466703278E-4	2.328929539295393E-4	39	TCRBV20						TCRBJ02	TCRBJ02-05	01	6	0	9	1	5	4	26	34	42	39	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAHWVSQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGGCTAGCGGGAGTTATACGCAGTATTTTGGCCCA	CSATASGSYTQYF	In	VDJ	1	88	1.9806080466703278E-4	2.328929539295393E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	4	2	7	3	2	26	36	49	39	51		TCRBV20-01,TCRBV20-or09_02												CSATASGSYTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAGGTCAGCAGTAAATTACGAGCAGTACTTCGGGCCG	CASSERSAVNYEQYF	In	VDJ	1	88	1.9806080466703278E-4	2.328929539295393E-4	45	TCRBV06						TCRBJ02	TCRBJ02-07	01	2	4	5	4	4	8	23	38	45	42	53		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSERSAVNYEQYF+TCRBV06-X+TCRBJ02-07	TCRBV06		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGATTAGCGGGAGGGCCTAACTAGAGCAGTTCTTCGGGCCA		Out	VDJ	1	88	1.9806080466703278E-4		41	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	5	0	10	2	8	19	27	40	29	48	TCRBV05,TCRBV11,TCRBV12													X+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAATCGGGACAGGGGAGCTTTCTTTGGACAA	CSANRDRGAFF	In	VDJ	1	89	2.0031149562915816E-4	2.355394647696477E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	2	10	5	0	26	34	-1	39	49		TCRBV20-01,TCRBV20-or09_02												CSANRDRGAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAGGGACTAGGGGAGAATGAGCAGTTCTTCGGGCCA	CSAKGLGENEQFF	In	VDJ	1	89	2.0031149562915816E-4	2.355394647696477E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	8	7	3	5	26	34	45	37	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSAKGLGENEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTGGACAGGGGGGGATACGCAGTATTTTGGCCCA	CSAWTGGDTQYF	In	VDJ	1	89	2.0031149562915816E-4	2.355394647696477E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	1	6	2	1	26	34	46	36	47		TCRBV20-01,TCRBV20-or09_02												CSAWTGGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACACGATCCTGCTAGGGGTCCAGGGCAGTTCTTCGGGCCA	CSARHDPARGPGQFF	In	VDJ	1	89	2.0031149562915816E-4	2.355394647696477E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	5	2	12	12	6	26	38	55	50	61		TCRBV20-01,TCRBV20-or09_02												CSARHDPARGPGQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGAGGGGTACCAGCCCCAGCATTTTGGTGAT	CSARGEGYQPQHF	In	VDJ	1	89	2.0031149562915816E-4	2.355394647696477E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	9	0	7	0	4	26	-1	46	39	50		TCRBV20-01,TCRBV20-or09_02												CSARGEGYQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*02	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGGGACAGGGGTGGGGTGGCTACACCTTCGGTTCG	CASRGQGWGGYTF	In	VDJ	1	89	2.0031149562915816E-4	2.355394647696477E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	2	7	0	5	24	-1	45	35	50		TCRBV24-01,TCRBV24-or09_02												CASRGQGWGGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCTCGAACAGGGGGCAATTGAAAAACTGTTTTTTGGCAGT	CASSLEQGAIEKLFF	In	VDJ	1	89	2.0031149562915816E-4	2.355394647696477E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	0	7	5	3	18	30	44	35	47	TCRBV07,TCRBV11													CASSLEQGAIEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCTCTCGGCGGGGGTTGGGACGAGCAGTACTTCGGGCCG	CASSPLGGGWDEQYF	In	VDJ	1	90	2.025621865912835E-4	2.381859756097561E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	7	2	5	8	5	26	37	52	45	57		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPLGGGWDEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCCCCCCCCCAGGGGGCCAGATACGCAGTATTTTGGCCCA	CSASPPPRGPDTQYF	In	VDJ	1	90	2.025621865912835E-4	2.381859756097561E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	0	4	9	0	26	37	-1	46	54		TCRBV20-01,TCRBV20-or09_02												CSASPPPRGPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCGGAACGACTGGGACAGGGGGGGAAAAACTGTTTTTTGGCAGT	CASGTTGTGGEKLFF	In	VDJ	1	90	2.025621865912835E-4	2.381859756097561E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	11	0	1	8	11	1	24	31	53	42	54		TCRBV24-01,TCRBV24-or09_02												CASGTTGTGGEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTCCAGGGGGTGTCTGGAAACACCATATATTTTGGAGAG	CASSVQGVSGNTIYF	In	VDJ	1	90	2.025621865912835E-4	2.381859756097561E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	4	1	1	1	2	23	37	45	38	47	TCRBV09,TCRBV21													CASSVQGVSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCCACAGGGTCGGGTTCTGGAAACACCATATATTTTGGAGAG	CASSPTGSGSGNTIYF	In	VDJ	1	91	2.048128775534089E-4	2.408324864498645E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	3	3	1	4	6	26	37	47	41	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPTGSGSGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCTCAGACAGGGAGGTACCTATTTTGGCTACACCTTCGGTTCG	CASSLRQGGTYFGYTF	In	VDJ	1	91	2.048128775534089E-4	2.408324864498645E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	3	7	4	12	26	38	49	42	61		TCRBV12-03,TCRBV12-04												CASSLRQGGTYFGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGGGGGCACACAGATACGCAGTATTTTGGCCCA	CSASGGHTDTQYF	In	VDJ	1	91	2.048128775534089E-4	2.408324864498645E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	8	1	2	0	2	26	-1	44	37	46		TCRBV20-01,TCRBV20-or09_02												CSASGGHTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCCACAAGCAGGGGGGAGATACGCAGTATTTTGGCCCA	CAHKQGGDTQYF	In	VDJ	1	91	2.048128775534089E-4	2.408324864498645E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	11	4	1	5	6	1	23	29	42	35	43	TCRBV06,TCRBV10													CAHKQGGDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTATGGGGGACCCCGGGAAAGGGGCTACACCGGGGAGCTGTTTTTTGGAGAA	CASSYGGPRERGYTGELFF	In	VDJ	1	91	2.048128775534089E-4	2.408324864498645E-4	57	unresolved						TCRBJ02	TCRBJ02-02	01	4	0	7	3	4	15	18	31	40	35	55	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGGPRERGYTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGGACAGTTGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	92	2.0706356851553427E-4		40	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	5	3	0	4	24	-1	43	37	47		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGAACAGCCCCGGGGGGCGAGCAGTACTTCGGGCCG	CASRTAPGGEQYF	In	VDJ	1	92	2.0706356851553427E-4	2.434789972899729E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	8	1	6	8	0	23	34	-1	42	49	TCRBV02,TCRBV12													CASRTAPGGEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCATGAGGGACCCGTTAGAGAGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	93	2.0931425947765965E-4		50	unresolved						TCRBJ02	TCRBJ02-07	01	3	0	7	2	3	11	23	37	45	40	56	TCRBV01,TCRBV04,TCRBV07,TCRBV17			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCGGGAGGGCGGGGGGCGCCAAAAACATTCAGTACTTCGGCGCC	CSAPGRAGGAKNIQYF	In	VDJ	1	93	2.0931425947765965E-4	2.461255081300813E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	6	7	1	1	10	1	26	34	52	44	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPGRAGGAKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTAAACAGGGGAATAATGAAAAACTGTTTTTTGGCAGT	CASSKQGNNEKLFF	In	VDJ	1	93	2.0931425947765965E-4	2.461255081300813E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	2	4	2	2	22	34	43	36	45	TCRBV02,TCRBV12													CASSKQGNNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGAGGACAGGGGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	93	2.0931425947765965E-4		38	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	11	1	2	1	2	1	24	31	42	33	43		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCACAGGGGGTAGGGGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPQGVGAGANVLTF	In	VDJ	1	93	2.0931425947765965E-4	2.461255081300813E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	3	1	2	2	6	18	30	40	32	46	TCRBV07,TCRBV11													CASSPQGVGAGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGCCGGGACAGGGGTCGAGCAGTACTTCGGGCCG	CSAAGTGVEQYF	In	VDJ	1	94	2.11564950439785E-4	2.487720189701897E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	2	6	4	1	26	34	48	38	49		TCRBV20-01,TCRBV20-or09_02												CSAAGTGVEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGGGCGCTGTACAATGAGCAGTTCTTCGGGCCA	CSASGALYNEQFF	In	VDJ	1	94	2.11564950439785E-4	2.487720189701897E-4	39	TCRBV20						TCRBJ02	TCRBJ02-01	01	3	7	0	4	1	4	26	37	43	38	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASGALYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCAACGGACTAGCGGGACCCCCGGTGGTCTTCGGGCCA	CASSNGLAGPPVVF	In	VDJ	1	94	2.11564950439785E-4	2.487720189701897E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	1	3	17	3	10	18	30	45	33	55	TCRBV07,TCRBV11													CASSNGLAGPPVVF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCTTGGCGGAGGGCACCTACGAGCAGTACTTCGGGCCG	CASSLAEGTYEQYF	In	VDJ	1	94	2.11564950439785E-4	2.487720189701897E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	10	0	2	6	2	20	31	43	37	45	TCRBV11,TCRBV23													CASSLAEGTYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTCTTTACTTCTGTGCCAGCAGTTTGCTATTTGGCAGGGGACTAGCGGGAGAGCTTGCGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	95	2.1381564140191038E-4		62	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	0	2	5	14	7	13	25	53	39	60		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAACAGTCGCCGAGCGGGAGGGTTTCTAGCACAGATACGCAGTATTTTGGCCCA	CASSQQSPSGRVSSTDTQYF	In	VDJ	1	95	2.1381564140191038E-4	2.514185298102981E-4	60	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	6	0	0	9	5	21	36	55	45	60	TCRBV01,TCRBV04													CASSQQSPSGRVSSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTATCCCCCGGGTTCACAACCGGGGAGCTGTTTTTTGGAGAA	CASSLSPGFTTGELFF	In	VDJ	1	95	2.1381564140191038E-4	2.514185298102981E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	8	4	5	6	6	19	33	43	39	49	TCRBV05,TCRBV11					01,02								CASSLSPGFTTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGGAGGGTGCTGAAGCTTTCTTTGGACAA	CASREGAEAFF	In	VDJ	1	96	2.1606633236403576E-4	2.5406504065040653E-4	33	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	10	0	6	0	2	26	-1	43	37	45		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASREGAEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*02	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCTGGGTCGGGAGTGACAATGAGCAGTTCTTCGGGCCA	CASSSWVGSDNEQFF	In	VDJ	1	96	2.1606633236403576E-4	2.5406504065040653E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	2	5	7	2	26	39	52	46	54		TCRBV12-03,TCRBV12-04												CASSSWVGSDNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGGGCCGGGACTAGAAGAGACCCAGTACTTCGGGCCA	CSAGPGLEETQYF	In	VDJ	1	96	2.1606633236403576E-4	2.5406504065040653E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	0	8	3	6	0	26	34	-1	40	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSAGPGLEETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTGGAATCCGTCAGACCAACCCTACGAGCAGTACTTCGGGCCG	CASSWNPSDQPYEQYF	In	VDJ	1	96	2.1606633236403576E-4	2.5406504065040653E-4	48	TCRBV24						TCRBJ02	TCRBJ02-07	01	6	1	8	2	1	15	24	36	40	37	55		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWNPSDQPYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGGAGCGCACCTAGCACAGATACGCAGTATTTTGGCCCA	CASSVGSAPSTDTQYF	In	VDJ	1	96	2.1606633236403576E-4	2.5406504065040653E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	6	6	0	2	5	23	39	45	41	50	TCRBV09,TCRBV21					unresolved								CASSVGSAPSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTAGAGAGAGCTCCTACGAGCAGTATTTCGGGCCG	CASSFRESSYEQYF	In	VDJ	1	97	2.1831702332616114E-4	2.567115514905149E-4	42	TCRBV12						TCRBJ02	TCRBJ02-07	01	3	4	5	16	19	3	26	40	62	59	65		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFRESSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCACAGCCCGGCGGAACCTATGGCTACACCTTCGGTTCG	CASSPQPGGTYGYTF	In	VDJ	1	97	2.1831702332616114E-4	2.567115514905149E-4	45	TCRBV03						TCRBJ01	TCRBJ01-02	01	4	3	5	4	1	11	26	39	44	40	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPQPGGTYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTACGGACAGGGGTACACTGAAGCTTTCTTTGGACAA	CASSYGQGYTEAFF	In	VDJ	1	97	2.1831702332616114E-4	2.567115514905149E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	2	3	3	1	26	38	50	41	51		TCRBV03-01,TCRBV03-02												CASSYGQGYTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGCGGGACTAGCGGGAGTCGCGAGCAGTTCTTCGGGCCA	CSASGGTSGSREQFF	In	VDJ	1	97	2.1831702332616114E-4	2.567115514905149E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	0	2	10	4	4	26	37	55	41	59		TCRBV20-01,TCRBV20-or09_02												CSASGGTSGSREQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATGGGGGACTTCCAATCCAGGCATTCAGTACTTCGGCGCC	CASSLWGTSNPGIQYF	In	VDJ	1	97	2.1831702332616114E-4	2.567115514905149E-4	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	6	0	10	9	6	11	24	36	48	42	59		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLWGTSNPGIQYF+TCRBV24-X+TCRBJ02-04	TCRBV24	TCRBD02-01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTCTCAGGGGGAATTGGTCGGCTTGAGCAGTTCTTCGGGCCA	CASSLFSGGIGRLEQFF	In	VDJ	1	97	2.1831702332616114E-4	2.567115514905149E-4	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	1	9	7	12	24	36	50	43	62		TCRBV24-01,TCRBV24-or09_02												CASSLFSGGIGRLEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACTTAGGGTCGAACACTGAAGCTTTCTTTGGACAA	CASSQDLGSNTEAFF	In	VDJ	1	98	2.205677142882865E-4	2.593580623306233E-4	45	TCRBV03						TCRBJ01	TCRBJ01-01	01	0	5	3	1	3	2	26	43	50	46	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDLGSNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCGGACTAGCGGAAGGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	98	2.205677142882865E-4		49	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	4	1	5	1	2	3	26	39	51	41	54		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD02-01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGTCACGATACCCGCCGGAAAAACTGTTTTTTGGCAGT	CASSLSRYPPEKLFF	In	VDJ	1	98	2.205677142882865E-4	2.593580623306233E-4	45	unresolved						TCRBJ01	TCRBJ01-04	01	3	2	8	8	5	9	18	32	39	37	48	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSRYPPEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCRGCYGTGTATKTYTGTGCCAGCAGCTTATTGGCGATAGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLLAIGSGANVLTF	In	VDJ	1	100	2.2506909621253726E-4	2.646510840108401E-4	51	unresolved						TCRBJ02	TCRBJ02-06	01	2	5	4	0	8	0	18	33	-1	41	44	TCRBV11,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLLAIGSGANVLTF+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCCCCGGACTCCTCTCGAGGAGCAGTTCTTCGGGCCA	CASSPRTPLEEQFF	In	VDJ	1	101	2.273197871746626E-4	2.672975948509485E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	1	10	10	4	9	19	31	40	35	49	TCRBV07,TCRBV11					01,02								CASSPRTPLEEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGCTTTAGCGGGAGCGTACAATGAGCAGTTCTTCGGGCCA	CASSVALAGAYNEQFF	In	VDJ	1	101	2.273197871746626E-4	2.672975948509485E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	2	4	7	2	24	36	52	43	54	TCRBV09,TCRBV21													CASSVALAGAYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCTCCACGGCGGGGGCTCAGGAAGCTTTCTTTGGACAA	CASSSTAGAQEAFF	In	VDJ	1	101	2.273197871746626E-4	2.672975948509485E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	7	2	8	6	5	24	36	49	42	54	TCRBV12,TCRBV21													CASSSTAGAQEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGGCCCAATTTCGAGAACACTGAAGCTTTCTTTGGACAA	CASRPNFENTEAFF	In	VDJ	1	102	2.29570478136788E-4	2.699441056910569E-4	42	TCRBV03						TCRBJ01	TCRBJ01-01	01	6	2	8	1	10	0	26	37	-1	47	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPNFENTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTGGCAAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCATCTGGATATTCGGAGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	102	2.29570478136788E-4		40				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	10	2	6	11	0	41	51	-1	62	66	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												X+X+TCRBJ02-03		TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGAAACGACAGACCCCCGCACGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	102	2.29570478136788E-4		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	11	2	5	7	12	11	22	25	42	37	53	TCRBV01,TCRBV17													X+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAATGGGCGGGAGAGGCAGATACGCAGTATTTTGGCCCA	CSAKWAGEADTQYF	In	VDJ	1	103	2.3182116909891337E-4	2.7259061653116533E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	7	2	4	5	3	26	36	48	41	51		TCRBV20-01,TCRBV20-or09_02												CSAKWAGEADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGAACCGGGACGGGAAGAGAGGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	103	2.3182116909891337E-4		49	TCRBV20						TCRBJ01	TCRBJ01-01	01	1	0	7	6	6	11	26	39	50	45	61		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCCGGACAGGCGCTCCTACGAGCAGTACTTCGGGCCG	CASSPDRRSYEQYF	In	VDJ	1	103	2.3182116909891337E-4	2.7259061653116533E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	4	0	3	2	24	35	45	38	47		TCRBV24-01,TCRBV24-or09_02												CASSPDRRSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGTAATGGGTACGCAGTATTTTGGCCCA	CASSQEVMGTQYF	In	VDJ	1	104	2.3407186006103875E-4	2.752371273712737E-4	39	TCRBV03						TCRBJ02	TCRBJ02-03	01	0	0	9	8	6	0	26	43	-1	49	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEVMGTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCTCTTTACTCGGACGCACTTAATTCACCCCTCCACTTTGGGAAC	CSARALYSDALNSPLHF	In	VDJ	1	104	2.3407186006103875E-4	2.752371273712737E-4	51	TCRBV20						TCRBJ01	TCRBJ01-06	01	1	1	7	6	10	5	26	39	53	49	58		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARALYSDALNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTCCGAATGGTGCAAATCGAGGGTATTTTGGCCCA	CASSPNGANRGYF	In	VDJ	1	104	2.3407186006103875E-4	2.752371273712737E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	11	1	14	16	0	23	35	-1	51	55	TCRBV24,TCRBV27													CASSPNGANRGYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGATCCCCCAGGACAGGGGGCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	104	2.3407186006103875E-4		44				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	0	5	8	0	18	29	-1	37	48	TCRBV05,TCRBV11,TCRBV12	TCRBV05-03,TCRBV11-03,TCRBV12-02												X+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCTAGCGAGCTACAATGAGCAGTTCTTCGGGCCA	CSASLASYNEQFF	In	VDJ	1	105	2.363225510231641E-4	2.778836382113821E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	6	3	1	2	26	37	44	38	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSASLASYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATTTACGAGGGAGCAGTACTTCGGGCCG	CASSEFTREQYF	In	VDJ	1	105	2.363225510231641E-4	2.778836382113821E-4	36	TCRBV06			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	11	1	7	5	0	23	38	-1	43	47		TCRBV06-01,TCRBV06-08												CASSEFTREQYF+TCRBV06-X+TCRBJ02-07	TCRBV06	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTGGGAACTAGCGGGGGTAGCACAGATACGCAGTATTTTGGCCCA	CASSLGTSGGSTDTQYF	In	VDJ	1	105	2.363225510231641E-4	2.778836382113821E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	3	2	0	4	1	18	32	47	36	48	TCRBV07,TCRBV11													CASSLGTSGGSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGCCAGTGAAAAACTGTTTTTTGGCAGT	CASSQASEKLFF	In	VDJ	1	106	2.3857324198528948E-4	2.805301490514905E-4	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	5	7	3	0	26	40	-1	43	46		TCRBV03-01,TCRBV03-02												CASSQASEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGGATCGGGTCCTGAGGATGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	106	2.3857324198528948E-4		50	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	8	4	3	4	11	23	37	45	41	56	TCRBV01,TCRBV04					01,02								X+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGAGACTAGCTCTTACAATGAGCAGTTCTTCGGGCCA	CSASETSSYNEQFF	In	VDJ	1	107	2.4082393294741486E-4	2.8317665989159894E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	2	7	4	3	3	26	37	47	40	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSASETSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGTTCTGAGGGGGGAAAAACTGTTTTTTGGCAGT	CASSLVLRGEKLFF	In	VDJ	1	107	2.4082393294741486E-4	2.8317665989159894E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	5	1	8	5	0	18	34	-1	39	45	TCRBV07,TCRBV11													CASSLVLRGEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTAGGACAGGGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CSA*DRVNTGELFF	Stop	VDJ	1	108	2.4307462390954024E-4		42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	3	1	2	1	26	35	45	37	46		TCRBV20-01,TCRBV20-or09_02												CSA*DRVNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCGACAACAGGGGAATCAGCCCCAGCATTTTGGTGAT	CASSRQQGNQPQHF	In	VDJ	1	108	2.4307462390954024E-4	2.858231707317073E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	2	4	5	0	24	36	-1	41	48		TCRBV24-01,TCRBV24-or09_02												CASSRQQGNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTGGGACAGTGGAATGAAAAACTGTTTTTTGGCAGT	CASSLGQWNEKLFF	In	VDJ	1	108	2.4307462390954024E-4	2.858231707317073E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	5	5	0	3	19	-1	40	33	43	TCRBV07,TCRBV11													CASSLGQWNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTCACAGGGGAGGGGCCAAAAACATTCAGTACTTCGGCGCC	CASSHRGGAKNIQYF	In	VDJ	1	110	2.4757600583379097E-4	2.9111619241192413E-4	45							TCRBJ02	TCRBJ02-04	01	5	3	2	1	1	4	36	48	56	49	60	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHRGGAKNIQYF+X+TCRBJ02-04			TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGAAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSRSGSTDTQYF	In	VDJ	1	110	2.4757600583379097E-4	2.9111619241192413E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	6	4	0	2	0	26	39	-1	41	47		TCRBV03-01,TCRBV03-02				01,02								CASSRSGSTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTACGGCTAGGGCAATTCACCCCTCCACTTTGGGAAC	CASSYG*GNSPLHF	Stop	VDJ	1	110	2.4757600583379097E-4		42	unresolved						TCRBJ01	TCRBJ01-06	01	4	5	3	7	6	1	23	36	46	42	47	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYG*GNSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGACCCAGGGGGCCCTACAATGAGCAGTTCTTCGGGCCA	CASRPRGPYNEQFF	In	VDJ	1	110	2.4757600583379097E-4	2.9111619241192413E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	0	2	3	0	23	34	-1	37	45	TCRBV02,TCRBV21													CASRPRGPYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCCCACACCGGGTGGTACTGAAGCTTTCTTTGGACAA	CASSPTPGGTEAFF	In	VDJ	1	111	2.4982669679591635E-4	2.9376270325203255E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	8	4	5	8	4	26	37	49	45	53		TCRBV03-01,TCRBV03-02				01,02								CASSPTPGGTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGACAGGGCTTATGGAAACACCATATATTTTGGAGAG	CSARDRAYGNTIYF	In	VDJ	1	111	2.4982669679591635E-4	2.9376270325203255E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	1	3	3	0	4	26	-1	45	37	49		TCRBV20-01,TCRBV20-or09_02												CSARDRAYGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCCTGACGGTTAGCTCTGGAAACACCATATATTTTGGAGAG	CASSLTVSSGNTIYF	In	VDJ	1	111	2.4982669679591635E-4	2.9376270325203255E-4	45	unresolved						TCRBJ01	TCRBJ01-03	01	5	2	7	0	2	6	18	30	35	32	41	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTVSSGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACTAGCGGGACCCCCAATGAGCAGTTCTTCGGGCCA	CSARTSGTPNEQFF	In	VDJ	1	112	2.5207738775804173E-4	2.964092140921409E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	3	3	6	0	4	26	-1	48	38	52		TCRBV20-01,TCRBV20-or09_02												CSARTSGTPNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGACAGGGTCTAATGAGCAGTTCTTCGGGCCA	CSAGTGSNEQFF	In	VDJ	1	113	2.543280787201671E-4	2.990557249322493E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	7	0	3	26	-1	44	35	47		TCRBV20-01,TCRBV20-or09_02												CSAGTGSNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGCCCGAGTCGCACGAGCAGTACTTCGGGCCG	CASSLSPESHEQYF	In	VDJ	1	114	2.5657876968229244E-4	3.0170223577235774E-4	42				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	11	2	5	9	4	24	36	48	45	52	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSPESHEQYF+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGCGAACCCGACAGTAGCCTAAACTATGGCTACACCTTCGGTTCG	CASSEPDSSLNYGYTF	In	VDJ	1	114	2.5657876968229244E-4	3.0170223577235774E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	5	2	3	7	23	38	46	41	53	TCRBV02,TCRBV21													CASSEPDSSLNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGCGAGCGGGAGGGTCTATGAGCAGTTCTTCGGGCCA	CSARDASGRVYEQFF	In	VDJ	1	115	2.588294606444178E-4	3.043487466124661E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	6	0	8	4	3	26	40	54	44	57		TCRBV20-01,TCRBV20-or09_02												CSARDASGRVYEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCACCAGCAGCCAAGAGTAGCTCGCGGGGGACTCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	116	2.610801516065432E-4		53	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	7	2	1	7	3	23	40	54	47	57	TCRBV01,TCRBV04													X+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATAGTTCCGATACGACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	116	2.610801516065432E-4		47	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	5	8	3	0	10	26	-1	46	43	56		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAAGACCGGATCAGGGTTCGGGGACACTGAAGCTTTCTTTGGACAA	XASKTGSGFGDTEAFF	In	VDJ	2	118	2.6558153353079396E-4	3.1228827913279135E-4	48	unresolved						TCRBJ01	TCRBJ01-01	01	7	4	3	3	9	7	23	33	47	42	54	TCRBV01,TCRBV17			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASKTGSGFGDTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGTAACAGGGCGGGGGAAAAACTGTTTTTTGGCAGT	CASSQGNRAGEKLFF	In	VDJ	2	118	2.6558153353079396E-4	3.1228827913279135E-4	45	unresolved						TCRBJ01	TCRBJ01-04	01	1	3	3	8	3	5	23	39	48	42	53	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGNRAGEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACAAACTACACTACAATGAGCAGTTCTTCGGGCCA	CSARDKLHYNEQFF	In	VDJ	2	118	2.6558153353079396E-4	3.1228827913279135E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	3	9	3	3	2	26	40	47	43	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDKLHYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTCAGCGACAGGGGGCAAACACTGAAGCTTTCTTTGGACAA	CASSQRQGANTEAFF	In	VDJ	2	118	2.6558153353079396E-4	3.1228827913279135E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	0	2	4	1	22	34	48	38	49	TCRBV09,TCRBV12													CASSQRQGANTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGCGAGGACAGGAAACACCATATATTTTGGAGAG	CASSARTGNTIYF	In	VDJ	2	119	2.6783222449291934E-4	3.149347899728997E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	1	6	4	3	0	24	37	-1	40	45		TCRBV24-01,TCRBV24-or09_02												CASSARTGNTIYF+TCRBV24-X+TCRBJ01-03	TCRBV24	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGGRGACWYGGCWSTGTATCTCTGYGCCAGCAGCTTAGTGCCCCAAGAGACCCAGTACTTCGGGCCA	CASSLVPQETQYF	In	VDJ	2	119	2.6783222449291934E-4	3.149347899728997E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	5	8	1	2	4	20	31	36	33	40	TCRBV07,TCRBV23					01,02								CASSLVPQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTGGGACTAGGAGGCTACGAGCAGTACTTCGGGCCG	CASSLGLGGYEQYF	In	VDJ	2	119	2.6783222449291934E-4	3.149347899728997E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	0	8	3	0	4	19	-1	41	33	45	TCRBV07,TCRBV11					01,02								CASSLGLGGYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGACTTTAACAGGGGGCGCATCCACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	120	2.700829154550447E-4		47	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	0	4	6	5	24	35	50	41	55		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCATACAGGAACAGGGACTGGGGGGGGAGCAGTTCTTCGGGCCA	CASIQEQGLGGEQFF	In	VDJ	2	120	2.700829154550447E-4	3.175813008130081E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	10	9	0	10	19	0	24	31	-1	50	57	TCRBV12,TCRBV21													CASIQEQGLGGEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACGGGCAGGGAGCAGAGACCCAGTACTTCGGGCCA	CSANGQGAETQYF	In	VDJ	2	121	2.723336064171701E-4	3.2022781165311654E-4	39	TCRBV20						TCRBJ02	TCRBJ02-05	01	4	4	3	4	5	3	26	36	46	41	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSANGQGAETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTATGGGGAGGATGGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSMGRMAGANVLTF	In	VDJ	2	121	2.723336064171701E-4	3.2022781165311654E-4	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	6	9	1	2	3	4	24	36	45	39	49		TCRBV24-01,TCRBV24-or09_02												CASSMGRMAGANVLTF+TCRBV24-X+TCRBJ02-06	TCRBV24	TCRBD02-01*02	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTGGACGAAGGGTTCGGCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	121	2.723336064171701E-4		47	unresolved						TCRBJ01	TCRBJ01-04	01	6	1	7	3	1	11	24	35	40	36	51	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCAGTTCAGAACACTGAAGCTTTCTTTGGACAA	CSAPVQNTEAFF	In	VDJ	2	122	2.745842973792954E-4	3.2287432249322495E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	5	1	2	4	26	34	39	36	43		TCRBV20-01,TCRBV20-or09_02												CSAPVQNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACCCTCAAGAGACCCAGTACTTCGGGCCA	CSANPQETQYF	In	VDJ	2	122	2.745842973792954E-4	3.2287432249322495E-4	33	TCRBV20						TCRBJ02	TCRBJ02-05	01	4	3	7	2	0	3	26	-1	38	36	41		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSANPQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCGGAGRCTGGGCTAAAAAACATTCARTACTTCGGCGCC	CSASEXGLKNIQYF	In	VDJ	2	122	2.745842973792954E-4	3.2287432249322495E-4	42	TCRBV20			unresolved			TCRBJ02	TCRBJ02-04	01	5	8	0	4	9	2	26	35	48	44	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02										CSASEXGLKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	unresolved	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTAGCGGCGGGGGGACCCGGCACAGATACGCAGTATTTTGGCCCA	CATSDLAAGGPGTDTQYF	In	VDJ	2	123	2.768349883414208E-4	3.255208333333333E-4	54	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	7	1	1	4	5	24	41	53	45	58		TCRBV24-01,TCRBV24-or09_02												CATSDLAAGGPGTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGACTACCCGGGGGAGAGCAGTACTTCGGGCCG	CASSQGLPGGEQYF	In	VDJ	2	124	2.790856793035462E-4	3.2816734417344173E-4	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	8	2	7	7	1	26	42	55	49	56		TCRBV03-01,TCRBV03-02												CASSQGLPGGEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGCTGACAGGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSPLTGANTEAFF	In	VDJ	2	125	2.8133637026567156E-4	3.3081385501355015E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	2	1	4	1	26	39	51	43	52		TCRBV03-01,TCRBV03-02												CASSPLTGANTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCATCCTGGCGGGGGGGCCAGGCGAGCAGTACTTCGGGCCG	CASSILAGGPGEQYF	In	VDJ	2	125	2.8133637026567156E-4	3.3081385501355015E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	7	0	6	6	5	18	30	45	36	50	TCRBV07,TCRBV11													CASSILAGGPGEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAAAAATCATCGAACACTGAAGCTTTCTTTGGACAA	CSAQKSSNTEAFF	In	VDJ	2	126	2.8358706122779694E-4	3.3346036585365856E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	6	1	0	9	26	-1	37	35	46		TCRBV20-01,TCRBV20-or09_02												CSAQKSSNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCTGTTCAGCCAACAGGGGACAAAGCAGTACTTCGGGCCG	CASSQDLFSQQGTKQYF	In	VDJ	2	126	2.8358706122779694E-4	3.3346036585365856E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	3	2	8	12	4	23	40	59	52	63	TCRBV01,TCRBV04													CASSQDLFSQQGTKQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCGCCCTAGCTGGGCTACAATGAGCAGTTCTTCGGGCCA	CATSDPP*LGYNEQFF	Stop	VDJ	2	128	2.880884431520477E-4		48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	4	7	3	6	4	24	38	49	44	53		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDPP*LGYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCTAGCGGGAGGGCCCAAGAGACCCAGTACTTCGGGCCA	CSASPSGRAQETQYF	In	VDJ	2	129	2.9033913411417303E-4	3.4139989837398375E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	4	0	1	2	1	26	37	51	39	52		TCRBV20-01,TCRBV20-or09_02												CSASPSGRAQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCCAGCCGGACACACCTTGGAAGGGGGCAGTACTTCGGGCCG	CASSPSRTHLGRGQYF	In	VDJ	2	129	2.9033913411417303E-4	3.4139989837398375E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	6	9	7	14	18	30	42	37	56	TCRBV07,TCRBV11													CASSPSRTHLGRGQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACCCAACGGACGGGACAGGCGAAGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	130	2.925898250762984E-4		53	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	0	4	1	5	5	26	41	54	46	59		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGTGGACTCTGGAGCTTTCTTTGGACAA	CATSDVDSGAFF	In	VDJ	2	130	2.925898250762984E-4	3.440464092140921E-4	36	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	1	10	10	2	4	24	39	46	41	50		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDVDSGAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGTCCCGACAGGGGGCCTTGGAACATTCAGTACTTCGGCGCC	CASSPDRGPWNIQYF	In	VDJ	2	130	2.925898250762984E-4	3.440464092140921E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	2	0	7	4	5	18	29	43	33	48	TCRBV05,TCRBV11													CASSPDRGPWNIQYF+X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTACCCCTATCCTACAATGAGCAGTTCTTCGGGCCA	CASSQVPLSYNEQFF	In	VDJ	2	131	2.948405160384238E-4	3.4669292005420053E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	4	9	1	5	0	26	42	-1	47	50		TCRBV03-01,TCRBV03-02				01,02								CASSQVPLSYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGCGGATACGGGACAGGCCTACGAGCAGTACTTCGGGCCG	CASSADTGQAYEQYF	In	VDJ	2	131	2.948405160384238E-4	3.4669292005420053E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	4	2	7	0	24	37	-1	44	52		TCRBV24-01,TCRBV24-or09_02												CASSADTGQAYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGCTAGGGGGGCCGTGAACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	131	2.948405160384238E-4		50	unresolved						TCRBJ02	TCRBJ02-03	01	1	5	1	2	2	8	19	34	42	36	50	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATTTGGAGGGGCGAACACTGAAGCTTTCTTTGGACAA	CSARFGGANTEAFF	In	VDJ	2	132	2.9709120700054917E-4	3.4933943089430895E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	10	0	1	3	2	26	38	47	41	49		TCRBV20-01,TCRBV20-or09_02												CSARFGGANTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCAACCATTACTAGCGGGAGGACAGGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	132	2.9709120700054917E-4		55				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	3	1	5	12	4	24	36	60	48	64	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												X+X+TCRBJ02-05		TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAGGGTAGCGGGGCATGGAATGAGCAGTTCTTCGGGCCA	CASSQEGSGAWNEQFF	In	VDJ	2	133	2.9934189796267455E-4	3.5198594173441736E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	3	7	3	5	23	40	51	43	56	TCRBV01,TCRBV04													CASSQEGSGAWNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATTCTCTAGTCGACCGGAGTGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	133	2.9934189796267455E-4		55	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	4	8	2	4	13	26	40	48	44	61		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD02-01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTGGCGGGCCTCCTGACTTTGGAGAG	CASSQGGGPPDF	In	VDJ	2	134	3.015925889247999E-4	3.546324525745257E-4	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	1	7	4	19	3	9	26	42	50	45	59		TCRBV03-01,TCRBV03-02				01,02								CASSQGGGPPDF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD02-01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTCTGTGACTAGCCGTCAACTTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSSVTSRQLSSYNEQFF	In	VDJ	2	134	3.015925889247999E-4	3.546324525745257E-4	57	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	7	0	4	11	18	31	42	35	53	TCRBV05,TCRBV11					01,02								CASSSVTSRQLSSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACCGGGATAGTAGCGGGAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	135	3.038432798869253E-4		50	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	5	2	0	10	0	26	38	-1	48	57		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCTACTAGCGGGAGTGACGATGAGCAGTTCTTCGGGCCA	CSAPTSGSDDEQFF	In	VDJ	2	135	3.038432798869253E-4	3.5727896341463414E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	3	2	8	3	5	26	35	49	38	54		TCRBV20-01,TCRBV20-or09_02												CSAPTSGSDDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAGGATTTGGAGCGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CSAREGFGAANTGELFF	In	VDJ	2	136	3.0609397084905063E-4	3.5992547425474255E-4	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	6	5	0	9	0	26	40	-1	49	54		TCRBV20-01,TCRBV20-or09_02				01,02								CSAREGFGAANTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTAGGGACAAGGAACTCCCCCGGGGAGCTGTTTTTTGGAGAA	CASSLGTRNSPGELFF	In	VDJ	2	137	3.08344661811176E-4	3.6257198509485097E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	6	6	3	10	26	38	47	41	57		TCRBV03-01,TCRBV03-02												CASSLGTRNSPGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTACTCGGGGGGGAGAGGCAGATACGCAGTATTTTGGCCCA	CSTRGGEADTQYF	In	VDJ	2	137	3.08344661811176E-4	3.6257198509485097E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	8	0	4	3	5	26	32	43	35	48		TCRBV20-01,TCRBV20-or09_02												CSTRGGEADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACTCTCGGACTAGCGGGAACTCCTACAATGAGCAGTTCTTCGGGCCA	CSANSRTSGNSYNEQFF	In	VDJ	2	137	3.08344661811176E-4	3.6257198509485097E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	1	3	0	6	1	26	36	54	42	55		TCRBV20-01,TCRBV20-or09_02												CSANSRTSGNSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACAGTAGGCTACAATGAGCAGTTCTTCGGGCCA	CSATVGYNEQFF	In	VDJ	2	137	3.08344661811176E-4	3.6257198509485097E-4	36	TCRBV20						TCRBJ02	TCRBJ02-01	01	4	4	5	3	0	4	26	-1	39	36	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATVGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGACTCGGGACAGGGTACTACAATGAGCAGTTCTTCGGGCCA	CASRLGTGYYNEQFF	In	VDJ	2	137	3.08344661811176E-4	3.6257198509485097E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	3	4	2	23	34	47	38	49	TCRBV06,TCRBV10													CASRLGTGYYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCGGGTCAAGGTCAGCGGGAGGGTCCTGGGAGACCCAGTACTTCGGGCCA	CSGSRSAGGSWETQYF	In	VDJ	2	138	3.105953527733014E-4	3.6521849593495933E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	9	6	0	5	12	6	26	31	53	43	59		TCRBV20-01,TCRBV20-or09_02												CSGSRSAGGSWETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCGCGAGGGGGACTAGCGGCGGGAATACGCAGTATTTTGGCCCA	CSARAARGTSGGNTQYF	In	VDJ	2	138	3.105953527733014E-4	3.6521849593495933E-4	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	0	5	7	8	5	26	39	58	47	63		TCRBV20-01,TCRBV20-or09_02				01,02								CSARAARGTSGGNTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCGGTGCAGGGGTTAGAGAGACCCAGTACTTCGGGCCA	CASGAGVRETQYF	In	VDJ	2	138	3.105953527733014E-4	3.6521849593495933E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	8	4	2	4	4	4	23	32	42	36	46	TCRBV06,TCRBV10													CASGAGVRETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCGGAGTTGAAGCTTTCTTTGGACAA	CSARGGVEAFF	In	VDJ	2	139	3.1284604373542677E-4	3.6786500677506775E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	7	5	7	0	3	26	-1	43	39	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGGVEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCAAGGTCGGGGGGCCTACGAGCAGTACTTCGGGCCG	CASSQGRGAYEQYF	In	VDJ	2	142	3.195981166218029E-4	3.7580453929539294E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	1	2	6	0	18	30	-1	36	43	TCRBV07,TCRBV11													CASSQGRGAYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACGGCAGGCGAATGAAAAACTGTTTTTTGGCAGT	CASSQRQANEKLFF	In	VDJ	2	143	3.218488075839283E-4	3.7845105013550135E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	4	5	3	2	26	41	48	44	50		TCRBV03-01,TCRBV03-02												CASSQRQANEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGGACACGGACCTACGAGCAGTACTTCGGGCCG	CASSQGTRTYEQYF	In	VDJ	2	143	3.218488075839283E-4	3.7845105013550135E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	6	2	1	4	26	40	47	41	51		TCRBV03-01,TCRBV03-02												CASSQGTRTYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCGGACAAATTTGGAGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	144	3.240994985460536E-4		40	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	1	6	4	0	8	19	-1	33	28	41	TCRBV05,TCRBV07													X+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGTCGGACCGGGCGGGAGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSQVGPGGRAYNEQFF	In	VDJ	2	145	3.26350189508179E-4	3.8374407181571813E-4	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	7	0	2	9	0	23	39	-1	48	57	TCRBV01,TCRBV04													CASSQVGPGGRAYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCCGATTGGGGGCTCCGAGCAGTACTTCGGGCCG	CASSPIGGSEQYF	In	VDJ	2	146	3.286008804703044E-4	3.8639058265582655E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	6	0	6	7	2	24	35	48	42	50		TCRBV24-01,TCRBV24-or09_02												CASSPIGGSEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGGTGGGACTAGCGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSLSVGLAGYNEQFF	In	VDJ	2	146	3.286008804703044E-4	3.8639058265582655E-4	51				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	4	3	8	0	24	36	-1	44	56	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01				01,02								CASSLSVGLAGYNEQFF+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GRGACWCGGCMCTKTATCTYTGCGCCAGCAGCCAAGGGACAAGCTCCTACGAGCAGTACTTCGGGCCG	CASSQGTSSYEQYF	In	VDJ	2	146	3.286008804703044E-4	3.8639058265582655E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	6	0	3	2	19	31	40	34	42	TCRBV05,TCRBV23													CASSQGTSSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGGGGGACACCCGGACGAGACCCAGTACTTCGGGCCA	CASSLGGHPDETQYF	In	VDJ	2	147	3.3085157143242976E-4	3.8903709349593496E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	6	5	5	7	24	36	47	41	54		TCRBV24-01,TCRBV24-or09_02												CASSLGGHPDETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGACAGGGAACGGCTACACCTTCGGTTCG	CSARDGTGNGYTF	In	VDJ	2	148	3.3310226239455514E-4	3.916836043360434E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	3	8	1	3	26	40	50	41	53		TCRBV20-01,TCRBV20-or09_02												CSARDGTGNGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCGATTAGAGTACAATGAGCAGTTCTTCGGGCCA	XASSRLEYNEQFF	In	VDJ	2	149	3.353529533566805E-4	3.9433011517615174E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	5	8	4	3	2	23	36	42	39	44	TCRBV01,TCRBV07,TCRBV17					01,02								XASSRLEYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTACGGACAGGGGACGAACACCATATATTTTGGAGAG	CASSYGQGTNTIYF	In	VDJ	2	149	3.353529533566805E-4	3.9433011517615174E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	1	2	7	3	3	26	38	50	41	53		TCRBV03-01,TCRBV03-02												CASSYGQGTNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATACGTATAATTCACCCCTCCACTTTGGGAAC	CASSQDTYNSPLHF	In	VDJ	2	151	3.398543352809312E-4	3.9962313685636857E-4	42	unresolved						TCRBJ01	TCRBJ01-06	01	0	3	7	4	1	1	23	40	43	41	44	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDTYNSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTCGGGACAGGGGGCTCGGTCAGCCCCAGCATTTTGGTGAT	CSATRDRGLGQPQHF	In	VDJ	2	152	3.421050262430566E-4	4.02269647696477E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	0	6	3	4	26	36	51	39	55		TCRBV20-01,TCRBV20-or09_02												CSATRDRGLGQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCCCCAGACAGGGGGCGAACCGGGGAGCTGTTTTTTGGAGAA	CASSPPDRGRTGELFF	In	VDJ	2	152	3.421050262430566E-4	4.02269647696477E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	2	0	5	5	2	23	36	51	41	53	TCRBV01,TCRBV04													CASSPPDRGRTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCGTTTATCGGGGATTCCTACGAGCAGTACTTCGGGCCG	CASSSFIGDSYEQYF	In	VDJ	2	152	3.421050262430566E-4	4.02269647696477E-4	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	8	3	1	8	2	24	36	49	44	51		TCRBV24-01,TCRBV24-or09_02												CASSSFIGDSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCTCGTCGGGGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	152	3.421050262430566E-4		44	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	8	4	1	5	0	18	31	-1	36	40	TCRBV07,TCRBV11					01,02								X+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCGTCACGGACAGGGTCGATCGAGCAGTACTTCGGGCCG	CASSSSRTGSIEQYF	In	VDJ	2	154	3.4660640816730736E-4	4.0756266937669376E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	3	6	6	5	18	31	45	37	50	TCRBV07,TCRBV11													CASSSSRTGSIEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCGTCCGGGACAGGGGAAGGTTTGAGTAAAACTGTTTTTTGGCAGT		Out	VDJ	2	154	3.4660640816730736E-4		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	11	0	2	10	10	11	22	25	45	35	56	TCRBV01,TCRBV17													X+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAAAGGACAGGGGTCCACCAATAAGAATGAAAAACTGTTTTTTGGCAGT	CASSKGQGSTNKNEKLFF	In	VDJ	2	155	3.4885709912943274E-4	4.102091802168022E-4	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	2	2	5	0	12	26	-1	50	42	62		TCRBV03-01,TCRBV03-02												CASSKGQGSTNKNEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCATCCTATTGGGGGAAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	155	3.4885709912943274E-4		47	TCRBV24						TCRBJ01	TCRBJ01-01	01	6	6	1	2	10	2	24	36	51	46	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGGTCGACTAGCGGGGGGGCCCAAGGAGAGACCCAGTACTTCGGGCCA	CASRSTSGGAQGETQYF	In	VDJ	2	155	3.4885709912943274E-4	4.102091802168022E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	2	0	4	3	7	18	29	46	32	53	TCRBV07,TCRBV11													CASRSTSGGAQGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCAAAGCGGGGGATCTTTACGAGCAGTACTTCGGGCCG	CSATKAGDLYEQYF	In	VDJ	2	156	3.511077900915581E-4	4.128556910569106E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	6	2	4	4	5	26	36	48	40	53		TCRBV20-01,TCRBV20-or09_02												CSATKAGDLYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCTATCAGGGGCCGAGACCCAGTACTTCGGGCCA	CATSDLSGAETQYF	In	VDJ	2	156	3.511077900915581E-4	4.128556910569106E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	2	5	5	2	24	38	49	43	51		TCRBV24-01,TCRBV24-or09_02												CATSDLSGAETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACAGGGAAGGTCCCTCAATCAGCCCCAGCATTTTGGTGAT	CASSEQGRSLNQPQHF	In	VDJ	2	156	3.511077900915581E-4	4.128556910569106E-4	48	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	3	3	0	9	23	-1	43	38	52		TCRBV06-01,TCRBV06-08												CASSEQGRSLNQPQHF+TCRBV06-X+TCRBJ01-05	TCRBV06	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCTGGGACAGGGGGGCACTGAAGCTTTCTTTGGACAA	CASSLGQGGTEAFF	In	VDJ	2	157	3.533584810536835E-4	4.1550220189701895E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	1	4	2	1	24	36	49	38	50		TCRBV24-01,TCRBV24-or09_02												CASSLGQGGTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCCCCAGGATCCGATACGCAGTATTTTGGCCCA	CASSAPGSDTQYF	In	VDJ	2	159	3.578598629779342E-4	4.207952235772358E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	4	6	4	4	24	36	44	40	48	TCRBV09,TCRBV21													CASSAPGSDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCGCGGGCAGAGCTAAAAGCAGTACTTCGGGCCG		Out	VDJ	2	160	3.601105539400596E-4		35	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	11	7	4	8	2	10	24	31	38	33	48		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGAGAACTCGGGGACTGAAGAGACCCAGTACTTCGGGCCA	CASSENSGTEETQYF	In	VDJ	2	160	3.601105539400596E-4	4.234417344173442E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	10	3	9	1	24	36	51	45	52	TCRBV09,TCRBV21					01,02								CASSENSGTEETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTCACTAGCGGGGTTCACACCGGGGAGCTGTTTTTTGGAGAA	CASSFTSGVHTGELFF	In	VDJ	2	161	3.6236124490218497E-4	4.2608824525745256E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	3	3	3	1	3	19	33	44	34	47	TCRBV07,TCRBV11													CASSFTSGVHTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACCCTAGGGAGGGGACAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	162	3.6461193586431035E-4		40	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	7	9	0	9	5	2	26	36	48	41	50		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD02-01*02	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCACATCGGCAGGGGCCGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	163	3.668626268264357E-4		47	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	2	2	8	3	26	39	53	47	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCGGAAGGCGACTAGCGGGGGGGCGAGAGACCCAGTACTTCGGGCCA	CASSPGRRLAGGRETQYF	In	VDJ	2	164	3.691133177885611E-4	4.3402777777777775E-4	54	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	2	0	4	9	2	26	39	62	48	64		TCRBV03-01,TCRBV03-02												CASSPGRRLAGGRETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGGGGGAGGCTACCACCCAGACACCGGGGAGCTGTTTTTTGGAGAA	CATSDGGGYHPDTGELFF	In	VDJ	2	164	3.691133177885611E-4	4.3402777777777775E-4	54	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	9	1	3	2	11	24	39	47	41	58		TCRBV24-01,TCRBV24-or09_02												CATSDGGGYHPDTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACGCTCCAGGGGGCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	166	3.736146997128118E-4		44	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	1	3	5	0	26	38	-1	43	50		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAGAGGGAAGAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	166	3.736146997128118E-4		43	TCRBV06			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	11	0	2	1	4	23	38	44	39	48		TCRBV06-01,TCRBV06-08												X+TCRBV06-X+TCRBJ01-01	TCRBV06	TCRBD02-01*02	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGCCAGGGAGGGAGTCGGCGCAGTATTTTGGCCCA	CASSLPGRESAQYF	In	VDJ	2	167	3.758653906749372E-4	4.41967310298103E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	9	0	10	6	6	24	36	49	42	55		TCRBV24-01,TCRBV24-or09_02												CASSLPGRESAQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCTTAATGAAAAACTGTTTTTTGGCAGT	CSARDLNEKLFF	In	VDJ	2	168	3.7811608163706257E-4	4.4461382113821136E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	4	10	4	1	0	26	40	-1	41	43		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCCTCGCCTCGTCCGGGAGAGGCGCTGAAGCTTTCTTTGGACAA	CASLASSGRGAEAFF	In	VDJ	2	169	3.8036677259918795E-4	4.472603319783198E-4	45				TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	8	8	2	6	11	5	36	45	62	56	67	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												CASLASSGRGAEAFF+X+TCRBJ01-01		TCRBD02-01*02	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGAAGACAGCAGCTTCTACATCTGCAGTGTTGCGGTGGGACCGGGACAGGGAGGGGTAGGGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	2	169	3.8036677259918795E-4		59	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	7	0	3	1	13	9	22	29	51	42	60		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGACGAGGGGACAAATTCACCCCTCCACTTTGGGAAC	CASSDEGTNSPLHF	In	VDJ	2	170	3.8261746356131333E-4	4.499068428184282E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	6	7	6	0	23	35	-1	41	47	TCRBV06,TCRBV10													CASSDEGTNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGGGGACTYGGCYSTSTATCTCTGTGCCAGCAGCCCAACAGGGAATCGAGAGACCCAGTACTTCGGGCCA	CASSPTGNRETQYF	In	VDJ	2	170	3.8261746356131333E-4	4.499068428184282E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	3	3	4	3	5	19	31	40	34	45	TCRBV05,TCRBV07													CASSPTGNRETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGGGGCCGGGACTTCAATTCCTACGAGCAGTACTTCGGGCCG	CASRGRDFNSYEQYF	In	VDJ	2	171	3.848681545234387E-4	4.525533536585366E-4	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	10	1	5	5	22	33	44	38	49		TCRBV12-03,TCRBV12-04				01,02								CASRGRDFNSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCTGGGACAGGTCAATTCACCCCTCCACTTTGGGAAC	CASSLGQVNSPLHF	In	VDJ	2	171	3.848681545234387E-4	4.525533536585366E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	4	7	2	2	18	30	40	32	42	TCRBV07,TCRBV11													CASSLGQVNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAAGGTATTTTACAATGAGCAGTTCTTCGGGCCA	CSARDKVFYNEQFF	In	VDJ	2	172	3.871188454855641E-4	4.5519986449864497E-4	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	0	5	4	4	2	5	26	40	45	42	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDKVFYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCGGGGTTAGCGGGGGCTACGAGCAGTACTTCGGGCCG	CASSGVSGGYEQYF	In	VDJ	2	172	3.871188454855641E-4	4.5519986449864497E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	5	2	3	5	0	18	30	-1	35	44	TCRBV07,TCRBV11													CASSGVSGGYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCCTAGCGGGGGGCACAGATACGCAGTATTTTGGCCCA	CSASLAGGTDTQYF	In	VDJ	2	173	3.893695364476894E-4	4.578463753387534E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	2	1	3	0	26	35	-1	38	48		TCRBV20-01,TCRBV20-or09_02												CSASLAGGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGGCCCGGGACAGGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	174	3.916202274098148E-4		44	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	3	3	5	0	24	38	-1	43	52		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGACTGGACAGGGAGCAGATACGCAGTATTTTGGCCCA	CATSETGQGADTQYF	In	VDJ	2	175	3.938709183719402E-4	4.631393970189702E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	1	3	4	4	2	24	38	50	42	52		TCRBV24-01,TCRBV24-or09_02												CATSETGQGADTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCTGTCATTTGGGGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	176	3.9612160933406556E-4		44	TCRBV24						TCRBJ01	TCRBJ01-04	01	0	0	9	0	0	0	24	-1	-1	42	45		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-04	TCRBV24		TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACACCGTCGTTCAGGTCCCGCCTGAGACCCAGTACTTCGGGCCA	CASSHTVVQVPPETQYF	In	VDJ	2	177	3.9837230029619094E-4	4.68432418699187E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	4	5	10	8	26	40	54	50	62		TCRBV03-01,TCRBV03-02												CASSHTVVQVPPETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACGCCGGGACTACAACCTACAATGAGCAGTTCTTCGGGCCA	CATSDAGTTTYNEQFF	In	VDJ	2	177	3.9837230029619094E-4	4.68432418699187E-4	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	9	2	4	3	24	38	49	42	52		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDAGTTTYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCCACTCTGGAAACACCATATATTTTGGAGAG	CASHSGNTIYF	In	VDJ	2	180	4.05124373182567E-4	4.763719512195122E-4	33	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	8	4	6	0	0	0	26	-1	-1	35	37		TCRBV03-01,TCRBV03-02												CASHSGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAAGTTGGGGGACGAGAGACCCAGTACTTCGGGCCA	CSAKVGGRETQYF	In	VDJ	2	180	4.05124373182567E-4	4.763719512195122E-4	39	TCRBV20						TCRBJ02	TCRBJ02-05	01	4	0	7	4	7	1	26	36	48	43	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKVGGRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCATGGGGGACAGGGACAGGTCACCGGGGAGCTGTTTTTTGGAGAA	XASSHGGQGQVTGELFF	In	VDJ	2	181	4.073750641446924E-4	4.790184620596206E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	3	4	3	6	23	37	49	40	55	TCRBV01,TCRBV04,TCRBV07,TCRBV17													XASSHGGQGQVTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGTAATGGACCCTAGGGAGAAAAAGAGACCCAGTACTTCGGGCCA	CSARDGNGP*GEKETQYF	Stop	VDJ	2	184	4.1412713703106854E-4		54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	9	2	3	15	3	26	40	60	55	63		TCRBV20-01,TCRBV20-or09_02												CSARDGNGP*GEKETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTCGGGACAAGAGACCCAGTACTTCGGGCCA	CSASSGQETQYF	In	VDJ	2	186	4.186285189553193E-4	4.922510162601626E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	8	3	2	2	0	26	37	-1	39	44		TCRBV20-01,TCRBV20-or09_02												CSASSGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTTTGGAGACACTGAAGCTTTCTTTGGACAA	CSASFGDTEAFF	In	VDJ	2	187	4.208792099174447E-4	4.94897527100271E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	10	2	3	4	0	26	37	-1	41	45		TCRBV20-01,TCRBV20-or09_02												CSASFGDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTATCGGGGACCAGGGAGCTGTTTTTTGGAGAA	CASSLSGTRELFF	In	VDJ	2	191	4.2988197376594615E-4	5.054835704607046E-4	39	TCRBV03						TCRBJ02	TCRBJ02-02	01	4	0	7	9	5	2	26	39	49	44	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSGTRELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTCTGTGCCAGCAGCAAAGGATGTCCTCCGTGTGCCCTGGGACTAACGGCCTTCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	191	4.2988197376594615E-4		70	TCRBV21			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	0	9	2	19	9	3	19	45	38	54		TCRBV21-or09_02,TCRBV21-01				01,02								X+TCRBV21-X+TCRBJ02-03	TCRBV21	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACSASWCRGCYSTKTAYYTCTGTGCCAGCAGYTTACAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSLQGNTEAFF	In	VDJ	2	192	4.321326647280715E-4	5.081300813008131E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	3	1	0	0	18	-1	-1	33	38	TCRBV07,TCRBV24													CASSLQGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGCAGGGACTACACCCAAACACCGGGGAGCTGTTTTTTGGAGAA	CATSEQGLHPNTGELFF	In	VDJ	2	193	4.343833556901969E-4	5.107765921409214E-4	51	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	0	9	2	3	6	24	38	48	41	54		TCRBV24-01,TCRBV24-or09_02				01,02								CATSEQGLHPNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTTAGCGGGACAGTTACTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	194	4.366340466523223E-4		43	unresolved			unresolved			TCRBJ02	TCRBJ02-07	01	0	0	5	3	0	3	26	-1	50	43	53	TCRBV12,TCRBV21			TCRBD01,TCRBD02										X+X+TCRBJ02-07	unresolved	unresolved	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTCCCCATAGCGGGGGGTCGTCGTGGGACCCCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	194	4.366340466523223E-4		61	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	5	1	1	5	14	18	31	46	36	60	TCRBV05,TCRBV11													X+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCGGACGGAAGTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	3	197	4.4338611953869837E-4		43	TCRBV03						TCRBJ01	TCRBJ01-04	01	4	1	7	4	2	5	26	39	45	41	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTATACCGGCCAGGGGCCGATACGCAGTATTTTGGCCCA	CASSLYRPGADTQYF	In	VDJ	3	198	4.4563681050082375E-4	5.240091463414634E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	2	6	7	2	26	41	54	48	56		TCRBV12-03,TCRBV12-04												CASSLYRPGADTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCCGAAAAGCGGGGGGGGCCGTTAATGAGCAGTTCTTCGGGCCA	CASRKAGGAVNEQFF	In	VDJ	3	199	4.4788750146294913E-4	5.266556571815719E-4	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	11	6	0	7	7	6	24	31	48	38	54		TCRBV24-01,TCRBV24-or09_02												CASRKAGGAVNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTTGGGACTAGCGGGGGAGAGCAGTACTTCGGGCCG	CASSFGTSGGEQYF	In	VDJ	3	199	4.4788750146294913E-4	5.266556571815719E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	0	2	7	1	1	18	32	47	33	48	TCRBV05,TCRBV11													CASSFGTSGGEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAACGGAGGGTATGGCTACACCTTCGGTTCG	CASSLNGGYGYTF	In	VDJ	3	203	4.568902653114506E-4	5.372417005420054E-4	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	10	0	5	3	0	26	41	-1	44	50		TCRBV12-03,TCRBV12-04												CASSLNGGYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD02-01*02	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGTGGACTAGCGGGGTCCGGTACAGATACGCAGTATTTTGGCCCA	CSARGGLAGSGTDTQYF	In	VDJ	3	205	4.6139164723570136E-4	5.425347222222222E-4	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	1	3	3	4	6	26	37	53	41	59		TCRBV20-01,TCRBV20-or09_02												CSARGGLAGSGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGTCGGACAGGGGAGCCGATGGCTACACCTTCGGTTCG	CSARESDRGADGYTF	In	VDJ	3	208	4.681437201220775E-4	5.504742547425474E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	2	6	3	5	26	40	52	43	57		TCRBV20-01,TCRBV20-or09_02												CSARESDRGADGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCTCGGGGAACTAGCTAGCAATGAGCAGTTCTTCGGGCCA	CASSLGELASNEQFF	In	VDJ	3	209	4.703944110842029E-4	5.531207655826558E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	3	7	6	7	3	23	36	49	43	52	TCRBV01,TCRBV04					01,02								CASSLGELASNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCGCCGGAGGACTAGCGGGAGCTATGCAGATACGCAGTATTTTGGCCCA	CASSRRRTSGSYADTQYF	In	VDJ	3	209	4.703944110842029E-4	5.531207655826558E-4	54	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	1	2	4	7	5	24	36	56	43	61		TCRBV24-01,TCRBV24-or09_02												CASSRRRTSGSYADTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCACCTAAAGGGGTTGAGAGCGAGCAGTACTTCGGGCCG		Out	VDJ	3	212	4.7714648397057896E-4		34	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	5	2	6	5	7	26	30	40	35	47		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAATTCCCCCCCGGATGGAATGAGCAGTTCTTCGGGCCA	CASSQEFPPGWNEQFF	In	VDJ	3	213	4.7939717493270434E-4	5.637068089430895E-4	48	TCRBV03						TCRBJ02	TCRBJ02-01	01	0	1	8	7	10	3	26	43	56	53	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEFPPGWNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTGCAGGGAACTATAATGAAAAACTGTTTTTTGGCAGT	CASSAGNYNEKLFF	In	VDJ	3	213	4.7939717493270434E-4	5.637068089430895E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	4	3	4	2	5	24	35	42	37	47	TCRBV02,TCRBV21													CASSAGNYNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCTGGACGGTGGAAGAAACACCATATATTTTGGAGAG	CASSLDGGRNTIYF	In	VDJ	3	215	4.838985568569551E-4	5.689998306233062E-4	42	TCRBV12						TCRBJ01	TCRBJ01-03	01	6	1	7	5	3	7	26	37	44	40	51		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDGGRNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12		TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATAATCGCCTCTCCTCTGGAAACACCATATATTTTGGAGAG	CASSQDNRLSSGNTIYF	In	VDJ	3	215	4.838985568569551E-4	5.689998306233062E-4	51	TCRBV03						TCRBJ01	TCRBJ01-03	01	0	10	0	0	5	5	26	43	50	48	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDNRLSSGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGCGGGGGATTAGCACAGATACGCAGTATTTTGGCCCA	CSAGRGISTDTQYF	In	VDJ	3	215	4.838985568569551E-4	5.689998306233062E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	7	2	0	2	3	26	35	44	37	47		TCRBV20-01,TCRBV20-or09_02												CSAGRGISTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGCCCGAAGTTCGGCACAGATACGCAGTATTTTGGCCCA	CASSPKFGTDTQYF	In	VDJ	3	215	4.838985568569551E-4	5.689998306233062E-4	42	unresolved						TCRBJ02	TCRBJ02-03	01	6	2	8	1	3	6	23	34	39	37	45	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPKFGTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACCCGTCAGTAGYGGGGGTGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	3	217	4.883999387812058E-4		53	TCRBV12			unresolved			TCRBJ02	TCRBJ02-03	01	2	6	1	1	12	1	26	41	58	53	59		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02										X+TCRBV12-X+TCRBJ02-03	TCRBV12	unresolved	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCAGGGGATTTTAGCACTGAAGCTTTCTTTGGACAA	CASSSGDFSTEAFF	In	VDJ	3	218	4.906506297433312E-4	5.769393631436314E-4	42	unresolved			unresolved			TCRBJ01	TCRBJ01-01	01	4	4	2	4	0	7	18	-1	37	31	44	TCRBV07,TCRBV11			TCRBD01,TCRBD02										CASSSGDFSTEAFF+X+TCRBJ01-01	unresolved	unresolved	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCACCTGGGACAGGGAGGGCCAGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASTWDREGQSSYNEQFF	In	VDJ	3	218	4.906506297433312E-4	5.769393631436314E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	0	3	0	6	10	24	31	46	37	56	TCRBV02,TCRBV21													CASTWDREGQSSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCCCGGGAGAATCCAAGAGACCCAGTACTTCGGGCCA	CSASPGRIQETQYF	In	VDJ	3	219	4.929013207054566E-4	5.795858739837398E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	8	2	1	3	3	26	37	46	40	49		TCRBV20-01,TCRBV20-or09_02												CSASPGRIQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGATCCCAGGGGGCCGGACCGGGGAGCTGTTTTTTGGAGAA	CSARIPGGRTGELFF	In	VDJ	3	222	4.996533935918327E-4	5.875254065040651E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	0	5	5	3	26	37	50	42	53		TCRBV20-01,TCRBV20-or09_02												CSARIPGGRTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTATGCAGGGGAGCTCTGGAAACACCATATATTTTGGAGAG	CASSMQGSSGNTIYF	In	VDJ	3	222	4.996533935918327E-4	5.875254065040651E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	4	2	0	3	2	24	36	45	39	47		TCRBV24-01,TCRBV24-or09_02												CASSMQGSSGNTIYF+TCRBV24-X+TCRBJ01-03	TCRBV24	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCGGGGCGCCTAGGAGGCCACAATGAGCAGTTCTTCGGGCCA	CASSSGRLGGHNEQFF	In	VDJ	3	223	5.019040845539581E-4	5.901719173441734E-4	48	TCRBV24						TCRBJ02	TCRBJ02-01	01	6	7	0	5	2	12	24	36	43	38	55		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGRLGGHNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGTCGACGCGGACAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSRRGQGNTEAFF	In	VDJ	3	224	5.041547755160835E-4	5.928184281842818E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	3	1	7	0	24	35	-1	42	50	TCRBV12,TCRBV21													CASSRRGQGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGGGTTTGCGCGGGAGCCCGAGACCCAGTACTTCGGGCCA	CASSLGFAREPETQYF	In	VDJ	3	226	5.086561574403342E-4	5.981114498644986E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	7	2	5	7	3	18	34	48	41	51	TCRBV07,TCRBV11													CASSLGFAREPETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGTGGGGCCCATAAGTGAGCAGTTCTTCGGGCCA	CASSQGVGPISEQFF	In	VDJ	3	228	5.131575393645849E-4	6.034044715447155E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	7	0	9	4	7	26	42	51	46	58		TCRBV03-01,TCRBV03-02												CASSQGVGPISEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAATAGCGGGAGTTGGCACAGATACGCAGTATTTTGGCCCA	CASSLIAGVGTDTQYF	In	VDJ	3	228	5.131575393645849E-4	6.034044715447155E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	5	2	1	1	3	18	33	43	34	46	TCRBV05,TCRBV11													CASSLIAGVGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTAATGGGTGCTCTTGCCTACAATGAGCAGTTCTTCGGGCCA	CSARVMGALAYNEQFF	In	VDJ	3	240	5.401658309100894E-4	6.351626016260162E-4	48	TCRBV20						TCRBJ02	TCRBJ02-01	01	1	0	9	2	4	8	26	39	46	43	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVMGALAYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCAAACAGGGTACGACGAGCAGTACTTCGGGCCG	CASSQTGYDEQYF	In	VDJ	3	248	5.581713586070924E-4	6.563346883468835E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	3	5	4	4	26	37	47	41	51		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSQTGYDEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTTAGCGGATTGCAAGAGACCCAGTACTTCGGGCCA	CSALSGLQETQYF	In	VDJ	3	248	5.581713586070924E-4	6.563346883468835E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	5	5	2	2	4	26	35	43	37	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSALSGLQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTCTACATCTGCAGTGCTAGAGATCTAAGGAGCGGACAGGGGTTGGTCCTTGGTTACAATGAGCAGTTCTTCGGGCCA	CSARDLRSGQGLVLGYNEQFF	In	VDJ	3	248	5.581713586070924E-4	6.563346883468835E-4	63	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	2	4	10	12	9	23	42	33	54		TCRBV20-01,TCRBV20-or09_02												CSARDLRSGQGLVLGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACCTTGTCGATGGCTACACCTTCGGTTCG	CASSQDLVDGYTF	In	VDJ	3	254	5.716755043798446E-4	6.722137533875338E-4	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	4	10	6	1	5	26	43	46	44	51		TCRBV03-01,TCRBV03-02				01,02								CASSQDLVDGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATGACTTGCGCGAGCAGTTCTTCGGGCCA	CASSHDLREQFF	In	VDJ	3	259	5.829289591904714E-4	6.854463075880759E-4	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	2	10	10	1	5	26	40	45	41	50		TCRBV03-01,TCRBV03-02				01,02								CASSHDLREQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCCGACAGGGGGGATGAAAAACTGTTTTTTGGCAGT	CASSSDRGDEKLFF	In	VDJ	3	261	5.874303411147222E-4	6.907393292682926E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	2	1	6	2	1	18	31	42	33	43	TCRBV07,TCRBV11													CASSSDRGDEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGTCCGCGCGTAACACCGGGGAGCTGTTTTTTGGAGAA	CASRSARNTGELFF	In	VDJ	3	262	5.896810320768476E-4	6.933858401084011E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	7	6	2	4	3	26	37	44	41	47		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASRSARNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGAAACCACAGGGGTTGGTACGAGCAGTACTTCGGGCCG	CSARNHRGWYEQYF	In	VDJ	3	263	5.91931723038973E-4	6.960323509485095E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	2	4	4	4	26	38	49	42	53		TCRBV20-01,TCRBV20-or09_02												CSARNHRGWYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGACCGGGGCCTAATCAGCCCCAGCATTTTGGTGAT	CAIRPGPNQPQHF	In	VDJ	3	263	5.91931723038973E-4	6.960323509485095E-4	39	unresolved						TCRBJ01	TCRBJ01-05	01	6	7	0	4	3	2	23	34	42	37	44	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAIRPGPNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATTCGGACAGGGGGAGTAGGGGAGCAGTACTTCGGGCCG	CSAIRTGGVGEQYF	In	VDJ	3	264	5.941824140010983E-4	6.986788617886179E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	1	7	3	7	26	36	49	39	56		TCRBV20-01,TCRBV20-or09_02												CSAIRTGGVGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGTAAACCGGGACAGGGAAACTACAATGAGCAGTTCTTCGGGCCA	CASKPGQGNYNEQFF	In	VDJ	3	266	5.986837959253491E-4	7.039718834688347E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	11	0	3	3	7	3	24	31	47	38	50		TCRBV24-01,TCRBV24-or09_02												CASKPGQGNYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGTGGTCGACAGGGGAAGCAGTTTAGCCAAAAACATTCAGTACTTCGGCGCC	CSAVVDRGSSLAKNIQYF	In	VDJ	3	268	6.031851778495999E-4	7.092649051490514E-4	54	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	2	2	0	6	9	26	35	49	41	58		TCRBV20-01,TCRBV20-or09_02												CSAVVDRGSSLAKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGGCAGGGACAGGGGGCTACGAGCAGTACTTCGGGCCG	CASRAGTGGYEQYF	In	VDJ	3	268	6.031851778495999E-4	7.092649051490514E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	1	3	4	0	24	35	-1	39	50		TCRBV24-01,TCRBV24-or09_02												CASRAGTGGYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGTGGCAGGGCTTACCTACGAGCAGTACTTCGGGCCG	CSASVAGLTYEQYF	In	VDJ	3	273	6.144386326602266E-4	7.224974593495935E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	3	2	5	4	26	37	47	42	51		TCRBV20-01,TCRBV20-or09_02												CSASVAGLTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCAGGCGCAGTCACTGAAGCTTTCTTTGGACAA	CASSLSGAVTEAFF	In	VDJ	4	278	6.256920874708535E-4	7.357300135501355E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	4	4	4	6	24	36	44	40	50	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSGAVTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGACAGGGGGAATAATTCACCCCTCCACTTTGGGAAC	CSARDRGNNSPLHF	In	VDJ	4	283	6.369455422814804E-4	7.489625677506775E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	1	1	5	0	1	26	-1	47	37	48		TCRBV20-01,TCRBV20-or09_02												CSARDRGNNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTCTACAGGGGACTGAAGCTTTCTTTGGACAA	CATSLQGTEAFF	In	VDJ	4	283	6.369455422814804E-4	7.489625677506775E-4	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	2	5	2	0	24	36	-1	38	45		TCRBV24-01,TCRBV24-or09_02												CATSLQGTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQANTGELFF	In	VJ	4	289	6.504496880542326E-4	7.64841632791328E-4	39	TCRBV03						TCRBJ02	TCRBJ02-02	01	1	0	0	0	0	0	26	-1	-1	-1	42		TCRBV03-01,TCRBV03-02												CASSQANTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCGGACGGACAAAGAGACCCAGTACTTCGGGCCA	CSARTDKETQYF	In	VDJ	4	293	6.594524519027341E-4	7.754276761517615E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	6	3	6	0	26	34	-1	40	45		TCRBV20-01,TCRBV20-or09_02												CSARTDKETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCGCGGGACAGGTCGACCGGGGAGCTGTTTTTTGGAGAA	CASSPRDRSTGELFF	In	VDJ	4	299	6.729565976754864E-4	7.913067411924119E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	4	5	5	3	26	37	50	42	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPRDRSTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCGGACTAGCGGGGGGGCCGAAGATACGCAGTATTTTGGCCCA	CASSRTSGGAEDTQYF	In	VDJ	4	309	6.954635072967401E-4	8.177718495934959E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	1	0	5	0	4	23	-1	51	36	55	TCRBV01,TCRBV04													CASSRTSGGAEDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCTTATTCCAGGGCTACGAGCAGTACTTCGGGCCG	CASSLFQGYEQYF	In	VDJ	4	309	6.954635072967401E-4	8.177718495934959E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	3	3	7	0	20	31	-1	38	43	TCRBV07,TCRBV23													CASSLFQGYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTTGGGCCCGAACACTGAAGCTTTCTTTGGACAA	CASSLGPNTEAFF	In	VDJ	4	314	7.06716962107367E-4	8.310044037940379E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	8	0	1	0	2	26	-1	44	40	46	TCRBV12,TCRBV21													CASSLGPNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGAACTCTACAATGAGCAGTTCTTCGGGCCA	CSARDELYNEQFF	In	VDJ	4	318	7.157197259558684E-4	8.415904471544716E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	3	10	3	3	0	26	40	-1	43	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDELYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGTACTTTAGCTATGGCTACACCTTCGGTTCG	CASSLSYFSYGYTF	In	VDJ	4	318	7.157197259558684E-4	8.415904471544716E-4	42				TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	3	10	4	7	4	24	36	46	43	50	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01				01,02								CASSLSYFSYGYTF+X+TCRBJ01-02		TCRBD02-01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAGACAGGGGGGAGCTACAATGAGCAGTTCTTCGGGCCA	CASSQETGGSYNEQFF	In	VDJ	4	325	7.314745626907461E-4	8.601160230352304E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	2	1	3	0	3	23	-1	49	40	52	TCRBV01,TCRBV04													CASSQETGGSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GCTGGCAAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTTTTACAGGCTTCAATGAGCAGTTCTTCGGGCCA	CASSFTGFNEQFF	In	VDJ	4	330	7.42728017501373E-4	8.733485772357723E-4	39				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	3	4	6	1	3	42	56	62	57	65	TCRBV27,TCRBV28	TCRBV27-01,TCRBV28-01												CASSFTGFNEQFF+X+TCRBJ02-01		TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCGGGAGGGGGCGACCAGATACGCAGTATTTTGGCCCA	CASSPGRGRPDTQYF	In	VDJ	4	331	7.449787084634982E-4	8.759950880758808E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	8	0	4	2	6	24	36	46	38	52		TCRBV24-01,TCRBV24-or09_02												CASSPGRGRPDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAGCGAAAGCAATGAGCAGTTCTTCGGGCCA	CASSLSESNEQFF	In	VDJ	4	334	7.517307813498744E-4	8.83934620596206E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	6	6	6	0	4	26	-1	45	41	49		TCRBV12-03,TCRBV12-04				01,02								CASSLSESNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGACTAGAACCACCGGGGAGCTGTTTTTTGGAGAA	CASSQGTRTTGELFF	In	VDJ	4	334	7.517307813498744E-4	8.83934620596206E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	1	8	4	0	3	26	-1	49	42	52		TCRBV03-01,TCRBV03-02				01,02								CASSQGTRTTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCGGGGGGGCGCGAAATGAGCAGTTCTTCGGGCCA	CASSSGGARNEQFF	In	VDJ	4	335	7.539814723119998E-4	8.865811314363144E-4	42	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	0	7	2	5	24	36	46	38	51		TCRBV24-01,TCRBV24-or09_02												CASSSGGARNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAGCCGGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQEPGSGANVLTF	In	VDJ	4	338	7.607335451983759E-4	8.945206639566396E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	0	8	4	0	2	0	23	40	-1	42	46	TCRBV01,TCRBV04					01,02								CASSQEPGSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD02-01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGTCGGTGGGGGCTTACGAGATACGCAGTATTTTGGCCCA	CASSLVGGGLRDTQYF	In	VDJ	4	340	7.652349271226267E-4	8.998136856368564E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	6	0	5	5	5	18	34	45	39	50	TCRBV07,TCRBV11													CASSLVGGGLRDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCAGGGACTTCTACCTACGAGCAGTACTTCGGGCCG	CASSPGTSTYEQYF	In	VDJ	4	341	7.67485618084752E-4	9.024601964769648E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	10	2	2	4	23	36	44	38	48	TCRBV01,TCRBV04					01,02								CASSPGTSTYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGACTCAGGGGGCCGGGAGCAGTACTTCGGGCCG	CASSQDSGGREQYF	In	VDJ	4	348	7.832404548196296E-4	9.209857723577236E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	0	7	4	3	20	35	47	39	50	TCRBV04,TCRBV23													CASSQDSGGREQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGGGACAGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSLGTGGTDTQYF	In	VDJ	5	361	8.124994373272594E-4	9.553904132791328E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	1	2	1	0	0	18	-1	-1	34	43	TCRBV07,TCRBV11													CASSLGTGGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCTCTACGACGGGAGGAAAGAATGAGCAGTTCTTCGGGCCA	CASSSTTGGKNEQFF	In	VDJ	5	363	8.170008192515102E-4	9.606834349593496E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	8	1	7	7	4	23	35	49	42	53	TCRBV01,TCRBV04													CASSSTTGGKNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCTCCCCTGGGACTAGCGGGAGTTGGGATACGCAGTATTTTGGCCCA	CASSSPGTSGSWDTQYF	In	VDJ	5	365	8.215022011757609E-4	9.659764566395664E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	0	2	6	6	4	24	36	56	42	60	TCRBV09,TCRBV21													CASSSPGTSGSWDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTTCATCCGGGGAGCTGTTTTTTGGAGAA	CASSFSSGELFF	In	VDJ	5	367	8.260035831000117E-4	9.712694783197832E-4	36	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	6	6	2	1	26	40	44	42	45		TCRBV12-03,TCRBV12-04												CASSFSSGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCGGGGAAGAAGAGACCCAGTACTTCGGGCCA	CASSPGEEETQYF	In	VDJ	5	368	8.282542740621371E-4	9.739159891598916E-4	39	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	3	3	2	3	26	38	45	40	48		TCRBV12-03,TCRBV12-04												CASSPGEEETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATAAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSQDKGNTEAFF	In	VDJ	5	375	8.440091107970146E-4	9.924415650406505E-4	42	TCRBV03						TCRBJ01	TCRBJ01-01	01	0	5	3	1	2	0	26	43	-1	45	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDKGNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAACTAGCGGGAGTGGGCGAGCAGTACTTCGGGCCG	CASSQELAGVGEQYF	In	VDJ	5	376	8.4625980175914E-4	9.950880758807588E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	3	2	6	0	4	26	-1	54	43	58		TCRBV03-01,TCRBV03-02												CASSQELAGVGEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTATAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFINTGELFF	In	VDJ	5	379	8.530118746455162E-4	0.001003027608401084	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	5	9	2	0	2	26	-1	42	40	44		TCRBV12-03,TCRBV12-04				01,02								CASSFINTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTTTCTCTCTGTATCAGGGGGCGTTAACCGGGGAGCTGTTTTTTGGAGAA	CASSFSLYQGALTGELFF	In	VDJ	5	380	8.552625656076415E-4	0.0010056741192411925	54				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	0	5	10	4	27	41	59	51	63	TCRBV27,TCRBV28	TCRBV27-01,TCRBV28-01												CASSFSLYQGALTGELFF+X+TCRBJ02-02		TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCAGTCCAGCCGTCCACCTACAATGAGCAGTTCTTCGGGCCA	CSAAVQPSTYNEQFF	In	VDJ	5	389	8.7551878426677E-4	0.001029492716802168	45	TCRBV20						TCRBJ02	TCRBJ02-01	01	5	4	5	2	1	12	26	35	39	36	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAAVQPSTYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCGGGAGCTGGGCTAGCGGCATCCAAGAGACCCAGTACTTCGGGCCA	CASGSWASGIQETQYF	In	VDJ	5	390	8.777694752288952E-4	0.0010321392276422764	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	8	4	5	1	10	3	26	35	52	45	55		TCRBV03-01,TCRBV03-02				01,02								CASGSWASGIQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTATAGCGGGAGAGATGAGCAGTTCTTCGGGCCA	CASSYSGRDEQFF	In	VDJ	5	393	8.845215481152714E-4	0.0010400787601626015	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	5	2	8	2	2	24	36	47	38	49		TCRBV24-01,TCRBV24-or09_02												CASSYSGRDEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAATTAGGCTAGCGGGGGCTATTAAAAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	5	395	8.890229300395221E-4		58	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	4	2	3	9	8	23	37	56	46	64		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCCTAGCGGGAGGGACTACGAGCAGTACTTCGGGCCG	CASSPSGRDYEQYF	In	VDJ	5	403	9.070284577365252E-4	0.0010665438685636857	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	4	0	3	2	1	24	35	49	37	50		TCRBV24-01,TCRBV24-or09_02												CASSPSGRDYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATATAAGGGACAGGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSQDIRDRGTGELFF	In	VDJ	5	415	9.340367492820296E-4	0.0010983019986449865	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	0	1	5	5	0	23	40	-1	45	56	TCRBV01,TCRBV04													CASSQDIRDRGTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAGACGGTAGCGGTTATTACAATGAGCAGTTCTTCGGGCCA	CASSEDGSGYYNEQFF	In	VDJ	5	416	9.36287440244155E-4	0.0011009485094850948	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	5	5	4	4	4	23	39	49	43	53	TCRBV02,TCRBV09					01,02								CASSEDGSGYYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCTTCAGGGGGACAGGGGATTCTGGGGAGCTGTTTTTTGGAGAA	CASSFRGTGDSGELFF	In	VDJ	5	423	9.520422769790325E-4	0.0011194740853658536	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	2	8	6	5	23	35	51	41	56	TCRBV01,TCRBV04													CASSFRGTGDSGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTCGGACTAGCGGGGGAAGAGACCCAGTACTTCGGGCCA	CATSVGLAGEETQYF	In	VDJ	6	438	9.858026414109131E-4	0.0011591717479674797	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	1	2	3	2	0	24	37	-1	39	52		TCRBV24-01,TCRBV24-or09_02												CATSVGLAGEETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTAACGGGACAGTTAGGTAACACCATATATTTTGGAGAG	CASSLTGQLGNTIYF	In	VDJ	6	451	0.001015061623918543	0.001193576388888889	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	0	5	7	2	6	18	33	42	35	48	TCRBV07,TCRBV11													CASSLTGQLGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGCGGCCGGCGCGGGCATGAGCAGTTCTTCGGGCCA	CASSQGGRRGHEQFF	In	VDJ	6	463	0.0010420699154640475	0.0012253345189701898	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	7	4	8	9	1	26	42	56	51	57		TCRBV03-01,TCRBV03-02				01,02								CASSQGGRRGHEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCCGAGGGAAGGGGAACCGGGGAGCTGTTTTTTGGAGAA	CASSLSEGRGTGELFF	In	VDJ	6	474	0.0010668275160474266	0.0012544461382113822	48							TCRBJ02	TCRBJ02-02	01	6	5	2	5	12	1	24	36	53	48	54	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSEGRGTGELFF+X+TCRBJ02-02			TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCAGGGGCGTTTGAAGCTTTCTTTGGACAA	CASSLSGAFEAFF	In	VDJ	6	478	0.001075830279895928	0.0012650321815718157	39				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	2	7	4	4	24	36	46	40	50	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSGAFEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGAGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSLSRAYNEQFF	In	VDJ	6	481	0.0010825823527823041	0.001272971714092141	42				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	11	0	2	5	0	24	36	-1	41	46	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSRAYNEQFF+X+TCRBJ02-01		TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TTTCTGTGCCAGCAGCGTAGGGTCAACGATACGAGGGACTAGCGGGAGATTGGAGTGAGCAGTTCTTCGGGCCA		Out	VDJ	6	494	0.001111841335289934		64	TCRBV21			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	2	9	18	7	4	16	48	34	55		TCRBV21-or09_02,TCRBV21-01												X+TCRBV21-X+TCRBJ02-01	TCRBV21	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCGAGGTAGCGATACGCAGTATTTTGGCCCA		Out	VDJ	7	515	0.0011591058454945668		35	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	5	7	6	5	0	24	35	-1	40	44		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCTCCGGACGTCTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSGRLSGANVLTF	In	VDJ	7	528	0.0011883648280021967	0.0013973577235772358	48	TCRBV24						TCRBJ02	TCRBJ02-06	01	7	1	7	0	4	4	24	35	43	39	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGRLSGANVLTF+TCRBV24-X+TCRBJ02-06	TCRBV24		TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTACCTCCGGGACATTGTACAATGAGCAGTTCTTCGGGCCA	CSTSGTLYNEQFF	In	VDJ	7	538	0.0012108717376234505	0.0014238228319783197	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	0	6	4	6	3	26	32	44	38	47		TCRBV20-01,TCRBV20-or09_02												CSTSGTLYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAGGGTTATAACTCGCGGGAGCAGTACTTCGGGCCG	CASSQGYNSREQYF	In	VDJ	7	543	0.0012221251924340773	0.0014370553861788617	42	unresolved			unresolved			TCRBJ02	TCRBJ02-07	01	3	7	5	7	12	0	23	37	-1	49	53	TCRBV01,TCRBV23			TCRBD01,TCRBD02										CASSQGYNSREQYF+X+TCRBJ02-07	unresolved	unresolved	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACCCGGGACAGGACGGTCCATGAGCAGTTCTTCGGGCCA	CSARTRDRTVHEQFF	In	VDJ	7	560	0.0012603869387902086	0.0014820460704607046	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	4	8	4	7	26	38	50	42	57		TCRBV20-01,TCRBV20-or09_02												CSARTRDRTVHEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCTCCCTGGGGGGCCAGGAAGATACGCAGTATTTTGGCCCA	XASSLGGQEDTQYF	In	VDJ	7	579	0.0013031500670705907	0.0015323297764227642	42	unresolved						TCRBJ02	TCRBJ02-03	01	8	6	0	5	6	5	23	32	44	38	49	TCRBV04,TCRBV17			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSLGGQEDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCTACAGGATTCACCGGGGAGCTGTTTTTTGGAGAA	CSARPTGFTGELFF	In	VDJ	7	584	0.0013144035218812175	0.0015455623306233062	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	3	4	4	3	3	26	38	46	41	49		TCRBV20-01,TCRBV20-or09_02												CSARPTGFTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACATTAGCGGGGGGGACCCTAAGGAGACCCAGTACTTCGGGCCA	CSARDISGGDPKETQYF	In	VDJ	7	585	0.001316654212843343	0.0015482088414634147	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	5	0	5	3	8	26	40	54	43	62		TCRBV20-01,TCRBV20-or09_02												CSARDISGGDPKETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCGACCCACAGGGGAGGGTTGGAACACTGAAGCTTTCTTTGGACAA	CASSRPTGEGWNTEAFF	In	VDJ	8	609	0.001370670795934352	0.0016117251016260162	51	unresolved						TCRBJ01	TCRBJ01-01	01	4	3	2	1	5	7	23	36	48	41	55	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRPTGEGWNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCGGGGGGACAGGGAAACTTTACTACGAGCAGTACTTCGGGCCG	CASGGTGKLYYEQYF	In	VDJ	8	617	0.001388676323631355	0.0016328971883468836	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	0	3	3	3	8	23	32	44	35	52	TCRBV02,TCRBV12													CASGGTGKLYYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTATATCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSISNTGELFF	In	VDJ	8	622	0.0013999297784419817	0.0016461297425474255	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	5	9	0	1	1	26	38	41	39	42		TCRBV12-03,TCRBV12-04				01,02								CASSISNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGTCAAAGGACCACGGGACAGGCCCCCGGGGAGCTGTTTTTTGGAGAA	CASSQRTTGQAPGELFF	In	VDJ	8	625	0.0014066818513283578	0.0016540692750677507	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	0	4	6	8	3	23	38	54	46	57	TCRBV01,TCRBV04													CASSQRTTGQAPGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCGGGACAGGGGAGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	8	627	0.0014111832332526085		40	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	9	0	2	4	1	2	24	33	44	34	46		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCCGGACAGGTTGCGAACACTGAAGCTTTCTTTGGACAA	CASSAGQVANTEAFF	In	VDJ	8	636	0.0014314394519117368	0.0016831808943089431	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	4	1	3	4	24	36	46	39	50	TCRBV09,TCRBV21													CASSAGQVANTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCTACTAGTTTTTCGGCAGATACGCAGTATTTTGGCCCA	CASSPTSFSADTQYF	In	VDJ	8	652	0.001467450507305743	0.0017255250677506776	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	3	8	4	3	8	24	36	44	39	52		TCRBV24-01,TCRBV24-or09_02				01,02								CASSPTSFSADTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGGGACAGGGGACTCTACGAGCAGTACTTCGGGCCG	CASSQGDRGLYEQYF	In	VDJ	9	705	0.0015867371282983877	0.0018657901422764228	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	2	3	0	3	23	-1	49	39	52	TCRBV01,TCRBV04													CASSQGDRGLYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGTGCCAGCAGCCGAGAATAGGATCTCTGTGCCAGCAGCTTGTGATACCGGGGGACGAGCAGTACTTCGGGCCG		Out	VDJ	9	731	0.0016452550933136474		68				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	2	5	36	0	0	12	-1	48	54	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02,TCRBV11-03												X+X+TCRBJ02-07		TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACTGGGGGGAAACACTGAAGCTTTCTTTGGACAA	CASSLLGGNTEAFF	In	VDJ	9	734	0.0016520071662000234	0.0019425389566395663	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	9	1	2	2	1	26	41	49	43	50		TCRBV12-03,TCRBV12-04												CASSLLGGNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCCGTGACAGGGTACACTGAAGCTTTCTTTGGACAA	CASSAVTGYTEAFF	In	VDJ	9	738	0.001661009930048525	0.001953125	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	3	3	5	1	24	36	48	41	49	TCRBV09,TCRBV21													CASSAVTGYTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCAGCGGGGGGTGGGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	11	847	0.0019063352449201906		47	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	6	1	7	4	5	26	40	53	44	58		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCGGATTCCAGGACAGCATCTACGAGCAGTACTTCGGGCCG	CASGFQDSIYEQYF	In	VDJ	11	871	0.0019603518280111995	0.0023051109417344174	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	11	1	5	3	10	3	24	31	47	41	50		TCRBV24-01,TCRBV24-or09_02												CASGFQDSIYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCACTTCCCAAGAGGGGGACATTCAGTACTTCGGCGCC	CATSQEGDIQYF	In	VDJ	12	905	0.002036875320723462	0.002395092310298103	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	10	5	1	8	9	0	23	30	-1	39	45	TCRBV02,TCRBV09													CATSQEGDIQYF+X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCACTGAATCAGCCCCAGCATTTTGGTGAT	CASSLSLNQPQHF	In	VDJ	12	937	0.002108897431511474	0.0024797806571815718	39				TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	3	10	4	5	1	24	36	44	41	45	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01				01,02								CASSLSLNQPQHF+X+TCRBJ01-05		TCRBD02-01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGCCACCTGGGACTAGCGACCATGGTAGATACGCAGTATTTTGGCCCA	CSARHLGLATMVDTQYF	In	VDJ	13	987	0.0022214319796177427	0.002612106199186992	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	6	5	8	8	26	35	53	43	61		TCRBV20-01,TCRBV20-or09_02				01,02								CSARHLGLATMVDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCGGGAGGCTAGCTGGCTACAATGAGCAGTTCTTCGGGCCA	CASSSGRLAGYNEQFF	In	VDJ	13	1009	0.002270947180784501	0.002670329437669377	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	8	1	3	2	8	24	36	45	38	53		TCRBV24-01,TCRBV24-or09_02												CASSSGRLAGYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCCCCCAGGAGGGGCGATGAGCAGTTCTTCGGGCCA	CATSDPPRRGDEQFF	In	VDJ	13	1050	0.0023632255102316413	0.0027788363821138213	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	10	0	8	7	3	24	39	52	46	55		TCRBV24-01,TCRBV24-or09_02												CATSDPPRRGDEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCACCCTGGGGGACACCATTTTGAACACTGAAGCTTTCTTTGGACAA	CASSTLGDTILNTEAFF	In	VDJ	14	1082	0.002435247621019653	0.00286352472899729	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	6	0	7	6	18	30	43	37	49	TCRBV07,TCRBV11													CASSTLGDTILNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGTTGGAATAATGAAAAACTGTTTTTTGGCAGT	CASSLGWNNEKLFF	In	VDJ	14	1115	0.0025095204227697904	0.0029508595867208673	42	TCRBV12						TCRBJ01	TCRBJ01-04	01	3	0	9	4	0	6	26	-1	43	40	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGWNNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12		TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGGGGACTAGCGGGAGGTCCTCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	15	1136	0.0025567849329744233		55	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	6	0	1	0	2	5	26	34	51	36	56		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD02-01*02	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATACTGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	17	1328	0.0029889175977024945		40	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	3	10	1	1	1	26	43	47	44	48		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGACTTAAGGGTGCGGCTAATGAAAAACTGTTTTTTGGCAGT	CSARGLKGAANEKLFF	In	VDJ	18	1401	0.0031532180379376467	0.00370776168699187	48	TCRBV20						TCRBJ01	TCRBJ01-04	01	1	5	3	3	6	5	26	39	49	45	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGLKGAANEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCCAGAGGGTAGCGGGAGAAGTTCGGCCAAAAACATTCAGTACTTCGGCGCC	CASSPEGSGRSSAKNIQYF	In	VDJ	19	1503	0.0033827885160744348	0.003977705792682927	57	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	0	5	2	1	3	7	23	40	52	43	59	TCRBV04,TCRBV23													CASSPEGSGRSSAKNIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01*02	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCATCTGGATATTCGGAGGATACGCAGTATTTTGGCCCA		Out	VDJ	22	1737	0.003909450201211772		40	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	11	10	2	6	14	0	24	31	-1	45	49		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAAGACCTACTCTGAACACTGAAGCTTTCTTTGGACAA	CASSQRPTLNTEAFF	In	VDJ	24	1894	0.004262808682265456	0.005012491531165311	45	unresolved						TCRBJ01	TCRBJ01-01	01	2	2	7	0	1	6	23	38	42	39	48	TCRBV04,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQRPTLNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCGACAGAAGGCGAGCAGTACTTCGGGCCG	CATSDSTEGEQYF	In	VDJ	30	2326	0.0052351071779036164	0.006155784214092141	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	5	6	1	4	24	40	46	41	50		TCRBV24-01,TCRBV24-or09_02												CATSDSTEGEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGATCGGGAGGGATGAGCAGTTCTTCGGGCCA	CASSLIGRDEQFF	In	VDJ	49	3799	0.00855037496511429	0.010054094681571816	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	8	0	8	3	0	26	40	-1	43	51		TCRBV12-03,TCRBV12-04												CASSLIGRDEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTACGGGCCTTCGTACAGAGACCCAGTACTTCGGGCCA	CASSFTGLRTETQYF	In	VDJ	51	3967	0.008928491046751353	0.010498708502710027	45	TCRBV12						TCRBJ02	TCRBJ02-05	01	3	8	0	4	3	8	26	40	47	43	55		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFTGLRTETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAAAATGCAGCGACGTACAATGAGCAGTTCTTCGGGCCA	CASSENAATYNEQFF	In	VDJ	68	5292	0.01191065657156747	0.014005335365853659	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	6	6	4	5	3	23	38	47	43	50	TCRBV02,TCRBV12					01,02								CASSENAATYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTACAGGCTTCAATGAGCAGTTCTTCGGGCCA	CASSFTGFNEQFF	In	VDJ	80	6224	0.01400830054826832	0.01647188346883469	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	4	6	3	3	24	36	44	39	47		TCRBV24-01,TCRBV24-or09_02												CASSFTGFNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCTCTCTGTATCAGGGGGCGTTAACCGGGGAGCTGTTTTTTGGAGAA	CASSFSLYQGALTGELFF	In	VDJ	83	6511	0.0146542488543983	0.017231432079945798	54	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	0	5	12	4	24	36	56	48	60		TCRBV24-01,TCRBV24-or09_02												CASSFSLYQGALTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGAAGGCGGCTACGAGCAGTACTTCGGGCCG	CASSVEGGYEQYF	In	VDJ	88	6861	0.015441990691142181	0.01815771087398374	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	7	5	3	3	0	23	39	-1	42	46	TCRBV09,TCRBV21					01,02								CASSVEGGYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGGGGTGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSVGGGSNQPQHF	In	VDJ	102	7969	0.017935756277177094	0.02109004488482385	45	unresolved			unresolved			TCRBJ01	TCRBJ01-05	01	5	5	1	1	2	4	24	36	44	38	48	TCRBV09,TCRBV21			TCRBD01,TCRBD02										CASSVGGGSNQPQHF+X+TCRBJ01-05	unresolved	unresolved	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCCGCCGACAGGGGGCACCATACACAGATACGCAGTATTTTGGCCCA	CATRRQGAPYTDTQYF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	10	2	0	2	6	6	23	30	46	36	52														CATRRQGAPYTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTCGGGGAGGGGACTGAAGCTTTCTTTGGACAA	CASSLGEGTEAFF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	9	0	5	5	1	23	34	46	39	47														CASSLGEGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCAAACCTCCGGGACAGGGTCCGGCTACACCTTCGGTTCG	CASSYQTSGTGSGYTF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	3	8	10	3	23	37	56	47	59														CASSYQTSGTGSGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGCTCAGGCCGGGGCCAACGTCCTGACTTTCGGGGCC	CASAQAGANVLTF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	8	4	4	4	3	2	23	32	39	35	41														CASAQAGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCCCTTACAGTTAACTATGGCTACACCTTCGGTTCG	CASSLTVNYGYTF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	3	5	1	6	1	23	32	42	38	43														CASSLTVNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAACCCGCCCCGATCACGAGGTAGGTGGCTACACCTTCGGTTCG		Out	VDJ	1	22	4.9515201166758194E-5		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	10	11	1	7	18	4	23	30	52	48	56														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAAATAAGTGGTGCCGACAGACTACGTGCCGAGCAGTACTTCGGGCCG	CASKISGADRLRAEQYF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	51	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	7	2	5	6	14	9	23	33	52	47	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKISGADRLRAEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCAGTAAAAATGGACAGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	23	5.176589212888357E-5		52	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	3	0	10	0	23	34	-1	44	52														X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGACTAGCGGGGGCCCCCTACAATGAGCAGTTCTTCGGGCCA	CASSRLAGAPYNEQFF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	2	2	2	2	3	23	34	48	36	51														CASSRLAGAPYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGGCAACCCGACTCCTACGAGCAGTACTTCGGGCCG	CASSRQPDSYEQYF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	5	9	0	0	1	7	23	35	39	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRQPDSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCTAGCGGACTTTTTTTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	23	5.176589212888357E-5		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	4	5	4	1	9	23	38	46	39	55						01,02								X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGACGACAGGGTTTCTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	24	5.401658309100894E-5		41	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	3	6	3	4	23	34	44	37	48														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGGGGGAGGCAAGAGACCCAGTACTTCGGGCCA	CASSYRGRQETQYF	In	VDJ	1	24	5.401658309100894E-5	6.351626016260163E-5	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	2	5	1	2	0	3	23	-1	44	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYRGRQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGTGGACTAGCGGGAGTCTAAATACGCAATATTTTGGCCCA		Out	VDJ	1	24	5.401658309100894E-5		50	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	1	2	15	3	13	23	38	54	41	67														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGACTAGACCTTGGGAAATGGGCTTTCTTTGGACAA	CASSRLDLGKWAFF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	2	8	11	2	14	23	34	42	36	56						01,02								CASSRLDLGKWAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACTCCGAACTCTCAAGAGACCCAGTACTTCGGGCCA	CASSTPNSQETQYF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	3	10	2	0	9	23	-1	38	35	47						01,02								CASSTPNSQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTGGGGGGGTAGCGGCAATGAAGCTTTCTTTGGACAA	CASSYWGGSGNEAFF	In	VDJ	1	25	5.6267274053134314E-5	6.616277100271002E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	9	0	7	0	9	23	-1	46	39	55														CASSYWGGSGNEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGGGGTCTCCTACGAGCAGTACTTCGGGCCG	CASSGVSYEQYF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	8	3	0	0	1	23	-1	39	34	40														CASSGVSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCTTGGGGGGTTCAGGATACGCAGTATTTTGGCCCA	CASSSWGVQDTQYF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	9	1	6	3	5	23	36	45	39	50														CASSSWGVQDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGGTCACAGGGAGGAGAGACCCAGTACTTCGGGCCA	CAIRSQGGETQYF	In	VDJ	1	26	5.851796501525969E-5	6.880928184281842E-5	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	6	3	3	4	3	3	23	34	43	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAIRSQGGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCGGGACAGGGGGGAACTCGCAGTTCTTCGGGCCA	CASSPGTGGNSQFF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	1	12	4	6	23	34	49	38	55														CASSPGTGGNSQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGACAGGGAGGGGCCGCTGAAGCTTTCTTTGGACAA	CASSRQGGAAEAFF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	5	2	3	6	1	8	23	35	43	36	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRQGGAAEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGACGGCACTGTTAACCGGGAGTACTTCGGGCCG	CASSYSDGTVNREYF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	0	1	7	11	0	16	23	-1	44	40	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSDGTVNREYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGTAAGGCGGCAGGGGGCGCCCCGGCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	28	6.301934693951043E-5		55	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	4	0	3	9	7	23	34	51	43	58														X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGGGTAGCGGGACCACAGCAAGAGACCCAGTACTTCGGGCCA	CASSRVAGPQQETQYF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	5	3	2	4	6	23	35	47	39	53														CASSRVAGPQQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGGAGGACTGAAGCTTTCTTTGGACAA	CASSYRRTEAFF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	10	1	5	1	0	23	38	-1	39	44														CASSYRRTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCGCGACGGGGCGGGCGGCTACACCTTCGGTTCG	CASRDGAGGYTF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	8	7	0	8	6	4	23	32	43	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRDGAGGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCGGACAGACATCTTCCGCGGGGAGCTGTTTTTTGGAGAA	CASRTDIFRGELFF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	1	5	7	1	10	23	32	39	33	49														CASRTDIFRGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCCTTAAACCAAACAGGGGCACCTACGAGCAGTACTTCGGGCCG	CASSPLKPNRGTYEQYF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	2	2	14	2	23	34	55	48	57														CASSPLKPNRGTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGGACAGGGGGCCAAGGAAACACCATATATTTTGGAGAG	CASRGTGGQGNTIYF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	0	0	4	1	3	23	34	47	35	50														CASRGTGGQGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTGCCGACTAGCAAGGCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	29	6.52700379016358E-5		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	2	7	2	5	5	23	35	47	40	52						01,02								X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCGGGACAGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSSGTGGYNEQFF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	1	3	2	0	23	36	-1	38	49														CASSSGTGGYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCTCGGGACTAGCGGGGGGGCACCAAGAGACCCAGTACTTCGGGCCA	CASGLAGGHQETQYF	In	VDJ	1	29	6.52700379016358E-5	7.674881436314363E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	11	0	0	0	2	1	23	29	47	31	48														CASGLAGGHQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATAGGAGGGAGACAGATACGTAGTATTTTGGCCCA	CASSYRRETDT*YF	Stop	VDJ	1	30	6.752072886376118E-5		42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	10	0	13	2	12	23	37	45	39	57														CASSYRRETDT*YF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGACCCTCCCGGCTACACCTTCGGTTCG	CASSYGDPPGYTF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	2	0	7	8	1	6	23	38	44	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGDPPGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCGGGACCAACTACGAGCAGTACTTCGGGCCG	CAISGTNYEQYF	In	VDJ	1	31	6.977141982588655E-5	8.204183604336043E-5	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	6	0	7	3	1	3	23	34	40	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISGTNYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCACCTTCAACTATGGCTACACCTTCGGTTCG	CASSSTFNYGYTF	In	VDJ	1	32	7.202211078801193E-5	8.468834688346883E-5	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	4	3	7	2	2	4	23	36	40	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSTFNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGATCTGGACAGGGGCTCTATGGCTACACCTTCGGTTCG	CASRSGQGLYGYTF	In	VDJ	1	33	7.427280175013729E-5	8.733485772357724E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	2	4	4	2	23	34	47	38	49														CASRSGQGLYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCGGAGAGAACACTGAAGCTTTCTTTGGACAA	CASSAGENTEAFF	In	VDJ	1	33	7.427280175013729E-5	8.733485772357724E-5	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	2	1	3	1	23	35	42	38	43														CASSAGENTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGACGACAGGGGAGACTGAAGCTTTCTTTGGACAA	CASRTTGETEAFF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	2	5	3	2	23	34	45	37	47														CASRTTGETEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTTAGGCCGGGGGATGAGCAGTTCTTCGGGCCA	CASSLRPGDEQFF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	2	8	7	0	23	35	-1	42	48														CASSLRPGDEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAATTGGGTCCACAGTGACAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	34	7.652349271226266E-5		49	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	3	5	3	9	3	23	37	50	46	53														X+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCTAGCGGACTTTTTTTTTACGAGCAGTACTTCGGGCCG	CASSYASGLFFYEQYF	In	VDJ	1	34	7.652349271226266E-5	8.998136856368564E-5	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	4	5	4	1	10	23	38	46	39	56						01,02								CASSYASGLFFYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCTGAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSAEGNTEAFF	In	VDJ	1	35	7.877418367438804E-5	9.262787940379404E-5	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	0	1	3	0	23	35	-1	38	43														CASSAEGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCACGGGACGGAAAATGAAGCTTTCTTTGGACAA	CASSYHGTENEAFF	In	VDJ	1	35	7.877418367438804E-5	9.262787940379404E-5	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	2	0	7	7	3	6	23	38	46	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYHGTENEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCGGTTTTATCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSYAVLSGANVLTF	In	VDJ	1	35	7.877418367438804E-5	9.262787940379404E-5	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	2	7	5	1	0	5	23	-1	42	38	47						01,02								CASSYAVLSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGCGGGGAGCGGGTAAGTTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	35	7.877418367438804E-5		43	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	11	6	4	2	6	6	23	29	41	35	47						01,02								X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCCCGAAAAAGTCGTCATATGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	36	8.10248746365134E-5		44	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	10	0	10	5	20	0	23	30	-1	50	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGTGCGGGGGGGCATACCGGGGAGCTGTTTTTTGGAGAA	CASSYGAGGHTGELFF	In	VDJ	1	36	8.10248746365134E-5	9.527439024390244E-5	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	7	0	5	3	3	23	38	50	41	53														CASSYGAGGHTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCGACAGCTATGGCTACACCTTCGGTTCG	CASSSDSYGYTF	In	VDJ	1	36	8.10248746365134E-5	9.527439024390244E-5	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	5	4	2	0	23	36	-1	38	43														CASSSDSYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACCCCAATCCCTAATGAAAAACTGTTTTTTGGCAGT	CASSYTPIPNEKLFF	In	VDJ	1	37	8.327556559863878E-5	9.792090108401084E-5	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	2	3	7	3	0	8	23	-1	40	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYTPIPNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCCCTAAGGGGCCTAAATACGCAGTATTTTGGCCCA	CASSLRGLNTQYF	In	VDJ	1	37	8.327556559863878E-5	9.792090108401084E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	5	2	7	6	5	23	32	43	38	48														CASSLRGLNTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGAGGAGGGCTTTTCTACAATGAGCAGTTCTTCGGGCCA	CAIRGGLFYNEQFF	In	VDJ	1	37	8.327556559863878E-5	9.792090108401084E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	10	0	3	1	5	23	34	41	35	46														CAIRGGLFYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAACCGAAGGAACACTGAAGCTTTCTTTGGACAA	CASSYNRRNTEAFF	In	VDJ	1	38	8.552625656076415E-5	1.0056741192411925E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	2	2	8	1	4	2	23	38	44	42	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYNRRNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAACAGGGATAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CANRDSSGANVLTF	In	VDJ	1	39	8.777694752288953E-5	1.0321392276422765E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	6	1	8	0	0	3	23	-1	37	34	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CANRDSSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTATGCGGCAGCGGGCCCAGCATTTTGGTGAT		Out	VDJ	1	39	8.777694752288953E-5		40	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	1	6	4	11	7	0	23	39	-1	46	52						01,02								X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCTAGCCCTCAGGGGGCGCGGCGAGCAGTACTTCGGGCCG	CASLALRGRGEQYF	In	VDJ	1	39	8.777694752288953E-5	1.0321392276422765E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	4	0	6	8	4	23	32	48	40	52														CASLALRGRGEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
TCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCTCTAGGTGGACTAGCGGGGGCCTTATAGACTACGAGCAGTACTTCGGGCCG	CASSSSRWTSGGLIDYEQYF	In	VDJ	1	39	8.777694752288953E-5	1.0321392276422765E-4	60	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	1	2	3	5	9	21	38	56	43	65														CASSSSRWTSGGLIDYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATGGGGGGACTAGTACAGATACGCAGTATTTTGGCCCA	CASSDGGTSTDTQYF	In	VDJ	1	40	9.00276384850149E-5	1.0586043360433605E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	8	3	6	1	23	35	49	41	50						01,02								CASSDGGTSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGTATACAGGGATAATTCTCCTACGAGCAGTACTTCGGGCCG	CASSCIQG*FSYEQYF	Stop	VDJ	1	40	9.00276384850149E-5		48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	3	0	4	6	23	36	46	40	52														CASSCIQG*FSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGATCTGGACAGGGCGTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASRSGQGVSNQPQHF	In	VDJ	1	41	9.227832944714028E-5	1.0850694444444444E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	3	0	4	3	23	34	46	38	49														CASRSGQGVSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGGGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	41	9.227832944714028E-5		37	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	2	0	7	4	1	0	23	38	-1	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCCCAAGGGAGCAGTCTGTTCTTCGGGCCA	CASSYPQGSSLFF	In	VDJ	1	41	9.227832944714028E-5	1.0850694444444444E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	9	2	15	6	6	23	38	49	44	55														CASSYPQGSSLFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTGACAGGGACGTCGGGGAGCTACACCTTCGGTTCG	CASSYLTGTSGSYTF	In	VDJ	1	41	9.227832944714028E-5	1.0850694444444444E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	3	9	1	10	23	39	47	40	57														CASSYLTGTSGSYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTAGGGGACGCCGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	42	9.452902040926564E-5		41	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	6	0	7	2	4	4	23	34	43	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGGCAGTTCTAGCACAGATACGCAGTATTTTGGCCCA	CASSDGSSSTDTQYF	In	VDJ	1	42	9.452902040926564E-5	1.1115345528455284E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	5	2	7	0	0	9	23	-1	38	35	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDGSSSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCGGTTCGACAGGCCCTAAGCTACGAGCAGTACTTCGGGCCG	CASSYPVRQALSYEQYF	In	VDJ	1	42	9.452902040926564E-5	1.1115345528455284E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	4	3	7	7	23	38	51	45	58														CASSYPVRQALSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCCCAGACCTCAGGGTCCATCAGCCCCAGCATTTTGGTGAT	CASSPPDLRVHQPQHF	In	VDJ	1	43	9.677971137139102E-5	1.1379996612466124E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	3	5	11	3	23	35	51	46	54														CASSPPDLRVHQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCAACAGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSYQQGSYEQYF	In	VDJ	1	43	9.677971137139102E-5	1.1379996612466124E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	3	0	2	0	23	38	-1	40	46														CASSYQQGSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGGACCGGGACCGAGCGCTTTTTGGGGAACACTGAAGCTTTCTTTGGACAA	CARTGTERFLGNTEAFF	In	VDJ	1	43	9.677971137139102E-5	1.1379996612466124E-4	51	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	9	0	7	1	4	15	23	31	40	35	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CARTGTERFLGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCTCAGCAAGCCAAAAACATTCAGTACTTCGGCGCC	CASRPQQAKNIQYF	In	VDJ	1	44	9.903040233351639E-5	1.1644647696476964E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-04	01	6	4	5	0	4	2	23	34	41	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPQQAKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01		TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGTGGGAGGGGCGATGAACTATGGCTACACCTTCGGTTCG	CASSVGGAMNYGYTF	In	VDJ	1	45	1.0128109329564176E-4	1.1909298780487805E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	9	0	2	3	6	23	34	44	37	50														CASSVGGAMNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTTGGGGGATTGCTCTATGGCTACACCTTCGGTTCG	CASSVGGLLYGYTF	In	VDJ	1	45	1.0128109329564176E-4	1.1909298780487805E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	6	1	4	3	6	23	35	43	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGGLLYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAAGTGGACACCTTAACTATGGCTACACCTTCGGTTCG	CASRSGHLNYGYTF	In	VDJ	1	46	1.0353178425776714E-4	1.2173949864498645E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	6	1	4	3	23	34	43	38	46														CASRSGHLNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGAGTGCTAGCGGGAGAAAGCAATGAGCAGTTCTTCGGGCCA	CAIRVLAGESNEQFF	In	VDJ	1	46	1.0353178425776714E-4	1.2173949864498645E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	2	6	4	4	23	34	48	38	52														CAIRVLAGESNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGAGGGGCGGGGGGCGTACAATGAGCAGTTCTTCGGGCCA	CASSEGRGAYNEQFF	In	VDJ	1	47	1.057824752198925E-4	1.2438600948509485E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	7	1	4	6	2	23	34	48	40	50														CASSEGRGAYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATACCACAGGGCGCAGGTCACCCCTCCACTTTGGGAAC	CASSYTTGRRSPLHF	In	VDJ	1	47	1.057824752198925E-4	1.2438600948509485E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	3	3	10	4	6	23	37	47	41	53														CASSYTTGRRSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGGGACAGGAGGTTTCACCCCTCCACTTTGGGAAC	CASSWGQEVSPLHF	In	VDJ	1	47	1.057824752198925E-4	1.2438600948509485E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	0	4	9	1	4	23	36	45	37	49														CASSWGQEVSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTAACGGGCCAACCCACAGAGACCCAGTACTTCGGGCCA	CASSVTGQPTETQYF	In	VDJ	1	48	1.0803316618201788E-4	1.2703252032520327E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	5	8	0	4	5	8	23	35	44	40	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVTGQPTETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAAGGGAGTGGATGGCTACACCTTCGGTTCG	CASSYKGVDGYTF	In	VDJ	1	48	1.0803316618201788E-4	1.2703252032520327E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	9	2	6	2	3	23	38	45	40	48														CASSYKGVDGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATTCAGGGGGCCTAGAACTATGGCTACACCTTCGGTTCG	CASIQGA*NYGYTF	Stop	VDJ	1	48	1.0803316618201788E-4		42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	0	2	2	4	23	33	43	35	47														CASIQGA*NYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCTCCCCGGGACTAGCGGGTGAGACCCAGTACTTCGGGCCA	CATSPGLAGETQYF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	10	0	4	5	7	1	23	30	49	37	50						01,02								CATSPGLAGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTGTCAGGGGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLSGGSNQPQHF	In	VDJ	1	50	1.1253454810626863E-4	1.3232554200542004E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	1	1	3	1	23	36	46	39	47														CASSLSGGSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGGGACAGGGCCTGATCAGCCCCAGCATTTTGGTGAT	CASSPGTGPDQPQHF	In	VDJ	1	51	1.14785239068394E-4	1.3497205284552846E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	3	5	3	4	23	35	47	38	51														CASSPGTGPDQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCCAAGGTTCGACGAGCAGTACTTCGGGCCG	CASSSPRFDEQYF	In	VDJ	1	51	1.14785239068394E-4	1.3497205284552846E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	4	5	4	5	5	4	23	36	44	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPRFDEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCGTGGCTAGCGGTCGGGAGACCCAGTACTTCGGGCCA	CASSSVASGRETQYF	In	VDJ	1	51	1.14785239068394E-4	1.3497205284552846E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	4	5	5	6	4	23	36	49	42	53						01,02								CASSSVASGRETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGACCCGACCAGAACACTGAAGCTTTCTTTGGACAA	CAIRPDQNTEAFF	In	VDJ	1	51	1.14785239068394E-4	1.3497205284552846E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	6	2	7	1	4	2	23	34	41	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAIRPDQNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGGACAGGGACACAGATACGCAGTATTTTGGCCCA	CASSEDRDTDTQYF	In	VDJ	1	52	1.1703593003051937E-4	1.3761856368563685E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	3	2	2	1	23	35	45	37	46														CASSEDRDTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCAGGGGGGGTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	52	1.1703593003051937E-4		43	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	2	4	1	1	0	2	23	-1	45	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACTGTACCGGGACAGGGGGGGAACACTGAAGCTTTCTTTGGACAA	CATVPGQGGNTEAFF	In	VDJ	1	53	1.1928662099264474E-4	1.4026507452574526E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	0	1	1	7	1	23	30	48	37	49														CATVPGQGGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGACGAGGGATTATGGCTACACCTTCGGTTCG		Out	VDJ	1	53	1.1928662099264474E-4		40	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	11	0	5	3	2	23	38	46	41	48														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCCCCAGGGAGGGCTTCACCCCTCCACTTTGGGAAC	CASSYAPGRASPLHF	In	VDJ	1	53	1.1928662099264474E-4	1.4026507452574526E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	2	9	0	9	6	1	23	38	51	44	52														CASSYAPGRASPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCAGGGTCTAGCACAGATACGCAGTATTTTGGCCCA	CASSSGSSTDTQYF	In	VDJ	1	53	1.1928662099264474E-4	1.4026507452574526E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	3	0	0	3	23	-1	41	36	44														CASSSGSSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACAGGGGGTAACAATCAGCCCCAGCATTTTGGTGAT	CASSYSTGGNNQPQHF	In	VDJ	1	54	1.2153731195477012E-4	1.4291158536585365E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	2	1	3	0	3	23	-1	49	40	52														CASSYSTGGNNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGGGGATCCGGGGACTGAAGCTTTCTTTGGACAA	CASSDGDPGTEAFF	In	VDJ	1	55	1.2378800291689549E-4	1.4555809620596207E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	3	5	2	8	23	35	42	37	50														CASSDGDPGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCCGGCCGAGTATAATTCACCCCTCCACTTTGGGAAC	CASSYPAEYNSPLHF	In	VDJ	1	55	1.2378800291689549E-4	1.4555809620596207E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-06	01	3	9	0	4	3	4	23	37	43	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYPAEYNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01		TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGAGGGGACAGGGCCTACAATGAGCAGTTCTTCGGGCCA	CAIRGDRAYNEQFF	In	VDJ	1	55	1.2378800291689549E-4	1.4555809620596207E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	2	2	0	23	34	-1	36	45														CAIRGDRAYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCTCGGACTCCCCTCCACCTGGCACAGATACGCAGTATTTTGGCCCA	CATSDSPPPGTDTQYF	In	VDJ	1	56	1.2603869387902087E-4	1.4820460704607045E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	10	1	10	1	4	12	23	30	39	34	51						01,02								CATSDSPPPGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTATCGACGGACGGGCGAACACTGAAGCTTTCTTTGGACAA	CASIDGRANTEAFF	In	VDJ	1	56	1.2603869387902087E-4	1.4820460704607045E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	9	1	7	1	7	4	23	31	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASIDGRANTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTCCTATGTCGGGGATAGATACGCAGTATTTTGGCCCA	CASTPMSGIDTQYF	In	VDJ	1	57	1.2828938484114622E-4	1.5085111788617887E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	8	3	5	9	2	23	33	47	42	49														CASTPMSGIDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACTCTCAGCGGTCAGGAACACTGAAGCTTTCTTTGGACAA	CASRLSAVRNTEAFF	In	VDJ	1	57	1.2828938484114622E-4	1.5085111788617887E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	6	5	1	6	4	23	34	45	40	49						01,02								CASRLSAVRNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGGGGACAGGGGATAGATACGCAGTATTTTGGCCCA	CASSYRGQGIDTQYF	In	VDJ	1	57	1.2828938484114622E-4	1.5085111788617887E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	0	2	5	2	2	23	38	50	40	52														CASSYRGQGIDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSYSGSGANVLTF	In	VDJ	1	57	1.2828938484114622E-4	1.5085111788617887E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	0	6	2	1	0	0	23	-1	-1	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGACAGGAAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSGQENTGELFF	In	VDJ	1	58	1.305400758032716E-4	1.5349762872628726E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	4	2	0	2	23	-1	42	35	44														CASSGQENTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGACTGGACAGGGCCAAGGGGCTTTCTTTGGACAA		Out	VDJ	1	58	1.305400758032716E-4		43	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	3	11	4	7	23	38	50	42	57														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCTTTGTGGGACTACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	58	1.305400758032716E-4		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	0	9	4	6	1	23	40	53	46	54						01,02								X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAGGGGAGGCCTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	58	1.305400758032716E-4		43	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	9	1	0	1	3	23	37	44	38	47														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGACTAGCGGGAGTATGGATACGCAGTATTTTGGCCCA	CASSPTSGSMDTQYF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	2	2	6	2	4	23	35	49	37	53														CASSPTSGSMDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAACTCAGGGGAAGTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	59	1.3279076676539698E-4		44	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	2	9	5	3	23	40	51	45	54														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCCGGGCATCCTCGGTTCACCCCTCCACTTTGGGAAC	CASSSPGILGSPLHF	In	VDJ	1	59	1.3279076676539698E-4	1.5614413956639567E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-06	01	4	8	0	9	4	8	23	36	44	40	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPGILGSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01		TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGAAAGGGACAGGGGGCATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	60	1.3504145772752236E-4		47	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	0	4	5	1	23	34	51	39	52														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGACAGGGGTGGAGACCCAGTACTTCGGGCCA	CASSYGTGVETQYF	In	VDJ	1	60	1.3504145772752236E-4	1.5879065040650406E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	0	2	5	0	2	23	-1	48	38	50														CASSYGTGVETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTGCAGGACACCTACGAGCAGTACYTCGGGCCG	CASSLQDTYEQYX	In	VDJ	1	61	1.372921486896477E-4	1.6143716124661248E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	6	2	5	0	23	35	-1	40	45														CASSLQDTYEQYX+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTCCCCCCCGGGGGCGCCATGTTCGAGCTCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	62	1.395428396517731E-4		53	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-06	01	14	6	0	0	7	12	23	26	39	33	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01		TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGAGAAACAGGGGATCCACAGATACGCAATATTTTGGCCCA	CASKRNRGSTDTQYF	In	VDJ	1	62	1.395428396517731E-4	1.6408367208672087E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	3	2	15	6	16	23	33	46	39	62														CASKRNRGSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGACTGGGGAGACCCAGTACTTCGGGCCA	CASSGTGETQYF	In	VDJ	1	62	1.395428396517731E-4	1.6408367208672087E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	10	5	0	3	23	-1	41	35	44						01,02								CASSGTGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATGAAGCGGGGGGAATAGATACGCAGTATTTTGGCCCA	CASSYEAGGIDTQYF	In	VDJ	1	62	1.395428396517731E-4	1.6408367208672087E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	6	1	5	3	3	23	37	49	40	52														CASSYEAGGIDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGAAACCCCTGGGACAGGGGTCGGTACAATGAGCAGTTCTTCGGGCCA	CASSYRNPWDRGRYNEQFF	In	VDJ	1	63	1.4179353061389847E-4	1.6673018292682928E-4	57	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	2	4	10	4	23	38	58	48	62														CASSYRNPWDRGRYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATACGAAAGCAAGATCAGCCCCAGCATTTTGGTGAT	CASIRKQDQPQHF	In	VDJ	1	63	1.4179353061389847E-4	1.6673018292682928E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	7	6	7	5	6	3	23	33	42	39	45						01,02								CASIRKQDQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCGATGGGAGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPMGGSGANVLTF	In	VDJ	1	65	1.462949125381492E-4	1.7202320460704606E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	6	9	1	0	6	0	23	34	-1	40	46														CASSPMGGSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACAGGGGTGGCAGATACGCAGTATTTTGGCCCA	CASSTGVADTQYF	In	VDJ	1	65	1.462949125381492E-4	1.7202320460704606E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	2	4	0	3	23	-1	42	35	45														CASSTGVADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCCTCCGGGACCGAACCTACGAGCAGTACTTCGGGCCG	CAISLRDRTYEQYF	In	VDJ	1	65	1.462949125381492E-4	1.7202320460704606E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	6	0	7	2	5	4	23	34	44	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISLRDRTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGGGGCTACGAGCAGTACTTCGGGCCG	CASSYSRGYEQYF	In	VDJ	1	66	1.4854560350027458E-4	1.7466971544715447E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	0	5	2	3	1	0	23	40	-1	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSRGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGGAGGGGCACAGATACGCAGTATTTTGGCCCA	CASSYSGRGTDTQYF	In	VDJ	1	67	1.5079629446239996E-4	1.7731622628726286E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	9	0	1	1	0	23	40	-1	41	48														CASSYSGRGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCGACGGTTACAATGAGCAGTTCTTCGGGCCA	CAISDGYNEQFF	In	VDJ	1	67	1.5079629446239996E-4	1.7731622628726286E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	6	2	7	4	1	3	23	34	38	35	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISDGYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAACGGGGCCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASKRGPNTGELFF	In	VDJ	1	68	1.5304698542452532E-4	1.7996273712737128E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	7	7	0	0	3	1	23	33	41	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKRGPNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGATTCTCGGACAGGGGTCGGGAGCAGTACTTCGGGCCG	CASRFSDRGREQYF	In	VDJ	1	68	1.5304698542452532E-4	1.7996273712737128E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	2	7	6	4	23	34	49	40	53														CASRFSDRGREQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTTTCCCTCGGTAGAAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	68	1.5304698542452532E-4		44	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	1	5	8	8	10	1	23	39	52	49	53						01,02								X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATGGGTCTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSYGSYSNQPQHF	In	VDJ	1	69	1.552976763866507E-4	1.8260924796747967E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	3	0	9	0	1	5	23	37	41	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGSYSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCACGACCTTTTCTGGCTACACCTTCGGTTCG	CASSPTTFSGYTF	In	VDJ	1	70	1.5754836734877608E-4	1.8525575880758808E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	6	2	7	7	6	6	23	34	43	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPTTFSGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCCGCGGGGCCTACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	71	1.5979905831090146E-4		44	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	7	3	2	3	4	23	37	46	40	50														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCACACCATGGGCAGGAAACACCATATATTTTGGAGAG	CAITPWAGNTIYF	In	VDJ	1	71	1.5979905831090146E-4	1.8790226964769647E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	10	8	0	4	9	1	23	30	43	39	44														CAITPWAGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTCACCTCAGAGGATACGCAGTATTTTGGCCCA	CASSLTSEDTQYF	In	VDJ	1	72	1.620497492730268E-4	1.9054878048780488E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	5	4	5	6	7	2	23	35	45	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTSEDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGTAATGGACTGGCTAATGAAAAACTGTTTTTTGGCAGT	CASSGNGLANEKLFF	In	VDJ	1	73	1.643004402351522E-4	1.9319529132791327E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	1	10	3	6	2	23	35	46	41	48						01,02								CASSGNGLANEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTTCGGGGATTCTTGAGTACAATGAGCAGTTCTTCGGGCCA	CASTSGILEYNEQFF	In	VDJ	1	74	1.6655113119727757E-4	1.958418021680217E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	8	3	4	3	9	23	33	41	36	50														CASTSGILEYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGAGGACTAGCGGAGGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	75	1.6880182215940295E-4		49	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	1	5	1	2	2	23	36	48	38	50						01,02								X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCACAGGGTCCAGGCCTGAAGCTTTCTTTGGACAA	CASSFTGSRPEAFF	In	VDJ	1	75	1.6880182215940295E-4	1.9848831300813008E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	3	6	2	7	23	36	44	38	51														CASSFTGSRPEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGAAGGGCTTGATGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	75	1.6880182215940295E-4		43	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	8	5	3	2	3	7	23	32	39	35	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCGGGCGGGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	76	1.710525131215283E-4		37	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	8	7	3	4	3	0	23	32	-1	35	41														X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTCAGGGGGTCCAAAGGGGACCCAGTACTTCGGGCCA	CASSSGGPKGTQYF	In	VDJ	1	77	1.7330320408365368E-4	2.0378133468834688E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	1	7	2	9	23	34	43	36	52														CASSSGGPKGTQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCCGGAATAGCGGGGGAGACCCAGTACTTCGGGCCA	CASSYAGIAGETQYF	In	VDJ	1	77	1.7330320408365368E-4	2.0378133468834688E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	5	3	5	7	0	23	38	-1	45	53														CASSYAGIAGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACGCTAGCCACCAAGACCGGGGAGCTGTTTTTTGGAGAA	CASTLATKTGELFF	In	VDJ	1	78	1.7555389504577906E-4	2.064278455284553E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	4	7	5	2	7	23	33	40	35	47						01,02								CASTLATKTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAACATCAAGGAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASRTSRNSNQPQHF	In	VDJ	1	78	1.7555389504577906E-4	2.064278455284553E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	6	1	8	0	8	1	23	34	45	42	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRTSRNSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGCTAGCGGGAGACACGGGGAGCTGTTTTTTGGAGAA	CASRASGRHGELFF	In	VDJ	1	78	1.7555389504577906E-4	2.064278455284553E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	4	2	7	2	3	23	34	46	36	49														CASRASGRHGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATTTACTCCCCGGGGAGGAACACTGAAGCTTTCTTTGGACAA	CASIYSPGRNTEAFF	In	VDJ	1	79	1.778045860079044E-4	2.0907435636856368E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	8	3	1	2	2	23	40	47	42	49						01,02								CASIYSPGRNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCATAATACTAGCGGGGGTATACAATGAGCAGTTCTTCGGGCCA	CASSIILAGVYNEQFF	In	VDJ	1	80	1.800552769700298E-4	2.117208672086721E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	3	2	4	6	2	23	34	51	40	53														CASSIILAGVYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGTCGGGATCATGAACACTGAAGCTTTCTTTGGACAA	CASRVGIMNTEAFF	In	VDJ	1	80	1.800552769700298E-4	2.117208672086721E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	8	3	0	3	3	23	34	42	37	45														CASRVGIMNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTGGACAGGGCGAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLDRASSGANVLTF	In	VDJ	1	80	1.800552769700298E-4	2.117208672086721E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	1	3	0	1	4	23	36	45	37	49														CASSLDRASSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTTTCCACGGGTCCCCCTCTAAAATACGAGCAGTACTTCGGGCCG	CASSFSTGPPLKYEQYF	In	VDJ	1	80	1.800552769700298E-4	2.117208672086721E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	8	4	4	6	13	23	36	46	42	59						01,02								CASSFSTGPPLKYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCCCTAGAGGGGAATCAGCCCCAGCATTTTGGTGAT	CASSYALEGNQPQHF	In	VDJ	1	81	1.8230596793215517E-4	2.143673780487805E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	2	5	2	4	7	0	23	38	-1	45	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYALEGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCCTGGGGCCGACCCCCGGGAGCATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	81	1.8230596793215517E-4		58	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	8	2	0	17	2	23	36	59	53	61														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCACCGCAGGGGGCGGATTGACTGAAGCTTTCTTTGGACAA	CASSTAGGGLTEAFF	In	VDJ	1	82	1.8455665889428055E-4	2.1701388888888888E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	0	5	5	6	23	34	47	39	53														CASSTAGGGLTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGAAGGAGGGCCTGACCTACGAGCAGTACTTCGGGCCG	CASRKEGLTYEQYF	In	VDJ	1	82	1.8455665889428055E-4	2.1701388888888888E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	10	0	2	3	5	23	34	43	37	48														CASRKEGLTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCAGGGGGGACAGCCCCAGCATTTTGGTGAT	CASRQGGQPQHF	In	VDJ	1	82	1.8455665889428055E-4	2.1701388888888888E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	1	7	1	2	23	34	42	35	44														CASRQGGQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGGTTAATCGGGGCGAGGGGCACTGAAGCTTTCTTTGGACAA	CASRGLIGARGTEAFF	In	VDJ	1	82	1.8455665889428055E-4	2.1701388888888888E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	6	5	2	4	16	0	23	34	-1	50	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGLIGARGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAACCTTTTCCTGAGGGCTACGAGCAGTACTTCGGGCCG	CASS*PFPEGYEQYF	Stop	VDJ	1	83	1.868073498564059E-4		45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	11	0	3	10	0	23	37	-1	47	52														CASS*PFPEGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATTCGACAGGGACGCCGGGGAGCTACACTTTCGGTTCG	CASSYSTGTPGSYTF	In	VDJ	1	83	1.868073498564059E-4	2.196603997289973E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	3	17	3	18	23	37	47	40	65														CASSYSTGTPGSYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACAACTCGCCGGGGAACACTGAAGCTTTCTTTGGACAA	CASNNSPGNTEAFF	In	VDJ	1	85	1.9130873178065667E-4	2.249534214092141E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	7	8	4	1	9	0	23	33	-1	42	46						01,02								CASNNSPGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTGGGGAGTATCCCGGGGCACAGATACGCAGTATTTTGGCCCA	CASSWGVSRGTDTQYF	In	VDJ	1	85	1.9130873178065667E-4	2.249534214092141E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	9	2	1	3	9	23	34	42	37	51														CASSWGVSRGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCCAGGGAGCGCACTCAGCCCCAGCATTTTGGTGAT	CASRPRERTQPQHF	In	VDJ	1	86	1.9355942274278205E-4	2.2759993224932248E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	6	4	3	6	3	7	23	34	42	37	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPRERTQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGAGGTCGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSYEVGSNQPQHF	In	VDJ	1	86	1.9355942274278205E-4	2.2759993224932248E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	2	11	1	0	0	4	23	-1	42	38	46														CASSYEVGSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGGGAGTCCGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSGSPGTGELFF	In	VDJ	1	87	1.958101137049074E-4	2.302464430894309E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	8	2	4	0	6	23	-1	40	34	46														CASSGSPGTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGGACAGGGCGACGGCTTTCTTTGGACAA	CASSWDRATAFF	In	VDJ	1	87	1.958101137049074E-4	2.302464430894309E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	3	11	0	5	23	-1	45	36	50														CASSWDRATAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTGAGGGACAGGGGGCGTGGGGCTACACCTTCGGTTCG	CASTEGQGAWGYTF	In	VDJ	1	88	1.9806080466703278E-4	2.328929539295393E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	0	8	4	4	23	33	49	37	53														CASTEGQGAWGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTGATAGGACTAGCGGGAAGAGGGACCACAATGAGCAGTTCTTCGGGCCA	CASTDRTSGKRDHNEQFF	In	VDJ	1	89	2.0031149562915816E-4	2.355394647696477E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	1	3	5	6	9	23	33	51	39	60														CASTDRTSGKRDHNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTACAGTAGCTTCACAGATACGCAGTATTTTGGCCCA	CASSYSSFTDTQYF	In	VDJ	1	89	2.0031149562915816E-4	2.355394647696477E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	5	7	2	2	2	23	38	44	40	46						01,02								CASSYSSFTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCACGGGGACAGGGTAATCAGCCCCAGCATTTTGGTGAT	CASSYSRGQGNQPQHF	In	VDJ	1	89	2.0031149562915816E-4	2.355394647696477E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	0	3	4	3	1	23	40	52	43	53														CASSYSRGQGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGCCAGCGGGAGGGCACACAGATACGCAGTATTTTGGCCCA	CASSSPAGGHTDTQYF	In	VDJ	1	89	2.0031149562915816E-4	2.355394647696477E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	6	0	2	4	2	23	36	50	40	52														CASSSPAGGHTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCTGGGACAGACTAACTATGGCTACACCTTCGGTTCG	CASLGQTNYGYTF	In	VDJ	1	90	2.025621865912835E-4	2.381859756097561E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	0	5	0	2	1	23	32	41	34	42														CASLGQTNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGAAGAAAGGGGTTTGGGAGCCAAGAGACCCAGTACTTCGGGCCA	CASGRKGFGSQETQYF	In	VDJ	1	92	2.0706356851553427E-4	2.434789972899729E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	8	5	2	1	7	8	23	32	44	39	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGRKGFGSQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACAGGATCGAACACTGAAGCTTTCTTTGGACAA	CASSYTGSNTEAFF	In	VDJ	1	93	2.0931425947765965E-4	2.461255081300813E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	4	1	0	3	23	-1	43	38	46														CASSYTGSNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACTGGAGGTTCCTACGAGCAGTACTTCGGGCCG	CASSYSTGGSYEQYF	In	VDJ	1	94	2.11564950439785E-4	2.487720189701897E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	10	1	1	4	1	23	40	49	44	50														CASSYSTGGSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGTAACAGGGAACACTGAAGCTTTCTTTGGACAA	CASRVTGNTEAFF	In	VDJ	1	95	2.1381564140191038E-4	2.514185298102981E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	4	1	4	0	23	34	-1	38	43														CASRVTGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTGGGCAGGGGGCCTTCACCCCTCCACTTTGGGAAC	CASSLGRGPSPLHF	In	VDJ	1	95	2.1381564140191038E-4	2.514185298102981E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	4	0	9	4	1	23	36	48	40	49														CASSLGRGPSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACTTCACAGGGCGGCGACACAGATACGCAGTATTTTGGCCCA	CATSQGGDTDTQYF	In	VDJ	1	96	2.1606633236403576E-4	2.5406504065040653E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	10	3	3	2	4	6	23	30	40	34	46														CATSQGGDTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCCGGACGGGAGAAGGAGATACGCAGTATTTTGGCCCA	CASSARTGEGDTQYF	In	VDJ	1	96	2.1606633236403576E-4	2.5406504065040653E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	8	2	5	7	4	23	35	48	42	52														CASSARTGEGDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGACTAGCGGGAGGGTCGGGCACCGGGGAGCTGTTTTTTGGAGAA	CAISGLAGGSGTGELFF	In	VDJ	1	96	2.1606633236403576E-4	2.5406504065040653E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	1	0	4	0	5	23	-1	50	35	55														CAISGLAGGSGTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTACACCGGCTCGGATGGCTACACCTTCGGTTCG		Out	VDJ	1	97	2.1831702332616114E-4		41	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	3	6	6	3	9	23	35	41	38	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGTCCCCCGAGCAGTACTTCGGGCCG	CASSYSSPEQYF	In	VJ	1	97	2.1831702332616114E-4	2.567115514905149E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	0	0	0	6	0	6	23	-1	40	-1	46														CASSYSSPEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTTTACACCGGGACAGGGTGAGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	98	2.205677142882865E-4		49	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	3	6	9	4	23	34	52	43	56														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGTCCCCGACGACAGGATTGAAAAACTGTTTTTTGGCAGT	CASSPVPDDRIEKLFF	In	VDJ	1	98	2.205677142882865E-4	2.593580623306233E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	4	7	12	2	23	35	53	47	55														CASSPVPDDRIEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCATAGGACCCGTCGGGGGATACACCATATATTTTGGAGAG	CASTIGPVGGYTIYF	In	VDJ	1	100	2.2506909621253726E-4	2.646510840108401E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	7	8	2	8	13	2	23	33	52	46	54														CASTIGPVGGYTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCACAGATTGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	101	2.273197871746626E-4		41	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	5	3	2	4	23	38	44	40	48														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGAATGGGCAGGGTGGGTGAGCAGTACTTCGGGCCG		Out	VDJ	1	101	2.273197871746626E-4		38	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	4	3	7	7	5	23	32	44	39	49														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGTAGCGTTGAAGCTTTCTTTGGACAA	CASSYRSVEAFF	In	VDJ	1	102	2.29570478136788E-4	2.699441056910569E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	5	6	7	2	1	23	38	45	40	46						01,02								CASSYRSVEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGACAGATGAGATCACCCCTCCACTTTGGGAAC	CASSYSGQMRSPLHF	In	VDJ	1	102	2.29570478136788E-4	2.699441056910569E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	0	5	10	0	6	23	-1	47	40	53														CASSYSGQMRSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGAGACCAATCAGCCCCAGCATTTTGGTGAT	CASSYGETNQPQHF	In	VDJ	1	103	2.3182116909891337E-4	2.7259061653116533E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	2	9	2	3	1	2	23	38	44	39	46														CASSYGETNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGTGGTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASRVVSGANVLTF	In	VDJ	1	104	2.3407186006103875E-4	2.752371273712737E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	6	0	10	0	3	1	23	34	39	37	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRVVSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCCTCAAGCGGGGGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CAILKRGGSYNEQFF	In	VDJ	1	104	2.3407186006103875E-4	2.752371273712737E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	10	6	0	0	6	0	23	30	-1	36	46														CAILKRGGSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTGGACACTACGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSWTLRANTEAFF	In	VDJ	1	105	2.363225510231641E-4	2.778836382113821E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	6	1	2	8	23	34	41	36	49														CASSWTLRANTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATGTTGGGGGGCAGTCTGAAGCTTTCTTTGGACAA	CASSYVGGQSEAFF	In	VDJ	1	105	2.363225510231641E-4	2.778836382113821E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	3	6	0	6	5	3	23	37	48	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYVGGQSEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTTCAGGGAGGGCGCTATGGCTACACCTTCGGTTCG	CASSFQGGRYGYTF	In	VDJ	1	105	2.363225510231641E-4	2.778836382113821E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	9	0	4	4	2	23	36	47	40	49														CASSFQGGRYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTGGGACAGGGAGACGCCAACGTCCTGACTTTCGGGGCC	CASSYLGQGDANVLTF	In	VDJ	1	106	2.3857324198528948E-4	2.805301490514905E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	0	3	7	2	4	23	38	49	40	53														CASSYLGQGDANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCAGGGGTTTCCCACGAGCAGTACTTCGGGCCG	CASSSGVSHEQYF	In	VDJ	1	106	2.3857324198528948E-4	2.805301490514905E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	2	5	0	6	23	-1	42	36	48														CASSSGVSHEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGAACGGACGGGCCAACACTGAAGCTTTCTTTGGACAA	CASRNGRANTEAFF	In	VDJ	1	107	2.4082393294741486E-4	2.8317665989159894E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	6	1	7	2	4	5	23	34	42	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRNGRANTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTATCGGGACAACCTACGAGCAGTACTTCGGGCCG	CASSIGTTYEQYF	In	VDJ	1	107	2.4082393294741486E-4	2.8317665989159894E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	6	2	3	1	23	35	44	38	45														CASSIGTTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTACCTGGGCGAACCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	107	2.4082393294741486E-4		53	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	1	8	0	0	4	4	23	39	47	43	51														X+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTTCGACAGACTAGAATAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	107	2.4082393294741486E-4		53	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	2	8	2	7	3	23	39	52	46	55						01,02								X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCGGGACAGCGCATGAACACTGAAGCTTTCTTTGGACAA	CASSPGQRMNTEAFF	In	VDJ	1	108	2.4307462390954024E-4	2.858231707317073E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	5	0	3	4	23	34	44	37	48														CASSPGQRMNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCTCCGGGACAACGATCAGATACGCAGTATTTTGGCCCA	CASSYPPGQRSDTQYF	In	VDJ	1	110	2.4757600583379097E-4	2.9111619241192413E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	0	6	4	5	5	23	38	49	43	54														CASSYPPGQRSDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTAGCGGGAGGCAGGAATGAGCAGTTCTTCGGGCCA	CASSLAGGRNEQFF	In	VDJ	1	111	2.4982669679591635E-4	2.9376270325203255E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	1	7	1	4	23	34	46	35	50														CASSLAGGRNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCTAACCAGGGGGGAGCCAAAAACATTCAGTACTTCGGCGCC	CASSYPNQGGAKNIQYF	In	VDJ	1	112	2.5207738775804173E-4	2.964092140921409E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	2	4	1	0	6	1	23	38	51	44	52														CASSYPNQGGAKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGTCACTAGCGGGGGGGCTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSSSLAGGLSYNEQFF	In	VDJ	1	112	2.5207738775804173E-4	2.964092140921409E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	3	0	0	4	2	23	36	53	40	55														CASSSSLAGGLSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGACGCGTCGGACCCCCAAGCTTTCTTTGGACAA	CASSDASDPQAFF	In	VDJ	1	113	2.543280787201671E-4	2.990557249322493E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	6	1	7	9	9	4	23	34	47	43	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDASDPQAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTCCTCGCTAGTCAGCCCCAGCATTTTGGTGAT	CASSLLASQPQHF	In	VDJ	1	115	2.588294606444178E-4	3.043487466124661E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	4	8	6	8	0	23	34	-1	42	46						01,02								CASSLLASQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCTCTAGCGGGGAATACAATGAGCAGTTCTTCGGGCCA	CASSPSSGEYNEQFF	In	VDJ	1	115	2.588294606444178E-4	3.043487466124661E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	3	4	4	2	23	35	48	39	50														CASSPSSGEYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCGGGACAGGGATAGACGAGCAGTACTTCGGGCCG	CASSYSGTGIDEQYF	In	VDJ	1	115	2.588294606444178E-4	3.043487466124661E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	3	5	1	4	23	40	50	41	54														CASSYSGTGIDEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTGGGACAGGGAATGAAAACTGTTTTTTGGCAGT		Out	VDJ	1	117	2.633308425686686E-4		40	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	3	10	1	4	23	36	46	37	50														X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACCGAAGCGGGGGGGCCGAGTGAGCAGTTCTTCGGGCCA	CASSTEAGGPSEQFF	In	VDJ	2	118	2.6558153353079396E-4	3.1228827913279135E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	6	0	9	5	5	23	35	50	40	55														CASSTEAGGPSEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGGGGGACAGTCTACCTCCGACAGATACGCAGTATTTTGGCCCA	CASSEGDSLPPTDTQYF	In	VDJ	2	118	2.6558153353079396E-4	3.1228827913279135E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	5	3	4	10	23	35	46	39	56														CASSEGDSLPPTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCCGGACAGGGGGCCTCCAATGAGCAGTTCTTCGGGCCA	CASSYAGQGASNEQFF	In	VDJ	2	119	2.6783222449291934E-4	3.149347899728997E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	1	0	6	3	3	23	38	52	41	55														CASSYAGQGASNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGGTGGACTACCTACGAGCAGTACTTCGGGCCG	CASSYRWTTYEQYF	In	VDJ	2	120	2.700829154550447E-4	3.175813008130081E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	1	9	2	4	0	23	38	-1	42	48						01,02								CASSYRWTTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTATTAGCGGGTTCCTACGAGCAGTACTTCGGGCCG	CASSLLAGSYEQYF	In	VDJ	2	120	2.700829154550447E-4	3.175813008130081E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	5	4	1	3	1	23	36	46	39	47						01,02								CASSLLAGSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACGGGACTAGCCGTAGATACGCAGTATTTTGGCCCA	CASTGLAVDTQYF	In	VDJ	2	122	2.745842973792954E-4	3.2287432249322495E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	0	7	5	1	3	23	33	43	34	46						01,02								CASTGLAVDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATGCGGGAGGGATTGAGCAGTACTTCGGGCCG	CASSYAGGIEQYF	In	VDJ	2	122	2.745842973792954E-4	3.2287432249322495E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	7	0	7	1	3	23	37	47	38	50														CASSYAGGIEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGACCCCGGGCGGCTAATTCACCCTTCCACTTTGGGAAC	CASSRPRAANSPFHF	In	VDJ	2	125	2.8133637026567156E-4	3.3081385501355015E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-06	01	5	8	0	17	7	14	23	35	46	42	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRPRAANSPFHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01		TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATTATCGGCAGGGGGGGCACTGAAGCTTTCTTTGGACAA	CASIIGRGGTEAFF	In	VDJ	2	127	2.858377521899223E-4	3.361068766937669E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	7	4	1	4	7	2	23	33	47	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASIIGRGGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGACCAGGAGAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASDQESSGANVLTF	In	VDJ	2	128	2.880884431520477E-4	3.3875338753387534E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	8	4	4	0	3	4	23	32	39	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASDQESSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGGGTTGAGGCTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASRGVEASSYNEQFF	In	VDJ	2	130	2.925898250762984E-4	3.440464092140921E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	6	6	1	0	0	10	23	-1	39	34	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGVEASSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGGGACGGAAATTCACCCCTCCACTTTGGGAAC	CASSRDGNSPLHF	In	VDJ	2	130	2.925898250762984E-4	3.440464092140921E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-06	01	5	0	7	7	1	3	23	35	41	36	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDGNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01		TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGATTTTTGGGGACGGATTCCTACGAGCAGTACTTCGGGCCG	CASRFLGTDSYEQYF	In	VDJ	2	131	2.948405160384238E-4	3.4669292005420053E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	6	0	7	1	7	4	23	34	46	41	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRFLGTDSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTAGCCGCACCCGAAGCTTTCTTTGGACAA	CASSLAAPEAFF	In	VDJ	2	133	2.9934189796267455E-4	3.5198594173441736E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	4	7	8	1	7	23	34	40	35	47						01,02								CASSLAAPEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGGTCGGCTAGACAGCAGTTCTTCGGGCCA	CASSYRSARQQFF	In	VDJ	2	134	3.015925889247999E-4	3.546324525745257E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	4	8	11	7	2	23	38	49	45	51						01,02								CASSYRSARQQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGTGCCAATGAGCAGTTCTTCGGGCCA	CASSYSGANEQFF	In	VDJ	2	134	3.015925889247999E-4	3.546324525745257E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	0	0	9	6	0	3	23	-1	43	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGANEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGCGACAGGGATCGGGACTAATGAAAAACTGTTTTTTGGCAGT	CASATGIGTNEKLFF	In	VDJ	2	134	3.015925889247999E-4	3.546324525745257E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	2	3	2	2	6	23	32	41	34	47														CASATGIGTNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCATTAGGACCAAACACCATATATTTTGGAGAG	CASSSLGPNTIYF	In	VDJ	2	137	3.08344661811176E-4	3.6257198509485097E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-03	01	4	1	7	6	5	1	23	36	45	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSLGPNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01		TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCCGCCCCCATACTAGCGGGGGGGCCAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	140	3.1509673469755215E-4		52	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	3	0	4	10	2	23	34	57	44	59														X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGAGGCCAGGGGGCTGACATTCAGTACTTCGGCGCC	CASSGGQGADIQYF	In	VDJ	2	141	3.1734742565967753E-4	3.731580284552846E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	4	0	8	6	2	23	35	49	41	51														CASSGGQGADIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCCGAGCAGGGGCTACGAACACCGGGGAGCTGTTTTTTGGAGAA	CAIRAGATNTGELFF	In	VDJ	2	146	3.286008804703044E-4	3.8639058265582655E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	10	4	2	0	6	3	23	30	42	36	45														CAIRAGATNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCCCCCGGAAGATTATCCTACGAGCAGTACTTCGGGCCG	CASSYPPGRLSYEQYF	In	VDJ	2	147	3.3085157143242976E-4	3.8903709349593496E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	2	1	8	1	6	6	23	38	47	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYPPGRLSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGATCAGGGGCGAGGATCCACTGAAGCTTTCTTTGGACAA	CASSYDQGRGSTEAFF	In	VDJ	2	150	3.376036443188059E-4	3.9697662601626015E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	2	4	3	8	23	38	47	41	55														CASSYDQGRGSTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCTCACGATGACACCTCGATGCGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	152	3.421050262430566E-4		52	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	2	6	4	8	9	23	36	48	44	57														X+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAAGACCGTAGGCTCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	156	3.511077900915581E-4		41	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-03	01	10	2	7	0	1	8	23	30	34	31	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01		TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCGAACCCGGGACAGTCGGGGCTACACCTTCGGTTCG		Out	VDJ	2	157	3.533584810536835E-4		44	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	8	9	4	23	35	51	44	55														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGAACAGGGTTCCACTGAAGCTTTCTTTGGACAA	CASREQGSTEAFF	In	VDJ	2	158	3.556091720158088E-4	4.1814871273712737E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	4	3	3	23	34	43	37	46														CASREQGSTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGCAGGGCACAGATACGCAGTATTTTGGCCCA	CASSYGQGTDTQYF	In	VDJ	2	158	3.556091720158088E-4	4.1814871273712737E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	4	1	3	0	23	38	-1	41	45														CASSYGQGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAAGGACCTCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	161	3.6236124490218497E-4		37	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	6	1	7	5	2	3	23	34	40	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTAGCGGGCCCCTACGAGCAGTACTTCGGGCCG	CASSLAGPYEQYF	In	VDJ	2	163	3.668626268264357E-4	4.313812669376694E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	4	4	2	0	2	23	-1	43	35	45						01,02								CASSLAGPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAAGGGACAGGGGGCGACTATGGCTACACCTTCGGTTCG	CASS*GTGGDYGYTF	Stop	VDJ	2	168	3.7811608163706257E-4		45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	0	3	1	1	23	37	50	38	51														CASS*GTGGDYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACTGCCCCCCATGAAAAACTGTTTTTTGGCAGT	CASSYSTAPHEKLFF	In	VDJ	2	168	3.7811608163706257E-4	4.4461382113821136E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	2	10	6	0	7	23	-1	44	40	51						01,02								CASSYSTAPHEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCCCTCCGGGACTGGGAATTAACTATGGCTACACCTTCGGTTCG	CASSAPPGLGINYGYTF	In	VDJ	2	170	3.8261746356131333E-4	4.499068428184282E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	0	10	1	8	6	23	35	49	43	55						01,02								CASSAPPGLGINYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGATCGGGACAGATGGGGACCCAGTACTTCGGGCCA	CASSRSGQMGTQYF	In	VDJ	2	172	3.871188454855641E-4	4.5519986449864497E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	5	7	5	5	23	35	47	40	52														CASSRSGQMGTQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTTATTGGTTACGGTAATACGCAGTATTTTGGCCCA	CASSFIGYGNTQYF	In	VDJ	2	172	3.871188454855641E-4	4.5519986449864497E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	8	5	7	10	2	23	36	49	46	51						01,02								CASSFIGYGNTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCCGAAGCGGAAAAACTGTTTTTTGGCAGT	CASSYAEAEKLFF	In	VDJ	2	174	3.916202274098148E-4	4.604928861788618E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	2	6	6	8	5	0	23	38	-1	43	47						01,02								CASSYAEAEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTCAAAAGGGGAGGGGACACTGAAGCTTTCTTTGGACAA	CASSLKRGGDTEAFF	In	VDJ	2	183	4.1187644606894316E-4	4.843114837398374E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	0	3	8	1	23	35	50	43	51														CASSLKRGGDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGGGCTTCTCTGGAAACACCATATATTTTGGAGAG	CASSSGFSGNTIYF	In	VDJ	2	185	4.163778279931939E-4	4.896045054200542E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-03	01	4	8	0	0	1	2	23	36	41	37	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGFSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01		TCRBJ01-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTCGGACAGTTGAACACTGAAGCTTTCTTTGGACAA	CASSVGQLNTEAFF	In	VDJ	2	194	4.366340466523223E-4	5.134231029810298E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	5	0	3	1	23	35	44	38	45														CASSVGQLNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCCTACACTGAAGCTTTCTTTGGACAA	CASSYPYTEAFF	In	VDJ	2	194	4.366340466523223E-4	5.134231029810298E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	4	10	3	2	0	23	38	-1	40	42						01,02								CASSYPYTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTACTAGGTCGTCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	3	198	4.4563681050082375E-4		44	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	3	8	4	3	5	23	35	43	38	48						01,02								X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACCGGGGGGAAAAGACTGAAGCTTTCTTTGGACAA	CASSDRGEKTEAFF	In	VDJ	3	200	4.501381924250745E-4	5.293021680216802E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	1	5	3	5	23	35	45	38	50														CASSDRGEKTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTGGGTCAGGGGTGGGGTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGQGWGNTGELFF	In	VDJ	3	205	4.6139164723570136E-4	5.425347222222222E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	2	2	6	6	23	35	47	41	53														CASSLGQGWGNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATCACTCCGACAGGGCTTGAGGCTTTCTTTGGACAA	CASITPTGLEAFF	In	VDJ	3	209	4.703944110842029E-4	5.531207655826558E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	3	11	7	6	23	33	47	40	53														CASITPTGLEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAAAAAACTAGCGGGAGAGGTCAGATACGCAGTATTTTGGCCCA		Out	VDJ	3	210	4.726451020463282E-4		50	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	3	2	4	4	4	23	37	52	41	56														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTACAGGGGGCAGCCCCAGCATTTTGGTGAT	CASSDYRGQPQHF	In	VDJ	3	214	4.816478658948297E-4	5.663533197831979E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	3	1	7	0	0	23	-1	-1	39	47														CASSDYRGQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGCGGTGATAATTCACCCCTCCACTTTGGGAAC	CASSYSGGDNSPLHF	In	VDJ	3	214	4.816478658948297E-4	5.663533197831979E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-06	01	0	8	0	5	0	4	23	-1	44	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGGDNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01		TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATCATAGGACTAGCGGGAGGGCCTAGCACAGATACGCAGTATTTTGGCCCA	CASIIGLAGGPSTDTQYF	In	VDJ	3	217	4.883999387812058E-4	5.74292852303523E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	1	0	0	5	3	23	33	53	38	56														CASIIGLAGGPSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTCTAGCGGGAGAAGGCCCGAGGTTCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	222	4.996533935918327E-4		58	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	2	2	2	14	23	35	47	37	61														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGCGGCCTATCCTACGAGCAGTACTTCGGGCCG	CASSYSGGLSYEQYF	In	VDJ	3	231	5.19909612250961E-4	6.113440040650406E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	0	8	0	1	0	6	23	-1	44	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGGLSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTAAATGAAAAACTGTTTTTTGGCAGT	CASSYLNEKLFF	In	VDJ	3	233	5.244109941752118E-4	6.166370257452574E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	2	4	9	5	0	0	23	-1	-1	38	41						01,02								CASSYLNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTTGCCATGGAGCGAAAACCTAAATGAAAAACTGTTTTTTGGCAGT	CASLPWSENLNEKLFF	In	VDJ	3	234	5.266616851373372E-4	6.192835365853659E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	8	6	6	5	9	8	23	32	45	41	53						01,02								CASLPWSENLNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAACAGGGCCACTGAAGCTTTCTTTGGACAA	CASSYNRATEAFF	In	VDJ	3	242	5.446672128343402E-4	6.404556233062331E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	3	4	1	1	23	38	45	39	46														CASSYNRATEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCTTTCGGCTAGCGGGAGGTAGCAATGAGCAGTTCTTCGGGCCA	CATFRLAGGSNEQFF	In	VDJ	3	264	5.941824140010983E-4	6.986788617886179E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	10	4	1	6	8	3	23	30	49	38	52														CATFRLAGGSNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGAACAGGACTTTCTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSRTGLSSSYNEQFF	In	VDJ	4	333	7.49480090387749E-4	8.812881097560976E-4	51	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	5	3	4	0	3	9	23	35	43	38	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRTGLSSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGGCCCGAGAACAGCGGGAGGGGAGAGACCCAGTACTTCGGGCCA	CAIRPENSGRGETQYF	In	VDJ	4	341	7.67485618084752E-4	9.024601964769648E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	6	0	4	10	1	23	34	54	44	55														CAIRPENSGRGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGAAGGGAATACGCAGTATTTTGGCCCA	CASSYSEGNTQYF	In	VDJ	5	356	8.012459825166326E-4	9.421578590785908E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	0	0	8	7	4	0	23	40	-1	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSEGNTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGAAGCGGGAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASKKRENTGELFF	In	VDJ	5	367	8.260035831000117E-4	9.712694783197832E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	6	3	1	3	0	23	33	-1	36	43														CASKKRENTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGGGACAGAAGCACAGATACGCAGTATTTTGGCCCA	CASSYRDRSTDTQYF	In	VDJ	5	369	8.305049650242625E-4	9.765625E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	0	5	0	1	1	23	38	46	39	47														CASSYRDRSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCGGAGGCGGGGAAGCAGATACGCAGTATTTTGGCCCA	CASSSGGGEADTQYF	In	VDJ	5	390	8.777694752288952E-4	0.0010321392276422764	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	7	3	4	6	3	23	36	48	42	51														CASSSGGGEADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGATGAGGGGGTATGAGACCCAGTACTTCGGGCCA	CASRMRGYETQYF	In	VDJ	5	399	8.980256938880236E-4	0.001055957825203252	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	5	1	5	4	3	23	34	44	38	47														CASRMRGYETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCCGGCGCATGGAGGGGGACACAGATACGCAGTATTTTGGCCCA	CATRRMEGDTDTQYF	In	VDJ	5	401	9.025270758122744E-4	0.0010612508468834689	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	10	5	1	2	12	1	23	30	48	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATRRMEGDTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACCGAGACCCAGTACTTCGGGCCA	CASSYSTETQYF	In	VDJ	5	420	9.452902040926564E-4	0.0011115345528455284	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	0	2	7	5	0	1	23	-1	43	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSTETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCCACAGGGAATCCTACGAGCAGTACTTCGGGCCG	CASSFHRESYEQYF	In	VDJ	6	431	9.700478046760356E-4	0.001140646172086721	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	3	1	3	2	23	36	45	39	47														CASSFHRESYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCGGGACTAGCGGGAGGGCTGGGTGAGCAGTTCTTCGGGCCA	CASSAGLAGGLGEQFF	In	VDJ	6	435	9.79050568524537E-4	0.0011512322154471546	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	0	9	2	5	23	35	53	37	58														CASSAGLAGGLGEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTTCAGGGGGGGAGCAGTACTTCGGGCCG	CASSPSGGEQYF	In	VDJ	7	510	0.00114785239068394	0.0013497205284552845	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	1	7	4	1	23	35	46	39	47														CASSPSGGEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCGATGGAAATACCTACGAGCAGTACTTCGGGCCG	CASSFDGNTYEQYF	In	VDJ	7	562	0.0012648883207144594	0.0014873390921409215	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	4	1	8	2	5	4	23	36	44	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFDGNTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAAACAGGGGTGGCCCTGAAGCTTTCTTTGGACAA	CASRNRGGPEAFF	In	VDJ	7	574	0.0012918966122599637	0.0015190972222222222	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	2	6	2	5	23	34	43	36	48														CASRNRGGPEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGGGACTCATGAAAAACTGTTTTTTGGCAGT	CASSPGTHEKLFF	In	VDJ	8	593	0.0013346597405403458	0.0015693809281842818	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	0	10	6	3	1	23	35	44	38	45						01,02								CASSPGTHEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACAGGGACGCCGGGGAGCTACACCTTCGGTTCG	CASSYSTGTPGSYTF	In	VDJ	9	689	0.0015507260729043816	0.0018234459688346884	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	3	9	0	10	23	-1	47	40	57														CASSYSTGTPGSYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCCCCCCGGGGCTTAGACATTTCTGAAGCTTTCTTTGGACAA	CASSPRGLDISEAFF	In	VDJ	10	764	0.0017195278950637846	0.0020219342818428186	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	8	7	0	6	7	10	23	32	44	39	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRGLDISEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGCTAGAGGAGCAGTTCTTCGGGCCA	CASSYGLEEQFF	In	VDJ	11	839	0.0018883297172231875	0.0022204225948509486	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	2	8	0	10	0	5	23	-1	42	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGLEEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATTAAACCCGGGGGACAGGGGGTTATTGAGCAGTTCTTCGGGCCA	CAIKPGGQGVIEQFF	In	VDJ	11	856	0.0019265914635793189	0.0022654132791327915	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	0	1	9	10	4	23	30	51	40	55														CAIKPGGQGVIEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGCGGGGGCTTCCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	13	993	0.0022349361253904947		43	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	7	2	2	2	5	23	35	44	37	49														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTAACTAGCGGCGAAACTACGAGCAGTACTTCGGGCCG		Out	VDJ	14	1100	0.0024757600583379096		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	3	5	3	3	5	23	38	49	41	54						01,02								X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCACAGGGGCCCACACCGGGGAGCTGTTTTTTGGAGAA	CASSTGAHTGELFF	In	VDJ	15	1189	0.002676071553967068	0.003146701388888889	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	2	3	1	3	23	34	42	35	45														CASSTGAHTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATGGTGGGGGTTTAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSYGGGLSSYNEQFF	In	VDJ	16	1244	0.0027998595568839635	0.003292259485094851	51	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	3	6	1	0	4	6	23	37	46	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGGGLSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCCGGATGTGAACACTGAAGCTTTCTTTGGACAA	CASTPDVNTEAFF	In	VDJ	16	1259	0.002833619921315844	0.003331957147696477	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	7	1	8	0	4	2	23	33	40	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTPDVNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCACCGGGGAGCCCACAGATACGCAGTATTTTGGCCCA	CASTTGEPTDTQYF	In	VDJ	16	1269	0.002856126830937098	0.003358422256097561	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	8	3	2	4	4	23	33	42	37	46						01,02								CASTTGEPTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGTGGACTAGCGGGAGTCTAGATACGCAGTATTTTGGCCCA		Out	VDJ	23	1802	0.004055745113749921		50	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	1	2	5	3	3	23	38	54	41	57														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGTGACCGAAAAACTGTTTTTTGGCAGT	CASSYVTEKLFF	In	VDJ	50	3902	0.008782196134213204	0.01032668529810298	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	2	2	7	8	2	1	23	38	43	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYVTEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGTTGGTGGTGGCGACGGCTATGGCTACACCTTCGGTTCG	CASSPVGGGDGYGYTF	In	VDJ	1	22	4.9515201166758194E-5	5.822323848238482E-5	48	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-02	01	3	2	7	4	13	2	24	38	54	51	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPVGGGDGYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01		TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGAAGGAACGGGGTCCTACGAGCAGTACTTCGGGCCG	CASSPEGTGSYEQYF	In	VDJ	1	23	5.176589212888357E-5	6.0869749322493224E-5	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	8	3	1	8	0	24	38	-1	46	51													Vb 18	CASSPEGTGSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGATAAGGGGCCCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	24	5.401658309100894E-5		41	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	5	2	7	4	2	24	39	48	43	50													Vb 18	X+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTACGGGGTGGCCGGTAATCGGGAGACCCAGTACTTCGGGCCA	CASYGVAGNRETQYF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	7	8	3	5	1	14	24	34	40	35	54													Vb 18	CASYGVAGNRETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGGGTCCAATCAGCCCCAGCATTTTGGTGAT	CASSPPGSNQPQHF	In	VDJ	1	27	6.076865597738506E-5	7.145579268292682E-5	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	0	6	2	3	0	2	24	-1	45	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPGSNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGACTGACAGGAGATACGCAGTATTTTGGCCCA	CASSRLTGDTQYF	In	VDJ	1	28	6.301934693951043E-5	7.410230352303523E-5	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	4	5	4	0	24	37	-1	41	47													Vb 18	CASSRLTGDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCGGGGAGGGTGAACACTGAAGCTTTCTTTGGACAA	CASSPPGRVNTEAFF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	9	0	0	4	0	24	38	-1	42	49													Vb 18	CASSPPGRVNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGAGAGACGGGACAGGGAGGAAGCCACAGATACGCAGTATTTTGGCCCA	CASSERRDREEATDTQYF	In	VDJ	1	30	6.752072886376118E-5	7.939532520325203E-5	54	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	3	2	7	7	24	36	52	43	59													Vb 18	CASSERRDREEATDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACGGGACAGGGCAACTATGGCTACACCTTCGGTTCG	CASSPTGQGNYGYTF	In	VDJ	1	33	7.427280175013729E-5	8.733485772357724E-5	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	3	2	2	1	24	39	50	41	51													Vb 18	CASSPTGQGNYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAATCAAAGAAACCGGGGAGCTGTTTTTTGGAGAA	CASSIKETGELFF	In	VDJ	1	35	7.877418367438804E-5	9.262787940379404E-5	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	5	2	8	5	6	1	24	36	44	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSIKETGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCCTTCCCGGAGCGGGAGGGGGAGATACGCAGTATTTTGGCCCA	CASLPGAGGGDTQYF	In	VDJ	1	40	9.00276384850149E-5	1.0586043360433605E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	6	0	5	8	2	24	33	51	41	53													Vb 18	CASLPGAGGGDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCGGCAGGCTCTCATCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSGRLSSGANVLTF	In	VDJ	1	42	9.452902040926564E-5	1.1115345528455284E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	4	4	1	3	6	24	35	42	38	48													Vb 18	CASSGRLSSGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGCCTCGGAGTGGGGCACTGAAGCTTTCTTTGGACAA	CASSPASEWGTEAFF	In	VDJ	1	43	9.677971137139102E-5	1.1379996612466124E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	2	6	2	4	10	0	24	39	-1	49	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPASEWGTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGTCTATAACAATGAGCAGTTCTTCGGGCCA	CASSPVYNNEQFF	In	VDJ	1	47	1.057824752198925E-4	1.2438600948509485E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	9	5	3	2	24	38	44	41	46						01,02							Vb 18	CASSPVYNNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCTACAGAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSPLQSTGELFF	In	VDJ	1	53	1.1928662099264474E-4	1.4026507452574526E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	3	5	4	3	2	24	38	45	41	47													Vb 18	CASSPLQSTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGGCCAGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSPGPGAYNEQFF	In	VDJ	1	54	1.2153731195477012E-4	1.4291158536585365E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	2	2	5	0	24	38	-1	43	49													Vb 18	CASSPGPGAYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGGGAGCTACGAGCAGTACTTCGGGCCG	CASSPPGSYEQYF	In	VDJ	1	61	1.372921486896477E-4	1.6143716124661248E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	9	2	3	1	0	24	41	-1	42	47													Vb 18	CASSPPGSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAAACAGATAAACATGAGCAGTTCTTCGGGCCA	CASSPQTDKHEQFF	In	VDJ	1	69	1.552976763866507E-4	1.8260924796747967E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	3	5	8	2	6	24	40	46	42	52													Vb 18	CASSPQTDKHEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCAGGAGGGGGCTTACAAGAGACCCAGTACTTCGGGCCA	CASSPPGGGLQETQYF	In	VDJ	1	70	1.5754836734877608E-4	1.8525575880758808E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	5	0	2	3	3	24	41	51	44	54													Vb 18	CASSPPGGGLQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGACCGGACTATAGCTACACCTTCGGTTCG	CASSRPDYSYTF	In	VDJ	1	74	1.6655113119727757E-4	1.958418021680217E-4	36	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	1	9	9	0	2	24	-1	47	41	49						01,02							Vb 18	CASSRPDYSYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD02-01	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCCGAACAGGGGAGACACCGGGGAGCTGTTTTTTGGAGAA	CASSPNRGDTGELFF	In	VDJ	1	86	1.9355942274278205E-4	2.2759993224932248E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	2	3	5	2	24	35	47	40	49													Vb 18	CASSPNRGDTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTAGCGCCGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPLAPSSYNEQFF	In	VDJ	1	87	1.958101137049074E-4	2.302464430894309E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	5	6	0	0	5	24	-1	45	40	50						01,02							Vb 18	CASSPLAPSSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATCACTCCAGGGTTCAAACATTCAGTACTTCGGCGCC	CASSPSLQGSNIQYF	In	VDJ	1	89	2.0031149562915816E-4	2.355394647696477E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	2	4	3	6	6	3	24	39	50	45	53													Vb 18	CASSPSLQGSNIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAAGGTGGGACAGGGACGCGGCAATCAGCCCCAGCATTTTGGTGAT	CASSPKVGQGRGNQPQHF	In	VDJ	1	92	2.0706356851553427E-4	2.434789972899729E-4	54	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	0	3	2	5	5	24	39	53	44	58													Vb 18	CASSPKVGQGRGNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATGGGGAGTAGAGCAGTACTTCGGGCCG	CASSPWGVEQYF	In	VDJ	1	95	2.1381564140191038E-4	2.514185298102981E-4	36	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	9	2	7	2	2	24	39	46	41	48													Vb 18	CASSPWGVEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCCGGGGGGCAGGGGCGAACAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	97	2.1831702332616114E-4		55	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	8	1	0	2	13	24	38	47	40	60													Vb 18	X+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGGAGGTGGGGGGCCCCAGCATTTTGGTGAT	CASSPPGGGGPQHF	In	VDJ	1	104	2.3407186006103875E-4	2.752371273712737E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	0	9	1	9	0	6	24	-1	47	41	53													Vb 18	CASSPPGGGGPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCTGACACGGTTGAATCTAACAACTATACTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	111	2.4982669679591635E-4		55	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	11	2	6	0	1	23	24	30	35	31	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATTTACGAGCGGAAATTACAATGAGCAGTTCTTCGGGCCA	CASSPFTSGNYNEQFF	In	VDJ	1	114	2.5657876968229244E-4	3.0170223577235774E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	6	5	4	6	4	24	39	50	45	54						01,02							Vb 18	CASSPFTSGNYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCCGGACTAGTGCTCACAGATACGCAGTATTTTGGCCCA	CASSPGLVLTDTQYF	In	VDJ	2	127	2.858377521899223E-4	3.361068766937669E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	1	8	2	4	4	24	35	46	39	50						01,02							Vb 18	CASSPGLVLTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01	TCRBJ02-03*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGACTTCGGGACTCGACTACGAGCAGTACTTCGGGCCG	CASSPTSGLDYEQYF	In	VDJ	2	131	2.948405160384238E-4	3.4669292005420053E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	0	10	3	6	3	24	38	50	44	53						01,02							Vb 18	CASSPTSGLDYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCGCAGGGGGCGTTCCAAAACATTCAGTACTTCGGCGCC	CASSPPQGAFQNIQYF	In	VDJ	2	145	3.26350189508179E-4	3.8374407181571813E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	4	0	5	4	5	24	38	50	42	55													Vb 18	CASSPPQGAFQNIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGTACCAAGAGACCCAGTACTTCGGGCCA	CASSPYQETQYF	In	VJ	2	149	3.353529533566805E-4	3.9433011517615174E-4	36	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	3	0	0	0	0	2	24	-1	38	-1	40													Vb 18	CASSPYQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTGGGACAGGGAGCGAAGGAGCAGTACTTCGGGCCG	CASSLGQGAKEQYF	In	VDJ	2	152	3.421050262430566E-4	4.02269647696477E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	3	7	1	7	24	37	47	38	54													Vb 18	CASSLGQGAKEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGGGTTCGGGCGGATGGTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPGFGRMVSYNEQFF	In	VDJ	2	159	3.578598629779342E-4	4.207952235772358E-4	54	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	3	8	0	0	7	7	24	38	49	45	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGFGRMVSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGAACTCCCGAGGCGAAAAACTGTTTTTTGGCAGT	CASSNSRGEKLFF	In	VDJ	2	159	3.578598629779342E-4	4.207952235772358E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	6	11	1	8	8	1	24	35	47	43	48													Vb 18	CASSNSRGEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTACAGGGTGTGAACACTGAAGCTTTCTTTGGACAA	CASSLQGVNTEAFF	In	VDJ	2	171	3.848681545234387E-4	4.525533536585366E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	3	0	1	2	24	37	44	38	46													Vb 18	CASSLQGVNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTCACGGGGGGAGGGCCTGAAGCTTTCTTTGGACAA	CASSPLTGGGPEAFF	In	VDJ	2	175	3.938709183719402E-4	4.631393970189702E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	8	1	6	3	5	24	40	50	43	55						01,02							Vb 18	CASSPLTGGGPEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTTTTTACAGCATCACTGAAGCTTTCTTTGGACAA	CASSPFYSITEAFF	In	VDJ	2	189	4.253805918416954E-4	5.001905487804878E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	5	4	5	3	24	38	47	43	50													Vb 18	CASSPFYSITEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCTCCTAAGTTCCGACGAGGACCTTCGGTTCG	CASSS*VPTRTF	Stop	VDJ	2	191	4.2988197376594615E-4		36	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	11	1	14	15	0	24	35	-1	50	54													Vb 18	CASSS*VPTRTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGAGCAGTTAAAGACCCAGTACTTCGGGCCA	CASSPEQLKTQYF	In	VDJ	3	202	4.546395743493252E-4	5.34595189701897E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	10	2	6	0	7	24	-1	42	38	49													Vb 18	CASSPEQLKTQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTCCCCTCGACAGGGTTAACCCGAATGAGCAGTTCTTCGGGCCA	CASSPLDRVNPNEQFF	In	VDJ	3	205	4.6139164723570136E-4	5.425347222222222E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	3	7	7	8	24	35	49	42	57													Vb 18	CASSPLDRVNPNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGCGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPPRGNTGELFF	In	VDJ	3	206	4.6364233819782674E-4	5.451812330623307E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	7	3	1	0	0	24	-1	-1	41	47													Vb 18	CASSPPRGNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCAGGGACAGGCAAACTACCTACGAGCAGTACTTCGGGCCG	CASSRDRQTTYEQYF	In	VDJ	3	218	4.906506297433312E-4	5.769393631436314E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	4	2	2	7	24	35	45	37	52													Vb 18	CASSRDRQTTYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCAGCCCCCCACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPQPPTNTGELFF	In	VDJ	3	219	4.929013207054566E-4	5.795858739837398E-4	48	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	3	4	5	0	1	7	24	38	42	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPQPPTNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCCAGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPPRGNTGELFF	In	VDJ	3	224	5.041547755160835E-4	5.928184281842818E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	4	2	1	0	0	24	-1	-1	41	47													Vb 18	CASSPPRGNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGTCTCGGGGGAAAAACTGTTTTTTGGCAGT	CASSPVSGEKLFF	In	VDJ	3	246	5.536699766828416E-4	6.510416666666666E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	8	3	8	5	0	24	38	-1	43	48													Vb 18	CASSPVSGEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-04*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACGGACAGGTTAGAGTCACCCCTCCACTTTGGGAAC	CASSPTDRLESPLHF	In	VDJ	3	254	5.716755043798446E-4	6.722137533875338E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	1	4	10	2	6	24	39	48	41	54													Vb 18	CASSPTDRLESPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-06*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCTCAAGGGGGAGGGAGAGCGAGCAGTACTTCGGGCCG	CASSPSRGRESEQYF	In	VDJ	4	308	6.932128163346147E-4	8.151253387533875E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	9	0	6	7	4	24	38	52	45	56													Vb 18	CASSPSRGRESEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACGGGGAGGGAGTTAAGACCCAGTACTTCGGGCCA		Out	VDJ	4	332	7.472293994256236E-4		44	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	9	0	6	3	5	24	39	49	42	54													Vb 18	X+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGGCCGGGACAGGGGCTGACTGAAGCTTTCTTTGGACAA	CASSRPGQGLTEAFF	In	VDJ	4	345	7.764883819332536E-4	9.130462398373984E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	2	5	4	3	24	37	51	41	54													Vb 18	CASSRPGQGLTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCCATACTAGCGGGAGGAGAGACCCAGTACTTCGGGCCA	CASSPPILAGGETQYF	In	VDJ	24	1857	0.004179533116666817	0.0049145706300813006	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	3	1	4	3	0	24	41	-1	44	56													Vb 18	CASSPPILAGGETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-05*01	8674B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				6260	5323	873	62	0	2543	2112	389	42	0	444308	377856	61996	4456	0	0.166223571	9.20855522	0.155399486	9.55438805				40253	0.133686066	0.0364636257	0.0310100205	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:55	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8503194656412247	MSKCC- Snyder- P01-01		5381.0	
